<!DOCTYPE HTML PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<HTML lang="pt-BR">
<HEAD>
<META http-equiv="Content-Type" content="text/html; charset=ISO-8859-1">
<link href="images/v2/fav_ico_lattes.ico" rel="Shortcut Icon">
<meta content="Sistema de Curr&iacute;culos Lattes 2.0 (CNPq)" http-equiv="generator">
<meta content="curr&iacute;culo,curriculo,curriculum,cv,vitae,lattes,produ&ccedil;&atilde;o,producao,cient&iacute;fica,cientifica,Brasil" http-equiv="keywords">
<TITLE>Curr&iacute;culo do Sistema de Curr&iacute;culos Lattes (Paulo Marcelo Gehm Hoff)</TITLE>
<link type="text/css" rel="stylesheet" href="css/import.css">
<link type="text/css" href="css/tablet-mobile.css" rel="stylesheet">
<link type="text/css" rel="stylesheet" href="css/jquery.megamenu.css">
<link type="text/css" rel="stylesheet" href="css/style_curiculo.css">
<link type="text/css" rel="stylesheet" href="css/v2/espelho.css">
<link type="text/css" rel="stylesheet" href="css/impressao.css">
<script type="text/javascript" src="js/v2/jquery.min.js"></script><script src="js/jquery.cookie.js" type="text/javascript"></script><script src="js/acessibilidade.js" type="text/javascript"></script><script type="text/javascript" src="js/v2/tooltip-position.js"></script><script type="text/javascript" src="js/v2/jquery.tipsy.js"></script><script type="text/javascript" src="js/v2/jquery.megamenu.js"></script><script type="text/javascript" src="js/v2/byOrder.js"></script><script type="text/javascript" src="js/v2/font-size.js"></script><script type="text/javascript" src="js/v2/cv_citacoes.js"></script><script type="text/javascript" src="js/v2/hint_ajax.js"></script><script type="text/javascript" src="js/v2/menuFlowScroll.js"></script><script type="text/javascript" src="js/v2/videoUtils.js"></script><script type="text/javascript">
			
			var menu = {
				iniciar: function(id) {
					jkmegamenu.definemenu("ancora-menu-" + id, "menu-" + id, "focus");
				}
			};
			
			function abreLinkHistoricoPublicacoes(codigo,nome){
            	var j = window.open("historicoAtualizacao.jsp?id="+codigo+"&nome="+nome+"&fromBusca=1", "historico","resizable=no,menubar=no,toolbar=no,status=yes,scrollbars=yes,width=550px,height=470px,left=0,top=0");
            	if(j){
            		j.focus();
            	} else {
            		alert('Por favor, desabilite o bloqueador de popups');
            	}
			}
			
			var autores = {
				exibir: function() {
					$(this).hide().parent().find(".autores-et-al").show();
				},
				ocultar: function() {
					$(this).parent().hide().parent().find(".autores-et-al-plus").show();
				}
			};
				
			$(document).ready(function(){
			
				$(".ajaxJCR").ajaxJCR();
				
				$(".ajaxCAPES").ajaxCAPES();
				
				$(".ajaxINPI").ajaxINPI();
				
				$("div.citacoes").verificarCitacoes();
				
				$(".tooltip").tipsy({gravity: 's'});
				
				$(".autores-et-al-plus").click(autores.exibir);
				
				$(".autores-et-al-minus").click(autores.ocultar);
        			
      		});			  
      		
      		                                
		
	</script><script type="text/javascript">
					
					  var _gaq = _gaq || [];
					  _gaq.push(['_setAccount', 'UA-35652740-1']);
					  _gaq.push(['_trackPageview']);
					
					  (function() {
					    var ga = document.createElement('script'); ga.type = 'text/javascript'; ga.async = true;
					    ga.src = ('https:' == document.location.protocol ? 'https://ssl' : 'http://www') + '.google-analytics.com/ga.js';
					    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(ga, s);
					  })();
					
					</script>
</HEAD>
<BODY>
<div class="page min-width">
<div class="header">
<div class="header-content max-width">
<div class="identity center">
<div class="combo">
<h1 class="escondido"> Curr&iacute;culo Lattes - Busca Textual - Visualiza&ccedil;&atilde;o do Curr&iacute;culo </h1>
<a href="http://lattes.cnpq.br/" title="Curr&iacute;culo Lattes" target="_blank"><img title="Curr&iacute;culo Lattes" alt="Curr&iacute;culo Lattes" src="images/titulo-sistema.png"></a>
</div>
<div class="menu-header">
<span class="tituloFlow"></span><span class="linksFlow"><a href="http://buscatextual.cnpq.br/buscatextual/visualizacv.do?id=K4261748J4&amp;idiomaExibicao=2" class="btn-br">English</a><a title="Imprimir curr&iacute;culo" class="bt-menu-header titBottom  icons-top icons-top-print" href="javascript:window.print()"></a><a title="Aumentar a fonte" class="bt-menu-header titBottom fontMais icons-top icons-top-fontMais" href="javascript:void(0)"></a><a title="Fonte padr&atilde;o" class="bt-menu-header titBottom fontMenos icons-top icons-top-fontMenos" href="javascript:void(0)"></a><a title="Alto contraste" class="bt-menu-header titBottom contraste icons-top icons-top-contraste-en" href="javascript:void(0)"></a><a href="download.do?metodo=apresentar&amp;idcnpq=1161396481073464" target="_blank" class="bt-menu-header titBottom fontMenos icons-top icons-top-xml" title="Baixar Currículo em XML" /><a title="Ajuda" class="bt-menu-header titBottom icons-top icons-top-help" target="_blank" href="http://ajuda.cnpq.br/index.php"></a></span>
</div>
<div class="logo">
<a target="_blank" href="http://cnpq.br/">
<h2>CNPq - Conselho Nacional de Desenvolvimento Cient&iacute;fico e Tecnol&oacute;gico</h2>
</a>
</div>
</div>
</div>
</div>
<div class="navigation-wrapper">
<div class="center navigation-wrapper-line">
<div class="menuPrincipal">
<div class="menuCtl menuAcesso">
<div class="menucent"><script type='text/javascript'>menu.iniciar("dados-gerais");</script>
		
		
		<a id="ancora-menu-dados-gerais" href="javascript:void(0)" class="acessibilidade"><span></span>Dados gerais</a>
		
	
		
		
		<div id="menu-dados-gerais" class="megamenu">
		
		<div class='column'><h3></h3><ul>
		
		
		<li><a href="#Identificacao">Identificação</a></li>
		
	
		
		
		<li><a href="#Endereco">Endereço</a></li>
		
	
		
		
		<li><a href="#Idiomas">Idiomas</a></li>
		
	
		
		
		<li><a href="#PremiosTitulos">Prêmios e títulos</a></li>
		
	
		
		
		<li><a href="#OutrasInformacoesRelevantes">Outras informações relevantes</a></li>
		
	</ul></div>
		
		
		<div class="clear"></div></div>
		
	<script type='text/javascript'>menu.iniciar("formacao");</script>
		
		
		<a id="ancora-menu-formacao" href="javascript:void(0)" class="acessibilidade separador"><span></span>Formação</a>
		
	
		
		
		<div id="menu-formacao" class="megamenu">
		
		<div class='column'><h3></h3><ul>
		
		
		<li><a href="#FormacaoAcademicaTitulacao">Formação acadêmica/titulação</a></li>
		
	</ul></div>
		
		
		<div class="clear"></div></div>
		
	<script type='text/javascript'>menu.iniciar("atuacao");</script>
		
		
		<a id="ancora-menu-atuacao" href="javascript:void(0)" class="acessibilidade separador"><span></span>Atuação</a>
		
	
		
		
		<div id="menu-atuacao" class="megamenu">
		
		<div class='column'><h3></h3><ul>
		
		
		<li><a href="#AtuacaoProfissional">Atuação profissional</a></li>
		
	
		
		
		<li><a href="#LinhaPesquisa">Linhas de pesquisa</a></li>
		
	
		
		
		<li><a href="#MembroCorpoEditorial">Membro de corpo editorial</a></li>
		
	
		
		
		<li><a href="#MembroComiteAssessoramento">Membro de comitê de assessoramento</a></li>
		
	
		
		
		<li><a href="#RevisorPeriodico">Revisor de periódico</a></li>
		
	
		
		
		<li><a href="#AreasAtuacao">Áreas de atuação</a></li>
		
	</ul></div>
		
		
		<div class="clear"></div></div>
		
	
		
		
		<a id="ancora-menu-projetos" href="#ProjetosPesquisa" class="acessibilidade separador"><span></span>Projetos</a>
		
	<script type='text/javascript'>menu.iniciar("projetos");</script>
		
		
		<div id="menu-projetos" class="megamenu">
		
		<div class='column'><h3></h3><ul>
		
		
		<li><a href="#ProjetosPesquisa">Projetos de pesquisa</a></li>
		
	
		
		
		<li><a href="#ProjetosDesenvolvimento">Projetos de desenvolvimento</a></li>
		
	</ul></div>
		
		
		<div class="clear"></div></div>
		
	<script type='text/javascript'>menu.iniciar("producoes");</script>
		
		
		<a id="ancora-menu-producoes" href="#ProducoesCientificas" class="acessibilidade separador"><span></span>Produções</a>
		
	
		
		
		<div id="menu-producoes" class="megamenu">
		
		<div class='column'><div class='subtitMenu'><a href='#ProducaoBibliografica'>Produção Bibliográfica</a></div><h3></h3><ul>
		
		
		<li><a href="#ArtigosCompletos">Artigos completos publicados em periódicos</a></li>
		
	
		
		
		<li><a href="#ArtigosAceitos">Artigos aceitos para publicação</a></li>
		
	
		
		
		<li><a href="#LivrosCapitulos">Livros e capítulos</a></li>
		
	
		
		
		<li><a href="#TextosJornaisRevistas">Textos em jornais ou revistas (magazine)</a></li>
		
	
		
		
		<li><a href="#TrabalhosPublicadosAnaisCongresso">Trabalhos publicados em anais de congressos</a></li>
		
	
		
		
		<li><a href="#ApresentacaoTrabalho">Apresentações de trabalho</a></li>
		
	
		
		
		<li><a href="#OutrasProducoesBibliograficas">Partitura musical</a></li>
		
	
		
		
		<li><a href="#OutrasProducoesBibliograficas">Tradução</a></li>
		
	
		
		
		<li><a href="#OutrasProducoesBibliograficas">Prefácio, pósfacio</a></li>
		
	
		
		
		<li><a href="#OutrasProducoesBibliograficas">Outras produções bibliográficas</a></li>
		
	</ul></div><div class='column'><div class='subtitMenu'><a href='#ProducaoTecnica'>Produção Técnica</a></div><h3></h3><ul>
		
		
		<li><a href="#AssessoriaConsultoria">Assessoria e consultoria</a></li>
		
	
		
		
		<li><a href="#SoftwareSemPatente">Programas de computador sem registro</a></li>
		
	
		
		
		<li><a href="#ProdutosTecnologicos">Produtos tecnológicos</a></li>
		
	
		
		
		<li><a href="#ProcessosTecnicas">Processos e técnicas</a></li>
		
	
		
		
		<li><a href="#TrabalhosTecnicos">Trabalhos técnicos</a></li>
		
	
		
		
		<li><a href="#DemaisProducaoTecnica">Cartas, mapas ou similares</a></li>
		
	
		
		
		<li><a href="#DemaisProducaoTecnica">Curso de curta duração ministrado</a></li>
		
	
		
		
		<li><a href="#DemaisProducaoTecnica">Desenvolvimento de material didático ou instrucional</a></li>
		
	
		
		
		<li><a href="#DemaisProducaoTecnica">Editoração</a></li>
		
	
		
		
		<li><a href="#ManutencaoObraArtistica">Manutenção de obra artística</a></li>
		
	
		
		
		<li><a href="#DemaisProducaoTecnica">Maquete</a></li>
		
	
		
		
		<li><a href="#EntrevistasMesasRedondas">Entrevistas, mesas redondas, programas e comentários na mídia</a></li>
		
	
		
		
		<li><a href="#DemaisProducaoTecnica">Relatório de pesquisa</a></li>
		
	
		
		
		<li><a href="#RedesSociais">Redes sociais, websites e blogs</a></li>
		
	
		
		
		<li><a href="#DemaisProducoesTecnicas">Outras produções técnicas</a></li>
		
	</ul></div><div class='column'><div class='subtitMenu'><a href='#ProducaoArtisticaCultural'>Produção Artística/Cultural</a></div><h3></h3><ul>
		
		
		<li><a href="#ArtesCenicas">Artes cênicas</a></li>
		
	
		
		
		<li><a href="#Musica">Música</a></li>
		
	
		
		
		<li><a href="#ArtesVisuais">Artes visuais</a></li>
		
	
		
		
		<li><a href="#OutrasProducoesArtisticas">Outras produções artísticas/culturais</a></li>
		
	</ul></div>
		
		
		<div class="clear"></div></div>
		
	<script type='text/javascript'>menu.iniciar("educacaoPopularizacaoCTA");</script>
		
		
		<a id="ancora-menu-educacaoPopularizacaoCTA" href="#EducacaoPopularizacaoCTA" class="acessibilidade separador"><span></span>Educação e Popularização de C & T</a>
		
	
		
		
		<div id="menu-educacaoPopularizacaoCTA" class="megamenu">
		
		<div class='column'><h3></h3><ul>
		
		
		<li><a href="#ArtigosEPCTA">Artigos</a></li>
		
	
		
		
		<li><a href="#LivrosCapitulosEPCTA">Livros e capítulos</a></li>
		
	
		
		
		<li><a href="#TextosJornaisEPCTA">Textos em jornais de notícias/revistas</a></li>
		
	
		
		
		<li><a href="#ApresentacoesTrabalhoEPCTA">Apresentações de trabalho</a></li>
		
	
		
		
		<li><a href="#ProgramaComputadorEPCTA">Programa de computador sem registro de patente</a></li>
		
	
		
		
		<li><a href="#CursosCurtaEPCTA">Cursos de curta duração ministrados</a></li>
		
	
		
		
		<li><a href="#MaterialDidaticoEPCTA">Desenvolvimento de material didático ou instrucional</a></li>
		
	
		
		
		<li><a href="#EntrevistasEPCTA">Entrevistas, mesas redondas, programas e comentários na mídia</a></li>
		
	
		
		
		<li><a href="#ProgramaComputadorRegistradoEPCTA">Programa de Computador registrado</a></li>
		
	
		
		
		<li><a href="#OrganizacaoEventosEPCTA">Organização de eventos, congressos, exposições e feiras</a></li>
		
	
		
		
		<li><a href="#RedesSociaisEPCTA">Redes sociais, websites e blogs</a></li>
		
	
		
		
		<li><a href="#ArtesVisuaisEPCTA">Artes Visuais</a></li>
		
	
		
		
		<li><a href="#ArtesCenicasEPCTA">Artes Cênicas</a></li>
		
	
		
		
		<li><a href="#MusicaEPCTA">Música</a></li>
		
	</ul></div>
		
		
		<div class="clear"></div></div>
		
	<script type='text/javascript'>menu.iniciar("eventos");</script>
		
		
		<a id="ancora-menu-eventos" href="#Eventos" class="acessibilidade separador"><span></span>Eventos</a>
		
	
		
		
		<div id="menu-eventos" class="megamenu">
		
		<div class='column'><h3></h3><ul>
		
		
		<li><a href="#ParticipacaoEventos">Participação em eventos, congressos, exposições e feiras</a></li>
		
	
		
		
		<li><a href="#OrganizacaoEventos">Organização de eventos, congressos, exposições e feiras</a></li>
		
	</ul></div>
		
		
		<div class="clear"></div></div>
		
	<script type='text/javascript'>menu.iniciar("orientacoes");</script>
		
		
		<a id="ancora-menu-orientacoes" href="#Orientacoes" class="acessibilidade separador"><span></span>Orientações</a>
		
	
		
		
		<div id="menu-orientacoes" class="megamenu">
		
		<div class='column'><h3></h3><ul>
		
		
		<li><a href="#Orientacoesconcluidas">Orientações e supervisões concluídas</a></li>
		
	
		
		
		<li><a href="#Orientacaoemandamento">Orientações e supervisões em andamento</a></li>
		
	</ul></div>
		
		
		<div class="clear"></div></div>
		
	<script type='text/javascript'>menu.iniciar("bancas");</script>
		
		
		<a id="ancora-menu-bancas" href="#Bancas" class="acessibilidade separador"><span></span>Bancas</a>
		
	
		
		
		<div id="menu-bancas" class="megamenu">
		
		<div class='column'><h3></h3><ul>
		
		
		<li><a href="#ParticipacaoBancasTrabalho">Participação em bancas de trabalhos de conclusão</a></li>
		
	
		
		
		<li><a href="#ParticipacaoBancasComissoes">Participação em bancas de comissões julgadoras</a></li>
		
	</ul></div>
		
		
		<div class="clear"></div></div>
		
	<script type='text/javascript'>menu.iniciar("citacoes");</script>
		
		
		<a id="ancora-menu-citacoes" href="#Citacoes" class="acessibilidade separador"><span></span>Citações</a>
		
	
		
		
		<div id="menu-citacoes" class="megamenu">
		
		<div class='column'><h3></h3><ul>
		
		
		<li><a href="#Citacoes">Citações no ISI</a></li>
		
	
		
		
		<li><a href="#Citacoes">Citações no SciELO</a></li>
		
	
		
		
		<li><a href="#Citacoes">Citações no SCOPUS</a></li>
		
	
		
		
		<li><a href="#Citacoes">Citações em outras bases bibliográficas</a></li>
		
	</ul></div>
		
		
		<div class="clear"></div></div>
		
	<script type='text/javascript'>menu.iniciar("informacoes-complementares");</script>
		
		
		<a id="ancora-menu-informacoes-complementares" href="javascript:void(0)" class="acessibilidade separador"><span></span>+</a>
		
	
		
		
		<div id="menu-informacoes-complementares" class="megamenu">
		
		<div class='column'><h3></h3><ul>
		
		
		<li><a href="visualizacv.do?metodo=apresentar&id=K4261748J4&tipo=completo&idiomaExibicao=1">Mostrar informações complementares</a></li>
		
	</ul></div>
		
		
		<div class="clear"></div></div>
		
	</div>
</div>
</div>
</div>
</div>
<div class="content-wrapper">
<div class="main-content max-width min-width center">
<div class="layout-cell layout-cell-12">
<div class="layout-cell-pad-main">
<img class="foto" src="http://servicosweb.cnpq.br/wspessoa/servletrecuperafoto?tipo=1&amp;id=K4261748J4"><div class="infpessoa">
<h2 class="nome">Paulo Marcelo Gehm Hoff</h2>
<ul class="informacoes-autor">
<li>
<span class="img_link icone-informacao-autor"></span>Endere&ccedil;o para acessar este CV: http://lattes.cnpq.br/1161396481073464</li>
<li>
<span class="img_cert icone-informacao-autor"></span>&Uacute;ltima atualiza&ccedil;&atilde;o do curr&iacute;culo em 04/09/2019</li>
</ul>
</div><br class="clear" /><div class="title-wrapper">
<h1 class="ui-hidden"></h1>
<hr class="separator">
<p class="resumo">Possui graduação em Medicina pela Universidade de Brasília (1991) e doutorado em em Ciências pela Universidade de São Paulo (2007). Professor Livre-Docente pela Universidade de São Paulo (2008). Atualmente é Presidente da Oncologia da Rede D'Or São Luiz; Conselheiro Científico do Grupo Técnico de Tumores Gastrointestinais; Coordenador do Comitê de Referência em Oncologia do Estado de São Paulo da Secretaria de Estado da Saúde; Membro Titular do Conselho de Depto de Radiologia e Oncologia da Faculdade de Medicina da USP; Membro do Conselho Deliberativo do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo; Vice-Presidente do Conselho Diretor do Icesp, do Hospital das Clínicas da Universidade de São Paulo; Diretor Geral do Icesp do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo; Presidente da Comissão de Farmacologia do Icesp; Presidente de Comitê Executivo do Icesp; Diretor do Núcleo de Pesquisa do Instituto do Câncer do Estado de São Paulo; Membro do Conselho Diretor - American Society of Clinical Oncology; FASCO 2018. Presidente da Comissão Científica da Agência Nacional de Vigilância Sanitária (2013-2018); Membro Titular da Cadeira 58 da Seção de Medicina da Academia Nacional de Medicina (2017). Tem experiência na área de Medicina, com ênfase em Oncologia, atuando principalmente nos seguintes temas: câncer, câncer colorretal, oncologia, colorectal cancer e chemotherapy.<span style="font-weight: bold" class="texto"> (Texto informado pelo autor)</span>
</p>
</div><br class="clear" /><div class="title-wrapper">
<a name="Identificacao">
<h1>Identifica&ccedil;&atilde;o</h1>
</a>
<hr class="separator">
<div class="layout-cell layout-cell-12 data-cell">
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>Nome</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Paulo Marcelo Gehm Hoff</div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>Nome em citações bibliográficas</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Hoff PM;Hoff PMG;Hoff P;Hoff, Paulo M.;Hoff, Paulo M. G.;HOFF, PAULO M.;HOFF, P. M.;HOFF, P M;HOFF, PAULO M;HOFF, Paulo Marcelo;HOFF, P.M.;HOFF, PAULO MARCELO GEHM;HOFF, PM;PAULO M. HOFF;Paulo M Hoff;Paulo Marcelo Gehm Hoff;HOFF, P;HOFF, P. M. G.;HOFF, PAULO;HOFF, PAULO MARCELO G;HOFF, PAULO M.;HOFF, PAULO MARCELO G.</div>
</div>
</div>
</div><br class="clear" /><div class="title-wrapper">
<a name="Endereco">
<h1>Endere&ccedil;o</h1>
</a>
<hr class="separator">
<div class="layout-cell layout-cell-12 data-cell">
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>Endereço Profissional</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Instituto do Câncer do Estado de São Paulo, Instituto do Câncer do Estado de São Paulo. <br class="clear" />Avenida Doutor Arnaldo, 251<br class="clear" />Pacaembu<br class="clear" />01246000 - São Paulo, SP - Brasil<br class="clear" />Telefone: (011) 38932735<br class="clear" />Fax: (011) 38932751</div>
</div>
</div><br class="clear" /></div><br class="clear" /><div class="title-wrapper">
<a name="FormacaoAcademicaTitulacao">
<h1>Forma&ccedil;&atilde;o acad&ecirc;mica/titula&ccedil;&atilde;o</h1>
</a>
<hr class="separator">
<div class="layout-cell layout-cell-12 data-cell">
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2006 - 2007</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Doutorado em Doutor em Ciências<span class="ajaxCAPES" data-param="&codigoCurso=&nivelCurso=D"></span>. <br class="clear" />Universidade de São Paulo, USP, Brasil.
		
	<br class="clear" />Título: Estudo de fase II avaliando eficácia e toxicidade de UFT (uracil e Tegafur) e leucovorin, administrados duas vezes ao dia, no tratamento de pacientes com câncer metastático de cólon e reto, Ano de obtenção: 2007. <br class="clear" />Orientador: <a class='icone-lattes' target='_blank' href='http://lattes.cnpq.br/3456781077547136'><img src='images/curriculo/logolattes.gif' /></a>Luiz Augusto Carneiro D'Albuquerque. <br class="clear" />Palavras-chave: UFT; Leucovorin; Câncer metastático; Pacientes; Tegafur; Uracil. <br class="clear" />Grande área: Ciências da Saúde<br class="clear" />Grande Área: Ciências da Saúde / Área: Medicina. <br class="clear" />Setores de atividade: Saúde Humana; Desenvolvimento de Produtos Tecnológicos Voltados Para A Saúde Humana. </div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>1992 - 1995</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Especialização - Residência médica<span class="ajaxCAPES" data-param="&codigoCurso=&nivelCurso="></span>. <br class="clear" />University of Miami, UMiami, Estados Unidos.
		
	Residência médica em: Medicina Interna<br class="clear" />Número do registro: . <br class="clear" />Grande área: Ciências da Saúde<br class="clear" />Grande Área: Ciências da Saúde / Área: Medicina / Subárea: Clínica Médica / Especialidade: Medicina Interna. </div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>1986 - 1991</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Graduação em Medicina<span class="ajaxCAPES" data-param="&codigoCurso=&nivelCurso="></span>. <br class="clear" />Universidade de Brasília, UnB, Brasil.
		
	</div>
</div>
</div><br class="clear" /></div><br class="clear" /><div class="title-wrapper">
<a name="FormacaoAcademicaPosDoutoradoLivreDocencia">
<h1>P&oacute;s-doutorado e Livre-doc&ecirc;ncia</h1>
</a>
<hr class="separator">
<div class="layout-cell layout-cell-12 data-cell">
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2008</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Livre-docência. <br class="clear" />Universidade de São Paulo, USP, Brasil.
		
	<br class="clear" />Título: Contribuição para o desenvolvimento de novos fármacos contra o câncer de cólon e reto, Ano de obtenção: 2008.<br class="clear" />Palavras-chave: Medicina; Cancerologia.<br class="clear" />Grande área: Ciências da Saúde<br class="clear" />Grande Área: Ciências da Saúde / Área: Medicina / Subárea: Oncologia Clinica. </div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>1995 - 1998</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Pós-Doutorado. <br class="clear" />The University of Texas Medical School at Houston, UT, Estados Unidos.
		
	<br class="clear" />Grande área: Ciências da Saúde<br class="clear" />Grande Área: Ciências da Saúde / Área: Medicina / Subárea: Clínica Médica / Especialidade: Cancerologia. <br class="clear" />Grande Área: Ciências da Saúde / Área: Medicina / Subárea: Clínica Médica / Especialidade: Hematologia. </div>
</div>
</div><br class="clear" /></div><br class="clear" /><div class="title-wrapper">
<a name="AtuacaoProfissional">
<h1>Atua&ccedil;&atilde;o Profissional</h1>
</a>
<hr class="separator">
<div class="layout-cell layout-cell-12 data-cell"><br class="clear" /><div class="inst_back">
<b>Grupo Técnico de Tumores Gastrointestinais, GTG, Brasil.
		
	</b>
</div>
<div class="layout-cell layout-cell-3 text-align-right subtit-1">
<div class="layout-cell-pad-5 text-align-right">
<b>Vínculo institucional</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5"><br class="clear" /></div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2013 - Atual</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Vínculo: Voluntário, Enquadramento Funcional: Conselheiro Científico</div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>Outras informações</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">GTG, assistir, promover, desenvolver e incentivar ações científicas, tecnológicas, culturais, educacionais e sociais, que visem, essencialmente, ao aperfeiçoamento do conhecimento dos tumores gastrointestinais e demais ciências médicas afins ou conexas.</div>
</div><br class="clear" /><br class="clear" /><div class="inst_back">
<b>Fundação de Amparo à Pesquisa do Estado de São Paulo, FAPESP, Brasil.
		
	</b>
</div>
<div class="layout-cell layout-cell-3 text-align-right subtit-1">
<div class="layout-cell-pad-5 text-align-right">
<b>Vínculo institucional</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5"><br class="clear" /></div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2013 - Atual</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Vínculo: , Enquadramento Funcional: </div>
</div><br class="clear" /><br class="clear" /><div class="inst_back">
<b>Secretaria de Estado da Saúde, SES, Brasil.
		
	</b>
</div>
<div class="layout-cell layout-cell-3 text-align-right subtit-1">
<div class="layout-cell-pad-5 text-align-right">
<b>Vínculo institucional</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5"><br class="clear" /></div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2012 - Atual</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Vínculo: Coordenador do Comitê Estadual, Enquadramento Funcional: Designado</div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>Outras informações</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">designado Coordenador do Comitê Estadual de Referência em Oncologia da SES.</div>
</div><br class="clear" /><br class="clear" /><div class="inst_back">
<b>Universidade de Brasília, UnB, Brasil.
		
	</b>
</div>
<div class="layout-cell layout-cell-3 text-align-right subtit-1">
<div class="layout-cell-pad-5 text-align-right">
<b>Vínculo institucional</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5"><br class="clear" /></div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>1990 - 1991</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Vínculo: Monitor, Enquadramento Funcional: Monitoria</div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>Outras informações</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Departamento de Neonatologia</div>
</div><br class="clear" /><div class="layout-cell layout-cell-3 text-align-right subtit-1">
<div class="layout-cell-pad-5 text-align-right">
<b>Vínculo institucional</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5"><br class="clear" /></div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>1988 - 1990</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Vínculo: Monitor, Enquadramento Funcional: Monitoria</div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>Outras informações</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Departamento de Gastroenterologia.</div>
</div><br class="clear" /><br class="clear" /><div class="inst_back">
<b>Agência Nacional de Vigilância Sanitária, ANVISA, Brasil.
		
	</b>
</div>
<div class="layout-cell layout-cell-3 text-align-right subtit-1">
<div class="layout-cell-pad-5 text-align-right">
<b>Vínculo institucional</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5"><br class="clear" /></div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2013 - 2018</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Vínculo: CCVISA, Membro Titular, Enquadramento Funcional: Assessoria</div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>Outras informações</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">A Comissão Científica em Vigilância Sanitária (CCVISA), instituída pelo Decreto nº 8.037/2013, dá apoio ao Conselho Consultivo da Anvisa, assessorando a Agência na avaliação e regulação de novas tecnologias de interesse da saúde e também nos temas e discussões técnico-científicas de vigilância sanitária. A atual composição da Comissão foi definida pela Portaria 1.495/16. Os membros da Comissão têm mandato de três anos, permitida uma única recondução pelo mesmo período. O grupo atua mediante demandas da diretoria colegiada da Anvisa e pode indicar consultores ad hoc ou instituições de ensino e pesquisa para a elaboração dos estudos e pareceres necessários para o seu trabalho. Membros da CCVISA: ? Mauro Martins Teixeira (titular) e Fernando Queiroz Cunha (suplente); ? Mayana Zatz (titular) e Maria Rita Passos-Bueno (suplente); ? Paulo Marcelo Ghem Hoff (titular). ? Gonzalo Vecina Neto (titular) e Marco Akerman (suplente); ? João Lauro Viana de Camargo (titular) e Maria Luiza Cotrim Sartor de Oliveira (suplente); ? Mario Borges Rosa (titular) e Edson Perini (suplente); ? Maurício Lima Barreto (titular) e Maria da Glória Lima Cruz Teixeira (suplente); ? Gustavo dos Santos Fernandes (suplente de Paulo Marcelo Ghem Hoff).</div>
</div><br class="clear" /><br class="clear" /><div class="inst_back">
<b>American Society of Clinical Oncology, ASCO, Brasil.
		
	</b>
</div>
<div class="layout-cell layout-cell-3 text-align-right subtit-1">
<div class="layout-cell-pad-5 text-align-right">
<b>Vínculo institucional</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5"><br class="clear" /></div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2013 - 2018</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Vínculo: Membro, Enquadramento Funcional: Membro do Conselho Diretor</div>
</div><br class="clear" /><br class="clear" /><div class="inst_back">
<b>Hospital Sírio-Libanês, SIRIO-LIBANÊS, Brasil.
		
	</b>
</div>
<div class="layout-cell layout-cell-3 text-align-right subtit-1">
<div class="layout-cell-pad-5 text-align-right">
<b>Vínculo institucional</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5"><br class="clear" /></div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2011 - 2017</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Vínculo: médico, Enquadramento Funcional: Membro efetivo da Comissão Médica</div>
</div><br class="clear" /><div class="layout-cell layout-cell-3 text-align-right subtit-1">
<div class="layout-cell-pad-5 text-align-right">
<b>Vínculo institucional</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5"><br class="clear" /></div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2006 - 2017</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Vínculo: Diretor Executivo, Enquadramento Funcional: Médico, Regime: Dedicação exclusiva. </div>
</div><br class="clear" /><div class="layout-cell layout-cell-3 text-align-right subtit-1">
<div class="layout-cell-pad-5 text-align-right">
<b>Atividades</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5"><br class="clear" /></div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>12/2006 - Atual</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Conselhos, Comissões e Consultoria, Instituto de Ensino e Pesquisa, . </div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b><br class="clear" /></b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Cargo ou função<br class="clear" />Membro do Conselho de Ensino e Pesquisa.
				
				</div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>02/2006 - Atual</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Direção e administração, Centro de Oncologia, . </div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b><br class="clear" /></b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Cargo ou função<br class="clear" />Médico Oncologista.</div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>02/2006 - Atual</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Direção e administração, Centro de Oncologia, . </div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b><br class="clear" /></b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Cargo ou função<br class="clear" />Cargo administrativo.</div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2006 - Atual</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Conselhos, Comissões e Consultoria, Padronização e Auditoria Transfusional, . </div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b><br class="clear" /></b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Cargo ou função<br class="clear" />Membro da Comissão de Padronização e Auditoria Transfusional.
				
				</div>
</div><br class="clear" /><div class="inst_back">
<b>Instituto do Câncer do Estado de São Paulo, ICESP, Brasil.
		
	</b>
</div>
<div class="layout-cell layout-cell-3 text-align-right subtit-1">
<div class="layout-cell-pad-5 text-align-right">
<b>Vínculo institucional</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5"><br class="clear" /></div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2015 - Atual</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Vínculo: Designação, Vice-Presidente, Enquadramento Funcional: Vice-Presidente do Conselho Diretor do ICESP</div>
</div><br class="clear" /><div class="layout-cell layout-cell-3 text-align-right subtit-1">
<div class="layout-cell-pad-5 text-align-right">
<b>Vínculo institucional</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5"><br class="clear" /></div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2011 - Atual</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Vínculo: Designação Diretor Geral, Enquadramento Funcional: Diretor Geral, designado.</div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>Outras informações</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Diretor Geral do ICESP, aprovado Condir ICESP em 17/01/2011. A missão de dirigir o Instituto altamente especializado e totalmente voltado ao tratamento do câncer. Ampliar o atendimento aos pacientes da rede pública, com a visão humanizada, com excelência e qualidade. Tornar o Instituto do Câncer do Estado de São Paulo Octávio Frias de Oliveira, um Centro de Referência Internacional na Área da Oncologia.</div>
</div><br class="clear" /><div class="layout-cell layout-cell-3 text-align-right subtit-1">
<div class="layout-cell-pad-5 text-align-right">
<b>Vínculo institucional</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5"><br class="clear" /></div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2008 - Atual</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Vínculo: Diretor, Enquadramento Funcional: Diretor do Núcleo (designação)</div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>Outras informações</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Diretor do Núcleo de Pesquisa Clínica do ICESP</div>
</div><br class="clear" /><br class="clear" /><div class="inst_back">
<b>Hospital das Clínicas da Universidade de São Paulo, HC-FMUSP, Brasil.
		
	</b>
</div>
<div class="layout-cell layout-cell-3 text-align-right subtit-1">
<div class="layout-cell-pad-5 text-align-right">
<b>Vínculo institucional</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5"><br class="clear" /></div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2016 - Atual</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Vínculo: Celetista, Enquadramento Funcional: Membro da Comissão de Arbitragem do HC-FMUSP</div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>Outras informações</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Sessão Conselho Deliberativo do HC-FMUSP de 06 de dezembro de 2016, designado Membro Titular da Comissão de Arbitragem que visa propor diretrizes acerca dos limites de atuação do Professor da respectiva Disciplina não responsável pela Divisão.</div>
</div><br class="clear" /><div class="layout-cell layout-cell-3 text-align-right subtit-1">
<div class="layout-cell-pad-5 text-align-right">
<b>Vínculo institucional</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5"><br class="clear" /></div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2012 - Atual</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Vínculo: , Enquadramento Funcional: Vice-Presidente do Conselho Diretor do ICESP</div>
</div><br class="clear" /><div class="layout-cell layout-cell-3 text-align-right subtit-1">
<div class="layout-cell-pad-5 text-align-right">
<b>Vínculo institucional</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5"><br class="clear" /></div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2011 - Atual</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Vínculo: Designação Diretor Geral, Enquadramento Funcional: Diretor Geral do ICESP</div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>Outras informações</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Diretor Geral ICESP, aprovado Condir ICESP em 17/01/2011. A missão de dirigir o Instituto altamente especializado e totalmente voltado ao tratamento do câncer. Ampliar o atendimento aos pacientes da rede pública, com a visão humanizada, com excelência e qualidade. Tornar o Instituto do Câncer do Estado de São Paulo Octávio Frias de Oliveira, um Centro de Referência Internacional na Área da Oncologia.</div>
</div><br class="clear" /><div class="layout-cell layout-cell-3 text-align-right subtit-1">
<div class="layout-cell-pad-5 text-align-right">
<b>Vínculo institucional</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5"><br class="clear" /></div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2010 - Atual</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Vínculo: Servidor Público, Enquadramento Funcional: Membro Suplente Conselho Deliberativo HCFMUSP</div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>Outras informações</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Portaria DOE - Atos do Governador de 12 de dezembro de 2014, Decreto nº 11-12-14, designado como Membro Suplente, em continuidade. Composição 04/12/18 Conselho Deliberativo Presidente Prof. Dr. Tarcisio Eloy Pessoa de Barros Filho Vice-Presidente Prof. Dr. Roger Chammas Membros Titulares Profa. Dra. Eloisa Silva Dutra de Oliveira Bonfá Prof. Dr. Giovanni Guido Cerri Prof. Dr. Luiz Augusto Carneiro D?Albuquerque Prof. Dr. Edmund Chada Baracat Prof. Dr. Carlos Roberto Ribeiro de Carvalho Prof. Dr. Wagner Farid Gattaz Prof. Dr. Fabio Biscegli Jatene Membros Suplentes Profa. Dra. Magda Maria Sales Carneiro Sampaio Prof. Dr. Venâncio Avancini Ferreira Alves Prof. Dr. Pedro Puech Leão Profa. Dra. Irene de Lourdes Noronha Prof. Dr. Paulo Marcelo Gëhm Hoff Prof. Dr. Eduardo Massad Prof. Dr. Gilberto Luis Camanho Regimento Interno do Conselho Deliberativo do HCFMUSP Comissão de Planejamento e Controle DOE de 24/1/19, Volume129 no. 17 - Ato do Governador de 23/1/19, designando Membros do Conselho Deliberativo do HC-FMUSP. Conselho Deliberativo Tel.: (0xx11) 2661-6388 / 3062-8517 / 2661-7743</div>
</div><br class="clear" /><div class="layout-cell layout-cell-3 text-align-right subtit-1">
<div class="layout-cell-pad-5 text-align-right">
<b>Vínculo institucional</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5"><br class="clear" /></div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2010 - Atual</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Vínculo: Servidor Público, Enquadramento Funcional: Membro Consel Integra Assist Sist FMUSP/HC</div>
</div><br class="clear" /><div class="layout-cell layout-cell-3 text-align-right subtit-1">
<div class="layout-cell-pad-5 text-align-right">
<b>Vínculo institucional</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5"><br class="clear" /></div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2009 - Atual</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Vínculo: Servidor Público, Enquadramento Funcional: Presidente da Comissão de Farmacologia ICESP.</div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>Outras informações</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">A Comissão de Farmácia tem por finalidade assessorar o Diretor Geral, na formulação de diretrizes para seleção, padronização, aquisição, distribuição e uso de fármacos, medicamentos, drogas, insumos farmacêuticos e correlatos no âmbito do Instituto</div>
</div><br class="clear" /><div class="layout-cell layout-cell-3 text-align-right subtit-1">
<div class="layout-cell-pad-5 text-align-right">
<b>Vínculo institucional</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5"><br class="clear" /></div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2008 - Atual</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Vínculo: , Enquadramento Funcional: Presidente de Comitê Executivo ICESP</div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>Outras informações</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Fórum de comunicação entre as Diretorias Médicas e Administrativas. Tem como objetivo discutir e expor questões propiciando melhor atendimento aos pacientes, salvaguardando a visão do Instituto.</div>
</div><br class="clear" /><div class="layout-cell layout-cell-3 text-align-right subtit-1">
<div class="layout-cell-pad-5 text-align-right">
<b>Vínculo institucional</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5"><br class="clear" /></div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2008 - 2011</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Vínculo: Servidor Público, Enquadramento Funcional: Diretor Clínico do ICESP</div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>Outras informações</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Designado.</div>
</div><br class="clear" /><div class="layout-cell layout-cell-3 text-align-right subtit-1">
<div class="layout-cell-pad-5 text-align-right">
<b>Atividades</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5"><br class="clear" /></div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>01/2008 - Atual</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Conselhos, Comissões e Consultoria, Instituto do Câncer de São Paulo - Otávio Frias de Oliveira, . </div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b><br class="clear" /></b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Cargo ou função<br class="clear" />Membro do grupo de trabalho da área clínica do Instituto do Câncer de São Paulo.
				
				</div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>01/2008 - Atual</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Conselhos, Comissões e Consultoria, Instituto do Câncer de São Paulo - Otávio Frias de Oliveira, . </div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b><br class="clear" /></b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Cargo ou função<br class="clear" />Membro do sub-brupo infraestrutura, estacionamento, informática, obras e outros do Instituto do Câncer de São Paulo.
				
				</div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>01/2008 - Atual</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Conselhos, Comissões e Consultoria, Instituto do Câncer de São Paulo - Otávio Frias de Oliveira, . </div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b><br class="clear" /></b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Cargo ou função<br class="clear" />Membro do sub-grupo estrutura de pesquisa do Instituto do Câncer de São Paulo.
				
				</div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>01/2008 - Atual</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Conselhos, Comissões e Consultoria, Instituto do Câncer de São Paulo - Otávio Frias de Oliveira, . </div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b><br class="clear" /></b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Cargo ou função<br class="clear" />Membro do sub-grupo fluxograma cirurgia, materiais do Instituto do Câncer de São Paulo.
				
				</div>
</div><br class="clear" /><div class="inst_back">
<b>Faculdade de Medicina da USP, FMUSP, Brasil.
		
	</b>
</div>
<div class="layout-cell layout-cell-3 text-align-right subtit-1">
<div class="layout-cell-pad-5 text-align-right">
<b>Vínculo institucional</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5"><br class="clear" /></div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2012 - Atual</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Vínculo: Servidor Público, Enquadramento Funcional: Membro do Comitê Técnico de Medicamentos</div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>Outras informações</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Composição do Comitê Técnico com o objetivo de promover a Política Estadual de Medicamentos Oncológicos, em consonância com a Política Nacional de Medicamentos, de acordo com Resolução SS-112, de 14.11.2012.</div>
</div><br class="clear" /><div class="layout-cell layout-cell-3 text-align-right subtit-1">
<div class="layout-cell-pad-5 text-align-right">
<b>Vínculo institucional</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5"><br class="clear" /></div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2011 - Atual</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Vínculo: Servidor Público, Enquadramento Funcional: Membro da Comissão - Residencia Medica</div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>Outras informações</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Portaria Diretoria da Faculdade de 13-4-2011 Comissão que fará revisão das atividades práticas, métodos de ensino e avaliação das competências, no prazo de 6 meses os Residentes em Clínica Médica de 1º e 2º anos.</div>
</div><br class="clear" /><div class="layout-cell layout-cell-3 text-align-right subtit-1">
<div class="layout-cell-pad-5 text-align-right">
<b>Vínculo institucional</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5"><br class="clear" /></div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2008 - Atual</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Vínculo: Servidor Público, Enquadramento Funcional: Membro Titular-Conselho Depto Radio e Onco</div>
</div><br class="clear" /><div class="layout-cell layout-cell-3 text-align-right subtit-1">
<div class="layout-cell-pad-5 text-align-right">
<b>Vínculo institucional</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5"><br class="clear" /></div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2013 - 2018</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Vínculo: Membro Titular, Enquadramento Funcional: Membro Titular da Comissão Especial HC 70 + 3</div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>Outras informações</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">.</div>
</div><br class="clear" /><div class="layout-cell layout-cell-3 text-align-right subtit-1">
<div class="layout-cell-pad-5 text-align-right">
<b>Vínculo institucional</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5"><br class="clear" /></div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2008 - 2017</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Vínculo: Servidor Público, Enquadramento Funcional: Membro da Congregação da FMUSP</div>
</div><br class="clear" /><div class="layout-cell layout-cell-3 text-align-right subtit-1">
<div class="layout-cell-pad-5 text-align-right">
<b>Atividades</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5"><br class="clear" /></div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>08/2018 - Atual</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Ensino, Programa de Pós-Graduação em Oncologia, Nível: Pós-Graduação</div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b><br class="clear" /></b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Disciplinas ministradas<br class="clear" />Disciplina MCM5899 - Fundamentos da Pesquisa Clínica<br class="clear" /></div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2008 - Atual</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Ensino, Disciplina Obrigatória UC17 - Oncologia, Nível: Graduação</div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b><br class="clear" /></b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Disciplinas ministradas<br class="clear" />Disciplina Obrigatória UC17 - Oncologia 67000012/MSP3171<br class="clear" /></div>
</div><br class="clear" /><div class="inst_back">
<b>Fundação Oncocentro de São Paulo, FOSP, Brasil.
		
	</b>
</div>
<div class="layout-cell layout-cell-3 text-align-right subtit-1">
<div class="layout-cell-pad-5 text-align-right">
<b>Vínculo institucional</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5"><br class="clear" /></div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2011 - 2016</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Vínculo: Membro Tit. Conselho Curador, Enquadramento Funcional: Membro Titular Conselho Curador Oncocentro SP</div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>Outras informações</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Nomeado Membro Titular como representante da Faculdade de Medicina da Universidade de São Paulo junto ao Conselho Curador da Fundação Oncocentro de São Paulo. Decreto do Governador em 12-4-16, cessando designação, a pedido.</div>
</div><br class="clear" /><br class="clear" /><div class="inst_back">
<b>Fundação Pró-Sangue Hemocentro de São Paulo, PRÓ-SANGUE, Brasil.
		
	</b>
</div>
<div class="layout-cell layout-cell-3 text-align-right subtit-1">
<div class="layout-cell-pad-5 text-align-right">
<b>Vínculo institucional</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5"><br class="clear" /></div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2010 - 2012</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Vínculo: Membro Titular, Enquadramento Funcional: Membro Grupo de Trabalho Pró-Sangue</div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>Outras informações</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Membro de Grupo de Trabalho para avaliar e estudar possíveis alterações legislativas e regulamentares da Fundação Pró-Sangue Hemocentro de São Paulo, representante da Casa Civil.</div>
</div><br class="clear" /><br class="clear" /><div class="inst_back">
<b>University of Texas, M. D. Anderson Cancer Center, UTMDACC, Estados Unidos.
		
	</b>
</div>
<div class="layout-cell layout-cell-3 text-align-right subtit-1">
<div class="layout-cell-pad-5 text-align-right">
<b>Vínculo institucional</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5"><br class="clear" /></div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2003 - 2006</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Vínculo: Associate Professor, Enquadramento Funcional: Deputy Chairman, Regime: Dedicação exclusiva. </div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>Outras informações</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Deputy Chairman of Gastrointestinal Medical Oncology</div>
</div><br class="clear" /><div class="layout-cell layout-cell-3 text-align-right subtit-1">
<div class="layout-cell-pad-5 text-align-right">
<b>Vínculo institucional</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5"><br class="clear" /></div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>1998 - 2001</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Vínculo: Servidor Público, Enquadramento Funcional: Professor Assistente, Regime: Dedicação exclusiva. </div>
</div><br class="clear" /><div class="layout-cell layout-cell-3 text-align-right subtit-1">
<div class="layout-cell-pad-5 text-align-right">
<b>Atividades</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5"><br class="clear" /></div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2005 - 2006</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Conselhos, Comissões e Consultoria, Institutional Review Board, . </div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b><br class="clear" /></b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Cargo ou função<br class="clear" />Membro, Institutional Review Board.
				
				</div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2005 - 2006</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Conselhos, Comissões e Consultoria, Chemotherapy, . </div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b><br class="clear" /></b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Cargo ou função<br class="clear" />Membro, Chemotherapy Policy Revision Committee.
				
				</div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2005 - 2006</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Conselhos, Comissões e Consultoria, Conflict of Interest Committee, . </div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b><br class="clear" /></b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Cargo ou função<br class="clear" />Membro, Conflict of Interest Committee.
				
				</div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2004 - 2006</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Conselhos, Comissões e Consultoria, Clinical Trial Finance Committee, . </div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b><br class="clear" /></b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Cargo ou função<br class="clear" />Membro, Clinical Trial Finance Committee.
				
				</div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2003 - 2006</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Direção e administração, Departamento de Oncologia Gastrintestinal, . </div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b><br class="clear" /></b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Cargo ou função<br class="clear" />Professor associado da medicina.</div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2003 - 2006</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Direção e administração, Departamento de Gatroenterologia, . </div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b><br class="clear" /></b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Cargo ou função<br class="clear" />Assessor presidente do departamento méidco de oncologia gastrointestinal.</div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2003 - 2005</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Conselhos, Comissões e Consultoria, Institutional Research Grants Program, . </div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b><br class="clear" /></b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Cargo ou função<br class="clear" />membro, Institutional Research Grants Program.
				
				</div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>07/1998 - 03/2001</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Ensino, Oncologia Médica, Nível: Especialização</div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b><br class="clear" /></b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Disciplinas ministradas<br class="clear" />Oncologia Médica<br class="clear" /></div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>07/1997 - 03/2001</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Pesquisa e desenvolvimento , Departamento de Oncologia Gastrintestinal, . </div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b><br class="clear" /></b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Linhas de pesquisa <br class="clear" /><a href='#LP_Tratamento de tumores gastrintestinais'>Tratamento de tumores gastrintestinais</a><br class="clear" /></div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2000 - 2001</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Conselhos, Comissões e Consultoria, Clinical Research Committe, . </div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b><br class="clear" /></b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Cargo ou função<br class="clear" />Membro, Clinical Research Committee.
				
				</div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2000 - 2001</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Conselhos, Comissões e Consultoria, Office of Protocol Research Quality Oversight Committee, . </div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b><br class="clear" /></b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Cargo ou função<br class="clear" />Membro, Office of Protocol Research Quality Oversight Committee.
				
				</div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>1998 - 2001</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Direção e administração, Departamento de Oncologia Gastrintestinal, . </div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b><br class="clear" /></b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Cargo ou função<br class="clear" />Professor Assistente.</div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>1998 - 2001</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Conselhos, Comissões e Consultoria, ATC Advisory Board, . </div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b><br class="clear" /></b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Cargo ou função<br class="clear" />Membro ATC Advisory Board Committee.
				
				</div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>1997 - 2001</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Conselhos, Comissões e Consultoria, Graduate Medical Education, . </div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b><br class="clear" /></b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Cargo ou função<br class="clear" />Membro Graduate Medical Education Committee.
				
				</div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>1997 - 2000</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Conselhos, Comissões e Consultoria, Institution Core Curriculum, . </div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b><br class="clear" /></b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Cargo ou função<br class="clear" />Membro Institution Core Curriculum Sub-committee.
				
				</div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>1997 - 1999</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Conselhos, Comissões e Consultoria, Fellowship Committee, . </div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b><br class="clear" /></b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Cargo ou função<br class="clear" />Fellowship Committee.
				
				</div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>1998 - 1998</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Conselhos, Comissões e Consultoria, Proton Pump Inhibitor Inhibitor Task Force, . </div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b><br class="clear" /></b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Cargo ou função<br class="clear" />Presidente, Proton Pump Inhibitor Task Force.
				
				</div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>1997 - 1998</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Direção e administração, Faculty Associate, . </div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b><br class="clear" /></b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Cargo ou função<br class="clear" />Junior Faculty Associate.</div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>1997 - 1998</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Direção e administração, Medical Oncology, . </div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b><br class="clear" /></b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Cargo ou função<br class="clear" />Chief-Fellow, Medical Oncology.</div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>1997 - 1998</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Conselhos, Comissões e Consultoria, CPR Advisory Group, . </div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b><br class="clear" /></b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Cargo ou função<br class="clear" />Membro CPR Advisory Group Committee.
				
				</div>
</div><br class="clear" /><div class="inst_back">
<b>Hospital Israelita Albert Einstein, Brasil.
		
	</b>
</div>
<div class="layout-cell layout-cell-3 text-align-right subtit-1">
<div class="layout-cell-pad-5 text-align-right">
<b>Vínculo institucional</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5"><br class="clear" /></div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2001 - 2003</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Vínculo: Médico, Enquadramento Funcional: Coordenador do NECC</div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>Outras informações</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Coordenador do Núcleo de Estudos Clínicos em Câncer</div>
</div><br class="clear" /><div class="layout-cell layout-cell-3 text-align-right subtit-1">
<div class="layout-cell-pad-5 text-align-right">
<b>Atividades</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5"><br class="clear" /></div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>03/2001 - 07/2003</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Direção e administração, Oncologia, . </div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b><br class="clear" /></b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Cargo ou função<br class="clear" />Coordenador do Centro de Estudos Clínicos em Câncer.</div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2002 - 2003</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Conselhos, Comissões e Consultoria, Comitê de Morte, Biópsia e Eventos Graves, . </div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b><br class="clear" /></b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Cargo ou função<br class="clear" />Membro, Comitê de Morte, Biópsia e Eventos Graves.
				
				</div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2002 - 2003</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Conselhos, Comissões e Consultoria, Farmácia, . </div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b><br class="clear" /></b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Cargo ou função<br class="clear" />Membro, Comitê de Farmácia e Terapêutica.
				
				</div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2002 - 2003</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Conselhos, Comissões e Consultoria, Comitê de Credenciais, . </div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b><br class="clear" /></b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Cargo ou função<br class="clear" />Membro, Comitê de Credenciais.
				
				</div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2001 - 2003</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Conselhos, Comissões e Consultoria, Oncologia, . </div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b><br class="clear" /></b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Cargo ou função<br class="clear" />Membro, Comitê Administrativo - Depto. de Oncologia Clínica.
				
				</div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2001 - 2003</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Conselhos, Comissões e Consultoria, Comitê de Ética em Pesquisa, . </div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b><br class="clear" /></b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Cargo ou função<br class="clear" />Membro, Comitê de Ética em Pesquisa.
				
				</div>
</div><br class="clear" /><div class="inst_back">
<b>Rede D'OR São Luiz, REDE D'OR, Brasil.
		
	</b>
</div>
<div class="layout-cell layout-cell-3 text-align-right subtit-1">
<div class="layout-cell-pad-5 text-align-right">
<b>Vínculo institucional</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5"><br class="clear" /></div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2017 - Atual</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Vínculo: Presidente da Oncologia, Enquadramento Funcional: designação.</div>
</div><br class="clear" /></div><br class="clear" /></div><br class="clear" /><div class="title-wrapper">
<a name="LinhaPesquisa">
<h1>Linhas de pesquisa</h1>
</a>
<hr class="separator">
<div class="layout-cell layout-cell-12 data-cell"><a name='LP_Tratamento de tumores gastrintestinais'></a><div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>1. </b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Tratamento de tumores gastrintestinais</div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b><br class="clear" /></b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Objetivo: tratar tumores gastrintestinais. </div>
</div>
</div><br class="clear" /></div><br class="clear" /><div class="title-wrapper">
<a name="ProjetosPesquisa">
<h1>Projetos de pesquisa</h1>
</a>
<hr class="separator">
<div class="layout-cell layout-cell-12 data-cell"><a name='PP_Toxicidade em pacientes portadores de doen&ccedil;a pulmonar intersticial com fibrose tratados com radio cirurgia estereot&aacute;xica extra-craniana para neoplasia de pulm&atilde;o: Relato de 4 casos e revis&atilde;o de literatura'></a><div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2014 - Atual</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Toxicidade em pacientes portadores de doença pulmonar intersticial com fibrose tratados com radio cirurgia estereotáxica extra-craniana para neoplasia de pulmão: Relato de 4 casos e revisão de literatura<br class="clear" /></div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b><br class="clear" /></b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Situação: Em andamento; Natureza: Pesquisa. <br class="clear" /><br class="clear" />Integrantes: Paulo Marcelo Gehm Hoff - Coordenador.<br class="clear" /></div>
</div><a name='PP_?	Avalia&ccedil;&atilde;o da implementa&ccedil;&atilde;o do fluxo gerenciado FGC20, modelo de gerenciamento do protocolo cl&iacute;nico institucional para o tratamento neoadjuvante de adenocarcinoma de reto'></a><div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2014 - Atual</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">?	Avaliação da implementação do fluxo gerenciado FGC20, modelo de gerenciamento do protocolo clínico institucional para o tratamento neoadjuvante de adenocarcinoma de reto<br class="clear" /></div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b><br class="clear" /></b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Situação: Em andamento; Natureza: Pesquisa. <br class="clear" /><br class="clear" />Integrantes: Paulo Marcelo Gehm Hoff - Coordenador.<br class="clear" /></div>
</div><a name='PP_?	Pacientes com Carcinoma Epiderm&oacute;ide de Canal Anal e o Impacto da Infec&ccedil;&atilde;o concomitante por HIV em progn&oacute;stico e Tratamento: Um estudo Retrospectivo'></a><div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2014 - Atual</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">?	Pacientes com Carcinoma Epidermóide de Canal Anal e o Impacto da Infecção concomitante por HIV em prognóstico e Tratamento: Um estudo Retrospectivo<br class="clear" /></div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b><br class="clear" /></b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Situação: Em andamento; Natureza: Pesquisa. <br class="clear" /><br class="clear" />Integrantes: Paulo Marcelo Gehm Hoff - Coordenador.<br class="clear" /></div>
</div><a name='PP_Redu&ccedil;&atilde;o de dose e/ou atraso do tratamento quimioter&aacute;pico em pacientes com contagem de neutr&oacute;filos abaixo de 1500/mm3'></a><div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2014 - Atual</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Redução de dose e/ou atraso do tratamento quimioterápico em pacientes com contagem de neutrófilos abaixo de 1500/mm3<br class="clear" /></div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b><br class="clear" /></b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Situação: Em andamento; Natureza: Pesquisa. <br class="clear" /><br class="clear" />Integrantes: Paulo Marcelo Gehm Hoff - Coordenador / Michel Fabiano Silva - Integrante.<br class="clear" /></div>
</div><a name='PP_Quimioterapia baseada em fluoruracila, irinotecana e oxaliplatina (FOLFIRINOX) como regime de primeira linha para c&acirc;ncer de p&acirc;ncreas localmente avan&ccedil;ado ou metast&aacute;tico: experi&ecirc;ncia do Instituto do C&acirc;ncer do Estado de S&atilde;o Paulo'></a><div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2014 - Atual</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Quimioterapia baseada em fluoruracila, irinotecana e oxaliplatina (FOLFIRINOX) como regime de primeira linha para câncer de pâncreas localmente avançado ou metastático: experiência do Instituto do Câncer do Estado de São Paulo<br class="clear" /></div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b><br class="clear" /></b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Situação: Em andamento; Natureza: Pesquisa. <br class="clear" /><br class="clear" />Integrantes: Paulo Marcelo Gehm Hoff - Coordenador.<br class="clear" /></div>
</div><a name='PP_?	Estudo de fase II piloto de metformina em pacientes com tumores neuroend&oacute;crinos bem diferenciados'></a><div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2014 - Atual</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">?	Estudo de fase II piloto de metformina em pacientes com tumores neuroendócrinos bem diferenciados<br class="clear" /></div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b><br class="clear" /></b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Situação: Em andamento; Natureza: Pesquisa. <br class="clear" /><br class="clear" />Integrantes: Paulo Marcelo Gehm Hoff - Coordenador.<br class="clear" /></div>
</div><a name='PP_Estudo Retrospectivo de Efic&aacute;cia e Toxicidade do Sorafenibe em C&acirc;ncer Medular de Tire&oacute;ide Avan&ccedil;ado'></a><div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2014 - Atual</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Estudo Retrospectivo de Eficácia e Toxicidade do Sorafenibe em Câncer Medular de Tireóide Avançado<br class="clear" /></div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b><br class="clear" /></b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Situação: Em andamento; Natureza: Pesquisa. <br class="clear" /><br class="clear" />Integrantes: Paulo Marcelo Gehm Hoff - Coordenador.<br class="clear" /></div>
</div><a name='PP_Avalia&ccedil;&atilde;o da implementa&ccedil;&atilde;o do fluxo gerenciado FGC20, modelo de gerenciamento do protocolo cl&iacute;nico institucional para o tratamento neoadjuvante de adenocarcinoma de reto'></a><div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2014 - Atual</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Avaliação da implementação do fluxo gerenciado FGC20, modelo de gerenciamento do protocolo clínico institucional para o tratamento neoadjuvante de adenocarcinoma de reto<br class="clear" /></div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b><br class="clear" /></b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Situação: Em andamento; Natureza: Pesquisa. <br class="clear" />Alunos envolvidos: Mestrado acadêmico: (1) . <br class="clear" /><br class="clear" />Integrantes: Paulo Marcelo Gehm Hoff - Coordenador / Silvia T Kobayashi - Integrante.<br class="clear" /></div>
</div><a name='PP_?	Redu&ccedil;&atilde;o de dose e/ou atraso do tratamento quimioter&aacute;pico em pacientes com contagem de neutr&oacute;filos abaixo de 1500/mm3'></a><div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2014 - Atual</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">?	Redução de dose e/ou atraso do tratamento quimioterápico em pacientes com contagem de neutrófilos abaixo de 1500/mm3<br class="clear" /></div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b><br class="clear" /></b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Situação: Em andamento; Natureza: Pesquisa. <br class="clear" /><br class="clear" />Integrantes: Paulo Marcelo Gehm Hoff - Coordenador.<br class="clear" /></div>
</div><a name='PP_Implica&ccedil;&atilde;o ps&iacute;quicas do carcinoma diferenciado de tireoide: ansiedade, depress&atilde;o e qualidade de vida'></a><div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2014 - Atual</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Implicação psíquicas do carcinoma diferenciado de tireoide: ansiedade, depressão e qualidade de vida<br class="clear" /></div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b><br class="clear" /></b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Situação: Em andamento; Natureza: Pesquisa. <br class="clear" /><br class="clear" />Integrantes: Paulo Marcelo Gehm Hoff - Coordenador / Isabella Drummond - Integrante.<br class="clear" /></div>
</div><a name='PP_Efeitos da Quimioterapia Adjuvante baseada em Fluoruracil (5-FU) com Oxaliplatina para C&acirc;ncer C&oacute;lon ressecado estadio III em S&atilde;o Paulo, Brasil: An&aacute;lise de efic&aacute;cia e seguran&ccedil;a'></a><div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2013 - Atual</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Efeitos da Quimioterapia Adjuvante baseada em Fluoruracil (5-FU) com Oxaliplatina para Câncer Cólon ressecado estadio III em São Paulo, Brasil: Análise de eficácia e segurança<br class="clear" /></div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b><br class="clear" /></b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Situação: Em andamento; Natureza: Pesquisa. <br class="clear" /><br class="clear" />Integrantes: Paulo Marcelo Gehm Hoff - Coordenador / Daniel F. Saragiotto - Integrante.<br class="clear" /></div>
</div><a name='PP_Estudo de Fase I de Mebendazol em Gliomas Recorrentes/Progressivos Graus OMS III e IV, ap&oacute;s falha de uma linha de tratamento.'></a><div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2013 - Atual</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Estudo de Fase I de Mebendazol em Gliomas Recorrentes/Progressivos Graus OMS III e IV, após falha de uma linha de tratamento.<br class="clear" /></div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b><br class="clear" /></b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Situação: Em andamento; Natureza: Pesquisa. <br class="clear" /><br class="clear" />Integrantes: Paulo Marcelo Gehm Hoff - Coordenador / Olavo Feher - Integrante.<br class="clear" /></div>
</div><a name='PP_Detec&ccedil;&atilde;o de mulheres com risco aumentado de ter uma muta&ccedil;&atilde;o relacionada ao c&acirc;ncer de ov&aacute;rio. Uma estrat&eacute;gia para selecionar pacientes com c&acirc;ncer de ov&aacute;rio relacionado a muta&ccedil;&otilde;es em S&atilde;o Paulo ? Desenvolvimento e implementa&ccedil;&atilde;o'></a><div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2013 - Atual</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Detecção de mulheres com risco aumentado de ter uma mutação relacionada ao câncer de ovário. Uma estratégia para selecionar pacientes com câncer de ovário relacionado a mutações em São Paulo ? Desenvolvimento e implementação<br class="clear" /></div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b><br class="clear" /></b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Situação: Em andamento; Natureza: Pesquisa. <br class="clear" /><br class="clear" />Integrantes: Paulo Marcelo Gehm Hoff - Coordenador / Maria Aparecida Koike Folgueira - Integrante / SIMONE MAISTRO - Integrante.<br class="clear" /></div>
</div><a name='PP_Educa&ccedil;&atilde;o do Paciente com C&acirc;ncer de Cabe&ccedil;a e Pesco&ccedil;o localmente avan&ccedil;ado e seus familiares para melhores desfechos em Quimiorradioterapia'></a><div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2013 - Atual</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Educação do Paciente com Câncer de Cabeça e Pescoço localmente avançado e seus familiares para melhores desfechos em Quimiorradioterapia<br class="clear" /></div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b><br class="clear" /></b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Situação: Em andamento; Natureza: Pesquisa. <br class="clear" /><br class="clear" />Integrantes: Paulo Marcelo Gehm Hoff - Coordenador / Milena Perez Mak - Integrante.<br class="clear" /></div>
</div><a name='PP_An&aacute;lise Retrospectiva dos Pacientes Portadores de Obstru&ccedil;&atilde;o Intestinal Maligna Internados no Instituto do C&acirc;ncer do Estado de S&atilde;o Paulo'></a><div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2013 - Atual</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Análise Retrospectiva dos Pacientes Portadores de Obstrução Intestinal Maligna Internados no Instituto do Câncer do Estado de São Paulo<br class="clear" /></div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b><br class="clear" /></b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Situação: Em andamento; Natureza: Pesquisa. <br class="clear" /><br class="clear" />Integrantes: Paulo Marcelo Gehm Hoff - Coordenador / Milena Perez Mak - Integrante.<br class="clear" /></div>
</div><a name='PP_Padr&otilde;es de Perfus&atilde;o e Difus&atilde;o na Resson&acirc;ncia Nuclear Magn&eacute;tica de Pacientes com Glioblastoma Multiforme podem Corresponder a Fatores Progn&oacute;sticos Isolados? Um Estudo Retrospectivo'></a><div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2013 - Atual</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Padrões de Perfusão e Difusão na Ressonância Nuclear Magnética de Pacientes com Glioblastoma Multiforme podem Corresponder a Fatores Prognósticos Isolados? Um Estudo Retrospectivo<br class="clear" /></div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b><br class="clear" /></b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Situação: Em andamento; Natureza: Pesquisa. <br class="clear" /><br class="clear" />Integrantes: Paulo Marcelo Gehm Hoff - Coordenador / Olavo Feher - Integrante.<br class="clear" /></div>
</div><a name='PP_Espiritualidade em Oncologia: Demanda, Caracter&iacute;sticas e sua Influ&ecirc;ncia na Qualidade de Vida dos Pacientes'></a><div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2013 - Atual</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Espiritualidade em Oncologia: Demanda, Características e sua Influência na Qualidade de Vida dos Pacientes<br class="clear" /></div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b><br class="clear" /></b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Descrição: Iniciação Científica.. <br class="clear" />Situação: Em andamento; Natureza: Pesquisa. <br class="clear" /><br class="clear" />Integrantes: Paulo Marcelo Gehm Hoff - Coordenador / Rachel P. Riechelmann - Integrante.<br class="clear" />Financiador(es): Fundação de Amparo à Pesquisa do Estado de São Paulo - Bolsa.</div>
</div><a name='PP_Estudo de Fase II, Prospectivo, Randomizado, N&atilde;o Comparativo, de Tratamento com Quimioterapia de Indu&ccedil;&atilde;o com Cisplatina e Gencitabina seguida de Quimioirradia&ccedil;&atilde;o ou Quimioirradia&ccedil;&atilde;o definitiva em Carcinoma Invasivos da C&eacute;rvice Uterina Localmente Avan&ccedil;ado'></a><div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2013 - Atual</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Estudo de Fase II, Prospectivo, Randomizado, Não Comparativo, de Tratamento com Quimioterapia de Indução com Cisplatina e Gencitabina seguida de Quimioirradiação ou Quimioirradiação definitiva em Carcinoma Invasivos da Cérvice Uterina Localmente Avançado<br class="clear" /></div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b><br class="clear" /></b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Situação: Em andamento; Natureza: Pesquisa. <br class="clear" /><br class="clear" />Integrantes: Paulo Marcelo Gehm Hoff - Coordenador / Heloisa Carvalho - Integrante.<br class="clear" /></div>
</div><a name='PP_Perfil de Express&atilde;o de Biomarcadores no Carcinoma de Canal Anal e Correla&ccedil;&atilde;o com Falha ao Tratamento com Quimio-Radioterapia'></a><div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2013 - Atual</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Perfil de Expressão de Biomarcadores no Carcinoma de Canal Anal e Correlação com Falha ao Tratamento com Quimio-Radioterapia<br class="clear" /></div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b><br class="clear" /></b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Situação: Em andamento; Natureza: Pesquisa. <br class="clear" /><br class="clear" />Integrantes: Paulo Marcelo Gehm Hoff - Coordenador / Renata Coudry - Integrante.<br class="clear" />Financiador(es): Fundação de Amparo à Pesquisa do Estado de São Paulo - Auxílio
										financeiro.</div>
</div><a name='PP_Efeitos Cognitivos da Quimioterapia Adjuvante em Pacientes com C&acirc;ncer de C&oacute;lon'></a><div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2013 - Atual</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Efeitos Cognitivos da Quimioterapia Adjuvante em Pacientes com Câncer de Cólon<br class="clear" /></div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b><br class="clear" /></b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Situação: Em andamento; Natureza: Pesquisa. <br class="clear" /><br class="clear" />Integrantes: Paulo Marcelo Gehm Hoff - Coordenador / Rachel P. Riechelmann - Integrante.<br class="clear" />Financiador(es): Fundação de Amparo à Pesquisa do Estado de São Paulo - Auxílio
										financeiro.</div>
</div><a name='PP_Quimioterapia de segunda linha baseada em paclitaxel em c&acirc;ncer urotelial localmente avan&ccedil;ado e metast&aacute;tico -analise retrospectiva'></a><div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2012 - 2013</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Quimioterapia de segunda linha baseada em paclitaxel em câncer urotelial localmente avançado e metastático -analise retrospectiva<br class="clear" /></div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b><br class="clear" /></b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Situação: Concluído; Natureza: Pesquisa. <br class="clear" /><br class="clear" />Integrantes: Paulo Marcelo Gehm Hoff - Coordenador / Milena Perez Mak - Integrante / Tatiana Strava Corrêa - Integrante.<br class="clear" /></div>
</div><a name='PP_Identifica&ccedil;&atilde;o de Muta&ccedil;&otilde;es Delet&eacute;rias Germinativas e Som&aacute;ticas no Gene E-caderina/ CDH1 de De Fatores Ambientais de Risco em Pacientes Jovens Portadores de C&acirc;ncer G&aacute;strico'></a><div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2012 - Atual</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Identificação de Mutações Deletérias Germinativas e Somáticas no Gene E-caderina/ CDH1 de De Fatores Ambientais de Risco em Pacientes Jovens Portadores de Câncer Gástrico<br class="clear" /></div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b><br class="clear" /></b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Situação: Em andamento; Natureza: Pesquisa. <br class="clear" /><br class="clear" />Integrantes: Paulo Marcelo Gehm Hoff - Coordenador / Maria Aparecida Koike Folgueira - Integrante / Rodrigo Santa Cruz Guindalin - Integrante.<br class="clear" /></div>
</div><a name='PP_Estudo fase II randomizado n&atilde;o-cego comparando IROX versus mFOLFOX6 no tratamento de pacientes com adenocarcinoma colorretal metast&aacute;tico com instabilidade de microssat&eacute;lites'></a><div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2012 - Atual</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Estudo fase II randomizado não-cego comparando IROX versus mFOLFOX6 no tratamento de pacientes com adenocarcinoma colorretal metastático com instabilidade de microssatélites<br class="clear" /></div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b><br class="clear" /></b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Situação: Em andamento; Natureza: Pesquisa. <br class="clear" /><br class="clear" />Integrantes: Paulo Marcelo Gehm Hoff - Coordenador / Rachel P. Riechelmann - Integrante / Giovani Barianni - Integrante.<br class="clear" /></div>
</div><a name='PP_Fatores Progn&oacute;sticos de Sobrevida limitada ap&oacute;s in&iacute;cio de quimioterapia paliativa em pacientes portadores de tumores s&oacute;lidos com performance status lim&iacute;trofe'></a><div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2012 - Atual</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Fatores Prognósticos de Sobrevida limitada após início de quimioterapia paliativa em pacientes portadores de tumores sólidos com performance status limítrofe<br class="clear" /></div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b><br class="clear" /></b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Situação: Em andamento; Natureza: Pesquisa. <br class="clear" /><br class="clear" />Integrantes: Paulo Marcelo Gehm Hoff - Coordenador / Castro Junior, Gilberto - Integrante / Milena Perez Mak - Integrante.<br class="clear" /></div>
</div><a name='PP_Avalia&ccedil;&atilde;o da Fun&ccedil;&atilde;o Hep&aacute;tica P&oacute;s- Quimioterapia atrav&eacute;s do Verde de Indocianina'></a><div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2012 - Atual</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Avaliação da Função Hepática Pós- Quimioterapia através do Verde de Indocianina<br class="clear" /></div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b><br class="clear" /></b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Situação: Em andamento; Natureza: Pesquisa. <br class="clear" /><br class="clear" />Integrantes: Paulo Marcelo Gehm Hoff - Coordenador / Wellington Andraus - Integrante / Carlos Andrés Rodrigues Oantanali - Integrante.<br class="clear" /></div>
</div><a name='PP_Desfechos cl&iacute;nicos em pacientes com c&acirc;ncer colorretal avan&ccedil;ado e baixo performance status submetidos a tratamento quimioter&aacute;pico.'></a><div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2012 - Atual</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Desfechos clínicos em pacientes com câncer colorretal avançado e baixo performance status submetidos a tratamento quimioterápico.<br class="clear" /></div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b><br class="clear" /></b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Situação: Em andamento; Natureza: Pesquisa. <br class="clear" /><br class="clear" />Integrantes: Paulo Marcelo Gehm Hoff - Coordenador / Rachel P. Riechelmann - Integrante / Marcela Crosara Alves Teixeira - Integrante.<br class="clear" /></div>
</div><a name='PP_An&aacute;lise retrospectiva dos pacientes com hipercalcemia maligna internados no ICESP'></a><div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2012 - Atual</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Análise retrospectiva dos pacientes com hipercalcemia maligna internados no ICESP<br class="clear" /></div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b><br class="clear" /></b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Situação: Em andamento; Natureza: Pesquisa. <br class="clear" /><br class="clear" />Integrantes: Paulo Marcelo Gehm Hoff - Coordenador / Milena Perez Mak - Integrante / Gustavo Pilotto - Integrante.<br class="clear" /></div>
</div><a name='PP_Perfil de Express&atilde;o de Biomarcadores em Pacientes com Carcinoma de Canal Anal e Correla&ccedil;&atilde;o com Falha ao Tratamento com Qu&iacute;mio-Radioterapia'></a><div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2011 - 2013</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Perfil de Expressão de Biomarcadores em Pacientes com Carcinoma de Canal Anal e Correlação com Falha ao Tratamento com Químio-Radioterapia<br class="clear" /></div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b><br class="clear" /></b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Situação: Concluído; Natureza: Pesquisa. <br class="clear" /><br class="clear" />Integrantes: Paulo Marcelo Gehm Hoff - Coordenador / Riechelmann, Rachel Simões Pimenta - Integrante / Oliveira, Suilane - Integrante / Caio Nahas - Integrante / Renata Coudry - Integrante / Camila M. V. Moniz - Integrante / Erlon Gil - Integrante / Jorge Sabbaga - Integrante.<br class="clear" /></div>
</div><a name='PP_Estudo observacional do tratamento Neoadjuvante com tr&ecirc;s drogas: CISPLATINA, PACLITAXEL E GENCITABINA em pacientes com carcinoma urotelial de bexiga m&uacute;sculo-invasivo . An&aacute;lise de Resposta patol&oacute;gica ap&oacute;s cistectomia radical como Principal Desfecho de An&aacute;l'></a><div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2011 - 2013</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Estudo observacional do tratamento Neoadjuvante com três drogas: CISPLATINA, PACLITAXEL E GENCITABINA em pacientes com carcinoma urotelial de bexiga músculo-invasivo . Análise de Resposta patológica após cistectomia radical como Principal Desfecho de Anál<br class="clear" /></div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b><br class="clear" /></b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Situação: Concluído; Natureza: Pesquisa. <br class="clear" /><br class="clear" />Integrantes: Paulo Marcelo Gehm Hoff - Integrante / Dzik C - Coordenador.<br class="clear" /></div>
</div><a name='PP_Ader&ecirc;ncia &agrave;s recomenda&ccedil;&otilde;es de uso de drogas antineopl&aacute;sicas orais por pacientes oncol&oacute;gicos'></a><div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2011 - 2012</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Aderência às recomendações de uso de drogas antineoplásicas orais por pacientes oncológicos<br class="clear" /></div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b><br class="clear" /></b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Situação: Concluído; Natureza: Pesquisa. <br class="clear" /><br class="clear" />Integrantes: Paulo Marcelo Gehm Hoff - Integrante / Riechelmann, Rachel Simões Pimenta - Coordenador / Guilherme Garcia - Integrante / Adriana Kumagai - Integrante.<br class="clear" /></div>
</div><a name='PP_Uso da Ciclofosfamida Oral em Pacientes com C&acirc;ncer de Pr&oacute;stata Metast&aacute;tico Castra&ccedil;&atilde;o-Resistente: an&aacute;lise retrospectiva'></a><div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2011 - 2012</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Uso da Ciclofosfamida Oral em Pacientes com Câncer de Próstata Metastático Castração-Resistente: análise retrospectiva<br class="clear" /></div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b><br class="clear" /></b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Situação: Concluído; Natureza: Pesquisa. <br class="clear" /><br class="clear" />Integrantes: Paulo Marcelo Gehm Hoff - Integrante / Dzik C - Coordenador / Romualdo Barroso de Sousa - Integrante.<br class="clear" /></div>
</div><a name='PP_Avalia&ccedil;&atilde;o retrospectiva dos pacientes com carcinoma medular renal tratados no Instituto do C&acirc;ncer do Estado de S&atilde;o Paulo: apresenta&ccedil;&atilde;o cl&iacute;nica, associa&ccedil;&atilde;o com anemia falciforme, tratamentos realizados, taxa de resposta ao tratamento e sobrevida'></a><div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2011 - 2012</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Avaliação retrospectiva dos pacientes com carcinoma medular renal tratados no Instituto do Câncer do Estado de São Paulo: apresentação clínica, associação com anemia falciforme, tratamentos realizados, taxa de resposta ao tratamento e sobrevida<br class="clear" /></div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b><br class="clear" /></b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Situação: Concluído; Natureza: Pesquisa. <br class="clear" /><br class="clear" />Integrantes: Paulo Marcelo Gehm Hoff - Coordenador / Ariel Kahn - Integrante / Marina Silvino - Integrante.<br class="clear" /></div>
</div><a name='PP_Desfechos cl&iacute;nicos e fatores prognosticos em pacientes com tumores s&oacute;lidos avan&ccedil;ados submetidos &agrave; drenagem transparietohep&aacute;tica de via biliar'></a><div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2011 - 2012</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Desfechos clínicos e fatores prognosticos em pacientes com tumores sólidos avançados submetidos à drenagem transparietohepática de via biliar<br class="clear" /></div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b><br class="clear" /></b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Situação: Concluído; Natureza: Pesquisa. <br class="clear" /><br class="clear" />Integrantes: Paulo Marcelo Gehm Hoff - Coordenador / Mak, Milena P. - Integrante / Marcela Crosara Alves Teixeira - Integrante.<br class="clear" /></div>
</div><a name='PP_Protocolo de Desenvolvimento - BioBanco USP -Rede Acad&ecirc;mica de Pesquisa sobre o C&acirc;ncer'></a><div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2011 - 2012</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Protocolo de Desenvolvimento - BioBanco USP -Rede Acadêmica de Pesquisa sobre o Câncer<br class="clear" /></div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b><br class="clear" /></b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Situação: Concluído; Natureza: Pesquisa. <br class="clear" /><br class="clear" />Integrantes: Paulo Marcelo Gehm Hoff - Integrante / Roger Chammas - Coordenador / Venâncio Avancini Ferreira Alves - Integrante.<br class="clear" /></div>
</div><a name='PP_Fatores Progn&oacute;sticos em Pacientes com C&acirc;ncer de Vias Biliares'></a><div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2011 - 2011</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Fatores Prognósticos em Pacientes com Câncer de Vias Biliares<br class="clear" /></div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b><br class="clear" /></b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Situação: Concluído; Natureza: Pesquisa. <br class="clear" /><br class="clear" />Integrantes: Paulo Marcelo Gehm Hoff - Coordenador / Rachel P. Riechelmann - Integrante / Camila M. V. Moniz - Integrante.<br class="clear" /></div>
</div><a name='PP_Ader&ecirc;ncia &agrave;s indica&ccedil;&otilde;es de colonoscopia para parentes em primeiro grau de pacientes..'></a><div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2011 - 2011</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Aderência às indicações de colonoscopia para parentes em primeiro grau de pacientes..<br class="clear" /></div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b><br class="clear" /></b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Situação: Concluído; Natureza: Pesquisa. <br class="clear" /><br class="clear" />Integrantes: Paulo Marcelo Gehm Hoff - Coordenador / Rachel P. Riechelmann - Integrante / Guilherme Garcia - Integrante.<br class="clear" /></div>
</div><a name='PP_S&iacute;ndrome EMPACT: Graves rea&ccedil;&otilde;es cut&acirc;neas associadas ao uso concomitante de Fenito&iacute;na e Radioterapia de Cr&acirc;nio em Pacientes com c&acirc;ncer de mama e met&aacute;stases cerebrais'></a><div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2011 - 2011</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Síndrome EMPACT: Graves reações cutâneas associadas ao uso concomitante de Fenitoína e Radioterapia de Crânio em Pacientes com câncer de mama e metástases cerebrais<br class="clear" /></div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b><br class="clear" /></b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Situação: Concluído; Natureza: Pesquisa. <br class="clear" /><br class="clear" />Integrantes: Paulo Marcelo Gehm Hoff - Coordenador / Max Sena Mano - Integrante / Deise Uema - Integrante.<br class="clear" /></div>
</div><a name='PP_Dividindo a experi&ecirc;ncia no tratametno de carcinoma medular renal: apresenta&ccedil;&atilde;o de s&eacute;rie de casos uni-institucional'></a><div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2011 - Atual</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Dividindo a experiência no tratametno de carcinoma medular renal: apresentação de série de casos uni-institucional<br class="clear" /></div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b><br class="clear" /></b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Situação: Em andamento; Natureza: Pesquisa. <br class="clear" /><br class="clear" />Integrantes: Paulo Marcelo Gehm Hoff - Coordenador / Deise Uema - Integrante / Ariel Kann - Integrante.<br class="clear" /></div>
</div><a name='PP_Estudo aleatorizado aberto de observa&ccedil;&atilde;o versus ressec&ccedil;&atilde;o cir&uacute;rgica em pacientes com c&acirc;ncer do reto que atingiram resposta cl&iacute;nica completa ap&oacute;s quimiorradioterapia neoadjuvante'></a><div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2011 - Atual</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Estudo aleatorizado aberto de observação versus ressecção cirúrgica em pacientes com câncer do reto que atingiram resposta clínica completa após quimiorradioterapia neoadjuvante<br class="clear" /></div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b><br class="clear" /></b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Situação: Em andamento; Natureza: Pesquisa. <br class="clear" /><br class="clear" />Integrantes: Paulo Marcelo Gehm Hoff - Coordenador / CAPARELI, FERNANDA - Integrante / Ivan Ceconello - Integrante / Ulysses Ribeiro - Integrante / Carlos Frederico Sparapan - Integrante / Guilherme Cotti - Integrante.<br class="clear" /></div>
</div><a name='PP_Estudo aleatorizado de fase III de tratamento adjuvante versus observa&ccedil;&atilde;o em pacientes com c&acirc;ncer de vias biliares'></a><div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2011 - Atual</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Estudo aleatorizado de fase III de tratamento adjuvante versus observação em pacientes com câncer de vias biliares<br class="clear" /></div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b><br class="clear" /></b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Situação: Em andamento; Natureza: Pesquisa. <br class="clear" /><br class="clear" />Integrantes: Paulo Marcelo Gehm Hoff - Integrante / Rachel P. Riechelmann - Coordenador / Giovanni Bariani - Integrante.<br class="clear" /></div>
</div><a name='PP_Estudo randomizado de fase III de quimioterapia adjuvante para pacientes com adenocarcinoma de reto que atingiram resposta sub&oacute;tima ap&oacute;s quimio-radioterapia neoadjuvante.'></a><div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2011 - Atual</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Estudo randomizado de fase III de quimioterapia adjuvante para pacientes com adenocarcinoma de reto que atingiram resposta subótima após quimio-radioterapia neoadjuvante.<br class="clear" /></div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b><br class="clear" /></b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Situação: Em andamento; Natureza: Pesquisa. <br class="clear" /><br class="clear" />Integrantes: Paulo Marcelo Gehm Hoff - Coordenador / Riechelmann, Rachel Simões Pimenta - Integrante / Sergio Nahas - Integrante / Caio Nahas - Integrante / Ivan Ceconello - Integrante.<br class="clear" /></div>
</div><a name='PP_A influ&ecirc;ncia da instabilidade microssat&eacute;lite e outros biomarcadores nos desfechos cl&iacute;nicos de pacientes com c&acirc;ncer colorretal avan&ccedil;ado: um estudo de caso controle'></a><div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2011 - Atual</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">A influência da instabilidade microssatélite e outros biomarcadores nos desfechos clínicos de pacientes com câncer colorretal avançado: um estudo de caso controle<br class="clear" /></div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b><br class="clear" /></b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Situação: Em andamento; Natureza: Pesquisa. <br class="clear" /><br class="clear" />Integrantes: Paulo Marcelo Gehm Hoff - Coordenador / Riechelmann, Rachel Simões Pimenta - Integrante / A. K. Alex - Integrante / Fernanda C. Capareli-Azevedo - Integrante / Renata Coudry - Integrante / Juliana F M Rego - Integrante.<br class="clear" /></div>
</div><a name='PP_Estudo de Fase II, Prospectivo, Randomizado, N&atilde;o Comparativo, de Tratamento com Quimioetrapia de Indu&ccedil;&atilde;o Baseada Cisplatina e Gencitabina seguida de Quimiorradia&ccedil;&atilde;o ou Quimiorradia&ccedil;&atilde;o Definitiva em Carcinomas Invasivos da C&eacute;rvice Uterina Localmente Avan&ccedil;a'></a><div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2011 - Atual</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Estudo de Fase II, Prospectivo, Randomizado, Não Comparativo, de Tratamento com Quimioetrapia de Indução Baseada Cisplatina e Gencitabina seguida de Quimiorradiação ou Quimiorradiação Definitiva em Carcinomas Invasivos da Cérvice Uterina Localmente Avança<br class="clear" /></div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b><br class="clear" /></b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Situação: Em andamento; Natureza: Pesquisa. <br class="clear" /><br class="clear" />Integrantes: Paulo Marcelo Gehm Hoff - Coordenador / Maria Del Estevez Diz - Integrante / Samantha Cabral - Integrante.<br class="clear" /></div>
</div><a name='PP_Estudo da Incid&ecirc;ncia, Fisiopatologia e Fatores Preditores da Cardiotoxidade em Pacientes portadores de neoplasias de mama ou c&oacute;lon em tratamento quimioter&aacute;pico'></a><div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2010 - 2012</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Estudo da Incidência, Fisiopatologia e Fatores Preditores da Cardiotoxidade em Pacientes portadores de neoplasias de mama ou cólon em tratamento quimioterápico<br class="clear" /></div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b><br class="clear" /></b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Situação: Concluído; Natureza: Pesquisa. <br class="clear" /><br class="clear" />Integrantes: Paulo Marcelo Gehm Hoff - Integrante / Roberto Kalil - Coordenador.<br class="clear" /></div>
</div><a name='PP_Estudo de fase II de substitui&ccedil;&atilde;o do 5-FU por capecitabina no esquema de Quimioradioterapia em pacientes com carcinoma de c&eacute;lulas escamosas do canal anal'></a><div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2010 - 2012</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Estudo de fase II de substituição do 5-FU por capecitabina no esquema de Quimioradioterapia em pacientes com carcinoma de células escamosas do canal anal<br class="clear" /></div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b><br class="clear" /></b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Situação: Concluído; Natureza: Pesquisa. <br class="clear" /><br class="clear" />Integrantes: Paulo Marcelo Gehm Hoff - Coordenador / Suilaine Coelho Ribeiro - Integrante.<br class="clear" /></div>
</div><a name='PP_Quimiotrapia Perioperat&oacute;ria com esquema EOX no tratamento do c&acirc;ncer g&aacute;strico e de jun&ccedil;&atilde;o Gasttroesof&aacute;gica.'></a><div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2010 - Atual</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Quimiotrapia Perioperatória com esquema EOX no tratamento do câncer gástrico e de junção Gasttroesofágica.<br class="clear" /></div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b><br class="clear" /></b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Situação: Em andamento; Natureza: Pesquisa. <br class="clear" /><br class="clear" />Integrantes: Paulo Marcelo Gehm Hoff - Coordenador / Luis Alberto Reis Mattos Júnior - Integrante.<br class="clear" /></div>
</div><a name='PP_Retrospective chart review to collect information to compare the toxicity and efficacy of bevacizumab-folfox in patients with metastatic colorectal cancer'></a><div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2005 - 2005</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Retrospective chart review to collect information to compare the toxicity and efficacy of bevacizumab-folfox in patients with metastatic colorectal cancer<br class="clear" /></div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b><br class="clear" /></b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Situação: Concluído; Natureza: Pesquisa. <br class="clear" /><br class="clear" />Integrantes: Paulo Marcelo Gehm Hoff - Coordenador.<br class="clear" /></div>
</div><a name='PP_A phase II study of oral DJ-927 administered as a single dose every three weeks to patients with advanced or metastatic adenocarcinoma of the colon or rectum'></a><div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2004 - 2004</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">A phase II study of oral DJ-927 administered as a single dose every three weeks to patients with advanced or metastatic adenocarcinoma of the colon or rectum<br class="clear" /></div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b><br class="clear" /></b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Situação: Concluído; Natureza: Pesquisa. <br class="clear" /><br class="clear" />Integrantes: Paulo Marcelo Gehm Hoff - Coordenador.<br class="clear" />Financiador(es): Daiichi Pharmaceuticals - Auxílio
										financeiro.</div>
</div><a name='PP_A randomized phase II study of bevacizumab in combination with cetuximab plus irinotecan, or in combination with cetuximab alone, in irinotecan refractory colorectal cancer (NCI #6444)'></a><div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2004 - 2004</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">A randomized phase II study of bevacizumab in combination with cetuximab plus irinotecan, or in combination with cetuximab alone, in irinotecan refractory colorectal cancer (NCI #6444)<br class="clear" /></div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b><br class="clear" /></b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Situação: Concluído; Natureza: Pesquisa. <br class="clear" /><br class="clear" />Integrantes: Paulo Marcelo Gehm Hoff - Coordenador.<br class="clear" /></div>
</div><a name='PP_A phase I/II study to evaluate the efficacy and toxicity of imatinib mesulate in combination with dacarbazine and capecitabine in medullary thyroid carcinoma'></a><div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2004 - 2004</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">A phase I/II study to evaluate the efficacy and toxicity of imatinib mesulate in combination with dacarbazine and capecitabine in medullary thyroid carcinoma<br class="clear" /></div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b><br class="clear" /></b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Situação: Concluído; Natureza: Pesquisa. <br class="clear" /><br class="clear" />Integrantes: Paulo Marcelo Gehm Hoff - Coordenador.<br class="clear" />Financiador(es): Novartis Pharmaceuticals - Auxílio
										financeiro.</div>
</div><a name='PP_Phase II trial of oxaliplatin in combination with bolus/infusional 5-FU/LV (Folfox4) in patients with advanced gastrointestinal (GI) cancers with varying degrees of renal impairment'></a><div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2004 - 2004</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Phase II trial of oxaliplatin in combination with bolus/infusional 5-FU/LV (Folfox4) in patients with advanced gastrointestinal (GI) cancers with varying degrees of renal impairment<br class="clear" /></div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b><br class="clear" /></b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Situação: Concluído; Natureza: Pesquisa. <br class="clear" /><br class="clear" />Integrantes: Paulo Marcelo Gehm Hoff - Coordenador.<br class="clear" />Financiador(es): SANOFI-Synthelabo - Auxílio
										financeiro.</div>
</div><a name='PP_Phase II study of irinotecan, leucovorin, 5-fluorouracil (Folfiri) plus bevacizumab as first-line treatment for metastatic colorectal cancer'></a><div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2004 - 2004</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Phase II study of irinotecan, leucovorin, 5-fluorouracil (Folfiri) plus bevacizumab as first-line treatment for metastatic colorectal cancer<br class="clear" /></div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b><br class="clear" /></b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Situação: Concluído; Natureza: Pesquisa. <br class="clear" /><br class="clear" />Integrantes: Paulo Marcelo Gehm Hoff - Coordenador.<br class="clear" />Financiador(es): Genentech - Auxílio
										financeiro.</div>
</div><a name='PP_A randomized, 3 arm multinational phase III study to investigate bevacizumab in combination with either intermittent capecitabine plus oxaliplatin or fluorouracil/leucovorin with oxaliplatin-vs-folfox-4 regimen alone as adjuvant chemo in colon carcinom'></a><div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2004 - 2004</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">A randomized, 3 arm multinational phase III study to investigate bevacizumab in combination with either intermittent capecitabine plus oxaliplatin or fluorouracil/leucovorin with oxaliplatin-vs-folfox-4 regimen alone as adjuvant chemo in colon carcinom<br class="clear" /></div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b><br class="clear" /></b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Situação: Concluído; Natureza: Pesquisa. <br class="clear" /><br class="clear" />Integrantes: Paulo Marcelo Gehm Hoff - Coordenador.<br class="clear" />Financiador(es): F Hoffman La Roche - Auxílio
										financeiro.</div>
</div><a name='PP_A phase II multicenter single arm clinical trial of ABX-EGF monotherapy in subjects with metastatic colorectal cancer following treatment with fluorpyrimidine, irinotecan and oxaliplatin chemotherapy'></a><div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2003 - 2003</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">A phase II multicenter single arm clinical trial of ABX-EGF monotherapy in subjects with metastatic colorectal cancer following treatment with fluorpyrimidine, irinotecan and oxaliplatin chemotherapy<br class="clear" /></div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b><br class="clear" /></b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Situação: Concluído; Natureza: Pesquisa. <br class="clear" /><br class="clear" />Integrantes: Paulo Marcelo Gehm Hoff - Coordenador.<br class="clear" />Financiador(es): Immunex Corporation - Auxílio
										financeiro.</div>
</div><a name='PP_A phase I study to determine the safety and pharmacokinetics of oral administration of TAS 102-9802 on a once daily schedule for five days a week with two days rest in patients with solid tumor'></a><div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2000 - 2000</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">A phase I study to determine the safety and pharmacokinetics of oral administration of TAS 102-9802 on a once daily schedule for five days a week with two days rest in patients with solid tumor<br class="clear" /></div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b><br class="clear" /></b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Situação: Concluído; Natureza: Pesquisa. <br class="clear" /><br class="clear" />Integrantes: Paulo Marcelo Gehm Hoff - Coordenador.<br class="clear" />Financiador(es): Taiho Pharmaceuticals - Auxílio
										financeiro.</div>
</div><a name='PP_Phase I study to determine the safety and pharmacokinetics of oral administration of TAS 102-9803 on a once daily schedule for five days every three weeks in patients with solid tumor'></a><div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2000 - 2000</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Phase I study to determine the safety and pharmacokinetics of oral administration of TAS 102-9803 on a once daily schedule for five days every three weeks in patients with solid tumor<br class="clear" /></div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b><br class="clear" /></b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Situação: Concluído; Natureza: Pesquisa. <br class="clear" /><br class="clear" />Integrantes: Paulo Marcelo Gehm Hoff - Coordenador.<br class="clear" />Financiador(es): Taiho Pharmaceuticals - Auxílio
										financeiro.</div>
</div><a name='PP_Phase I study to determine the safety and pharmacokinetics of intravenous administration of TAS 106-9902 on a once per week for 3 consecutive weeks every 28 day schedule in patients with solid tumor'></a><div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2000 - 2000</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Phase I study to determine the safety and pharmacokinetics of intravenous administration of TAS 106-9902 on a once per week for 3 consecutive weeks every 28 day schedule in patients with solid tumor<br class="clear" /></div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b><br class="clear" /></b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Situação: Concluído; Natureza: Pesquisa. <br class="clear" /><br class="clear" />Integrantes: Paulo Marcelo Gehm Hoff - Coordenador.<br class="clear" />Financiador(es): Taiho Pharmaceuticals - Auxílio
										financeiro.</div>
</div><a name='PP_Retrospective chart review to collect information on the subsequent therapies of patients with colorecal cancer who were treated with capecitabine on protocol: DM98-018'></a><div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2000 - 2000</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Retrospective chart review to collect information on the subsequent therapies of patients with colorecal cancer who were treated with capecitabine on protocol: DM98-018<br class="clear" /></div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b><br class="clear" /></b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Situação: Concluído; Natureza: Pesquisa. <br class="clear" /><br class="clear" />Integrantes: Paulo Marcelo Gehm Hoff - Coordenador.<br class="clear" /></div>
</div><a name='PP_A randomized open-label, multicenter phase III study of 5-FU/Leucovorin with or without concomitant SU5416 in patients with metastatic colorectal cancer'></a><div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2000 - 2000</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">A randomized open-label, multicenter phase III study of 5-FU/Leucovorin with or without concomitant SU5416 in patients with metastatic colorectal cancer<br class="clear" /></div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b><br class="clear" /></b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Situação: Concluído; Natureza: Pesquisa. <br class="clear" /><br class="clear" />Integrantes: Paulo Marcelo Gehm Hoff - Coordenador.<br class="clear" />Financiador(es): Sugen - Auxílio
										financeiro.</div>
</div><a name='PP_A compassionate use of study of oxaliplatin for previously treated colorectal cancer patients (LTS7072A)'></a><div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>1999 - 1999</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">A compassionate use of study of oxaliplatin for previously treated colorectal cancer patients (LTS7072A)<br class="clear" /></div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b><br class="clear" /></b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Situação: Concluído; Natureza: Pesquisa. <br class="clear" /><br class="clear" />Integrantes: Paulo Marcelo Gehm Hoff - Coordenador.<br class="clear" />Financiador(es): Sanofi Pharmaceuticals - Auxílio
										financeiro.</div>
</div><a name='PP_Phase I study to determine the safety &amp; pharmacokinetcis of oral administration of BMS-247616 on a twice daily schedule five days a week with two days rest in patients with solid tumors (CA157-001)'></a><div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>1999 - 1999</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Phase I study to determine the safety & pharmacokinetcis of oral administration of BMS-247616 on a twice daily schedule five days a week with two days rest in patients with solid tumors (CA157-001)<br class="clear" /></div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b><br class="clear" /></b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Situação: Concluído; Natureza: Pesquisa. <br class="clear" /><br class="clear" />Integrantes: Paulo Marcelo Gehm Hoff - Coordenador.<br class="clear" />Financiador(es): Bristol-Myers Squibb - Auxílio
										financeiro.</div>
</div><a name='PP_Phase I study to determine the safety and pharmacokinetics of oral administration of TAS102 on a once daily for 14 days in patientes with solid tumors'></a><div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>1999 - 1999</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Phase I study to determine the safety and pharmacokinetics of oral administration of TAS102 on a once daily for 14 days in patientes with solid tumors<br class="clear" /></div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b><br class="clear" /></b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Situação: Concluído; Natureza: Pesquisa. <br class="clear" /><br class="clear" />Integrantes: Paulo Marcelo Gehm Hoff - Coordenador.<br class="clear" />Financiador(es): Taiho Pharmaceuticals - Auxílio
										financeiro.</div>
</div><a name='PP_Joint USA/Japan study of oral uracil/ftorafur (UFT) plus leucovorin in patientes with metastatic colorectal carcinoma (T98-1274/10030010)'></a><div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>1999 - 1999</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Joint USA/Japan study of oral uracil/ftorafur (UFT) plus leucovorin in patientes with metastatic colorectal carcinoma (T98-1274/10030010)<br class="clear" /></div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b><br class="clear" /></b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Situação: Concluído; Natureza: Pesquisa. <br class="clear" /><br class="clear" />Integrantes: Paulo Marcelo Gehm Hoff - Coordenador.<br class="clear" />Financiador(es): Taiho Pharmaceuticals - Auxílio
										financeiro.</div>
</div><a name='PP_A phase Ii study of Orzel (UFT + leucovorin) given as a twice-daily regimen in the treatment of patients with metastatic colorectal cancer (UFT/MEN.04 Theradex # B99-1320)'></a><div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>1999 - 1999</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">A phase Ii study of Orzel (UFT + leucovorin) given as a twice-daily regimen in the treatment of patients with metastatic colorectal cancer (UFT/MEN.04 Theradex # B99-1320)<br class="clear" /></div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b><br class="clear" /></b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Situação: Concluído; Natureza: Pesquisa. <br class="clear" /><br class="clear" />Integrantes: Paulo Marcelo Gehm Hoff - Coordenador.<br class="clear" />Financiador(es): Bristol-Myers Squibb - Auxílio
										financeiro.</div>
</div><a name='PP_Phase I study to determine the safety and phamacokinetics of intravenous administration of TAS 106-9901 on a once every 21 days schedule in patients with solid tumors'></a><div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>1999 - 1999</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Phase I study to determine the safety and phamacokinetics of intravenous administration of TAS 106-9901 on a once every 21 days schedule in patients with solid tumors<br class="clear" /></div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b><br class="clear" /></b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Situação: Concluído; Natureza: Pesquisa. <br class="clear" /><br class="clear" />Integrantes: Paulo Marcelo Gehm Hoff - Coordenador.<br class="clear" />Financiador(es): Taiho Pharmaceuticals - Auxílio
										financeiro.</div>
</div><a name='PP_Multicenter phase II study of 5-FU or UFT in combination with leucovorin in patients with previously untreated metastatic colorectal carcinoma'></a><div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>1998 - 1998</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Multicenter phase II study of 5-FU or UFT in combination with leucovorin in patients with previously untreated metastatic colorectal carcinoma<br class="clear" /></div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b><br class="clear" /></b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Situação: Concluído; Natureza: Pesquisa. <br class="clear" /><br class="clear" />Integrantes: Paulo Marcelo Gehm Hoff - Coordenador.<br class="clear" />Financiador(es): Taiho Pharmaceuticals - Auxílio
										financeiro.</div>
</div><a name='PP_Phase II study of dolastatin (NSC#376128) administered intravenously every 21 days to patients with metastatic colorectal cancer'></a><div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>1998 - 1998</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Phase II study of dolastatin (NSC#376128) administered intravenously every 21 days to patients with metastatic colorectal cancer<br class="clear" /></div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b><br class="clear" /></b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Situação: Concluído; Natureza: Pesquisa. <br class="clear" /><br class="clear" />Integrantes: Paulo Marcelo Gehm Hoff - Coordenador.<br class="clear" />Financiador(es): NCI - Auxílio
										financeiro.</div>
</div><a name='PP_A randomized, open-label phase III study of a 28-day oral regimen of 5-fluorouracil plus 776C85 versus intravenous 5-Fluorouracil plus leucovorin as first-line therapy in patients with metastatic/advanced colorectal cancer (FUMA3008)'></a><div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>1998 - 1998</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">A randomized, open-label phase III study of a 28-day oral regimen of 5-fluorouracil plus 776C85 versus intravenous 5-Fluorouracil plus leucovorin as first-line therapy in patients with metastatic/advanced colorectal cancer (FUMA3008)<br class="clear" /></div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b><br class="clear" /></b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Situação: Concluído; Natureza: Pesquisa. <br class="clear" /><br class="clear" />Integrantes: Paulo Marcelo Gehm Hoff - Coordenador.<br class="clear" />Financiador(es): GlaxoWelcome - Auxílio
										financeiro.</div>
</div><a name='PP_Phase II study of MGI-114(NSC#683863) admininstered intravenously for five days every 28 days to patients with metastatic colorectal cancer'></a><div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>1998 - 1998</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Phase II study of MGI-114(NSC#683863) admininstered intravenously for five days every 28 days to patients with metastatic colorectal cancer<br class="clear" /></div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b><br class="clear" /></b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Situação: Concluído; Natureza: Pesquisa. <br class="clear" /><br class="clear" />Integrantes: Paulo Marcelo Gehm Hoff - Coordenador.<br class="clear" />Financiador(es): NCI - Auxílio
										financeiro.</div>
</div><a name='PP_A phase I study to determine the safety and pharmacokinetics of FK317 in patients with solid tumors(98-0-045)'></a><div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>1998 - 1998</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">A phase I study to determine the safety and pharmacokinetics of FK317 in patients with solid tumors(98-0-045)<br class="clear" /></div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b><br class="clear" /></b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Situação: Concluído; Natureza: Pesquisa. <br class="clear" /><br class="clear" />Integrantes: Paulo Marcelo Gehm Hoff - Coordenador.<br class="clear" />Financiador(es): Fujisawa - Auxílio
										financeiro.</div>
</div><a name='PP_An open-label study of capecitabine in patients with metastatic colorectal carcinoma demonstrating progression on r-Fluorouracil therapy'></a><div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>1998 - 1998</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">An open-label study of capecitabine in patients with metastatic colorectal carcinoma demonstrating progression on r-Fluorouracil therapy<br class="clear" /></div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b><br class="clear" /></b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Situação: Concluído; Natureza: Pesquisa. <br class="clear" /><br class="clear" />Integrantes: Paulo Marcelo Gehm Hoff - Coordenador.<br class="clear" />Financiador(es): Hoffman LaRoche - Auxílio
										financeiro.</div>
</div><a name='PP_Phase I trial of escalating doses of Y-Methylene-10-Deazaaminopteriin (MDAM) administered daily for five consecutive days in patients with advanced solid tumors'></a><div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>1998 - 1998</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Phase I trial of escalating doses of Y-Methylene-10-Deazaaminopteriin (MDAM) administered daily for five consecutive days in patients with advanced solid tumors<br class="clear" /></div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b><br class="clear" /></b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Situação: Concluído; Natureza: Pesquisa. <br class="clear" /><br class="clear" />Integrantes: Paulo Marcelo Gehm Hoff - Coordenador.<br class="clear" />Financiador(es): Bionumerik Pharmaceuticals - Auxílio
										financeiro.</div>
</div><a name='PP_Phase II study of intravenous DX-8951f administered daily for five days every three weeks to patients with advanced or metastatic adenocarcinoma of the colon or rectum (8951A-PRT007)'></a><div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>1998 - 1998</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Phase II study of intravenous DX-8951f administered daily for five days every three weeks to patients with advanced or metastatic adenocarcinoma of the colon or rectum (8951A-PRT007)<br class="clear" /></div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b><br class="clear" /></b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Situação: Concluído; Natureza: Pesquisa. <br class="clear" /><br class="clear" />Integrantes: Paulo Marcelo Gehm Hoff - Coordenador.<br class="clear" />Financiador(es): Daiichi Pharmaceuticals - Auxílio
										financeiro.</div>
</div><a name='PP_A multi-center study evaluating the addition of oxaliplatin to 5-fluorouracil-based chemotherapy in subjects with advanced refractory colorectal cancer'></a><div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>1997 - 1997</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">A multi-center study evaluating the addition of oxaliplatin to 5-fluorouracil-based chemotherapy in subjects with advanced refractory colorectal cancer<br class="clear" /></div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b><br class="clear" /></b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Situação: Concluído; Natureza: Pesquisa. <br class="clear" /><br class="clear" />Integrantes: Paulo Marcelo Gehm Hoff - Coordenador.<br class="clear" />Financiador(es): Sanofi Pharmaceuticals - Auxílio
										financeiro.</div>
</div><a name='PP_Phase I study to determine the safety and pharmacokinetics of oral administration of S-1 on a twice daily schedule for 28 days in patients with solid tumors'></a><div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>1997 - 1997</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Phase I study to determine the safety and pharmacokinetics of oral administration of S-1 on a twice daily schedule for 28 days in patients with solid tumors<br class="clear" /></div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b><br class="clear" /></b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Situação: Concluído; Natureza: Pesquisa. <br class="clear" /><br class="clear" />Integrantes: Paulo Marcelo Gehm Hoff - Coordenador.<br class="clear" />Financiador(es): Taiho Pharmaceuticals - Auxílio
										financeiro.</div>
</div><a name='PP_A Clinical trial comparing oral Uracil/Ftorafur (UFT) + Leucovorin (LV) with 5-Fluorouracil(5-FU) + LV in the treatment of patients with stages II &amp; III carcinoma of the colon'></a><div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>1997 - 1997</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">A Clinical trial comparing oral Uracil/Ftorafur (UFT) + Leucovorin (LV) with 5-Fluorouracil(5-FU) + LV in the treatment of patients with stages II & III carcinoma of the colon<br class="clear" /></div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b><br class="clear" /></b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Situação: Concluído; Natureza: Pesquisa. <br class="clear" /><br class="clear" />Integrantes: Paulo Marcelo Gehm Hoff - Coordenador.<br class="clear" />Financiador(es): NSABP - Outra.</div>
</div><a name='PP_A phase I dose escalation study of intravenous DX-8951F administered by a 24-hour continuos infusion every three weeks to patients with advanced solid tumors (8951A-PRT003)'></a><div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>1997 - 1997</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">A phase I dose escalation study of intravenous DX-8951F administered by a 24-hour continuos infusion every three weeks to patients with advanced solid tumors (8951A-PRT003)<br class="clear" /></div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b><br class="clear" /></b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Situação: Concluído; Natureza: Pesquisa. <br class="clear" /><br class="clear" />Integrantes: Paulo Marcelo Gehm Hoff - Coordenador.<br class="clear" />Financiador(es): Daiichi Pharmaceuticals - Auxílio
										financeiro.</div>
</div><a name='PP_A phase I open label assessment of the pharmacokinetics, metabolism, and safety of BOF-42 in patients with non-resectable solid tumors'></a><div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>1997 - 1997</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">A phase I open label assessment of the pharmacokinetics, metabolism, and safety of BOF-42 in patients with non-resectable solid tumors<br class="clear" /></div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b><br class="clear" /></b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Situação: Concluído; Natureza: Pesquisa. <br class="clear" /><br class="clear" />Integrantes: Paulo Marcelo Gehm Hoff - Coordenador.<br class="clear" />Financiador(es): Otsuka - Auxílio
										financeiro.</div>
</div><a name='PP_A phase I open label assessment of the pharmacokinetics, metabolism, and safety of BOF-A2 administered with calcium leucovorin in patients with advanced colorectal cancer'></a><div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>1997 - 1997</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">A phase I open label assessment of the pharmacokinetics, metabolism, and safety of BOF-A2 administered with calcium leucovorin in patients with advanced colorectal cancer<br class="clear" /></div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b><br class="clear" /></b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Situação: Concluído; Natureza: Pesquisa. <br class="clear" /><br class="clear" />Integrantes: Paulo Marcelo Gehm Hoff - Coordenador.<br class="clear" />Financiador(es): Otsuka - Auxílio
										financeiro.</div>
</div><a name='PP_Phase I trial of preoperative combined oral UFT plus leucovorin and radiation therapy for rectal cancer'></a><div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>1996 - 1996</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Phase I trial of preoperative combined oral UFT plus leucovorin and radiation therapy for rectal cancer<br class="clear" /></div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b><br class="clear" /></b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Situação: Concluído; Natureza: Pesquisa. <br class="clear" /><br class="clear" />Integrantes: Paulo Marcelo Gehm Hoff - Coordenador.<br class="clear" />Financiador(es): Bristol-Myers Squibb - Auxílio
										financeiro.</div>
</div><a name='PP_A prospective, rand, multicent, phase III clincal trial compare effects of panores (17-1A monoclonal antibody) injection + 5-Fu based chemotherapy vs. 5-FU based chemotherapy in patients with surgically resected'></a><div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>1995 - 1995</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">A prospective, rand, multicent, phase III clincal trial compare effects of panores (17-1A monoclonal antibody) injection + 5-Fu based chemotherapy vs. 5-FU based chemotherapy in patients with surgically resected<br class="clear" /></div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b><br class="clear" /></b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Situação: Concluído; Natureza: Pesquisa. <br class="clear" /><br class="clear" />Integrantes: Paulo Marcelo Gehm Hoff - Coordenador.<br class="clear" />Financiador(es): Burroughs Eletrônica Ltda - Auxílio
										financeiro.</div>
</div>
</div><br class="clear" /></div><br class="clear" /><div class="title-wrapper">
<a name="ProjetosDesenvolvimento">
<h1>Projetos de desenvolvimento</h1>
</a>
<hr class="separator">
<div class="layout-cell layout-cell-12 data-cell"><a name='PP_Estudo de Fase II Multic&ecirc;ntrico de Tratamento com Hu3S193 em Mulheres com C&acirc;ncer de Mama Avan&ccedil;ado com Progress&atilde;o Ap&oacute;s Tratamento Hormonal - HumanaH'></a><div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2014 - Atual</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Estudo de Fase II Multicêntrico de Tratamento com Hu3S193 em Mulheres com Câncer de Mama Avançado com Progressão Após Tratamento Hormonal - HumanaH<br class="clear" /></div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b><br class="clear" /></b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Descrição: Edital MCT/CNPQ/CT-Saude/MS/SCTIE/DECIT 52/2009.
firmatura: 07-11-2014 vigente até 06-11-2017
publicado DOU 12-11-2014. <br class="clear" />Situação: Em andamento; Natureza: Desenvolvimento. <br class="clear" /><br class="clear" />Integrantes: Paulo Marcelo Gehm Hoff - Coordenador / Max Sena Mano - Integrante / Bernardo Garicochea - Integrante / Ruffo de Freitas Junior - Integrante / Susane Crocamo V. da Costa - Integrante / Manoel Odorico de Moraes Filho - Integrante / Luciana Spillari Viola - Integrante / Sérgio Vicente Serrano - Integrante.<br class="clear" /></div>
</div>
</div><br class="clear" /></div><br class="clear" /><div class="title-wrapper">
<a name="MembroCorpoEditorial">
<h1>Membro de corpo editorial</h1>
</a>
<hr class="separator">
<div class="layout-cell layout-cell-12 data-cell">
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2010 - Atual</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Periódico: Clinics</div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2010 - Atual</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Periódico: Journal of Clinical Oncology</div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2010 - Atual</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Periódico: Onco& - Oncologia para todas as especialidades</div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2008 - Atual</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Periódico: Case reports in oncology</div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2005 - 2005</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Periódico: Current Colorectal Cancer Reports</div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2005 - 2005</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Periódico: Applied Cancer Research</div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2005 - 2005</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Periódico: Cancer and Chemotherapy Reviews</div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2005 - 2005</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Periódico: Oncology (Basel)</div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2004 - Atual</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Periódico: Hematology/Oncology Clinics of North America</div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2003 - Atual</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Periódico: Hospital Albert Einstein</div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2002 - 2004</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Periódico: Jornal de Oncologia Clínica</div>
</div>
</div><br class="clear" /></div><br class="clear" /><div class="title-wrapper">
<a name="MembroComiteAssessoramento">
<h1>Membro de comit&ecirc; de assessoramento</h1>
</a>
<hr class="separator">
<div class="layout-cell layout-cell-12 data-cell">
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2015 - Atual</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Agência de fomento: ASCO</div>
</div>
</div><br class="clear" /></div><br class="clear" /><div class="title-wrapper">
<a name="RevisorPeriodico">
<h1>Revisor de peri&oacute;dico</h1>
</a>
<hr class="separator">
<div class="layout-cell layout-cell-12 data-cell">
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2010 - 2012</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Periódico: JOURNAL OF CLINICAL ONCOLOGY</div>
</div>
</div><br class="clear" /></div><br class="clear" /><div class="title-wrapper">
<a name="AreasAtuacao">
<h1>&Aacute;reas de atua&ccedil;&atilde;o</h1>
</a>
<hr class="separator">
<div class="layout-cell layout-cell-12 data-cell">
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>1. </b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Grande área: Ciências da Saúde / Área: Medicina / Subárea: Oncologia. <br class="clear" /></div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2. </b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Grande área: Ciências da Saúde / Área: Medicina. <br class="clear" /></div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>3. </b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Grande área: Ciências da Saúde / Área: Medicina / Subárea: Clínica Médica/Especialidade: Cancerologia. <br class="clear" /></div>
</div>
</div><br class="clear" /></div><br class="clear" /><div class="title-wrapper">
<a name="Idiomas">
<h1>Idiomas</h1>
</a>
<hr class="separator">
<div class="layout-cell layout-cell-12 data-cell">
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>Português</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Compreende Bem, Fala Bem, Lê Bem, Escreve Bem. </div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>Inglês</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Compreende Bem, Fala Bem, Lê Bem, Escreve Bem. </div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>Espanhol</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Compreende Bem, Fala Bem, Lê Bem, Escreve Razoavelmente. </div>
</div>
</div><br class="clear" /></div><br class="clear" /><div class="title-wrapper">
<a name="PremiosTitulos">
<h1>Pr&ecirc;mios e t&iacute;tulos</h1>
</a>
<hr class="separator">
<div class="layout-cell layout-cell-12 data-cell">
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2019</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">VIII Solenidade de outorga do Colar Cândido Fontoura 2019, Sindusfarma. </div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2019</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Solenidade Ordem do Mérito - Entrega de comenda - Grã-cruz, Liga Bahiana de Oncologia. </div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2018</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Prêmio Doctalks 2018 - Personalidade Médica, Doctalks. </div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2018</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">FASCO - Fellow of the American Society of Clinical Oncology - Reconhecimento aos Membros da ASCO, extraordinário serviço voluntário, dedicação e compromisso. Os esforços em prol da especialidade, ca, ASCO - Annual Meeting 2018 - Chicago. </div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2018</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Titulo de Cidadão Paulistano, Câmara Municipal de São Paulo - Vereador Toninho Paiva - Publicado DOE 64 de 17/1/2019 pg. 78/79. </div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2018</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Consagração " Outorga Medalha Embaixador Sérgio Vieira de Mello", Organização das Nações Unidas. </div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2018</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Homenagem "Liderança exercida em prol da implantação e do desenvolvimento do ICESP", Instituto do Câncer do Estado de São Paulo. </div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2017</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Mérito profissional, Associação Beneficente e Cultural da Comunidade do Hospital das Clínicas. </div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2017</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Membro Titular, eleição, ANM, posse em 14/3/2017., Academia Nacional de Medicina, ANM. </div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2017</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Outorga Colar "IBrahim de Ameida Nobre - Tribuno da Revolução Paulista"., Governo do Estado de São Paulo, Decreto nº 62.677, de 07 de julho de 2017. </div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2017</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Senior Fellowship Award, University of Miami Health System. </div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2017</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Prêmio Calor Humano, Associação Beneficente e Cultural da Comunidade do Hospital das Clínicas. </div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2016</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Menção honrosa, Liga Bahiana Contra o Câncer. </div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2016</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Destaques do Ano, OBME - Organização Brasileira de Mulheres Empresariais. </div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2016</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Menção honrosa - por dedicação e comprometimento no desempenho das funções., Instituto do Câncer do Estado de São Paulo - ICESP. </div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2015</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Diploma de homenagem ao Dr. Paulo Hoff, OBME - Organização Brasileira de Mulheres Empresariais. </div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2015</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Menção de agradecimento, Escola de Educação Permanente do HC-FMUSP. </div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2015</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Outorga da Medalha do "1º Centenário da Centro Médico da Polícia Militar", Policia Militar de São Paulo - Centro médico. </div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2015</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Mérito profissional., Academia Brasileira de Ciências, Artes, História e Literatura. </div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2014</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Medalha Grão Merito "Fagundes dos Reis", Prefeitura Municipal de Passo Fundo. </div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2014</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Prêmio Jabuti 2014, Câmara Brasileira do Livro - ABL, 56º edição, mais tradicional premiação da literatura brasileira.. </div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2014</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Medalha Brigadeiro Tobias, Polícia Militar do Estado de São Paulo. </div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2013</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Lide Saúde 2013, Fórum de Saúde e Bem Estar. </div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2012</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Prêmio José Francisco Xavier Sigaud de Excelência Médica. ?Um das autoridades médicas mundiais em neoplasias gastrointestinanais", Congresso Franco-Brasileiro. </div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2009</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Prêmio Análise Medicina 2009 "Um dos mais admirados na especialidade Oncologia, Análise Editorial. </div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2009</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Título de cidadão honorário de Santa Bárbara do Sul, Camara Municipal de Vereadores de Santa Bárbara do Sil. </div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2009</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Título de cidadão honorário de Brasília, . </div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2009</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Professor MS-6 nível A, por mérito., Faculdade de Medicina da USP. </div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2008</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">America's top Oncologist, Guide to America's Top Oncologists. </div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2008</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Prêmio Cepoc, Centro de Pesquisas Oncológicas de Campinas. </div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2008</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Medalha do Mérito Alvorada, Governo do Distrito Federal. </div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2007</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">V Prêmio Carmem Prudente, Associação Brasileira de Cuidados Paliativos. </div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2005</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">"America's Top Physicians", Consumer's Research Council of America. </div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2003</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Premio de Pesquisador Eminente em Cancer, South American Office for Drug Development (SOAD) e Sociedade Brasileira de Cancerologia (SBC). </div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2000</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Professor do Ano, M.D. Anderson Cancer Center. </div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>1998</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Merit Award, American Society of Clinical Oncology. </div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>1998</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Outstanding Achievement Award in Cancer Research, Pharmacia & Upjohn Research. </div>
</div>
</div><br class="clear" /></div><br class="clear" /><div class="title-wrapper">
<a name="ProducoesCientificas">
<h1>Produ&ccedil;&otilde;es</h1>
</a>
<hr class="separator">
<div class="layout-cell layout-cell-12 data-cell">
<a name="ProducaoBibliografica"></a><br class="clear" /><div class="inst_back">
<b>Produção bibliográfica</b>
</div>
<a name="Citacoes"></a><div class="cita-artigos"> <b>Citações</b> </div><br class="clear"><div class="layout-cell layout-cell-12"><div class="layout-cell layout-cell-6"><div class="layout-cell-pad"> <div class="science_cont"><div class="web_s">Web of Science<a href="http://www.researcherid.com/rid/M-7662-2017" target='_blank' ><img src="/buscatextual/images/curriculo/researcherID.gif"/></a></div><div class="trab">Total de trabalhos:240</div><div class="cita">Total de citações:2573</div><div class="fator">Fator H:25</div><div class="detalhes"><a href="http://www.researcherid.com/rid/M-7662-2017" target='_blank' >Hoff, Paulo M. PH</a>&nbsp;&nbsp;Data:&nbsp;03/08/2017</div></div></div></div></div><br class="clear"><div class="layout-cell layout-cell-12"><div class="layout-cell layout-cell-6"><div class="layout-cell-pad"> <div class="science_cont"><div class="web_s">SCOPUS<a href="http://www.scopus.com/authid/detail.url?authorId=24724333500" target='_blank' ><img src="/buscatextual/images/curriculo/scopus.png"/></a></div><div class="trab">Total de trabalhos:189</div><div class="cita">Total de citações:8998</div><div class="detalhes"><a href="http://www.scopus.com/authid/detail.url?authorId=24724333500" target='_blank' >Hoff P.M., Hoff P, Hoff PMG, Paulo M Hoff -  h Index (42)</a>&nbsp;&nbsp;Data:&nbsp;26/07/2017</div></div></div></div></div><br class="clear"><div class="layout-cell layout-cell-12"><div class="layout-cell layout-cell-6"><div class="layout-cell-pad"> <div class="science_cont"><div class="web_s">Outras</div><div class="trab">Total de trabalhos:281</div><div class="cita">Total de citações:5411</div><div class="detalhes">Hoff PM, Hoff P, Hoff PMG, Paulo M Hoff -  h Index (33)&nbsp;&nbsp;Data:&nbsp;28/06/2016</div></div></div></div></div><br class="clear"><div id="artigos-completos">
<div class="cita-artigos">
<b><a name="ArtigosCompletos"></a>Artigos completos publicados em periódicos</b>
</div><br class="clear" /><div class="layout-cell-6">
<div class="sub_tit_form">
<label for="combo-ordenacao-citacao">Ordenar por</label><select class="input-text input-login-select" id="combo-ordenacao-citacao"><option value="1"> Ordem Cronol&oacute;gica </option><option value="2"> N&uacute;mero de cita&ccedil;&otilde;es Web of science </option><option value="3"> N&uacute;mero de cita&ccedil;&otilde;es Scopus </option><option value="4"> Numero de cita&ccedil;&otilde;es Scielo </option><option value="5"> Primeiro autor </option><option value="6"> Impacto JCR </option><option value="7"> Ordem de Import&acirc;ncia </option></select>
</div>
</div>
<script type="text/javascript">
			
				var ordenacao = {
					engine: {
						textual: function(seletor) {
						
							$("#artigos-completos").find(".artigo-completo").sortElements(function(a, b){
								var v1 = $(a).find(seletor).text();
								var v2 = $(b).find(seletor).text();
								return (v1 > v2) ? 1 : -1;
							});
						},
						numerico: function(seletor) {
						
							$("#artigos-completos").find(".artigo-completo").sortElements(function(a, b){
								var v1 = parseInt($(a).find(seletor).text(), 10);
								var v2 = parseInt($(b).find(seletor).text(), 10);
								if (isNaN(v1)) v1 = 0;
								if (isNaN(v1)) v2 = 0;
								return (v1 < v2) ? 1 : -1;
							});
						},
						numerico_crescente: function(seletor) {
						
							$("#artigos-completos").find(".artigo-completo").sortElements(function(a, b){
								var v1 = parseInt($(a).find(seletor).text(), 10);
								var v2 = parseInt($(b).find(seletor).text(), 10);
								if (isNaN(v1)) v1 = 0;
								if (isNaN(v1)) v2 = 0;
								return (v1 > v2) ? 1 : -1;
							});
						}
					},
					change: function(e) {
					
						var combo = $(e.target),
							valor = combo.val();
							
						if (valor == 1) ordenacao.engine.numerico("span[data-tipo-ordenacao='ano']");
						if (valor == 2) ordenacao.engine.numerico("span[data-tipo-ordenacao='1']");
						if (valor == 3) ordenacao.engine.numerico("span[data-tipo-ordenacao='3']");						
						if (valor == 4) ordenacao.engine.numerico("span[data-tipo-ordenacao='2']");
						if (valor == 5) ordenacao.engine.textual("span[data-tipo-ordenacao='autor']");
						if (valor == 6) ordenacao.engine.numerico("span[data-tipo-ordenacao='jcr']");
						if (valor == 7) ordenacao.engine.numerico_crescente("span[data-tipo-ordenacao='importancia']");
							
					}
				};
			
				$("#combo-ordenacao-citacao").bind("change", ordenacao.change);
			
			</script>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>1. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>VICTOR, CAROLINA RIBEIRO</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2019</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1200/jgo.19.00103" target="_blank"></a>VICTOR, CAROLINA RIBEIRO ; FUJIKI, FERNANDA KAORI ; TAKEDA, FLAVIO ROBERTO ; <b>HOFF, PAULO MARCELO GEHM</b> ; DE CASTRIA, TIAGO BIACHI . Safety and Effectiveness of Chemotherapy for Metastatic Esophageal Cancer in a Community Hospital in Brazil. JOURNAL OF GLOBAL ONCOLOGY<sup><img id='23789506_1' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='23789506' /></sup>, v. 1, p. 1-10, 2019. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1200/jgo.19.00103&issn=23789506&volume=1&issue=&paginaInicial=1&titulo=Safety and Effectiveness of Chemotherapy for Metastatic Esophageal Cancer in a Community Hospital in Brazil&sequencial=1&nomePeriodico=JOURNAL OF GLOBAL ONCOLOGY" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>BRAGHIROLI, MARIA I.</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2018</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1097/mnm.0000000000000810" target="_blank"></a>BRAGHIROLI, MARIA I. ; MOTA, JOSÉ M. ; DUARTE, PAULO S. ; MORITA, TIAGO O. ; BARIANI, GIOVANNI M. ; NEBULONI, DANIELA ; BUCHPIGUEL, CARLOS A. ; <b>HOFF, PAULO M.</b> ; RIECHELMANN, RACHEL P. . Evaluation of 18F-FDG PET-CT as a prognostic marker in advanced biliary tract cancer. NUCLEAR MEDICINE COMMUNICATIONS<sup><img id='01433636_2' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='01433636' /></sup>, v. 1, p. 1, 2018. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1097/mnm.0000000000000810&issn=01433636&volume=1&issue=&paginaInicial=1&titulo=Evaluation of 18F-FDG PET-CT as a prognostic marker in advanced biliary tract cancer&sequencial=2&nomePeriodico=NUCLEAR MEDICINE COMMUNICATIONS" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>3. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>ARAI, ROBERTO J.</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2018</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1186/s40364-018-0135-x" target="_blank"></a>ARAI, ROBERTO J. ; PETRY, VANESSA ; <b>HOFF, PAULO M.</b> ; MANO, MAX S. . Serum levels of VEGF and MCSF in HER2+ / HER2- breast cancer patients with metronomic neoadjuvant chemotherapy. Biomarker Research<sup><img id='20507771_3' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='20507771' /></sup>, v. 6, p. 1-6, 2018. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1186/s40364-018-0135-x&issn=20507771&volume=6&issue=&paginaInicial=1&titulo=Serum levels of VEGF and MCSF in HER2+ / HER2- breast cancer patients with metronomic neoadjuvant chemotherapy&sequencial=3&nomePeriodico=Biomarker Research" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>4. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>GIRARDI, DANIEL M.</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2018</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1007/s12029-018-0166-4" target="_blank"></a>GIRARDI, DANIEL M. ; FARIA, LUIZA DIB B. B. ; TEIXEIRA, MARCELA C. ; Costa, Frederico P. ; <b>HOFF, PAULO MARCELO G.</b> ; FERNANDES, GUSTAVO S. . Second-Line Treatment for Advanced Pancreatic Adenocarcinoma: Is There a Role for Gemcitabine?. JOURNAL OF GASTROINTESTINAL CANCER<sup><img id='19416628_4' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='19416628' /></sup>, v. 1, p. 1, 2018. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1007/s12029-018-0166-4&issn=19416628&volume=1&issue=&paginaInicial=1&titulo=Second-Line Treatment for Advanced Pancreatic Adenocarcinoma: Is There a Role for Gemcitabine?&sequencial=4&nomePeriodico=JOURNAL OF GASTROINTESTINAL CANCER" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>5. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>OVERMAN, MICHAEL J</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2018</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1093/jnci/djx288" target="_blank"></a>OVERMAN, MICHAEL J ; Ferrarotto, Renata ; RAGHAV, KANWAL ; GEORGE, BINSAH ; QIAO, WEI ; MACHADO, KARIME K ; SALTZ, LEONARD B ; MAZARD, THIBAULT ; VAUTHEY, J N ; <b>HOFF, PAULO M</b> ; HOBBS, BRIAN ; LOYER, EVELYN M ; Kopetz, Scott . The Addition of Bevacizumab to Oxaliplatin-Based Chemotherapy: Impact Upon Hepatic Sinusoidal Injury and Thrombocytopenia. JNCI-Journal of the National Cancer Institute<sup><img id='00278874_5' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='00278874' /></sup>, v. 1, p. 1, 2018. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1093/jnci/djx288&issn=00278874&volume=1&issue=&paginaInicial=1&titulo=The Addition of Bevacizumab to Oxaliplatin-Based Chemotherapy: Impact Upon Hepatic Sinusoidal Injury and Thrombocytopenia&sequencial=5&nomePeriodico=JNCI-Journal of the National Cancer Institute" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>6. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>SJOQUIST, KATRIN M</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2018</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1093/jnci/djx253" target="_blank"></a>SJOQUIST, KATRIN M RENFRO, LINDSAY A SIMES, R JOHN TEBBUTT, NIALL C CLARKE, STEPHEN SEYMOUR, MATTHEW T ADAMS, RICHARD MAUGHAN, TIMOTHY S SALTZ, LEONARD GOLDBERG, RICHARD M SCHMOLL, HANS-JOACHIM VAN CUTSEM, ERIC DOUILLARD, JEAN-YVES <b>HOFF, PAULO M</b> HECHT, JOEL RANDOLPH Tournigand, Christophe PUNT, CORNELIS J A KOOPMAN, MIRIAM HURWITZ, HERBERT HEINEMANN, VOLKER FALCONE, ALFREDO PORSCHEN, RAINER FUCHS, CHARLES DIAZ-RUBIO, EDUARDO ARANDA, ENRIQUE ,  <a title="Clique para visualizar todos os autores" class="tooltip autores-et-al-plus" href="javascript:void(0)">et al.<span></span></a><span class='autores-et-al'>BOKEMEYER, CARSTEN SOUGLAKOS, IOANNIS KABBINAVAR, FAIROOZ F CHIBAUDEL, BENOIST MEYERS, JEFFREY P SARGENT, DANIEL J de Gramont, Aimery ZALCBERG, JOHN R <a href="javascript:void(0)" title="Clique para ocultar os autores" class="tooltip autores-et-al-minus"></a></span> ; Personalizing Survival Predictions in Advanced Colorectal Cancer: The ARCAD Nomogram Project. JNCI-Journal of the National Cancer Institute<sup><img id='00278874_6' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='00278874' /></sup>, v. 110, p. 638-648, 2018. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1093/jnci/djx253&issn=00278874&volume=110&issue=&paginaInicial=638&titulo=Personalizing Survival Predictions in Advanced Colorectal Cancer: The ARCAD Nomogram Project&sequencial=6&nomePeriodico=JNCI-Journal of the National Cancer Institute" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>7. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>AVILA, MÔNICA SAMUEL</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2018</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1016/j.jacc.2018.02.049" target="_blank"></a>AVILA, MÔNICA SAMUEL ; AYUB-FERREIRA, SILVIA MOREIRA ; DE BARROS WANDERLEY, MAURO ROGERIO ; DAS DORES CRUZ, FATIMA ; GONÇALVES BRANDÃO, SARA MICHELLY ; RIGAUD, VAGNER OLIVEIRA CARVALHO ; HIGUCHI-DOS-SANTOS, MARÍLIA HARUMI ; <a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/5495055834774817" target="_blank">Hajjar, Ludhmila Abrahão</a> ; KALIL FILHO, ROBERTO ; <b>HOFF, Paulo Marcelo</b> ; SAHADE, MARINA ; FERRARI, MARCELA S.M. ; DE PAULA COSTA, ROMULO LEOPOLDO ; MANO, MAX SENNA ; BITTENCOURT VIANA CRUZ, CECILIA BEATRIZ ; ABDUCH, MARIA CRISTINA ; LOFRANO ALVES, MARCO STEPHAN ; GUIMARAES, GUILHERME VEIGA ; ISSA, VICTOR SARLI ; BITTENCOURT, MARCIO SOMMER ; BOCCHI, EDIMAR ALCIDES . Carvedilol for Prevention of Chemotherapy-Related Cardiotoxicity. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY<sup><img id='07351097_7' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='07351097' /></sup>, v. 71, p. 2281-2290, 2018. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1016/j.jacc.2018.02.049&issn=07351097&volume=71&issue=&paginaInicial=2281&titulo=Carvedilol for Prevention of Chemotherapy-Related Cardiotoxicity&sequencial=7&nomePeriodico=JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>8. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>GIRARDI, DANIEL M.</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2018</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1186/s12885-018-4305-x" target="_blank"></a>GIRARDI, DANIEL M. ; DE LIMA, MARIANA A. ; PEREIRA, GABRIEL C. B. ; NEGRÃO, MARCELO V. ; LÓPEZ, ROSSANA V. M. ; CAPARELI, FERNANDA C. ; Sabbaga, Jorge ; <b>HOFF, PAULO MARCELO G.</b> . Chemoradiotherapy versus chemotherapy as adjuvant treatment for localized gastric cancer: a propensity score-matched analysis. BMC CANCER<sup><img id='14712407_8' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='14712407' /></sup>, v. 18, p. 1, 2018. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1186/s12885-018-4305-x&issn=14712407&volume=18&issue=&paginaInicial=1&titulo=Chemoradiotherapy versus chemotherapy as adjuvant treatment for localized gastric cancer: a propensity score-matched analysis&sequencial=8&nomePeriodico=BMC CANCER" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>9. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>TABERNERO, JOSEP</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2018</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1016/S1470-2045(18)30481-9" target="_blank"></a>TABERNERO, JOSEP ; <b>HOFF, PAULO M</b> ; SHEN, LIN ; OHTSU, ATSUSHI ; SHAH, MANISH A ; CHENG, KAREN ; SONG, CHUNYAN ; WU, HAIYAN ; ENG-WONG, JENNIFER ; KIM, KATHERINE ; KANG, YOON-KOO . Pertuzumab plus trastuzumab and chemotherapy for HER2-positive metastatic gastric or gastro-oesophageal junction cancer (JACOB): final analysis of a double-blind, randomised, placebo-controlled phase 3 study. LANCET ONCOLOGY<sup><img id='14702045_9' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='14702045' /></sup>, v. 19, p. 1372-1384, 2018. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1016/S1470-2045(18)30481-9&issn=14702045&volume=19&issue=&paginaInicial=1372&titulo=Pertuzumab plus trastuzumab and chemotherapy for HER2-positive metastatic gastric or gastro-oesophageal junction cancer (JACOB): final analysis of a double-blind, randomised, placebo-controlled phase 3 study&sequencial=9&nomePeriodico=LANCET ONCOLOGY" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>10. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>LANDEIRO, LUCIANA C. G.</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2018</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1002/cncr.31735" target="_blank"></a>LANDEIRO, LUCIANA C. G. ; GAGLIATO, DEBORA M. ; FÊDE, ANGELO B. ; FRAILE, NATALIA M. ; LOPEZ, ROSSANA M. ; DA FONSECA, LEONARDO G. ; PETRY, VANESSA ; TESTA, LAURA ; <b>HOFF, PAULO M.</b> ; MANO, MAX S. . Return to work after breast cancer diagnosis: An observational prospective study in brazil. CANCER<sup><img id='0008543X_10' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='0008543X' /></sup>, v. 1, p. 1, 2018. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1002/cncr.31735&issn=0008543X&volume=1&issue=&paginaInicial=1&titulo=Return to work after breast cancer diagnosis: An observational prospective study in brazil&sequencial=10&nomePeriodico=CANCER" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>11. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>DA FONSECA, LEONARDO GOMES</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2018</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1186/s12885-018-5173-0" target="_blank"></a>DA FONSECA, LEONARDO GOMES ; MARTA, GUILHERME NADER ; BRAGHIROLI, MARIA IGNEZ FREITAS MELRO ; CHAGAS, ALINE LOPES ; CARRILHO, FLAIR JOSE ; <b>HOFF, Paulo Marcelo</b> ; Sabbaga, Jorge . Safety and efficacy of cytotoxic chemotherapy in hepatocellular carcinoma after first-line treatment with sorafenib. BMC CANCER<sup><img id='14712407_11' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='14712407' /></sup>, v. 18, p. 1, 2018. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1186/s12885-018-5173-0&issn=14712407&volume=18&issue=&paginaInicial=1&titulo=Safety and efficacy of cytotoxic chemotherapy in hepatocellular carcinoma after first-line treatment with sorafenib&sequencial=11&nomePeriodico=BMC CANCER" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>12. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>MOTA, JOSE MAURICIO</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2018</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1097/md.0000000000013517" target="_blank"></a>MOTA, JOSE MAURICIO ; SOUSA, LUANA GUIMARÃES ; Braghiroli, Maria Ignez ; SIQUEIRA, LUIZ TENÓRIO ; NETO, JOÃO EVANGELISTA BEZERRA ; CHAPCHAP, PAULO ; HOFF, ANA A. DE OLIVEIRA ; <b>HOFF, PAULO M.</b> . Pembrolizumab for metastatic adrenocortical carcinoma with high mutational burden. MEDICINE<sup><img id='00257974_12' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='00257974' /></sup>, v. 97, p. e13517, 2018. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1097/md.0000000000013517&issn=00257974&volume=97&issue=&paginaInicial=e13517&titulo=Pembrolizumab for metastatic adrenocortical carcinoma with high mutational burden&sequencial=12&nomePeriodico=MEDICINE" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>13. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Hoff PM</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2017</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1016/j.soc.2016.07.013" target="_blank"></a><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>; Pazdur R . Pathology of Anal Cancer. Surgical Oncology Clinics of North America<sup><img id='10553207_13' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='10553207' /></sup>, v. 26, n.7, p. 57-71, 2017. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1016/j.soc.2016.07.013&issn=10553207&volume=26&issue=&paginaInicial=57&titulo=Pathology of Anal Cancer&sequencial=13&nomePeriodico=Surgical Oncology Clinics of North America" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>14. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>RAMOS, RICARDO EMANUEL DE OLIVEIRA</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2017</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1200/jgo.2016.006890" target="_blank"></a>RAMOS, RICARDO EMANUEL DE OLIVEIRA ; PEREZ MAK, MILENA ; ALVES, MICHEL FABIANO SILVA ; PIOTTO, GUSTAVO HENRIQUE MUNHOZ ; TAKAHASHI, TIAGO KENJI ; GOMES DA FONSECA, LEONARDO ; SILVINO, MARINA CAVALCANTI MAROJA ; <b>HOFF, Paulo Marcelo</b> ; DE CASTRO, GILBERTO . Malignancy-Related Hypercalcemia in Advanced Solid Tumors: Survival Outcomes. JOURNAL OF GLOBAL ONCOLOGY<sup><img id='23789506_14' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='23789506' /></sup>, v. 1, p. JGO.2016.006890-6, 2017. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1200/jgo.2016.006890&issn=23789506&volume=1&issue=&paginaInicial=JGO.2016.006890&titulo=Malignancy-Related Hypercalcemia in Advanced Solid Tumors: Survival Outcomes&sequencial=14&nomePeriodico=JOURNAL OF GLOBAL ONCOLOGY" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>15. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>CONNELL, LOUISE C.</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2017</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1007/s11864-017-0463-3" target="_blank"></a>CONNELL, LOUISE C. ; MOTA, JOSÉ MAURICIO ; Braghiroli, Maria Ignez ; <b>HOFF, PAULO M.</b> . The Rising Incidence of Younger Patients With Colorectal Cancer: Questions About Screening, Biology, and Treatment. CURRENT TREATMENT OPTIONS IN ONCOLOGY<sup><img id='15272729_15' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='15272729' /></sup>, v. 18, p. 1, 2017. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1007/s11864-017-0463-3&issn=15272729&volume=18&issue=&paginaInicial=1&titulo=The Rising Incidence of Younger Patients With Colorectal Cancer: Questions About Screening, Biology, and Treatment&sequencial=15&nomePeriodico=CURRENT TREATMENT OPTIONS IN ONCOLOGY" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>16. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>SHAH, MANISH A.</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2017</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1200/JCO.2016.71.6852" target="_blank"></a>SHAH, MANISH A. ; XU, RUI-HUA ; BANG, YUNG-JUE ; <b>HOFF, PAULO M.</b> ; LIU, TIANSHU ; HERRÁEZ-BARANDA, LUIS A. ; XIA, FAN ; GARG, AMIT ; SHING, MONA ; TABERNERO, JOSEP . HELOISE: Phase IIIb Randomized Multicenter Study Comparing Standard-of-Care and Higher-Dose Trastuzumab Regimens Combined With Chemotherapy as First-Line Therapy in Patients With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma. JOURNAL OF CLINICAL ONCOLOGY<sup><img id='0732183X_16' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='0732183X' /></sup>, v. 1, p. JCO.2016.71.685, 2017. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1200/JCO.2016.71.6852&issn=0732183X&volume=1&issue=&paginaInicial=JCO.2016.71.685&titulo=HELOISE: Phase IIIb Randomized Multicenter Study Comparing Standard-of-Care and Higher-Dose Trastuzumab Regimens Combined With Chemotherapy as First-Line Therapy in Patients With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma&sequencial=16&nomePeriodico=JOURNAL OF CLINICAL ONCOLOGY" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>17. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>DE ANDRADE, DANIEL CIAMPI</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2017</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1634/theoncologist.2017-0235" target="_blank"></a>DE ANDRADE, DANIEL CIAMPI JACOBSEN TEIXEIRA, MANOEL GALHARDONI, RICARDO FERREIRA, KARINE S.L. BRAZ MILENO, PAULA SCISCI, NATHALIA ZANDONAI, ALEXANDRA TEIXEIRA, WILLIAM G.J. SARAGIOTTO, DANIEL F. SILVA, VALQUÍRIA RAICHER, IRINA CURY, RUBENS GISBERT MACARENCO, RICARDO OTTO HEISE, CARLOS WILSON IERVOLINO BROTTO, MARIO ANDRADE DE MELLO, ALBERTO ZINI MEGALE, MARCELO HENRIQUE CURTI DOURADO, LUIZ MENDES BAHIA, LUCIANA LILIAN RODRIGUES, ANTONIA PARRAVANO, DANIELLA TIZUE FUKUSHIMA, JULIA LEFAUCHEUR, JEAN'PASCAL BOUHASSIRA, DIDIER SOBROZA, EVANDRO ,  <a title="Clique para visualizar todos os autores" class="tooltip autores-et-al-plus" href="javascript:void(0)">et al.<span></span></a><span class='autores-et-al'>RICHELMANN, RACHEL P. <b>HOFF, PAULO M.</b> VALÉRIO DA SILVA, FERNANDA CHILE, THAIS DALE, CAMILA S. NEBULONI, DANIELA SENNA, LUIZ BRENTANI, HELENA PAGANO, ROSANA L. DE SOUZA, ÂNGELA M. <a href="javascript:void(0)" title="Clique para ocultar os autores" class="tooltip autores-et-al-minus"></a></span> ; Pregabalin for the Prevention of Oxaliplatin Induced Painful Neuropathy: A Randomized, Double Blind Trial. ONCOLOGIST<sup><img id='10837159_17' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='10837159' /></sup>, v. 22, p. 1154-e105, 2017. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1634/theoncologist.2017-0235&issn=10837159&volume=22&issue=&paginaInicial=1154&titulo=Pregabalin for the Prevention of Oxaliplatin Induced Painful Neuropathy: A Randomized, Double Blind Trial&sequencial=17&nomePeriodico=ONCOLOGIST" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>18. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>HOFF, P.M.</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2017</span><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P.M.</a></b>; Munhoz RR ; LIMA, A. A. P. ; SASSE, ANDRE DEEKE ; TRAINA, TIFFANY A. ; HUDIS, CLIFFORD ; MARQUES, R. . The role of LHRH agonists in ovarian function preservation in premenopausal womem undergoing chemortherapy for early stage breast cancer: A systematic review and meta-analysis.. JOURNAL OF CLINICAL ONCOLOGY<sup><img id='0732183X_18' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='0732183X' /></sup>, v. 1, p. 1-5, 2017. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=&issn=0732183X&volume=1&issue=&paginaInicial=1&titulo=The role of LHRH agonists in ovarian function preservation in premenopausal womem undergoing chemortherapy for early stage breast cancer: A systematic review and meta-analysis.&sequencial=18&nomePeriodico=JOURNAL OF CLINICAL ONCOLOGY" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>19. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>MOTA, JOSÉ MAURÍCIO</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2017</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1159/000448111" target="_blank"></a>MOTA, JOSÉ MAURÍCIO ; SCARANTI, MARIANA ; FONSECA, LEONARDO G. ; TOLÓI, DIEGO ARAÚJO ; DE CAMARGO, VERIDIANA PIRES ; MUNHOZ, RODRIGO RAMELLA ; FEHER, OLAVO ; <b>HOFF, PAULO M.</b> . Response to Paclitaxel in an Adult Patient with Advanced<bold></bold> Kaposiform Hemangioendothelioma. CASE REPORTS IN ONCOLOGY<sup><img id='16626575_19' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='16626575' /></sup>, v. 1, p. 481-487, 2017. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1159/000448111&issn=16626575&volume=1&issue=&paginaInicial=481&titulo=Response to Paclitaxel in an Adult Patient with Advanced<bold></bold> Kaposiform Hemangioendothelioma&sequencial=19&nomePeriodico=CASE REPORTS IN ONCOLOGY" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>20. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>RIECHELMANN, R. P.</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2017</span>RIECHELMANN, R. P. ; <b>Paulo Marcelo Gehm Hoff</b> . Uso de regorafenibe em pacientes com câncer colorretal metastático previamente tratados com bevacizumabe ou aflibercepte: experiência clínica uni-instituciona. ONCOLOGY<sup><img id='00302414_20' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='00302414' /></sup>, v. 1, p. 1, 2017. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=&issn=00302414&volume=1&issue=&paginaInicial=1&titulo=Uso de regorafenibe em pacientes com câncer colorretal metastático previamente tratados com bevacizumabe ou aflibercepte: experiência clínica uni-instituciona&sequencial=20&nomePeriodico=ONCOLOGY" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>21. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>KOBAYASHI, SILVIA T.</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2017</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1097/XEB.0000000000000099" target="_blank"></a>KOBAYASHI, SILVIA T. ; DIZ, MARIA D. P. E. ; CAMPOLINA, ALESSANDRO G. ; DE SOÁREZ, PATRICIA C. ; RIBEIRO, ULYSSES ; NAHAS, SERGIO C. ; VASCONCELOS, KARINA G. M. C. ; CAPARELI, FERNANDA ; CECCONELLO, IVAN ; <b>HOFF, PAULO M.</b> . Integrated care pathway for rectal cancer treatment. INTERNATIONAL JOURNAL OF EVIDENCE-BASED HEALTHCARE (PRINT)<sup><img id='17441595_21' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='17441595' /></sup>, v. 15, p. 53-62, 2017. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1097/XEB.0000000000000099&issn=17441595&volume=15&issue=&paginaInicial=53&titulo=Integrated care pathway for rectal cancer treatment&sequencial=21&nomePeriodico=INTERNATIONAL JOURNAL OF EVIDENCE-BASED HEALTHCARE (PRINT)" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>22. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>ASPRINO, PAULA FONTES</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2017</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1530/erc-17-0286" target="_blank"></a>ASPRINO, PAULA FONTES ; LINCK, RUDINEI DIOGO MARQUES ; CESAR, JONATAS ; FREITAS, FLORÊNCIO PORTO ; KOYAMA, FERNANDA CHRISTTANINI ; Riechelmann, Rachel Simões Pimenta ; COSTA, FREDERICO PEREGO ; <b>HOFF, PAULO</b> ; GALANTE, PEDRO ALEXANDRE FAVORETTO ; MEYER, DIOGO ; CAMARGO, ANAMARIA ARANHA ; Sabbaga, Jorge . <i>TSC2</i> rare germline variants in non-tuberous sclerosis patients with neuroendocrine neoplasias. ENDOCRINE-RELATED CANCER<sup><img id='13510088_22' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='13510088' /></sup>, v. 1, p. ERC-17-0286, 2017. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1530/erc-17-0286&issn=13510088&volume=1&issue=&paginaInicial=ERC-17-0286&titulo=<i>TSC2</i> rare germline variants in non-tuberous sclerosis patients with neuroendocrine neoplasias&sequencial=22&nomePeriodico=ENDOCRINE-RELATED CANCER" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>23. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Hoff PM</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2017</span><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>. Next-generation Sequencing-based genomic profiling. Clinics<sup><img id='18075932_23' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='18075932' /></sup>, v. 01, p. 10, 2017. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=&issn=18075932&volume=01&issue=&paginaInicial=10&titulo=Next-generation Sequencing-based genomic profiling&sequencial=23&nomePeriodico=Clinics" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>24. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>DE M RÊGO, JULIANA FLORINDA</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2017</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.3332/ecancer.2017.767" target="_blank"></a>DE M RÊGO, JULIANA FLORINDA ; SALLES SCORTEGAGNA DE MEDEIROS, RAPHAEL ; Braghiroli, Maria Ignez ; GALVÃO, BRENO ; EVANGELISTA BEZERRA NETO, JOÃO ; RAMELLA MUNHOZ, RODRIGO ; GUERRA, JULIANA ; NONOGAKI, SUELY ; KIMURA, LIDIA ; PFIFFER, TULIO EDUARDO ; DE GASTRO JR, GILBERTO ; <b>HOFF, Paulo Marcelo</b> ; ROCHA FILHO, DUILIO ; PEREGO COSTA, FREDERICO ; RIECHELMANN, RACHEL P . Expression of ERCC1, Bcl-2, Lin28a, and Ki-67 as biomarkers of response to first-line platinum-based chemotherapy in patients with high-grade extrapulmonary neuroendocrine carcinomas or small cell lung cancer. ECANCERMEDICALSCIENCE<sup><img id='17546605_24' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='17546605' /></sup>, v. 11, p. 767, 2017. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.3332/ecancer.2017.767&issn=17546605&volume=11&issue=&paginaInicial=767&titulo=Expression of ERCC1, Bcl-2, Lin28a, and Ki-67 as biomarkers of response to first-line platinum-based chemotherapy in patients with high-grade extrapulmonary neuroendocrine carcinomas or small cell lung cancer&sequencial=24&nomePeriodico=ECANCERMEDICALSCIENCE" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>25. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>FERNANDES, GUSTAVO DOS SANTOS</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2017</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1007/s12029-017-0001-3" target="_blank"></a>FERNANDES, GUSTAVO DOS SANTOS ; Braghiroli, Maria Ignez ; ARTIOLI, MICHELLE ; PATERLINI, ANA CAROLINA CARVALHO ROCHA ; TEIXEIRA, MARCELA CROSARA ; GUMZ, BRENDA PIRES ; GIRARDI, DANIEL DA MOTTA ; BRAGHIROLI, ODDONE F. M. ; COSTA, FREDERICO PEREGO ; <b>HOFF, PAULO M.</b> . Combination of Irinotecan, Oxaliplatin and 5-Fluorouracil as a Rechallenge Regimen for Heavily Pretreated Metastatic Colorectal Cancer Patients. JOURNAL OF GASTROINTESTINAL CANCER<sup><img id='19416628_25' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='19416628' /></sup>, v. 1, p. 1, 2017. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1007/s12029-017-0001-3&issn=19416628&volume=1&issue=&paginaInicial=1&titulo=Combination of Irinotecan, Oxaliplatin and 5-Fluorouracil as a Rechallenge Regimen for Heavily Pretreated Metastatic Colorectal Cancer Patients&sequencial=25&nomePeriodico=JOURNAL OF GASTROINTESTINAL CANCER" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>26. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>RENFRO, LINDSAY A.</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2017</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1200/JCO.2016.71.5771" target="_blank"></a>RENFRO, LINDSAY A. GOLDBERG, RICHARD M. GROTHEY, AXEL SOBRERO, ALBERTO ADAMS, RICHARD SEYMOUR, MATTHEW T. HEINEMANN, VOLKER SCHMOLL, HANS-JOACHIM DOUILLARD, JEAN-YVES HURWITZ, HERBERT FUCHS, CHARLES S. DIAZ-RUBIO, EDUARDO PORSCHEN, RAINER Tournigand, Christophe CHIBAUDEL, BENOIST <b>HOFF, PAULO M.</b> KABBINAVAR, FAIROOZ F. FALCONE, ALFREDO TEBBUTT, NIALL C. PUNT, CORNELIS J.A. HECHT, J. RANDOLPH SOUGLAKOS, JOHN BOKEMEYER, CARSTEN VAN CUTSEM, ERIC SALTZ, LEONARD ,  <a title="Clique para visualizar todos os autores" class="tooltip autores-et-al-plus" href="javascript:void(0)">et al.<span></span></a><span class='autores-et-al'>de Gramont, Aimery SARGENT, DANIEL J. <a href="javascript:void(0)" title="Clique para ocultar os autores" class="tooltip autores-et-al-minus"></a></span> ; Clinical Calculator for Early Mortality in Metastatic Colorectal Cancer: An Analysis of Patients From 28 Clinical Trials in the Aide et Recherche en Cancérologie Digestive Database. JOURNAL OF CLINICAL ONCOLOGY<sup><img id='0732183X_26' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='0732183X' /></sup>, v. 35, p. 1929-1937, 2017. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1200/JCO.2016.71.5771&issn=0732183X&volume=35&issue=&paginaInicial=1929&titulo=Clinical Calculator for Early Mortality in Metastatic Colorectal Cancer: An Analysis of Patients From 28 Clinical Trials in the Aide et Recherche en Cancérologie Digestive Database&sequencial=26&nomePeriodico=JOURNAL OF CLINICAL ONCOLOGY" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>27. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>BRANCO, FERNANDA</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2017</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.5604/16652681.1231585" target="_blank"></a>BRANCO, FERNANDA ; ALENCAR, REGIANE ; VOLT, FERNANDA ; SARTORI, GIOVANA ; DODE, ANDRESSA ; KIKUCHI, LUCIANA ; TANI, CLAUDIA ; CHAGAS, ALINE ; PFIFFER, TULIO ; <b>HOFF, PAULO</b> ; CARRILHO, FLAIR ; ALVES DE MATTOS, ANGELO . The Impact of Early Dermatologic Events in the Survival of Patients with Hepatocellular Carcinoma Treated with Sorafenib. Annals of Hepatology<sup><img id='16652681_27' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='16652681' /></sup>, v. 16, p. 263-268, 2017. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.5604/16652681.1231585&issn=16652681&volume=16&issue=&paginaInicial=263&titulo=The Impact of Early Dermatologic Events in the Survival of Patients with Hepatocellular Carcinoma Treated with Sorafenib&sequencial=27&nomePeriodico=Annals of Hepatology" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>28. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>RIECHELMANN, RACHEL P</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2017</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.3332/ecancer.2017.716" target="_blank"></a>RIECHELMANN, RACHEL P WESCHENFELDER, RUI F COSTA, FREDERICO P CHAVES ANDRADE, ALINE BERSCH OSVALD, ALESSANDRO QUIDUTE, ANA ROSA P DOS SANTOS, ALLAN HOFF, ANA AMÉLIA O GUMZ, BRENDA BUCHPIGUEL, CARLOS VILHEINA PEREIRA, BRUNO S MUNIZ LOURENÇO JUNIOR, DELMAR REIS DA ROCHA FILHO, DUILIO ANTUNES FONSECA, EDUARDO LINHARES RIELLO MELLO, EDUARDO FERRARI MAKDISSI, FABIO LUIZ WAECHTER, FABIO CARNEVALE, FRANCISCO CESAR COURA-FILHO, GEORGE B ANDRADE DE PAULO, GUSTAVO COLAGIOVANNI GIROTTO, GUSTAVO EVANGELISTA BEZERRA NETO, JOÃO GLASBERG, JOÃO CASALI-DA-ROCHA, JOSE CLAUDIO FLORINDA M REGO, JULIANA ,  <a title="Clique para visualizar todos os autores" class="tooltip autores-et-al-plus" href="javascript:void(0)">et al.<span></span></a><span class='autores-et-al'>RODRIGUES DE MEIRELLES, LUCIANA HAJJAR, LUDHMILA MENEZES, MARCO BRONSTEIN, MARCELLO D TATIT SAPIENZA, MARCELO BARISSON VILLARES FRAGOSO, MARIA CANDIDA ALBERGARIA PEREIRA, MARIA ADELAIDE BARRAS, MILTON MANOUKIAN FORONES, NORA GALVÃO DO AMARAL, PAULO CEZAR SALLES SCORTEGAGNA DE MEDEIROS, RAPHAEL ARAUJO, RAPHAEL L C FRANÇA BEZERRA, REGIS OTAVIANO D?ALPINO PEIXOTO, RENATA AGUIAR JR, SAMUEL RIBEIRO JR, ULYSSES PFIFFER, TULIO <b>HOFF, PAULO M</b> COUTINHO, ANELISA K <a href="javascript:void(0)" title="Clique para ocultar os autores" class="tooltip autores-et-al-minus"></a></span> ; Guidelines for the management of neuroendocrine tumours by the Brazilian gastrointestinal tumour group. ECANCERMEDICALSCIENCE<sup><img id='17546605_28' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='17546605' /></sup>, v. 11, p. 716, 2017. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.3332/ecancer.2017.716&issn=17546605&volume=11&issue=&paginaInicial=716&titulo=Guidelines for the management of neuroendocrine tumours by the Brazilian gastrointestinal tumour group&sequencial=28&nomePeriodico=ECANCERMEDICALSCIENCE" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>29. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>CHU, MICHAEL P.</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2017</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1001/jamaoncol.2016.3358" target="_blank"></a>CHU, MICHAEL P. ; HECHT, J. RANDOLPH ; SLAMON, DENNIS ; WAINBERG, ZEV A. ; BANG, YUNG-JUE ; <b>HOFF, PAULO M.</b> ; SOBRERO, ALBERTO ; QIN, SHUKUI ; AFENJAR, KAREN ; HOUE, VINCENT ; KING, KAREN ; KOSKI, SHERYL ; MULDER, KAREN ; HILLER, JULIE PRICE ; SCARFE, ANDREW ; SPRATLIN, JENNIFER ; HUANG, YINGJIE J. ; KHAN-WASTI, SABA ; CHUA, NEIL ; SAWYER, MICHAEL B. . Association of Proton Pump Inhibitors and Capecitabine Efficacy in Advanced Gastroesophageal Cancer. JAMA Oncology<sup><img id='23742437_29' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='23742437' /></sup>, v. 3, p. 767, 2017. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1001/jamaoncol.2016.3358&issn=23742437&volume=3&issue=&paginaInicial=767&titulo=Association of Proton Pump Inhibitors and Capecitabine Efficacy in Advanced Gastroesophageal Cancer&sequencial=29&nomePeriodico=JAMA Oncology" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>30. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>NAHAS, SERGIO CARLOS</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2016</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1097/DCR.0000000000000558" target="_blank"></a>NAHAS, SERGIO CARLOS ; RIZKALLAH NAHAS, CAIO SERGIO ; SPARAPAN MARQUES, CARLOS FREDERICO ; RIBEIRO, ULYSSES ; COTTI, GUILHERME CUTAIT ; IMPERIALE, ANTONIO ROCCO ; CAPARELI, FERNANDA CUNHA ; CHIH CHEN, ANDRE TSIN ; <b>HOFF, PAULO M.</b> ; CECCONELLO, IVAN . Pathologic Complete Response in Rectal Cancer. Diseases of the Colon & Rectum<sup><img id='00123706_30' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='00123706' /></sup>, v. 59, p. 255-263, 2016. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1097/DCR.0000000000000558&issn=00123706&volume=59&issue=&paginaInicial=255&titulo=Pathologic Complete Response in Rectal Cancer&sequencial=30&nomePeriodico=Diseases of the Colon & Rectum" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>31. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>OLIVEIRA, SUILANE COELHO RIBEIRO</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2016</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1007/s12029-015-9790-4" target="_blank"></a>OLIVEIRA, SUILANE COELHO RIBEIRO ; MONIZ, CAMILA MOTTA VENCHIARUTTI ; RIECHELMANN, RACHEL ; ALEX, ALEXANDRA KICHFY ; BRAGHIROLLI, MARIA IGNEZ ; BARIANI, GIOVANNI ; NAHAS, CAIO ; <b>HOFF, PAULO MARCELO GEHM</b> . Phase II Study of Capecitabine in Substitution of 5-FU in the Chemoradiotherapy Regimen for Patients with Localized Squamous Cell Carcinoma of the Anal Canal. Journal of Gastrointestinal Cancer (Print)<sup><img id='19416628_31' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='19416628' /></sup>, v. 47, p. 75-81, 2016. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1007/s12029-015-9790-4&issn=19416628&volume=47&issue=&paginaInicial=75&titulo=Phase II Study of Capecitabine in Substitution of 5-FU in the Chemoradiotherapy Regimen for Patients with Localized Squamous Cell Carcinoma of the Anal Canal&sequencial=31&nomePeriodico=Journal of Gastrointestinal Cancer (Print)" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>32. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>ALENCAR, R. S. S. M.</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2016</span>ALENCAR, R. S. S. M. ; Luciana Kikuchi ; TANI, C. M. ; CHAGAS, A. L. ; Pfiffer TE ; <b>Hoff, Paulo M. G.</b> . Better Management of Adverse Events Favors Sorafenib Treatment of HCC Patients and Impact on Survival. Journal of Cancer Therapy (Print)<sup><img id='21511934_32' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='21511934' /></sup>, v. 7, p. 275-284, 2016. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=&issn=21511934&volume=7&issue=&paginaInicial=275-284&titulo=Better Management of Adverse Events Favors Sorafenib Treatment of HCC Patients and Impact on Survival&sequencial=32&nomePeriodico=Journal of Cancer Therapy (Print)" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>33. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>MEGALE, ÂNGELA ALICE AMADEU</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2016</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.4236/jct.2016.72015" target="_blank"></a>MEGALE, ÂNGELA ALICE AMADEU ; JÚNIOR, JORGE MÁRIO DA COSTA FERREIRA ; RANGEL, LETÍCIA BATISTA AZEVEDO ; DIZ, MARIA DEL PILAR ESTEVEZ ; MANO, MAX SENNA ; <b>HOFF, PAULO MARCELO GEHM</b> ; LOPES, PRISCILA HESS ; ARAI, ROBERTO JUN ; DA SILVA, WILMAR DIAS . Novel Immunogenic Epitopes in the NaPi-IIb Protein: Production of Monospecific Antibodies Using Synthetic Peptides Outlined on Isoform Specific Regions of the Type IIb Sodium-Dependent Phosphate Transporter (NaPi-IIb). Journal of Cancer Therapy (Print)<sup><img id='21511934_33' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='21511934' /></sup>, v. 07, p. 129-151, 2016. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.4236/jct.2016.72015&issn=21511934&volume=07&issue=&paginaInicial=129&titulo=Novel Immunogenic Epitopes in the NaPi-IIb Protein: Production of Monospecific Antibodies Using Synthetic Peptides Outlined on Isoform Specific Regions of the Type IIb Sodium-Dependent Phosphate Transporter (NaPi-IIb)&sequencial=33&nomePeriodico=Journal of Cancer Therapy (Print)" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>34. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>MIRANDA, VANESSA DA COSTA</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2016</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1016/j.clcc.2016.04.011" target="_blank"></a>MIRANDA, VANESSA DA COSTA ; Braghiroli, Maria Ignez ; FARIA, LUIZA DIB ; BARIANI, GIOVANNI ; ALEX, ALEXANDRA ; BEZERRA NETO, JOÃO EVANGELISTA ; CAPARELI, FERNANDA C. ; Sabbaga, Jorge ; SANTOS, JULIANA FERREIRA LOBO DOS ; <b>HOFF, PAULO M.</b> ; RIECHELMANN, RACHEL P. . METFU: a phase II trial of metformin combined with 5FU in patients with refractory metastatic colorectal cancer. Clinical Colorectal Cancer<sup><img id='15330028_34' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='15330028' /></sup>, v. 1, p. 1, 2016. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1016/j.clcc.2016.04.011&issn=15330028&volume=1&issue=&paginaInicial=1&titulo=METFU: a phase II trial of metformin combined with 5FU in patients with refractory metastatic colorectal cancer&sequencial=34&nomePeriodico=Clinical Colorectal Cancer" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>35. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>XAVIER, F. D.</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2016</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1200/JGO.2015.002527" target="_blank"></a>XAVIER, F. D. ; <b>HOFF, P. M. G.</b> ; BRAGHIROLI, M. I. ; PATERLINI, A. C. C. R. ; SOUZA, K. T. ; FARIA, L. D. B. B. ; FERREIRA, F. S. B. ; MACHADO, K. K. ; FERNANDES, G. D. S. . Rivaroxaban: An Affordable and Effective Alternative in Cancer-Related Thrombosis?. Journal of Global Oncology<sup><img id='23789506_35' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='23789506' /></sup>, v. 1, p. 1-8, 2016. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1200/JGO.2015.002527&issn=23789506&volume=1&issue=&paginaInicial=1&titulo=Rivaroxaban: An Affordable and Effective Alternative in Cancer-Related Thrombosis?&sequencial=35&nomePeriodico=Journal of Global Oncology" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>36. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>PROTÁSIO, BRUNO MENDONÇA</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2016</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1016/j.clcc.2016.07.001" target="_blank"></a>PROTÁSIO, BRUNO MENDONÇA ; MATUTINO, ADRIANA ; LAGE, LIANA VALENTE ; SANTANA, IURI ; RAMOS, RICARDO ; Sabbaga, Jorge ; CAPARELI, FERNANDA ; SARAGIOTTO, DANIEL ; RIECHELMANN, RACHEL ; <b>HOFF, PAULO</b> . Safety and efficacy of a modified FLOX adjuvant regimen for patients with stage III colorectal cancer treated in the community. Clinical Colorectal Cancer<sup><img id='15330028_36' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='15330028' /></sup>, v. 1, p. 1, 2016. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1016/j.clcc.2016.07.001&issn=15330028&volume=1&issue=&paginaInicial=1&titulo=Safety and efficacy of a modified FLOX adjuvant regimen for patients with stage III colorectal cancer treated in the community&sequencial=36&nomePeriodico=Clinical Colorectal Cancer" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>37. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>SHAH, MANISH A.</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2016</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1158/1538-7445.AM2016-CT108" target="_blank"></a>SHAH, MANISH A. ; XU, RUIHUA ; BANG, YUNG-JUE ; <b>HOFF, PAULO M.</b> ; LIU, TIANSHU ; HERRAEZ-BARANDA, LUIS A. ; XIA, FAN ; GARG, AMIT ; SHING, MONA ; TABERNERO, JOSEP . Abstract CT108: HELOISE: phase IIIB randomized multicenter study comparing two trastuzumab (H) dose regimens combined with chemotherapy (CT) as first-line (1L) therapy in patients (pts) with HER2-positive metastatic gastric/gastroesophageal junction adenocarcinoma (mGC/GEJC):. CANCER RESEARCH<sup><img id='00085472_37' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='00085472' /></sup>, v. 76, p. CT108-CT108, 2016. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1158/1538-7445.AM2016-CT108&issn=00085472&volume=76&issue=&paginaInicial=CT108&titulo=Abstract CT108: HELOISE: phase IIIB randomized multicenter study comparing two trastuzumab (H) dose regimens combined with chemotherapy (CT) as first-line (1L) therapy in patients (pts) with HER2-positive metastatic gastric/gastroesophageal junction adenocarcinoma (mGC/GEJC):&sequencial=37&nomePeriodico=CANCER RESEARCH" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>38. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>DE CASTRONEVES, LUCIANA AUDI</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2016</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1089/thy.2015.0334" target="_blank"></a>DE CASTRONEVES, LUCIANA AUDI ; NEGRÃO, MARCELO VAILATI ; DE FREITAS, RICARDO MIGUEL COSTA ; PAPADIA, CARLA ; LIMA, JOSÉ VIANA ; Fukushima, Julia T. ; SIMÃO, EDUARDO FURQUIM ; KULCSAR, MARCO AURÉLIO VAMONDES ; TAVARES, MARCOS ROBERTO ; JORGE, ALEXANDER AUGUSTO DE LIMA ; DE CASTRO, GILBERTO ; <b>HOFF, Paulo Marcelo</b> ; HOFF, ANA OLIVEIRA . Sorafenib for the Treatment of Progressive Metastatic Medullary Thyroid Cancer: Efficacy and Safety Analysis. Thyroid (New York)<sup><img id='10507256_38' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='10507256' /></sup>, v. 26, p. 414-419, 2016. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1089/thy.2015.0334&issn=10507256&volume=26&issue=&paginaInicial=414&titulo=Sorafenib for the Treatment of Progressive Metastatic Medullary Thyroid Cancer: Efficacy and Safety Analysis&sequencial=38&nomePeriodico=Thyroid (New York)" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>39. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>ALEX, ALEXANDRA KHICHFY</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2016</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1016/j.clcc.2016.11.001" target="_blank"></a>ALEX, ALEXANDRA KHICHFY ; SIQUEIRA, SHEILA ; COUDRY, RENATA ; SANTOS, JULIANA ; ALVES, MICHEL ; <b>HOFF, PAULO M.</b> ; RIECHELMANN, RACHEL P. . Response to Chemotherapy and Prognosis in Metastatic Colorectal Cancer With DNA Deficient Mismatch Repair. Clinical Colorectal Cancer<sup><img id='15330028_39' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='15330028' /></sup>, v. 1, p. 1, 2016. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1016/j.clcc.2016.11.001&issn=15330028&volume=1&issue=&paginaInicial=1&titulo=Response to Chemotherapy and Prognosis in Metastatic Colorectal Cancer With DNA Deficient Mismatch Repair&sequencial=39&nomePeriodico=Clinical Colorectal Cancer" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>40. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>SOUZA, KARLA T</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2016</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.3332/ecancer.2016.699" target="_blank"></a>SOUZA, KARLA T ; PEREIRA, ALL ; ARAUJO, RAPHAEL L ; COELHO RIBEIRO OLIVEIRA, SUILANE ; <b>HOFF, PAULO M</b> ; RIECHELMANN, RACHEL P . Replacing 5-fluorouracil by capecitabine in localised squamous cell carcinoma of the anal canal: systematic review and meta-analysis. ECANCERMEDICALSCIENCE<sup><img id='17546605_40' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='17546605' /></sup>, v. 10, p. 1, 2016. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.3332/ecancer.2016.699&issn=17546605&volume=10&issue=&paginaInicial=1&titulo=Replacing 5-fluorouracil by capecitabine in localised squamous cell carcinoma of the anal canal: systematic review and meta-analysis&sequencial=40&nomePeriodico=ECANCERMEDICALSCIENCE" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>41. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>MOTA, JOSE MAURICIO</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2016</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1016/j.critrevonc.2016.05.015" target="_blank"></a>MOTA, JOSE MAURICIO ; FONSECA, LEONARDO G. ; Braghiroli, Maria Ignez ; <b>HOFF, PAULO M.</b> . Review on TAS-102 development and its use for metastatic colorectal cancer. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY<sup><img id='10408428_41' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='10408428' /></sup>, v. 104, p. 91-97, 2016. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1016/j.critrevonc.2016.05.015&issn=10408428&volume=104&issue=&paginaInicial=91&titulo=Review on TAS-102 development and its use for metastatic colorectal cancer&sequencial=41&nomePeriodico=CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>42. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>FREIRE, M. P.</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2015</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1007/s10096-014-2233-5" target="_blank"></a>FREIRE, M. P. ; PIERROTTI, L. C. ; FILHO, H. H. C. ; IBRAHIM, K. Y. ; MAGRI, A. S. G. K. ; BONAZZI, P. R. ; HAJAR, L. ; DIZ, M. P. E. ; <a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/9234342804994191" target="_blank">PEREIRA, J.</a> ; <b>HOFF, P. M.</b> ; ABDALA, E. . Infection with Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae in cancer patients. European Journal of Clinical Microbiology & Infectious Diseases (Print)<sup><img id='09349723_42' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='09349723' /></sup>, v. 34, p. 277-286, 2015. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1007/s10096-014-2233-5&issn=09349723&volume=34&issue=&paginaInicial=277&titulo=Infection with Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae in cancer patients&sequencial=42&nomePeriodico=European Journal of Clinical Microbiology & Infectious Diseases (Print)" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>43. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>PEREIRA, ALLAN ANDRESSON LIMA</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2015</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.3109/0284186x.2015.1044022" target="_blank"></a>PEREIRA, ALLAN ANDRESSON LIMA ; REGO, JULIANA FLORINDA DE MENDONÇA ; MUNHOZ, RODRIGO RAMELA ; <b>HOFF, Paulo Marcelo</b> ; SASSE, ANDRE DEEKE ; RIECHELMANN, RACHEL P. . The impact of complete chemotherapy stop on the overall survival of patients with advanced colorectal cancer in first-line setting: A meta-analysis of randomized trials. Acta Oncologica (Stockholm)<sup><img id='0284186X_43' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='0284186X' /></sup>, v. 1, p. 1-10, 2015. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.3109/0284186x.2015.1044022&issn=0284186X&volume=1&issue=&paginaInicial=1&titulo=The impact of complete chemotherapy stop on the overall survival of patients with advanced colorectal cancer in first-line setting: A meta-analysis of randomized trials&sequencial=43&nomePeriodico=Acta Oncologica (Stockholm)" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>44. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>PETRY, V.</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2015</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1590/1414-431x20144354" target="_blank"></a>PETRY, V. ; GAGLIATO, D.M. ; LEAL, A.I.C. ; ARAI, R.J. ; LONGO, E. ; ANDRADE, F. ; <a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/0859257055321927" target="_blank">RICCI, M.D.</a> ; PIATO, J.R. ; BARROSO-SOUSA, R. ; <b>HOFF, P.M.</b> ; MANO, M.S. . Metronomic chemotherapy in the neoadjuvant setting: results of two parallel feasibility trials (TraQme and TAME) in patients with HER2+ and HER2&#8722; locally advanced breast cancer. Brazilian journal of medical and biological research<sup><img id='1414431X_44' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='1414431X' /></sup>, v. 00, p. 000-000, 2015. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1590/1414-431x20144354&issn=1414431X&volume=00&issue=&paginaInicial=000&titulo=Metronomic chemotherapy in the neoadjuvant setting: results of two parallel feasibility trials (TraQme and TAME) in patients with HER2+ and HER2&#8722; locally advanced breast cancer&sequencial=44&nomePeriodico=Brazilian journal of medical and biological research" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>45. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>GIRARDI, DANIEL DA MOTTA</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2015</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.4322/acr.2015.008" target="_blank"></a>GIRARDI, DANIEL DA MOTTA ; SILVA, DOUGLAS RAFAEL ALMEIDA ; VILLAÇA, PAULA RIBEIRO ; SOUZA, CIRO EDUARDO ; FONSECA, LEONARDO GOMES DA ; BASTOS, DIOGO ASSED ; <b>HOFF, PAULO MARCELO GEHM</b> . Acquired hemophilia A in a patient with advanced prostate cancer. Autopsy and Case Reports<sup><img id='22361960_45' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='22361960' /></sup>, v. 5, p. 45-48, 2015. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.4322/acr.2015.008&issn=22361960&volume=5&issue=&paginaInicial=45&titulo=Acquired hemophilia A in a patient with advanced prostate cancer&sequencial=45&nomePeriodico=Autopsy and Case Reports" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>46. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>CAIRES, INACELLI QUEIROZ DE SOUZA</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2015</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1016/j.ejogrb.2015.05.007" target="_blank"></a>CAIRES, INACELLI QUEIROZ DE SOUZA ; SOUZA, KARLA TEIXEIRA ; NEGRÃO, MARCELO VAILATI ; OLIVEIRA, JULIA ANDRADE DE ; BARROSO-SOUSA, ROMUALDO ; LIMA, RAFAEL CAIRES ALVINO DE ; <b>HOFF, PAULO MARCELO GEHM</b> ; DIZ, MARIA DEL PILAR ESTEVEZ . Definitive chemoradiotherapy for advanced cervical cancer: should it be different in the elderly?. European Journal of Obstetrics, Gynecology, and Reproductive Biology<sup><img id='03012115_46' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='03012115' /></sup>, v. 1, p. 86-89, 2015. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1016/j.ejogrb.2015.05.007&issn=03012115&volume=1&issue=&paginaInicial=86&titulo=Definitive chemoradiotherapy for advanced cervical cancer: should it be different in the elderly?&sequencial=46&nomePeriodico=European Journal of Obstetrics, Gynecology, and Reproductive Biology" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>47. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Braghiroli, Maria Ignez</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2015</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.3332/ecancer.2015.563" target="_blank"></a>Braghiroli, Maria Ignez ; DE CELIS FERRARI, ANEZKA C R ; PFIFFER, TULIO EDOUARDO ; KICHFY ALEX, ALEXANDRA ; NEBULONI, DANIELA ; CARNEIRO, ALLYNE S ; CAPARELLI, FERNANDA ; SENNA, LUIZ ; LOBO, JULIANA ; <b>HOFF, Paulo Marcelo</b> ; RIECHELMANN, RACHEL P . Phase II trial of metformin and paclitaxel for patients with gemcitabine-refractory advanced adenocarcinoma of the pancreas. ecancermedicalscience<sup><img id='17546605_47' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='17546605' /></sup>, v. 9, p. 1-3, 2015. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.3332/ecancer.2015.563&issn=17546605&volume=9&issue=&paginaInicial=1&titulo=Phase II trial of metformin and paclitaxel for patients with gemcitabine-refractory advanced adenocarcinoma of the pancreas&sequencial=47&nomePeriodico=ecancermedicalscience" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>48. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>MUNHOZ, RODRIGO R.</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2015</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1001/jamaoncol.2015.3251" target="_blank"></a>MUNHOZ, RODRIGO R. ; PEREIRA, ALLAN A. L. ; SASSE, ANDRÉ D. ; <b>HOFF, PAULO M.</b> ; TRAINA, TIFFANY A. ; HUDIS, CLIFFORD A. ; MARQUES, RICARDO J. . Gonadotropin-Releasing Hormone Agonists for Ovarian Function Preservation in Premenopausal Women Undergoing Chemotherapy for Early-Stage Breast Cancer. JAMA Oncology<sup><img id='23742437_48' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='23742437' /></sup>, v. 1, p. 1, 2015. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1001/jamaoncol.2015.3251&issn=23742437&volume=1&issue=&paginaInicial=1&titulo=Gonadotropin-Releasing Hormone Agonists for Ovarian Function Preservation in Premenopausal Women Undergoing Chemotherapy for Early-Stage Breast Cancer&sequencial=48&nomePeriodico=JAMA Oncology" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>49. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>GARCIA, GH</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2015</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.6061/clinics/2015(10)07" target="_blank"></a>GARCIA, GH ; RIECHELMANN, RP ; <b>HOFF, PM</b> . Adherence to colonoscopy recommendations for first-degree relatives of young patients diagnosed with colorectal cancer. Clinics (USP. Impresso)<sup><img id='18075932_49' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='18075932' /></sup>, v. 70, p. 696-699, 2015. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.6061/clinics/2015(10)07&issn=18075932&volume=70&issue=&paginaInicial=696&titulo=Adherence to colonoscopy recommendations for first-degree relatives of young patients diagnosed with colorectal cancer&sequencial=49&nomePeriodico=Clinics (USP. Impresso)" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>50. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>SANTINI, FERNANDO COSTA</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2015</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1007/s11888-015-0294-1" target="_blank"></a>SANTINI, FERNANDO COSTA ; Braghiroli, Maria Ignez ; <b>HOFF, PAULO M.</b> . Are There Strategies to Integrate the Continuum of Care for Metastatic Colorectal Cancer When Resources Are Limited?. Current Colorectal Cancer Reports<sup><img id='15563790_50' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='15563790' /></sup>, v. 11, p. 311-316, 2015. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1007/s11888-015-0294-1&issn=15563790&volume=11&issue=&paginaInicial=311&titulo=Are There Strategies to Integrate the Continuum of Care for Metastatic Colorectal Cancer When Resources Are Limited?&sequencial=50&nomePeriodico=Current Colorectal Cancer Reports" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>51. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>CHEN, Z-Y</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2015</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1038/bjc.2015.61" target="_blank"></a>CHEN, Z-Y ; RAGHAV, K ; LIEU, C H ; JIANG, Z-Q ; ENG, C ; VAUTHEY, J-N ; CHANG, G J ; QIAO, W ; MORRIS, J ; HONG, D ; <b>HOFF, P</b> ; TRAN, H ; MENTER, D G ; HEYMACH, J ; OVERMAN, M ; Kopetz, S . Cytokine profile and prognostic significance of high neutrophil-lymphocyte ratio in colorectal cancer. British Journal of Cancer<sup><img id='00070920_51' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='00070920' /></sup>, v. 112, p. 1088-1097, 2015. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1038/bjc.2015.61&issn=00070920&volume=112&issue=&paginaInicial=1088&titulo=Cytokine profile and prognostic significance of high neutrophil-lymphocyte ratio in colorectal cancer&sequencial=51&nomePeriodico=British Journal of Cancer" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>52. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>TEFFERI, AYALEW</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2015</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1016/j.mayocp.2015.06.001" target="_blank"></a>TEFFERI, AYALEW KANTARJIAN, HAGOP RAJKUMAR, S. VINCENT BAKER, LAWRENCE H. ABKOWITZ, JAN L. ADAMSON, JOHN W. ADVANI, RANJANA HIRA ALLISON, JAMES ANTMAN, KAREN H. BAST, ROBERT C. BENNETT, JOHN M. BENZ, EDWARD J. BERLINER, NANCY BERTINO, JOSEPH BHATIA, RAVI BHATIA, SMITA BHOJWANI, DEEPA Blanke, Charles D. BLOOMFIELD, CLARA D. BOSSERMAN, LINDA BROXMEYER, HAL E. BYRD, JOHN C. CABANILLAS, FERNANDO CANELLOS, GEORGE PETER CHABNER, BRUCE A. ,  <a title="Clique para visualizar todos os autores" class="tooltip autores-et-al-plus" href="javascript:void(0)">et al.<span></span></a><span class='autores-et-al'>CHANAN-KHAN, ASHER CHESON, BRUCE CLARKSON, BAYARD COHN, SUSAN L. COLON-OTERO, GERARDO CORTES, JORGE COUTRE, STEVEN CRISTOFANILLI, MASSIMO CURRAN, WALTER J. DALEY, GEORGE Q. DEANGELO, DANIEL J. DEEG, H. JOACHIM EINHORN, LAWRENCE H. ERBA, HARRY P. ESTEVA, FRANCISCO J. ESTEY, ELIHU FIDLER, ISAIAH J. FORAN, JAMES FORMAN, STEPHEN FREIREICH, EMIL FUCHS, CHARLES GEORGE, JAMES N. GERTZ, MORIE A. GIRALT, SERGIO GOLOMB, HARVEY GREENBERG, PETER GUTTERMAN, JORDAN HANDIN, ROBERT I. HELLMAN, SAMUEL <b>HOFF, Paulo Marcelo</b> HOFFMAN, RONALD HONG, WAUN KI HOROWITZ, MARY Hortobagyi, Gabriel N. HUDIS, CLIFFORD ISSA, JEAN PIERRE JOHNSON, BRUCE EVAN KANTOFF, PHILIP W. KAUSHANSKY, KENNETH KHAYAT, DAVID KHURI, FADLO R. KIPPS, THOMAS J. KRIPKE, MARGARET KYLE, ROBERT A. LARSON, RICHARD A. LAWRENCE, THEODORE S. LEVINE, ROSS LINK, MICHAEL P. LIPPMAN, SCOTT M. LONIAL, SAGAR LYMAN, GARY H. MARKMAN, MAURIE MENDELSOHN, JOHN MEROPOL, NEAL J. MESSINGER, YOAV MULVEY, THERESE M. O?BRIEN, SUSAN PEREZ-SOLER, ROMAN POLLOCK, RAPHAEL PRCHAL, JOSEF PRESS, OLIVER RADICH, JERALD RAI, KANTI ROSENBERG, SAUL A. ROWE, JACOB M. RUGO, HOPE RUNOWICZ, CAROLYN D. SANDMAIER, BRENDA M. SAVEN, ALAN SCHAFER, ANDREW I. SCHIFFER, CHARLES SEKERES, MIKKAEL A. SILVER, RICHARD T. SIU, LILLIAN L. STEENSMA, DAVID P. STEWART, F. MARC STOCK, WENDY STONE, RICHARD STORB, RAINER STRONG, LOUISE C. TALLMAN, MARTIN S. THOMPSON, MICHAEL UENO, NAOTO T. VAN ETTEN, RICHARD A. VOSE, JULIE M. WIERNIK, PETER H. WINER, ERIC P. YOUNES, ANAS ZELENETZ, ANDREW D. LEMAISTRE, CHARLES A. <a href="javascript:void(0)" title="Clique para ocultar os autores" class="tooltip autores-et-al-minus"></a></span> ; In Support of a Patient-Driven Initiative and Petition to Lower the High Price of Cancer Drugs. Mayo Clinic Proceedings<sup><img id='00256196_52' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='00256196' /></sup>, v. 90, p. 996-1000, 2015. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1016/j.mayocp.2015.06.001&issn=00256196&volume=90&issue=&paginaInicial=996&titulo=In Support of a Patient-Driven Initiative and Petition to Lower the High Price of Cancer Drugs&sequencial=52&nomePeriodico=Mayo Clinic Proceedings" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>53. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>VAN CUTSEM, ERIC</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2015</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1007/s11523-015-0402-9" target="_blank"></a>VAN CUTSEM, ERIC ; JOULAIN, FLORENCE ; <b>HOFF, PAULO M.</b> ; MITCHELL, EDITH ; RUFF, PAUL ; LAKOMÝ, RADEK ; PRAUSOVÁ, JANA ; MOISEYENKO, VLADIMIR M. ; VAN HAZEL, GUY ; CUNNINGHAM, DAVID ; ARNOLD, DIRK ; SCHMOLL, HANS-JOACHIM ; TEN TIJE, ALBERT J. ; MCKENDRICK, JOSEPH ; KRÖNING, HENDRIK ; HUMBLET, YVES ; GRÁVALOS, CRISTINA ; LE-GUENNEC, SOLENN ; ANDRIA, MICHAEL ; DOCHY, EMMANUELLE ; VISHWANATH, RAGHU L. ; MACARULLA, TERESA ; TABERNERO, JOSEP . Aflibercept Plus FOLFIRI vs. Placebo Plus FOLFIRI in Second-Line Metastatic Colorectal Cancer: a Post Hoc Analysis of Survival from the Phase III VELOUR Study Subsequent to Exclusion of Patients who had Recurrence During or Within 6&nbsp;Months of Completing Adjuvant Oxaliplatin-Based Therapy. Targeted Oncology<sup><img id='17762596_53' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='17762596' /></sup>, v. 1, p. 1-17, 2015. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1007/s11523-015-0402-9&issn=17762596&volume=1&issue=&paginaInicial=1&titulo=Aflibercept Plus FOLFIRI vs. Placebo Plus FOLFIRI in Second-Line Metastatic Colorectal Cancer: a Post Hoc Analysis of Survival from the Phase III VELOUR Study Subsequent to Exclusion of Patients who had Recurrence During or Within 6&nbsp;Months of Completing Adjuvant Oxaliplatin-Based Therapy&sequencial=53&nomePeriodico=Targeted Oncology" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>54. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>RUFF, PAUL</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2015</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1016/j.ejca.2014.10.019" target="_blank"></a>RUFF, PAUL ; FERRY, DAVID R. ; LAKOM', RADEK ; PRAUSOVÁ, JANA ; VAN HAZEL, GUY A. ; <b>HOFF, PAULO M.</b> ; CUNNINGHAM, DAVID ; ARNOLD, DIRK ; SCHMOLL, HANS J. ; MOISEYENKO, VLADIMIR M. ; MCKENDRICK, JOSEPH J. ; TEN TIJE, ALBERT J. ; VISHWANATH, RAGHU L. ; BHARGAVA, PANKAJ ; CHEVALIER, SOAZIG ; MACARULLA, TERESA ; VAN CUTSEM, ERIC . Time course of safety and efficacy of aflibercept in combination with FOLFIRI in patients with metastatic colorectal cancer who progressed on previous oxaliplatin-based therapy. European Journal of Cancer<sup><img id='09598049_54' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='09598049' /></sup>, v. 51, p. 18-26, 2015. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1016/j.ejca.2014.10.019&issn=09598049&volume=51&issue=&paginaInicial=18&titulo=Time course of safety and efficacy of aflibercept in combination with FOLFIRI in patients with metastatic colorectal cancer who progressed on previous oxaliplatin-based therapy&sequencial=54&nomePeriodico=European Journal of Cancer" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>55. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>COSTA MIRANDA, VANESSA</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2014</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1007/s12029-013-9568-5" target="_blank"></a>COSTA MIRANDA, VANESSA ; Braghiroli, Maria Ignez ; FARIA, LUIZA DIB BATISTA BUGIATO ; SIQUEIRA, SHEILA APARECIDA COELHO ; Sabbaga, Jorge ; <b>HOFF, PAULO M.</b> ; RIECHELMANN, RACHEL P. . ERCC1 in Advanced Biliary Tract Cancer Patients Treated with Chemotherapy: Prognostic and Predictive Roles. Journal of Gastrointestinal Cancer (Print)<sup><img id='19416628_55' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='19416628' /></sup>, v. 45, p. 80-86, 2014. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1007/s12029-013-9568-5&issn=19416628&volume=45&issue=&paginaInicial=80&titulo=ERCC1 in Advanced Biliary Tract Cancer Patients Treated with Chemotherapy: Prognostic and Predictive Roles&sequencial=55&nomePeriodico=Journal of Gastrointestinal Cancer (Print)" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>56. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>HOFF, P.M.</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2014</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1200/jco.2013.50.8077" target="_blank"></a><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P.M.</a></b>; SARAGIOTTO, D. F. ; Barrios CH ; <a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/0925776607072404" target="_blank">del Giglio, A.</a> ; Coutinho, Anelisa K. ; Andrade AC ; Dutra C ; Forones NM ; Correa M ; do Socorro O Portella M ; Passos VQ ; Chinen RN ; Van Eyll, B. . Randomized Phase III Trial Exploring the Use of Long-Acting Release Octreotide in the Prevention of Chemotherapy-Induced Diarrhea in Patients With Colorectal Cancer: The LARCID Trial. Journal of Clinical Oncology<sup><img id='0732183X_56' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='0732183X' /></sup>, v. 32, p. 1006-1011, 2014. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1200/jco.2013.50.8077&issn=0732183X&volume=32&issue=&paginaInicial=1006&titulo=Randomized Phase III Trial Exploring the Use of Long-Acting Release Octreotide in the Prevention of Chemotherapy-Induced Diarrhea in Patients With Colorectal Cancer: The LARCID Trial&sequencial=56&nomePeriodico=Journal of Clinical Oncology" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>57. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>TESTA, LAURA</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2014</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1007/s11888-014-0213-x" target="_blank"></a>TESTA, LAURA ; Braghiroli, Maria Ignez ; HERMAN, PAULO ; <b>HOFF, PAULO M.</b> . Management of Colon Cancer and Liver Metastases: Is There a Role for Molecularly Targeted Agents?. Current Colorectal Cancer Reports<sup><img id='15563790_57' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='15563790' /></sup>, v. 9, p. 317-325, 2014. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1007/s11888-014-0213-x&issn=15563790&volume=9&issue=&paginaInicial=317&titulo=Management of Colon Cancer and Liver Metastases: Is There a Role for Molecularly Targeted Agents?&sequencial=57&nomePeriodico=Current Colorectal Cancer Reports" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>58. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>HOFF, P M</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2014</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1038/bjc.2014.619" target="_blank"></a><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P M</a></b>; LIMA, A. A. P. ; REGO, JULIANA FLORINDA DE MENDONCA ; MORRIS, V. K. ; Overman M ; ENG, C . Association between KRAS mutation and lung metastasis in advanced colorectal cancer. British Journal of Cancer<sup><img id='00070920_58' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='00070920' /></sup>, p. 424--428, 2014. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1038/bjc.2014.619&issn=00070920&volume=&issue=&paginaInicial=424-&titulo=Association between KRAS mutation and lung metastasis in advanced colorectal cancer&sequencial=58&nomePeriodico=British Journal of Cancer" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>59. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>K, V.</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2014</span>K, V. ; <b>HOFF, P M</b> ; RIBEIRO, U. ; CHEN, A. ; CV, H. . Liver Irradiation Increases Relapse-Free Survival in Adjuvant Gastric Cancer Treatment. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS<sup><img id='1879355X_59' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='1879355X' /></sup>, v. 87, p. S301-S301, 2014. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=&issn=1879355X&volume=87&issue=&paginaInicial=S301-S301&titulo=Liver Irradiation Increases Relapse-Free Survival in Adjuvant Gastric Cancer Treatment&sequencial=59&nomePeriodico=INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>60. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>HOFF, P M</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2014</span><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P M</a></b>; Elias D ; LG, F. ; SILVA, F. ; PFR, M. . Ovarian adenosarcoma simulating a simple cyst a young patient. Autopsy and Case Reports<sup><img id='22361960_60' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='22361960' /></sup>, v. 4, p. 55-60, 2014. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=&issn=22361960&volume=4&issue=&paginaInicial=55-60&titulo=Ovarian adenosarcoma simulating a simple cyst a young patient&sequencial=60&nomePeriodico=Autopsy and Case Reports" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>61. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>DA FONSECA, LEONARDO GOMES</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2014</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.4081/cp.2014.635" target="_blank"></a>DA FONSECA, LEONARDO GOMES ; BARROSO-SOUSA, ROMUALDO ; Sabbaga, Jorge ; <b>HOFF, Paulo Marcelo</b> . Acute acalculous cholecystitis in a patient with metastatic renal cell carcinoma treated with sunitinib. Clinics and Practice<sup><img id='20397283_61' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='20397283' /></sup>, v. 4, p. 24-25, 2014. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.4081/cp.2014.635&issn=20397283&volume=4&issue=&paginaInicial=24&titulo=Acute acalculous cholecystitis in a patient with metastatic renal cell carcinoma treated with sunitinib&sequencial=61&nomePeriodico=Clinics and Practice" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>62. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>GOMES DA FONSECA, LEONARDO</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2014</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1159/000365950" target="_blank"></a>GOMES DA FONSECA, LEONARDO ; DE MELO GAGLIATO, DEBORA ; Takahashi, Tiago K. ; PEREZ MAK, MILENA ; BARROSO-SOUSA, ROMUALDO ; TESTA, LAURA ; PETRY HELENA, VANESSA ; DE PAULA COSTA, ROMULO ; <b>HOFF, PAULO M.</b> ; MANO, MAX S. . Cardiac Safety of (Neo)Adjuvant Trastuzumab in the Community Setting: A Single-Center Experience. Breast Care<sup><img id='16613805_62' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='16613805' /></sup>, v. 9, p. 3-3, 2014. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1159/000365950&issn=16613805&volume=9&issue=&paginaInicial=3&titulo=Cardiac Safety of (Neo)Adjuvant Trastuzumab in the Community Setting: A Single-Center Experience&sequencial=62&nomePeriodico=Breast Care" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>63. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>DA FONSECA, LEONARDO GOMES</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2014</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1007/s12032-014-0264-5" target="_blank"></a>DA FONSECA, LEONARDO GOMES ; BARROSO-SOUSA, ROMULADO ; BENTO, AFONSO DA SILVA ALVES ; BLANCO, BRUNA PACCOLA ; VALENTE, GABRIEL LUIS ; PFIFFER, TULIO EDUARDO FLESCH ; <b>HOFF, Paulo Marcelo</b> ; Sabbaga, Jorge . Pre-treatment neutrophil-to-lymphocyte ratio affects survival in patients with advanced hepatocellular carcinoma treated with sorafenib. Medical Oncology (Northwood)<sup><img id='13570560_63' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='13570560' /></sup>, v. 31, p. 31-31, 2014. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1007/s12032-014-0264-5&issn=13570560&volume=31&issue=&paginaInicial=31&titulo=Pre-treatment neutrophil-to-lymphocyte ratio affects survival in patients with advanced hepatocellular carcinoma treated with sorafenib&sequencial=63&nomePeriodico=Medical Oncology (Northwood)" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>64. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>SANTANA, IURI A.</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2014</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1007/s12282-014-0564-9" target="_blank"></a>SANTANA, IURI A. ; OLIVEIRA, JULIA ANDRADE ; DA SILVA LIMA, JULIANNE MARIA ; TESTA, LAURA ; PIATO, JOSÉ ROBERTO M. ; <b>HOFF, PAULO M.</b> ; MANO, MAX S. . Feasibility of two schedules of weekly paclitaxel in HER2-negative early breast cancer in a Brazilian community setting. Breast Cancer (Tokyo. 1994)<sup><img id='13406868_64' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='13406868' /></sup>, v. 9, p. 1, 2014. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1007/s12282-014-0564-9&issn=13406868&volume=9&issue=&paginaInicial=1&titulo=Feasibility of two schedules of weekly paclitaxel in HER2-negative early breast cancer in a Brazilian community setting&sequencial=64&nomePeriodico=Breast Cancer (Tokyo. 1994)" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>65. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>CROSARA TEIXEIRA, MARCELA</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2014</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1016/j.clcc.2014.09.010" target="_blank"></a>CROSARA TEIXEIRA, MARCELA ; MARQUES, DANIEL FERNANDES ; FERRARI, ANEZKA CELIS ; ALVES, MICHEL FABIANO SILVA ; ALEX, ALEXANDRA KHICHFY ; Sabbaga, Jorge ; <b>HOFF, PAULO M.</b> ; RIECHELMANN, RACHEL P. . The effects of palliative chemotherapy in metastatic colorectal cancer patients with an ECOG perfomance status of 3 and 4. Clinical Colorectal Cancer<sup><img id='15330028_65' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='15330028' /></sup>, v. 14, p. 52-57, 2014. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1016/j.clcc.2014.09.010&issn=15330028&volume=14&issue=&paginaInicial=52&titulo=The effects of palliative chemotherapy in metastatic colorectal cancer patients with an ECOG perfomance status of 3 and 4&sequencial=65&nomePeriodico=Clinical Colorectal Cancer" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>66. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>HOFF, P.M.</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2014</span><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P.M.</a></b>; GARICOCHEA, B. ; Leal A ; FERREIRA, F. S. B. ; VILELA, V. A. L. ; NOVIS, Y. S. . Angioimmunoblastic T-Cell Lymphoma: Clinical Aspects and Recent Advances In Biology and Therapy. Journal of Analytical Oncology<sup><img id='19277210_66' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='19277210' /></sup>, v. 3, p. 191-200, 2014. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=&issn=19277210&volume=3&issue=&paginaInicial=191-200&titulo=Angioimmunoblastic T-Cell Lymphoma: Clinical Aspects and Recent Advances In Biology and Therapy&sequencial=66&nomePeriodico=Journal of Analytical Oncology" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>67. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>SHI, Q.</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2014</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1200/JCO.2014.56.5887" target="_blank"></a>SHI, Q. DE GRAMONT, A. GROTHEY, A. ZALCBERG, J. CHIBAUDEL, B. Schmoll, H.-J. SEYMOUR, M. T. ADAMS, R. SALTZ, L. GOLDBERG, R. M. PUNT, C. J. A. Douillard, J.-Y. <b>HOFF, P. M.</b> HECHT, J. R. HURWITZ, H. DIAZ-RUBIO, E. PORSCHEN, R. TEBBUTT, N. C. FUCHS, C. SOUGLAKOS, J. FALCONE, A. TOURNIGAND, C. KABBINAVAR, F. F. HEINEMANN, V. Van Cutsem, E. ,  <a title="Clique para visualizar todos os autores" class="tooltip autores-et-al-plus" href="javascript:void(0)">et al.<span></span></a><span class='autores-et-al'>BOKEMEYER, C. BUYSE, M. SARGENT, D. J. <a href="javascript:void(0)" title="Clique para ocultar os autores" class="tooltip autores-et-al-minus"></a></span> ; Individual Patient Data Analysis of Progression-Free Survival Versus Overall Survival As a First-Line End Point for Metastatic Colorectal Cancer in Modern Randomized Trials: Findings From the Analysis and Research in Cancers of the Digestive System Database. Journal of Clinical Oncology<sup><img id='0732183X_67' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='0732183X' /></sup>, v. 33, p. 22-28, 2014. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1200/JCO.2014.56.5887&issn=0732183X&volume=33&issue=&paginaInicial=22&titulo=Individual Patient Data Analysis of Progression-Free Survival Versus Overall Survival As a First-Line End Point for Metastatic Colorectal Cancer in Modern Randomized Trials: Findings From the Analysis and Research in Cancers of the Digestive System Database&sequencial=67&nomePeriodico=Journal of Clinical Oncology" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>68. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>BARIANI, G. M.</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2013</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1200/JCO.2012.46.6706" target="_blank"></a><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/4792805111122908" target="_blank">BARIANI, G. M.</a> ; DE CELIS FERRARI, A. C. R. ; <b>HOFF, P. M.</b> ; KRZYZANOWSKA, M. K. ; RIECHELMANN, R. P. . Self-Reported Conflicts of Interest of Authors, Trial Sponsorship, and the Interpretation of Editorials and Related Phase III Trials in Oncology. Journal of Clinical Oncology<sup><img id='15277755_68' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='15277755' /></sup>, v. 31, p. 2289-2295, 2013. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1200/JCO.2012.46.6706&issn=15277755&volume=31&issue=&paginaInicial=2289&titulo=Self-Reported Conflicts of Interest of Authors, Trial Sponsorship, and the Interpretation of Editorials and Related Phase III Trials in Oncology&sequencial=68&nomePeriodico=Journal of Clinical Oncology" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>69. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Guindalini RSC</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2013</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1186/1897-4287-11-1" target="_blank"></a>Guindalini RSC ; de Oliveira EP ; Sivino MC ; <b>Hoff PM</b> ; Garicochea, B. . Should extragonadal germ cell tumors be included in studies of families with testicular germ cell tumors?. Hereditary Cancer in Clinical Practice (Online)<sup><img id='18974287_69' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='18974287' /></sup>, v. 11, p. 1, 2013. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1186/1897-4287-11-1&issn=18974287&volume=11&issue=&paginaInicial=1&titulo=Should extragonadal germ cell tumors be included in studies of families with testicular germ cell tumors?&sequencial=69&nomePeriodico=Hereditary Cancer in Clinical Practice (Online)" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>70. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>SPENCER, S K M</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2013</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1038/bjc.2013.649" target="_blank"></a>SPENCER, S K M ; POMMIER, A J C ; MORGAN, S R ; BARRY, S T ; ROBERTSON, J D ; <b>HOFF, P M</b> ; JÜRGENSMEIER, J M . Prognostic/predictive value of 207 serum factors in colorectal cancer treated with cediranib and/or chemotherapy. British Journal of Cancer<sup><img id='00070920_70' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='00070920' /></sup>, v. 109, p. 2765-2773, 2013. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1038/bjc.2013.649&issn=00070920&volume=109&issue=&paginaInicial=2765&titulo=Prognostic/predictive value of 207 serum factors in colorectal cancer treated with cediranib and/or chemotherapy&sequencial=70&nomePeriodico=British Journal of Cancer" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>71. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>RIECHELMANN, R. P.</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2013</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1093/annonc/mdt073" target="_blank"></a>RIECHELMANN, R. P. ; ALEX, A. ; CRUZ, L. ; <a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/4792805111122908" target="_blank">BARIANI, G. M.</a> ; <b>HOFF, P. M.</b> . Non-inferiority cancer clinical trials: scope and purposes underlying their design. Annals of Oncology<sup><img id='15698041_71' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='15698041' /></sup>, v. 24, p. 1942-1947, 2013. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1093/annonc/mdt073&issn=15698041&volume=24&issue=&paginaInicial=1942&titulo=Non-inferiority cancer clinical trials: scope and purposes underlying their design&sequencial=71&nomePeriodico=Annals of Oncology" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>72. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>SMITH, JOHN C.</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2013</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1016/j.ejca.2013.02.023" target="_blank"></a>SMITH, JOHN C. ; BROOKS, LAURA ; <b>HOFF, PAULO M.</b> ; MCWALTER, GAEL ; DEARDEN, SIMON ; MORGAN, SHETHAH R. ; WILSON, DAVID ; ROBERTSON, JANE D. ; JÜRGENSMEIER, JULIANE M. . KRAS mutations are associated with inferior clinical outcome in patients with metastatic colorectal cancer, but are not predictive for benefit with cediranib. European Journal of Cancer<sup><img id='09598049_72' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='09598049' /></sup>, v. 49, p. 2424-2432, 2013. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1016/j.ejca.2013.02.023&issn=09598049&volume=49&issue=&paginaInicial=2424&titulo=KRAS mutations are associated with inferior clinical outcome in patients with metastatic colorectal cancer, but are not predictive for benefit with cediranib&sequencial=72&nomePeriodico=European Journal of Cancer" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>73. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>FREIRE, MARISTELA P.</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2013</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1086/671006" target="_blank"></a>FREIRE, MARISTELA P. ; PIERROTTI, LIGIA C. ; ZERATI, ANTÔNIO E. ; ARAÚJO, PEDRO H. X. N. ; MOTTA-LEAL-FILHO, J. M. ; DUARTE, LAIANE P. G. ; IBRAHIM, KARIM Y. ; SOUZA, ANTONIA A. L. ; DIZ, MARIA P. E. ; PEREIRA, JULIANA ; <b>HOFF, PAULO M.</b> ; Abdala, Edson . Infection Related to Implantable Central Venous Access Devices in Cancer Patients: Epidemiology and Risk Factors. Infection Control and Hospital Epidemiology<sup><img id='15596834_73' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='15596834' /></sup>, v. 34, p. 671-677, 2013. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1086/671006&issn=15596834&volume=34&issue=&paginaInicial=671&titulo=Infection Related to Implantable Central Venous Access Devices in Cancer Patients: Epidemiology and Risk Factors&sequencial=73&nomePeriodico=Infection Control and Hospital Epidemiology" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>74. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>CROSARA TEIXEIRA, MARCELA</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2013</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1007/s12029-013-9509-3" target="_blank"></a>CROSARA TEIXEIRA, MARCELA ; Mak, Milena Perez ; MARQUES, DANIEL FERNANDES ; CAPARELI, FERNANDA ; CARNEVALE, FRANCISCO CESAR ; MOREIRA, AIRTON MOTA ; RIBEIRO, ULYSSES ; CECCONELLO, IVAN ; <b>HOFF, PAULO M.</b> . Percutaneous Transhepatic Biliary Drainage in Patients with Advanced Solid Malignancies: Prognostic Factors and Clinical Outcomes. Journal of Gastrointestinal Cancer (Print)<sup><img id='19416628_74' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='19416628' /></sup>, v. 44, p. 398-403, 2013. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1007/s12029-013-9509-3&issn=19416628&volume=44&issue=&paginaInicial=398&titulo=Percutaneous Transhepatic Biliary Drainage in Patients with Advanced Solid Malignancies: Prognostic Factors and Clinical Outcomes&sequencial=74&nomePeriodico=Journal of Gastrointestinal Cancer (Print)" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>75. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>FERNANDES, G.S.</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2013</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1159/000356564" target="_blank"></a>FERNANDES, G.S. ; CORRÊA, T.S. ; CARVALHO, E.P.B. ; KATZ, A. ; <b>HOFF, P.M.</b> . Gastric and Endobronchial Metastases in a Case of Lobular Breast Cancer. Case Reports in Oncology<sup><img id='16626575_75' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='16626575' /></sup>, v. 6, p. 555-560, 2013. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1159/000356564&issn=16626575&volume=6&issue=&paginaInicial=555&titulo=Gastric and Endobronchial Metastases in a Case of Lobular Breast Cancer&sequencial=75&nomePeriodico=Case Reports in Oncology" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>76. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>FERRAROTTO, R.</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2013</span>FERRAROTTO, R. ; TESTA, L. ; RIECHELMANN, R. P. ; SAHADE, M. ; Siqueira LT ; Costa FP ; <b>HOFF, P.M.</b> . Combination of capecitabine and oxaliplatin is an effective treatment option for advanced neuroendocrine tumors. Rare Tumors<sup><img id='20363613_76' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='20363613' /></sup>, v. 5, p. 1, 2013. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=&issn=20363613&volume=5&issue=&paginaInicial=1&titulo=Combination of capecitabine and oxaliplatin is an effective treatment option for advanced neuroendocrine tumors&sequencial=76&nomePeriodico=Rare Tumors" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>77. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>GARCIA, G.</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2013</span>GARCIA, G. ; <b>HOFF, P.M.</b> ; Riechelmann RP . Physicians and patients adherence rates to recommended screening with colonoscopy for first-degree relatives of patients diagnosed with colorectal cancer before the age 50. European Journal of Cancer<sup><img id='09598049_77' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='09598049' /></sup>, v. 49, p. S526-S527-S527, 2013. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=&issn=09598049&volume=49&issue=&paginaInicial=S526-S527&titulo=Physicians and patients adherence rates to recommended screening with colonoscopy for first-degree relatives of patients diagnosed with colorectal cancer before the age 50&sequencial=77&nomePeriodico=European Journal of Cancer" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>78. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Alves, M. F. S</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2013</span>Alves, M. F. S ; Mak, Milena P. ; Piotto, G. H. M ; Takahashi, Tiago K. ; Ramos, R. E. O. ; <b>HOFF, P.M.</b> . Malignancy-related hypercalcemia in the bisphosphonate era. European Journal of Cancer<sup><img id='09598049_78' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='09598049' /></sup>, v. 49, p. S288-S288, 2013. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=&issn=09598049&volume=49&issue=&paginaInicial=S288-S288&titulo=Malignancy-related hypercalcemia in the bisphosphonate era&sequencial=78&nomePeriodico=European Journal of Cancer" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>79. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Bitton, R. C</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2013</span>Bitton, R. C ; Castria, T. B ; Amaral, A. A ; Lollo, J. G. ; Costa e Silva, Verônica Torres ; <b>HOFF, P.M.</b> ; <a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/9380674942905578" target="_blank">Castro G</a> . Predicting adverse outcomes after cisplatin administration in head & neck and thoracic cancer. European Journal of Cancer<sup><img id='09598049_79' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='09598049' /></sup>, v. 49, p. S279-S27, 2013. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=&issn=09598049&volume=49&issue=&paginaInicial=S279-S27&titulo=Predicting adverse outcomes after cisplatin administration in head & neck and thoracic cancer&sequencial=79&nomePeriodico=European Journal of Cancer" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>80. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Braghiroli, Maria Ignez</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2013</span>Braghiroli, Maria Ignez ; FARIA, LUIZA DIB BATISTA BUGIATO ; COSTA MIRANDA, VANESSA ; RIECHELMANN, R. P. ; <b>HOFF, P.M.</b> . Lack of association between ERCC1 expression in biliary tract malignancy and response to chemotherapy. European Journal of Cancer<sup><img id='09598049_80' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='09598049' /></sup>, v. 49, p. S627-S628, 2013. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=&issn=09598049&volume=49&issue=&paginaInicial=S627-S628&titulo=Lack of association between ERCC1 expression in biliary tract malignancy and response to chemotherapy&sequencial=80&nomePeriodico=European Journal of Cancer" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>81. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Braghiroli, Maria Ignez</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2013</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1007/s11888-013-0187-0" target="_blank"></a>Braghiroli, Maria Ignez ; RIECHELMANN, RACHEL P. ; Sabbaga, Jorge ; <b>HOFF, PAULO M.</b> . Do We Need another Antiangiogenesis Agent for Colorectal Cancer: are Bevacizumab and Aflibercept the Same?. Current Colorectal Cancer Reports<sup><img id='15563790_81' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='15563790' /></sup>, v. 9, p. 317-325, 2013. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1007/s11888-013-0187-0&issn=15563790&volume=9&issue=&paginaInicial=317&titulo=Do We Need another Antiangiogenesis Agent for Colorectal Cancer: are Bevacizumab and Aflibercept the Same?&sequencial=81&nomePeriodico=Current Colorectal Cancer Reports" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>82. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>MUNHOZ, RODRIGO RAMELLA</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2013</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.4081/rt.2013.e39" target="_blank"></a>MUNHOZ, RODRIGO RAMELLA ; REGO, JULIANA FLORINDA DE MENDONCA ; FERRARI, ANEZKA RUBIM DE CELIS ; Braghiroli, Maria Ignez ; BARIANI, GIOVANNI MENDONCA ; <b>HOFF, Paulo Marcelo</b> ; COSTA, FREDERICO PEREGO ; PFIFFER, TULIO EDUARDO FLESCH ; RIECHELMANN, RACHEL . Combination of irinotecan and a platinum agent for poorly differentiated neuroendocrine carcinomas. Rare Tumors<sup><img id='20363613_82' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='20363613' /></sup>, v. 5, p. 1, 2013. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.4081/rt.2013.e39&issn=20363613&volume=5&issue=&paginaInicial=1&titulo=Combination of irinotecan and a platinum agent for poorly differentiated neuroendocrine carcinomas&sequencial=82&nomePeriodico=Rare Tumors" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>83. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>HOFF, P M</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2013</span><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P M</a></b>; LIMA, C. ; SOUSA, R. B. ; OLIVEIRA, J. ; SOUZA, K. T. . Definitive chemoradiotherapy (CRT) for advanced cervical cancer (CC): Should it be different in elderly?. EUROPEAN JOURNAL OF CANCER<sup><img id='18790852_83' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='18790852' /></sup>, v. 49, p. S722-S722, 2013. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=&issn=18790852&volume=49&issue=&paginaInicial=S722-S722&titulo=Definitive chemoradiotherapy (CRT) for advanced cervical cancer (CC): Should it be different in elderly?&sequencial=83&nomePeriodico=EUROPEAN JOURNAL OF CANCER" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>84. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>HOFF, P M</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2013</span><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P M</a></b>; Castria, T. B ; CASTRO JUNIOR, G. ; AMARAL, A. ; SILVA, V. C. E. . Comparison of CKD-EPI, MDRD and Cockcroft-Gault to estimate baseline renal function in patients with head & neck and thoracic cancers. European Journal of Cancer<sup><img id='09598049_84' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='09598049' /></sup>, v. 49, p. 1325, 2013. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=&issn=09598049&volume=49&issue=&paginaInicial=1325&titulo=Comparison of CKD-EPI, MDRD and Cockcroft-Gault to estimate baseline renal function in patients with head & neck and thoracic cancers&sequencial=84&nomePeriodico=European Journal of Cancer" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>85. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>HOFF, P M</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2013</span><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P M</a></b>; Cecotti HC ; PIERROTTI, LIGIA C. ; Abdala, Edson ; CASTRO JUNIOR, G. . Risk factors for severe complications during febrile neutropenic episodes in patients with solid tumors. EUROPEAN JOURNAL OF CANCER<sup><img id='18790852_85' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='18790852' /></sup>, v. 49, p. S272-S272, 2013. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=&issn=18790852&volume=49&issue=&paginaInicial=S272-S272&titulo=Risk factors for severe complications during febrile neutropenic episodes in patients with solid tumors&sequencial=85&nomePeriodico=EUROPEAN JOURNAL OF CANCER" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>86. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>HOFF, P M</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2013</span><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P M</a></b>; Sommeijer, Dirkje W.) ; Shi, Qian . Prognostic Value of early objective tumor response (EOTR) to first line systemic therapy in metastatic colorectal cancer. ASIA-PAC J CLIN ONCO<sup><img id='17437555_86' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='17437555' /></sup>, v. 9, p. 76-76, 2013. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=&issn=17437555&volume=9&issue=&paginaInicial=76-76&titulo=Prognostic Value of early objective tumor response (EOTR) to first line systemic therapy in metastatic colorectal cancer&sequencial=86&nomePeriodico=ASIA-PAC J CLIN ONCO" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>87. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>HOFF, P M</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2013</span><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P M</a></b>; CROSARA TEIXEIRA, MARCELA ; Marques DF ; FERRARI, C. L. S. . Should patients with advanced colorectal cancer and ECOG 3/4 be treated with chemotherapy?. European Journal of Cancer<sup><img id='09598049_87' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='09598049' /></sup>, v. 49, p. S288-S288, 2013. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=&issn=09598049&volume=49&issue=&paginaInicial=S288-S288&titulo=Should patients with advanced colorectal cancer and ECOG 3/4 be treated with chemotherapy?&sequencial=87&nomePeriodico=European Journal of Cancer" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>88. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>DQ, M.</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2013</span>DQ, M. ; Mak, Milena P. ; BC, B. ; Takagaki TY ; SARAGIOTTO, DANIEL F. ; <b>HOFF, P M</b> . Palliative chemotherapy in patients with malignant bowel obstruction. European Journal of Cancer<sup><img id='09598049_88' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='09598049' /></sup>, v. 2, p. S281-S282, 2013. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=&issn=09598049&volume=2&issue=&paginaInicial=S281-S282&titulo=Palliative chemotherapy in patients with malignant bowel obstruction&sequencial=88&nomePeriodico=European Journal of Cancer" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>89. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>HOFF, P M</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2013</span><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P M</a></b>; SOUSA, R. B. ; MUNHOZ, RODRIGO RAMELLA ; GOMES, L. . Outcomes of sunitinib therapy in patients (pts) with metastatic renal cell carcinoma (mRCC) with poor risk features. Journal of Clinical Oncology<sup><img id='15277755_89' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='15277755' /></sup>, v. 31, p. 476, 2013. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=&issn=15277755&volume=31&issue=&paginaInicial=476&titulo=Outcomes of sunitinib therapy in patients (pts) with metastatic renal cell carcinoma (mRCC) with poor risk features&sequencial=89&nomePeriodico=Journal of Clinical Oncology" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>90. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Almeida da Cruz, Livia</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2012</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1016/j.clcc.2011.05.004" target="_blank"></a>Almeida da Cruz, Livia ; <b>Hoff PM</b> ; Ferrari, Claudio Luiz Seabra ; Riechelmann, Rachel Simões Pimenta ; <b>Hoff PM</b> ; <b>Hoff, Paulo M. G.</b> . Unilateral Hand-Foot Syndrome: Does It Take Sides? Case Report and Literature Review. Clinical Colorectal Cancer<sup><img id='15330028_90' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='15330028' /></sup>, v. 11, p. 82-84, 2012. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1016/j.clcc.2011.05.004&issn=15330028&volume=11&issue=&paginaInicial=82&titulo=Unilateral Hand-Foot Syndrome: Does It Take Sides? Case Report and Literature Review&sequencial=90&nomePeriodico=Clinical Colorectal Cancer" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>91. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Machado KK</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2012</span>Machado KK ; <b>Hoff PM</b> ; <b>HOFF, P. M.</b> . Autonomy versus paternalism in Latin America. ONCOLOGY-NEW YORK<sup><img id='08909091_91' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='08909091' /></sup>, v. 26(1), p. 46-47, 2012. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=&issn=08909091&volume=26(1)&issue=&paginaInicial=46&titulo=Autonomy versus paternalism in Latin America&sequencial=91&nomePeriodico=ONCOLOGY-NEW YORK" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>92. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Ferrarotto, Renata</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2012</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1016/j.ejca.2012.01.008" target="_blank"></a>Ferrarotto, Renata ; Machado, Karime ; Mak, Milena P. ; Shah, Neeraj ; Takahashi, Tiago K. ; Costa, Frederico P. ; Overman, Michael J. ; Kopetz, Scott ; <b>Hoff PM</b> . A multicenter, multinational analysis of mitomycin C in refractory metastatic colorectal cancer. European Journal of Cancer<sup><img id='09598049_92' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='09598049' /></sup>, v. 48, p. 820-826, 2012. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1016/j.ejca.2012.01.008&issn=09598049&volume=48&issue=&paginaInicial=820&titulo=A multicenter, multinational analysis of mitomycin C in refractory metastatic colorectal cancer&sequencial=92&nomePeriodico=European Journal of Cancer" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>93. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Baselga, J.</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2012</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1200/JCO.2011.36.7771" target="_blank"></a>Baselga, J. ; Segalla, J. G. M. ; Roche, H. ; <a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/0925776607072404" target="_blank">del Giglio, A.</a> ; Pinczowski, H. ; Ciruelos, E. M. ; Filho, S. C. ; Gomez, P. ; Van Eyll, B. ; Bermejo, B. ; Llombart, A. ; Garicochea, B. ; Duran, M. A. C. ; <b>Hoff PM</b> ; Espie, M. ; de Moraes, A. A. J. G. ; <a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/6886335376140604" target="_blank">Ribeiro, R. A.</a> ; Mathias, C. ; Gil Gil, M. ; Ojeda, B. ; Morales, J. ; Kwon Ro, S. ; Li, S. ; Costa, F. . Sorafenib in Combination With Capecitabine: An Oral Regimen for Patients With HER2-Negative Locally Advanced or Metastatic Breast Cancer. Journal of Clinical Oncology<sup><img id='0732183X_93' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='0732183X' /></sup>, v. 30, p. 1484-1491, 2012. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1200/JCO.2011.36.7771&issn=0732183X&volume=30&issue=&paginaInicial=1484&titulo=Sorafenib in Combination With Capecitabine: An Oral Regimen for Patients With HER2-Negative Locally Advanced or Metastatic Breast Cancer&sequencial=93&nomePeriodico=Journal of Clinical Oncology" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>94. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Hammond-Thelin, Lisa A.</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2012</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1007/s10637-010-9535-y" target="_blank"></a>Hammond-Thelin, Lisa A. ; Thomas, Melanie B. ; Iwasaki, Michiko ; Abbruzzese, James L. ; Lassere, Yvonne ; Meyers, Christina A. ; <b>Hoff PM</b> ; <b>Hoff, Paulo</b> ; Bono, Johann ; Norris, Jody ; Matsushita, Hitoshi ; Mita, Akira ; Rowinsky, Eric K. . Phase I and pharmacokinetic study of 3 -C-ethynylcytidine (TAS-106), an inhibitor of RNA polymerase I, II and III,in patients with advanced solid malignancies. Investigational New Drugs<sup><img id='01676997_94' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='01676997' /></sup>, v. 30, p. 316-326, 2012. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1007/s10637-010-9535-y&issn=01676997&volume=30&issue=&paginaInicial=316&titulo=Phase I and pharmacokinetic study of 3 -C-ethynylcytidine (TAS-106), an inhibitor of RNA polymerase I, II and III,in patients with advanced solid malignancies&sequencial=94&nomePeriodico=Investigational New Drugs" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>95. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Mak, Milena Perez</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2012</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1007/s00520-012-1474-z" target="_blank"></a>Mak, Milena Perez ; Costa e Silva, Verônica Torres ; Martin, Regina Matsunaga ; Lerario, Antonio Marcondes ; Yu, Luis ; <b>Hoff PM</b> ; Castro Junior, Gilberto . Advanced prostate cancer as a cause of oncogenic osteomalacia: an underdiagnosed condition. Supportive Care in Cancer<sup><img id='09414355_95' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='09414355' /></sup>, v. 20, p. 2195-2197, 2012. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1007/s00520-012-1474-z&issn=09414355&volume=20&issue=&paginaInicial=2195&titulo=Advanced prostate cancer as a cause of oncogenic osteomalacia: an underdiagnosed condition&sequencial=95&nomePeriodico=Supportive Care in Cancer" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>96. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Hoff PM</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2012</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1016/j.clcc.2011.10.004" target="_blank"></a><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>; Saad, Everardo D. ; Costa, Frederico ; Coutinho, Anelisa K. ; Caponero, Ricardo ; Prolla, Gabriel ; Gansl, Rene C. . Literature Review and Practical Aspects on the Management of Oxaliplatin-Associated Toxicity. Clinical Colorectal Cancer<sup><img id='15330028_96' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='15330028' /></sup>, v. 11, p. 93-100, 2012. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1016/j.clcc.2011.10.004&issn=15330028&volume=11&issue=&paginaInicial=93&titulo=Literature Review and Practical Aspects on the Management of Oxaliplatin-Associated Toxicity&sequencial=96&nomePeriodico=Clinical Colorectal Cancer" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>97. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Braghiroli, Maria Ignez</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2012</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1586/era.12.13" target="_blank"></a>Braghiroli, Maria Ignez ; Sabbaga, Jorge ; <b>Hoff PM</b> . Bevacizumab: overview of the literature. Expert Review of Anticancer Therapy<sup><img id='14737140_97' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='14737140' /></sup>, v. 12, p. 567-580, 2012. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1586/era.12.13&issn=14737140&volume=12&issue=&paginaInicial=567&titulo=Bevacizumab: overview of the literature&sequencial=97&nomePeriodico=Expert Review of Anticancer Therapy" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>98. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Jardim, D. L.</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2012</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1093/annonc/mds074" target="_blank"></a>Jardim, D. L. ; Rodrigues, C. A. ; Novis, Y. A. S. ; Rocha, V. G. ; Hoff, P. M. ; <b>Hoff PM</b> . Oxaliplatin-related thrombocytopenia. Annals of Oncology<sup><img id='09237534_98' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='09237534' /></sup>, v. 23, p. 1937-1942, 2012. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1093/annonc/mds074&issn=09237534&volume=23&issue=&paginaInicial=1937&titulo=Oxaliplatin-related thrombocytopenia&sequencial=98&nomePeriodico=Annals of Oncology" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>99. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>SAHADE, M.</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2012</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.2217/fon.12.73" target="_blank"></a>SAHADE, M. ; Capareli-Azevedo FC ; <b>Hoff PM</b> ; <b>HOFF, P. M.</b> . Cediranib: a VEGF receptor tyrosine kinase inhibitor. FUTURE ONCOL<sup><img id='14796694_99' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='14796694' /></sup>, v. 8, p. 775-781, 2012. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.2217/fon.12.73&issn=14796694&volume=8&issue=&paginaInicial=775&titulo=Cediranib: a VEGF receptor tyrosine kinase inhibitor&sequencial=99&nomePeriodico=FUTURE ONCOL" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>100. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Ferrarotto, Renata</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2012</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1016/j.clcc.2012.06.002" target="_blank"></a>Ferrarotto, Renata ; <b>Hoff PM</b> ; <b>HOFF, P. M.</b> . Antiangiogenic drugs for colorectal cancer: exploring new possibilities. Clinical Colorectal Cancer<sup><img id='15330028_100' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='15330028' /></sup>, v. 12, p. 1-7, 2012. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1016/j.clcc.2012.06.002&issn=15330028&volume=12&issue=&paginaInicial=1&titulo=Antiangiogenic drugs for colorectal cancer: exploring new possibilities&sequencial=100&nomePeriodico=Clinical Colorectal Cancer" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>101. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Oliveira, S.</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2012</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1016/j.clinre.2011.10.008" target="_blank"></a>Oliveira, S. ; TEIXEIRA, L. ; <b>Hoff PM</b> ; <b>HOFF, P. M.</b> ; GRAMONT, A. ; TOURNIGAND, C. . Squamous-cell carcinoma of the anal canal: room for improvement with targeted therapy. CLIN RES HEPATOL GAS<sup><img id='22107401_101' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='22107401' /></sup>, v. 36, p. 209-213, 2012. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1016/j.clinre.2011.10.008&issn=22107401&volume=36&issue=&paginaInicial=209&titulo=Squamous-cell carcinoma of the anal canal: room for improvement with targeted therapy&sequencial=101&nomePeriodico=CLIN RES HEPATOL GAS" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>102. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>HOFF, P. M.</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2012</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1200/JCO.2012.42.6031" target="_blank"></a><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P. M.</a></b>; HOCHHAUS, A. ; PESTALOZZI, B. C. ; TEBBUTT, N. C. ; LI, J. ; KIM, T. W. ; KOYNOV, K. D. ; KURTEVA, G. ; PINTER, T. ; CHENG, Y. ; Van Eyll, B. ; PIKE, L. ; FIELDING, A. ; ROBERTSON, J. D. ; SAUNDERS, M. P. . Cediranib Plus FOLFOX/CAPOX Versus Placebo Plus FOLFOX/CAPOX in Patients With Previously Untreated Metastatic Colorectal Cancer: A Randomized, Double-Blind, Phase III Study (HORIZON II). Journal of Clinical Oncology<sup><img id='0732183X_102' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='0732183X' /></sup>, v. 30, p. 3596-3603, 2012. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1200/JCO.2012.42.6031&issn=0732183X&volume=30&issue=&paginaInicial=3596&titulo=Cediranib Plus FOLFOX/CAPOX Versus Placebo Plus FOLFOX/CAPOX in Patients With Previously Untreated Metastatic Colorectal Cancer: A Randomized, Double-Blind, Phase III Study (HORIZON II)&sequencial=102&nomePeriodico=Journal of Clinical Oncology" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>103. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>HOFF, PAULO M.</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2012</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1016/j.ctrv.2012.04.006" target="_blank"></a><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, PAULO M.</a></b>; MACHADO, KARIME KALIL . Role of angiogenesis in the pathogenesis of cancer. Cancer Treatment Reviews<sup><img id='03057372_103' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='03057372' /></sup>, v. 38, p. 825-833, 2012. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1016/j.ctrv.2012.04.006&issn=03057372&volume=38&issue=&paginaInicial=825&titulo=Role of angiogenesis in the pathogenesis of cancer&sequencial=103&nomePeriodico=Cancer Treatment Reviews" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>104. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>de Gramont, Aimery</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2012</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1016/S1470-2045(12)70509-0" target="_blank"></a>de Gramont, Aimery ; VAN CUTSEM, ERIC ; SCHMOLL, HANS-JOACHIM ; TABERNERO, JOSEP ; CLARKE, STEPHEN ; MOORE, MALCOLM J ; CUNNINGHAM, DAVID ; CARTWRIGHT, THOMAS H ; HECHT, J RANDOLPH ; RIVERA, FERNANDO ; IM, SEOCK-AH ; BODOKY, GYÖRGY ; SALAZAR, RAMON ; MAINDRAULT-GOEBEL, FRÉDÉRIQUE ; SHACHAM-SHMUELI, EINAT ; BAJETTA, EMILIO ; MAKRUTZKI, MARTINA ; SHANG, AIJING ; ANDRÉ, THIERRY ; <b>HOFF, PAULO M</b> . Bevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (AVANT): a phase 3 randomised controlled trial. Lancet Oncology<sup><img id='14702045_104' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='14702045' /></sup>, v. 13, p. 1225-1233, 2012. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1016/S1470-2045(12)70509-0&issn=14702045&volume=13&issue=&paginaInicial=1225&titulo=Bevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (AVANT): a phase 3 randomised controlled trial&sequencial=104&nomePeriodico=Lancet Oncology" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>105. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Mak, Milena P.</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2012</span>Mak, Milena P. ; Takagaki TY ; <b>HOFF, P.M.</b> ; Castro Jr G ; Snitcovsky IM . Excision repair cross-complementary grouo 1 (ERCC1) as a prognostic biomarker in patientes (pts) with solid tumors: A meta-analysis on detection methodsa. Journal of Clinical Oncology<sup><img id='0732183X_105' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='0732183X' /></sup>, v. 30, p. e21040, 2012. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=&issn=0732183X&volume=30&issue=&paginaInicial=e21040&titulo=Excision repair cross-complementary grouo 1 (ERCC1) as a prognostic biomarker in patientes (pts) with solid tumors: A meta-analysis on detection methodsa&sequencial=105&nomePeriodico=Journal of Clinical Oncology" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>106. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>MARQUES, DANIEL FERNANDES</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2012</span>MARQUES, DANIEL FERNANDES ; Santana, IA ; GUINDALIN, R. S. C. ; Neto, HS ; CROSARA TEIXEIRA, MARCELA ; Teixeira, MJ ; <b>HOFF, P.M.</b> ; Feher O . Does pilocytic astrocytoma (PA) in adults have a different prognosis than PA in children?. Journal of Clinical Oncology<sup><img id='0732183X_106' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='0732183X' /></sup>, v. 30, p. 2038, 2012. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=&issn=0732183X&volume=30&issue=&paginaInicial=2038&titulo=Does pilocytic astrocytoma (PA) in adults have a different prognosis than PA in children?&sequencial=106&nomePeriodico=Journal of Clinical Oncology" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>107. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Petry, V</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2012</span>Petry, V ; <a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/4792805111122908" target="_blank">Leal AI</a> ; <a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/4792805111122908" target="_blank">Arai RJ</a> ; Piato, JR ; <b>HOFF, P.M.</b> . Metronic chemotherapy (MC): Results of two feasibility trials in patients (pts) with HER2 positive (HER2+) and negative (HER2-) locally advanced breast cancer (LABC). Journal of Clinical Oncology<sup><img id='0732183X_107' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='0732183X' /></sup>, v. 30, p. e11513, 2012. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=&issn=0732183X&volume=30&issue=&paginaInicial=e11513&titulo=Metronic chemotherapy (MC): Results of two feasibility trials in patients (pts) with HER2 positive (HER2+) and negative (HER2-) locally advanced breast cancer (LABC)&sequencial=107&nomePeriodico=Journal of Clinical Oncology" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>108. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>REIS, FABIANA</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2012</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.5935/0104-7795.20120031" target="_blank"></a>REIS, FABIANA ; <a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/0228531403374909" target="_blank">CECATTO, REBECA BOLTES</a> ; BRITO, CHRISTINA MAY MORAN DE ; <b>HOFF, PAULO MARCELO GEHM</b> ; BATTISTELLA, LINAMARA RIZZO . Impact of two different exercise programs on persistent cancer-related fatigue and physical fitness. Acta Fisiatrica (USP)<sup><img id='01047795_108' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='01047795' /></sup>, v. 19, p. 198-202, 2012. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.5935/0104-7795.20120031&issn=01047795&volume=19&issue=&paginaInicial=198&titulo=Impact of two different exercise programs on persistent cancer-related fatigue and physical fitness&sequencial=108&nomePeriodico=Acta Fisiatrica (USP)" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>109. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Ferrarotto, Renata</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2012</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1007/s11888-012-0131-8" target="_blank"></a>Ferrarotto, Renata ; Sabbaga, Jorge ; CAPARELI, FERNANDA C. ; SARAGIOTTO, DANIEL F. ; <b>HOFF, PAULO M.</b> . Best Strategy in the Approach of Advanced Colorectal Cancer: Aggressive or Non-aggressive Chemotherapy?. Current Colorectal Cancer Reports<sup><img id='15563790_109' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='15563790' /></sup>, v. 8, p. 177-185, 2012. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1007/s11888-012-0131-8&issn=15563790&volume=8&issue=&paginaInicial=177&titulo=Best Strategy in the Approach of Advanced Colorectal Cancer: Aggressive or Non-aggressive Chemotherapy?&sequencial=109&nomePeriodico=Current Colorectal Cancer Reports" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>110. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>HOFF, P M</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2012</span><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P M</a></b>; SCLUMBERGER, M. ; MASSICOTTE, M. ; NASCIMENTO, C. L. ; CHOUGNET, C. . Kinase inhibitors for advanced medullary thyroid carcinoma. Clinics (USP. Impresso)<sup><img id='18075932_110' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='18075932' /></sup>, v. 67, p. 21, 2012. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=&issn=18075932&volume=67&issue=&paginaInicial=21&titulo=Kinase inhibitors for advanced medullary thyroid carcinoma&sequencial=110&nomePeriodico=Clinics (USP. Impresso)" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>111. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Miraglia, João L.</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2011</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1371/journal.pone.0027214" target="_blank"></a>Miraglia, João L. ; Abdala, Edson ; <b>Hoff PM</b> ; <b>Hoff, Paulo M.</b> ; Luiz, André M. ; Oliveira, Danise S. ; Saad, Carla G. S. ; Laurindo, Ieda M. M. ; Viso, Ana T. R. ; Tayra, Angela ; Pierrotti, Lígia C. ; Azevedo, Luiz S. ; Campos, Lúcia Maria A. ; Aikawa, Nádia E. ; <a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/6562171344607679" target="_blank">Timenetsky, Maria do Carmo S. T.</a> ; Luna, Expedito ; <a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/2554853704952225" target="_blank">Cardoso, Maria Regina A.</a> ; Guedes, José da S. ; Raw, Isaias ; <a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/4720283421615359" target="_blank">Kalil, Jorge</a> ; Precioso, Alexander R. . Immunogenicity and Reactogenicity of 2009 Influenza A (H1N1) Inactivated Monovalent Non-Adjuvanted Vaccine in Elderly and Immunocompromised Patients. Plos One<sup><img id='19326203_111' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='19326203' /></sup>, v. 6, p. e27214, 2011. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1371/journal.pone.0027214&issn=19326203&volume=6&issue=&paginaInicial=e27214&titulo=Immunogenicity and Reactogenicity of 2009 Influenza A (H1N1) Inactivated Monovalent Non-Adjuvanted Vaccine in Elderly and Immunocompromised Patients&sequencial=111&nomePeriodico=Plos One" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>112. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Ferrarotto, Renata</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2011</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1016/j.clcc.2011.03.023" target="_blank"></a>Ferrarotto, Renata ; Pathak, Priyanka ; Maru, Dipen ; Agarwal, Atin ; Overman, Michael ; <b>Hoff PM</b> ; <b>Hoff, Paulo M.</b> ; Kopetz, Scott . Durable Complete Responses in Metastatic Colorectal Cancer Treated with Chemotherapy Alone. Clinical Colorectal Cancer<sup><img id='15330028_112' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='15330028' /></sup>, v. 10, p. 178-182, 2011. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1016/j.clcc.2011.03.023&issn=15330028&volume=10&issue=&paginaInicial=178&titulo=Durable Complete Responses in Metastatic Colorectal Cancer Treated with Chemotherapy Alone&sequencial=112&nomePeriodico=Clinical Colorectal Cancer" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>113. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Hajjar, Ludhmila Abrahão</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2011</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1590/S1807-59322011001200007" target="_blank"></a><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/5495055834774817" target="_blank">Hajjar, Ludhmila Abrahão</a> ; Nakamura, Rosana Ely ; Almeida, Juliano Pinheiro de ; Fukushima, Julia T. ; <b>Hoff PM</b> ; <b>HOFF, P. M.</b> ; Vincent, Jean-Louis ; Auler Júnior, José Otávio Costa ; Galas, Filomena Regina Barbosa Gomes . Lactate and base deficit are predictors of mortality in critically ill patients with cancer. Clinics (USP. Impresso)<sup><img id='18075932_113' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='18075932' /></sup>, v. 66, p. 2037-2042, 2011. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1590/S1807-59322011001200007&issn=18075932&volume=66&issue=&paginaInicial=2037&titulo=Lactate and base deficit are predictors of mortality in critically ill patients with cancer&sequencial=113&nomePeriodico=Clinics (USP. Impresso)" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>114. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>KALIL, R.</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2011</span>KALIL, R. ; <a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/4792805111122908" target="_blank">HAJJAR, L. A.</a> ; <b>HOFF, P.M.</b> . I Diretriz Brasileira de Cardio-Oncologia. Arquivos Brasileiros de Cardiologia (Impresso)<sup><img id='0066782X_114' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='0066782X' /></sup>, v. 96, p. 01-52, 2011. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=&issn=0066782X&volume=96&issue=&paginaInicial=01&titulo=I Diretriz Brasileira de Cardio-Oncologia&sequencial=114&nomePeriodico=Arquivos Brasileiros de Cardiologia (Impresso)" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>115. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Ferrari ARD</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2011</span>Ferrari ARD ; Braghiroli, Maria Ignez ; <a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/4792805111122908" target="_blank">BARIANI, G. M.</a> ; Munhoz RR ; Pfiffer TE ; <b>HOFF, P.M.</b> ; Riechelmann, Rachel Simões Pimenta . Extrapulmonary Poorly Differentiated Neuroendocrine Carcinomas (PDNEC) Treated with Cisplatin Plus Irinotecan. Annals of Oncology<sup><img id='09237534_115' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='09237534' /></sup>, v. 22, p. 80-80, 2011. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=&issn=09237534&volume=22&issue=&paginaInicial=80-80&titulo=Extrapulmonary Poorly Differentiated Neuroendocrine Carcinomas (PDNEC) Treated with Cisplatin Plus Irinotecan&sequencial=115&nomePeriodico=Annals of Oncology" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>116. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>CAPARELLI-AZEVEDO, F.</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2011</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1007/s11888-011-0107-0" target="_blank"></a>CAPARELLI-AZEVEDO, F. ; RIECHELMANN, R. ; <b>HOFF, PM</b> . Future Solutions for Patients with Metastatic Colorectal Cancer Positive for K-RAS Mutations. Current Colorectal Reports<sup><img id='15563804_116' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='15563804' /></sup>, v. 7, p. 275-280, 2011. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1007/s11888-011-0107-0&issn=15563804&volume=7&issue=&paginaInicial=275&titulo=Future Solutions for Patients with Metastatic Colorectal Cancer Positive for K-RAS Mutations&sequencial=116&nomePeriodico=Current Colorectal Reports" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>117. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Kopetz S</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2010</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1200/JCO.2009.24.8252" target="_blank"></a>Kopetz S ; <b>Hoff PM</b> ; <b>HOFF, P. M.</b> ; Morris JS ; Wolff RA ; Eng C ; Glover KY ; Adinin R ; Overmann MJ ; Valero V ; Wen S ; Lieu C ; Yan S ; Tran HT ; Ellis LM ; Abbruzzese JL ; Heymach JV . Phase II trial of infusional fluorouracil, irinotecan, and bevacizumab fo metastatic colorectal cancer: efficacy and circulating angiogenic biomarkers associated with therapeutic resistance. Journal of Clinical Oncology<sup><img id='0732183X_117' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='0732183X' /></sup>, v. 28, p. 453-459, 2010. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1200/JCO.2009.24.8252&issn=0732183X&volume=28&issue=&paginaInicial=453&titulo=Phase II trial of infusional fluorouracil, irinotecan, and bevacizumab fo metastatic colorectal cancer: efficacy and circulating angiogenic biomarkers associated with therapeutic resistance&sequencial=117&nomePeriodico=Journal of Clinical Oncology" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>118. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Overmann MJ</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2010</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1200/JCO.2009.27.5701" target="_blank"></a>Overmann MJ ; Maru DM ; Charnsangavej, C. ; Loyer EM ; Wang H ; Pathak P ; Eng C ; <b>Hoff PM</b> ; <b>HOFF, P. M.</b> ; Vauthey J-N ; Wolff RA ; Kopetz, S . Oxaliplatin-mediated increase in spleen size as a biomarker for the development of hepatic sinusoidal injury. Journal of Clinical Oncology<sup><img id='0732183X_118' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='0732183X' /></sup>, v. 20(28), p. 2549-2555, 2010. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1200/JCO.2009.27.5701&issn=0732183X&volume=20(28)&issue=&paginaInicial=2549&titulo=Oxaliplatin-mediated increase in spleen size as a biomarker for the development of hepatic sinusoidal injury&sequencial=118&nomePeriodico=Journal of Clinical Oncology" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>119. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Rodrigues CA</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2010</span>Rodrigues CA ; Ferrarotto R ; Kalil Filho R ; Novis YA ; <b>Hoff PM</b> ; <b>HOFF, P. M.</b> . Venous thromboembolism and cancer: a systematic review. Journal of Thrombosis and Thrombolysis<sup><img id='09295305_119' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='09295305' /></sup>, v. 30, p. 67-78, 2010. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=&issn=09295305&volume=30&issue=&paginaInicial=67&titulo=Venous thromboembolism and cancer: a systematic review&sequencial=119&nomePeriodico=Journal of Thrombosis and Thrombolysis" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>120. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Barra WF</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2010</span>Barra WF ; <a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/9380674942905578" target="_blank">Castro G</a> ; <a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/4792805111122908" target="_blank">Hoff AO</a> ; Siqueira SA ; <b>Hoff PM</b> ; <b>HOFF, P. M.</b> . Symptomatic hypoglycemia related to inappropriately high igf-ii serum levels in a patient with desmoplastic small round cell tumor. Case Reports in Medicine<sup><img id='16879635_120' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='16879635' /></sup>, v. 2010, p. 684045, 2010. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=&issn=16879635&volume=2010&issue=&paginaInicial=684045&titulo=Symptomatic hypoglycemia related to inappropriately high igf-ii serum levels in a patient with desmoplastic small round cell tumor&sequencial=120&nomePeriodico=Case Reports in Medicine" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>121. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Oliveira SC</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2010</span>Oliveira SC ; Machado KK ; Sabbaga J ; <b>Hoff PM</b> ; <b>HOFF, P. M.</b> . Integration of anti-vascular endothelial growth factor therapies with cytotoxic chemotherapy in the treatment of colorectal cancer. Cancer Journal (Sudbury)<sup><img id='15289117_121' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='15289117' /></sup>, v. 16, p. 220-225, 2010. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=&issn=15289117&volume=16&issue=&paginaInicial=220&titulo=Integration of anti-vascular endothelial growth factor therapies with cytotoxic chemotherapy in the treatment of colorectal cancer&sequencial=121&nomePeriodico=Cancer Journal (Sudbury)" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>122. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Fontao-Wendel R</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2010</span>Fontao-Wendel R ; <b>Hoff PM</b> ; <b>HOFF, P. M.</b> ; Lazar A ; <a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1026563052473840" target="_blank">Freitas D</a> ; Novis YA ; Tsujita M ; Balthazar A ; Pierotti M ; Wendel S . Immune-mediated pancytopenia induced by oxaliplatin: a case report. Transfusion (Arlington, Va.)<sup><img id='00411132_122' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='00411132' /></sup>, v. 2010, p. 1453-1459, 2010. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=&issn=00411132&volume=2010&issue=&paginaInicial=1453&titulo=Immune-mediated pancytopenia induced by oxaliplatin: a case report&sequencial=122&nomePeriodico=Transfusion (Arlington, Va.)" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>123. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>dos Santos Fernandes G</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2010</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1590/s1807-59322010000600013" target="_blank"></a>dos Santos Fernandes G ; Katz A ; Calabrich A ; <b>Hoff PM</b> ; <b>HOFF, P. M.</b> . Reversible serum carcinoembriogenic antigen (CEA) elevation due to orlistat use: a case report. Clinics (USP. Impresso)<sup><img id='18075932_123' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='18075932' /></sup>, v. 65, p. 645-646, 2010. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1590/s1807-59322010000600013&issn=18075932&volume=65&issue=&paginaInicial=645&titulo=Reversible serum carcinoembriogenic antigen (CEA) elevation due to orlistat use: a case report&sequencial=123&nomePeriodico=Clinics (USP. Impresso)" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>124. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Bastos DA</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2010</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1177/1758834010367905" target="_blank"></a>Bastos DA ; Ribeiro SC ; <a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1026563052473840" target="_blank">Freitas D</a> ; <b>Hoff PM</b> ; <b>HOFF, P. M.</b> . Combination therapy in high-risk stage II or stage III colon cancer: current practice and future prospects. Therapeutic Advances in Medical Oncology<sup><img id='17588359_124' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='17588359' /></sup>, v. 2, p. 261-272, 2010. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1177/1758834010367905&issn=17588359&volume=2&issue=&paginaInicial=261&titulo=Combination therapy in high-risk stage II or stage III colon cancer: current practice and future prospects&sequencial=124&nomePeriodico=Therapeutic Advances in Medical Oncology" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>125. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Arai RJ</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2010</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1016/s1470-2045(10)70168-6" target="_blank"></a><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/4792805111122908" target="_blank">Arai RJ</a> ; Mano MS ; <a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/9380674942905578" target="_blank">de Castro G Jr</a> ; Diz Mdel P ; <b>Hoff PM</b> ; <b>HOFF, P. M.</b> . Building research capacity and clinical trials in developing countries. Lancet Oncology<sup><img id='14702045_125' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='14702045' /></sup>, v. 11, p. 712-713, 2010. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1016/s1470-2045(10)70168-6&issn=14702045&volume=11&issue=&paginaInicial=712&titulo=Building research capacity and clinical trials in developing countries&sequencial=125&nomePeriodico=Lancet Oncology" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>126. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Salto Ramalho A</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2010</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.3892/or_00001001" target="_blank"></a>Salto Ramalho A ; Dantas Lopes A ; Talans A ; Parlato Sakiyama BY ; Stelko Pereira GL ; <b>HOFF, P. M.</b> ; <b>Hoff PM</b> ; <a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/9380674942905578" target="_blank">de Castro G Jr</a> . Molecular targets for therapeutic interventions in human papillomavirus-related cancers(review). Oncology Reports<sup><img id='1021335X_126' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='1021335X' /></sup>, v. 24, p. 1419-1426, 2010. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.3892/or_00001001&issn=1021335X&volume=24&issue=&paginaInicial=1419&titulo=Molecular targets for therapeutic interventions in human papillomavirus-related cancers(review)&sequencial=126&nomePeriodico=Oncology Reports" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>127. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Mano MS</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2010</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.4081/rt.2010.e49" target="_blank"></a>Mano MS ; <a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/4792805111122908" target="_blank">Arai RJ</a> ; <b>Hoff PM</b> ; <b>HOFF, P. M.</b> . Rare tumors research in emerging countries. Rare Tumors<sup><img id='20363605_127' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='20363605' /></sup>, v. 30, p. e49-e49, 2010. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.4081/rt.2010.e49&issn=20363605&volume=30&issue=&paginaInicial=e49&titulo=Rare tumors research in emerging countries&sequencial=127&nomePeriodico=Rare Tumors" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>128. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Heinemann V</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2010</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1159/000314993" target="_blank"></a>Heinemann V ; <b>Hoff PM</b> ; <b>HOFF, P. M.</b> . Bevacizumab plus irinotecan-based regimens in the treatment of metastatic colorectal cancer. Oncology (Basel)<sup><img id='00302414_128' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='00302414' /></sup>, v. 79, p. 118-128, 2010. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1159/000314993&issn=00302414&volume=79&issue=&paginaInicial=118&titulo=Bevacizumab plus irinotecan-based regimens in the treatment of metastatic colorectal cancer&sequencial=128&nomePeriodico=Oncology (Basel)" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>129. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Hajjar, L. A.</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2010</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1093/annonc/mdq254" target="_blank"></a>Hajjar, L. A. ; <a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1409367562944345" target="_blank">Mauad, T.</a> ; <a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/5859663944556076" target="_blank">Galas, F. R. B. G.</a> ; Kumar, A. ; da Silva, L. F. F. ; <a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/9233100316137120" target="_blank">Dolhnikoff, M.</a> ; Trielli, T. ; Almeida, J. P. ; Borsato, M. R. L. ; Abdalla, E. ; Pierrot, L. ; Kalil Filho, R. ; <a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/4792805111122908" target="_blank">Auler, J. O. C.</a> ; <a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/5450805572417395" target="_blank">Saldiva, P. H. N.</a> ; <b>Hoff PM</b> ; <b>HOFF, P. M.</b> . Severe novel influenza A (H1N1) infection in cancer patients. Annals of Oncology<sup><img id='09237534_129' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='09237534' /></sup>, v. 21, p. 2333-2341, 2010. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1093/annonc/mdq254&issn=09237534&volume=21&issue=&paginaInicial=2333&titulo=Severe novel influenza A (H1N1) infection in cancer patients&sequencial=129&nomePeriodico=Annals of Oncology" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>130. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Takahashi TK</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2010</span>Takahashi TK ; Barbosa CCL ; Bugano D ; Takagaki TY ; Feher O ; <b>Hoff PM</b> ; <b>HOFF, P. M.</b> ; Castro Jr G . Carcinoma pulmonar de células não-pequenas em pacientes com idade igual ou superior a 65 anos tratados com quimioterapia: análise de segurança e eficácia. Revista Brasileira de Oncologia Clínica<sup><img id='18066054_130' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='18066054' /></sup>, v. 7(22), p. 108-113, 2010. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=&issn=18066054&volume=7(22)&issue=&paginaInicial=108&titulo=Carcinoma pulmonar de células não-pequenas em pacientes com idade igual ou superior a 65 anos tratados com quimioterapia: análise de segurança e eficácia&sequencial=130&nomePeriodico=Revista Brasileira de Oncologia Clínica" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>131. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Fernandes GS</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2009</span>Fernandes GS ; Blanke CD ; <a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1026563052473840" target="_blank">Freitas D</a> ; Guedes R ; <b>Hoff PM</b> ; <b>HOFF, P. M.</b> . Perioperative treatment of gastrointestinal stromal tumors. Oncology (Basel)<sup><img id='00302414_131' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='00302414' /></sup>, v. 23, p. 54-61, 2009. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=&issn=00302414&volume=23&issue=&paginaInicial=54&titulo=Perioperative treatment of gastrointestinal stromal tumors&sequencial=131&nomePeriodico=Oncology (Basel)" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>132. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Arai RJ</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2009</span><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/4792805111122908" target="_blank">Arai RJ</a> ; <b>Hoff PM</b> ; <b>HOFF, P. M.</b> ; <a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/9380674942905578" target="_blank">de Castro G Jr</a> ; Stern A . Ethical responsibility of phase 0 trials. Clinical Cancer Research<sup><img id='10780432_132' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='10780432' /></sup>, v. 1, p. 1121-1122, 2009. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=&issn=10780432&volume=1&issue=&paginaInicial=1121&titulo=Ethical responsibility of phase 0 trials&sequencial=132&nomePeriodico=Clinical Cancer Research" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>133. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Akaishi E</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2009</span>Akaishi E ; Teixeira F ; Katayama M ; Mizumoto N ; Costa FP ; Buzaid AC ; <b>Hoff PM</b> ; <b>HOFF, P. M.</b> . Peritonectomy for peritoneal carcinomatosis: long-term outcomes form a single Brazilian institution. World Journal of Surgery<sup><img id='03642313_133' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='03642313' /></sup>, v. Jan, p. a ser informada-a ser informada, 2009. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=&issn=03642313&volume=Jan&issue=&paginaInicial=a ser informada&titulo=Peritonectomy for peritoneal carcinomatosis: long-term outcomes form a single Brazilian institution&sequencial=133&nomePeriodico=World Journal of Surgery" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>134. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Claret L</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2009</span>Claret L ; Girard P ; <b>Hoff PM</b> ; <b>HOFF, P. M.</b> ; Van Cutsem E ; Zuideveld K ; Jorga K ; Fagerberg J ; Bruno R . Model-based prediction of phase III overalll survival in colorectal cancer on the basis of phase Ii tumor dynamics. Journal of Clinical Oncology<sup><img id='0732183X_134' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='0732183X' /></sup>, v. 27, p. 1-1, 2009. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=&issn=0732183X&volume=27&issue=&paginaInicial=1&titulo=Model-based prediction of phase III overalll survival in colorectal cancer on the basis of phase Ii tumor dynamics&sequencial=134&nomePeriodico=Journal of Clinical Oncology" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>135. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>dos Santos Fernandes G</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2009</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1590/s1807-59322009000800018" target="_blank"></a>dos Santos Fernandes G ; de Castro Cotti GC ; <a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1026563052473840" target="_blank">Freitas D</a> ; <b>Hoff PM</b> ; <b>HOFF, P. M.</b> . Downstaging of a rectal gastrointestinal stromal tumor by neoadjuvant imatinib therapy allowing for a conservative surgical approach. Clinics (USP. Impresso)<sup><img id='18075932_135' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='18075932' /></sup>, v. 64, p. 819-821, 2009. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1590/s1807-59322009000800018&issn=18075932&volume=64&issue=&paginaInicial=819&titulo=Downstaging of a rectal gastrointestinal stromal tumor by neoadjuvant imatinib therapy allowing for a conservative surgical approach&sequencial=135&nomePeriodico=Clinics (USP. Impresso)" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>136. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Freitas D</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2009</span><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1026563052473840" target="_blank">Freitas D</a> ; dos Santos Fernandes G ; <b>Hoff PM</b> ; <b>HOFF, P. M.</b> ; Cunha JE . Medical management of pancreatic adenocarcinoma. Pancreatology<sup><img id='14243903_136' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='14243903' /></sup>, v. 9, p. 223-232, 2009. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=&issn=14243903&volume=9&issue=&paginaInicial=223&titulo=Medical management of pancreatic adenocarcinoma&sequencial=136&nomePeriodico=Pancreatology" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>137. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Saad ED</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2009</span>Saad ED ; Katz A ; <b>Hoff PM</b> ; <b>HOFF, P. M.</b> ; Buyse M . Progression-free survival as surrogate and as true end point: insights from the breat and colorectal cancer literature. Annals of Oncology<sup><img id='09237534_137' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='09237534' /></sup>, v. 21, p. 7-12, 2009. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=&issn=09237534&volume=21&issue=&paginaInicial=7&titulo=Progression-free survival as surrogate and as true end point: insights from the breat and colorectal cancer literature&sequencial=137&nomePeriodico=Annals of Oncology" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>138. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Politano S</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2008</span>Politano S ; Overman M ; Pathak P ; Chadha R ; Glover K ; Chang DZ ; Wolff RA ; <b>Hoff PM</b> ; <b>HOFF, P. M.</b> ; Abbruzzese J ; Eng C ; Kopetz S . Second-line chemotherapy use in metastatic colon cancer varies by disease responsiveness. Clinical Colorectal Cancer<sup><img id='15330028_138' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='15330028' /></sup>, v. 7, p. 55-59, 2008. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=&issn=15330028&volume=7&issue=&paginaInicial=55&titulo=Second-line chemotherapy use in metastatic colon cancer varies by disease responsiveness&sequencial=138&nomePeriodico=Clinical Colorectal Cancer" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>139. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Yao, J. C.</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2008</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1200/JCO.2007.13.6374" target="_blank"></a>Yao, J. C. ; Phan, A. ; <b>Hoff PM</b> ; Chen, H. X. ; Charnsangavej, C. ; Yeung, S.-C. J. ; Hess, K. ; Ng, C. ; Abbruzzese, J. L. ; Ajani, J. A. ; <b>Hoff PM</b> ; <b>HOFF, P. M.</b> . Targeting Vascular Endothelial Growth Factor in Advanced Carcinoid Tumor: A Random Assignment Phase II Study of Depot Octreotide With Bevacizumab and Pegylated Interferon Alfa-2b. Journal of Clinical Oncology<sup><img id='0732183X_139' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='0732183X' /></sup>, v. 26, p. 1316-1323, 2008. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1200/JCO.2007.13.6374&issn=0732183X&volume=26&issue=&paginaInicial=1316&titulo=Targeting Vascular Endothelial Growth Factor in Advanced Carcinoid Tumor: A Random Assignment Phase II Study of Depot Octreotide With Bevacizumab and Pegylated Interferon Alfa-2b&sequencial=139&nomePeriodico=Journal of Clinical Oncology" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>140. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Haller, D. G.</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2008</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1200/JCO.2007.15.2090" target="_blank"></a>Haller, D. G. ; Cassidy, J. ; Clarke, S. J. ; Cunningham, D. ; Van Cutsem, E. ; <b>Hoff PM</b> ; <b>HOFF, P. M.</b> ; Rothenberg, M. L. ; Saltz, L. B. ; Schmoll, H.-J. ; Allegra, C. ; Bertino, J. R. ; Douillard, J.-Y. ; Gustavsson, B. G. ; Milano, G. ; O Connell M ; Rustum, Y. ; Tabernero, J. ; Gilberg, F. ; Sirzen, F. ; Twelves, C. . Potential Regional Differences for the Tolerability Profiles of Fluoropyrimidines. Journal of Clinical Oncology<sup><img id='0732183X_140' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='0732183X' /></sup>, v. 26, p. 2118-2123, 2008. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1200/JCO.2007.15.2090&issn=0732183X&volume=26&issue=&paginaInicial=2118&titulo=Potential Regional Differences for the Tolerability Profiles of Fluoropyrimidines&sequencial=140&nomePeriodico=Journal of Clinical Oncology" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>141. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Whitehead, Robert P.</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2008</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1007/s10637-008-9190-8" target="_blank"></a>Whitehead, Robert P. ; Rankin, Cathryn ; <b>Hoff PM</b> ; <b>Hoff, Paulo M. G.</b> ; Gold, Philip J. ; Billingsley, Kevin G. ; Chapman, Robert A. ; Wong, Lucas ; Ward, John H. ; Abbruzzese, James L. ; Blanke, Charles D. . Phase II trial of romidepsin (NSC-630176) in previously treated colorectal cancer patients with advanced disease: a Southwest Oncology Group study (S0336). Investigational New Drugs<sup><img id='01676997_141' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='01676997' /></sup>, p. 00-00, 2008. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1007/s10637-008-9190-8&issn=01676997&volume=&issue=&paginaInicial=00&titulo=Phase II trial of romidepsin (NSC-630176) in previously treated colorectal cancer patients with advanced disease: a Southwest Oncology Group study (S0336)&sequencial=141&nomePeriodico=Investigational New Drugs" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>142. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Overmann MJ</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2008</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1002/cncr.23822" target="_blank"></a>Overmann MJ ; Kopetz S ; Wen S ; <b>Hoff PM</b> ; <b>HOFF, P. M.</b> ; Fogelman D ; Morris J ; Abbruzzese JL ; Ajani JA ; Wolff RA . Chemotherapy with 5-fluorouracil and a platinum compound improves outcomes in metastatic small bowel adenocarcinoma. Cancer<sup><img id='0008543X_142' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='0008543X' /></sup>, v. 113, p. 2038-2045, 2008. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1002/cncr.23822&issn=0008543X&volume=113&issue=&paginaInicial=2038&titulo=Chemotherapy with 5-fluorouracil and a platinum compound improves outcomes in metastatic small bowel adenocarcinoma&sequencial=142&nomePeriodico=Cancer" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>143. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Hoff PM</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2008</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1038/sj.bjc.6604541" target="_blank"></a><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>; Kopetz, S ; Thomas, M B ; Langleben, A ; Rinaldi, D ; Anthony, L ; Wolff, R A ; Lassere, Y ; Abbruzzese, J L ; <b>Hoff PM</b> ; <b>HOFF, P. M.</b> . A phase II study of UFT with leucovorin administered as a twice daily schedule in the treatment of patients with metastatic colorectal cancer. British Journal of Cancer<sup><img id='00070920_143' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='00070920' /></sup>, v. 99, p. 722-726, 2008. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1038/sj.bjc.6604541&issn=00070920&volume=99&issue=&paginaInicial=722&titulo=A phase II study of UFT with leucovorin administered as a twice daily schedule in the treatment of patients with metastatic colorectal cancer&sequencial=143&nomePeriodico=British Journal of Cancer" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>144. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Saad, Everardo D.</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2008</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1590/S1807-59322008000300001" target="_blank"></a>Saad, Everardo D. ; Pinheiro, Cecília M. A. ; <a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/4784198389504165" target="_blank">Masson, André L. S.</a> ; Borghesi, Gustavo ; <b>Hoff PM</b> ; <b>Hoff, Paulo M. G.</b> ; Prisco, Flavio E. . Increasing output and low publication rate of Brazilian studies presented at the American Society of Clinical Oncology Annual Meetings. Clinics (São Paulo)<sup><img id='18075932_144' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='18075932' /></sup>, v. 63, p. 293-296, 2008. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1590/S1807-59322008000300001&issn=18075932&volume=63&issue=&paginaInicial=293&titulo=Increasing output and low publication rate of Brazilian studies presented at the American Society of Clinical Oncology Annual Meetings&sequencial=144&nomePeriodico=Clinics (São Paulo)" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>145. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Overman, Michael J.</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2008</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1007/s10637-008-9142-3" target="_blank"></a>Overman, Michael J. ; Varadhachary, Gauri ; Kopetz, Scott ; Thomas, Melanie B. ; Fukushima, Masakazu ; Kuwata, Keizo ; Mita, Akira ; Wolff, Robert A. ; Xiong, Henry ; <b>Hoff PM</b> ; <b>HOFF, P. M.</b> ; Abbruzzese, James L. . Phase 1 study of TAS-102 administered once daily on a 5-day-per-week schedule in patients with solid tumors. Investigational New Drugs<sup><img id='01676997_145' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='01676997' /></sup>, v. 26, p. 445-454, 2008. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1007/s10637-008-9142-3&issn=01676997&volume=26&issue=&paginaInicial=445&titulo=Phase 1 study of TAS-102 administered once daily on a 5-day-per-week schedule in patients with solid tumors&sequencial=145&nomePeriodico=Investigational New Drugs" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>146. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Kopetz S</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2008</span>Kopetz S ; <a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1026563052473840" target="_blank">Freitas D</a> ; Calabrich AF ; <b>Hoff PM</b> ; <b>HOFF, P. M.</b> . Adjuvant chemotherapy for stage II colon cancer. Oncology (Basel)<sup><img id='00302414_146' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='00302414' /></sup>, v. mar, p. 260-270, 2008. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=&issn=00302414&volume=mar&issue=&paginaInicial=260&titulo=Adjuvant chemotherapy for stage II colon cancer&sequencial=146&nomePeriodico=Oncology (Basel)" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>147. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>HÉNIN, E</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2008</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1038/clpt.2008.220" target="_blank"></a>HÉNIN, E ; YOU, B ; VANCUTSEM, E ; <b>HOFF, PM</b> ; CASSIDY, J ; TWELVES, C ; ZUIDEVELD, KP ; SIRZEN, F ; DARTOIS, C ; FREYER, G ; TOD, M ; GIRARD, P . A Dynamic Model of Hand-and-Foot Syndrome in Patients Receiving Capecitabine. Clinical Pharmacology and Therapeutics<sup><img id='00099236_147' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='00099236' /></sup>, v. 85, p. 418-425, 2008. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1038/clpt.2008.220&issn=00099236&volume=85&issue=&paginaInicial=418&titulo=A Dynamic Model of Hand-and-Foot Syndrome in Patients Receiving Capecitabine&sequencial=147&nomePeriodico=Clinical Pharmacology and Therapeutics" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>148. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Rhee J</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2007</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1007/s10350-007-0228-3" target="_blank"></a>Rhee J ; <b>Hoff PM</b> ; <b>Hoff, Paulo M.</b> . EGFR-Targeted Therapies in Colorectal Cancer. Diseases of the Colon & Rectum<sup><img id='00123706_148' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='00123706' /></sup>, v. 50, n.10, p. 1259-1270, 2007. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1007/s10350-007-0228-3&issn=00123706&volume=50&issue=&paginaInicial=1259&titulo=EGFR-Targeted Therapies in Colorectal Cancer&sequencial=148&nomePeriodico=Diseases of the Colon & Rectum" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>149. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Phan, Lan K.</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2007</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1007/s10350-006-0786-9" target="_blank"></a>Phan, Lan K. ; <b>Hoff PM</b> ; <b>Hoff, Paulo M.</b> . Evidence of Clinical Activity for Cetuximab Combined with Irinotecan in a Patient with Refractory Anal Canal Squamous-Cell Carcinoma: Report of a Case. Diseases of the Colon & Rectum<sup><img id='00123706_149' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='00123706' /></sup>, v. 50, p. 395-398, 2007. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1007/s10350-006-0786-9&issn=00123706&volume=50&issue=&paginaInicial=395&titulo=Evidence of Clinical Activity for Cetuximab Combined with Irinotecan in a Patient with Refractory Anal Canal Squamous-Cell Carcinoma: Report of a Case&sequencial=149&nomePeriodico=Diseases of the Colon & Rectum" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>150. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Hoff PM</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2007</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1200/JCO.2006.09.8384" target="_blank"></a><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>; Ellis, L. M. ; <b>Hoff PM</b> ; <b>HOFF, P. M.</b> . Targeted Therapy Trials: Approval Strategies, Target Validation, or Helping Patients?. Journal of Clinical Oncology<sup><img id='0732183X_150' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='0732183X' /></sup>, v. 25, p. 1639-1641, 2007. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1200/JCO.2006.09.8384&issn=0732183X&volume=25&issue=&paginaInicial=1639&titulo=Targeted Therapy Trials: Approval Strategies, Target Validation, or Helping Patients?&sequencial=150&nomePeriodico=Journal of Clinical Oncology" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>151. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Yao JC</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2007</span>Yao JC ; <b>Hoff PM</b> . Preface. Hematology/Oncology Clinics of North America<sup><img id='08898588_151' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='08898588' /></sup>, v. 21, p. xiii-xiv, 2007. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=&issn=08898588&volume=21&issue=&paginaInicial=xiii&titulo=Preface&sequencial=151&nomePeriodico=Hematology/Oncology Clinics of North America" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>152. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Hoff AO</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2007</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1016/j.hoc.2007.04.002" target="_blank"></a><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/4792805111122908" target="_blank">Hoff AO</a> ; <b>Hoff PM</b> ; <b>Hoff PM</b> ; <b>HOFF, P. M.</b> . Medullary Thyroid Carcinoma. Hematology/Oncology Clinics of North America<sup><img id='08898588_152' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='08898588' /></sup>, v. 21, p. 475-488, 2007. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1016/j.hoc.2007.04.002&issn=08898588&volume=21&issue=&paginaInicial=475&titulo=Medullary Thyroid Carcinoma&sequencial=152&nomePeriodico=Hematology/Oncology Clinics of North America" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>153. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>YAO, J</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2007</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1016/j.hoc.2007.04.001" target="_blank"></a>YAO, J ; <b>Hoff PM</b> ; <b>Hoff PM</b> ; <b>HOFF, P. M.</b> . Molecular Targeted Therapy for Neuroendocrine Tumors. Hematology/Oncology Clinics of North America<sup><img id='08898588_153' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='08898588' /></sup>, v. 21, p. 575-581, 2007. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1016/j.hoc.2007.04.001&issn=08898588&volume=21&issue=&paginaInicial=575&titulo=Molecular Targeted Therapy for Neuroendocrine Tumors&sequencial=153&nomePeriodico=Hematology/Oncology Clinics of North America" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>154. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Hoff PM</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2007</span><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>. Novel agents and targets for the therapy of advanced colon cancer. Clinical Advances in Hematology & Oncology: H&O<sup><img id='15430790_154' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='15430790' /></sup>, v. 5, p. 365-366, 2007. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=&issn=15430790&volume=5&issue=&paginaInicial=365&titulo=Novel agents and targets for the therapy of advanced colon cancer&sequencial=154&nomePeriodico=Clinical Advances in Hematology & Oncology: H&O" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>155. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Verslype C</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2007</span>Verslype C ; Van Cutsem E ; Dicato M ; Cascinu S ; Cunningham D ; Diaz-Rubio E ; Glimelius B ; Haller D ; Haustermans K ; Heinemann V ; <b>Hoff PM</b> ; Johnston PG ; Kerr D ; Labianca R . The management of pancreatic cancer. Current expert opinion and recommendations derived from the 8th world congress on gastrointestinal cancer. Annals of Oncology<sup><img id='09237534_155' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='09237534' /></sup>, v. 18, p. vii1-vii10, 2007. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=&issn=09237534&volume=18&issue=&paginaInicial=vii1&titulo=The management of pancreatic cancer. Current expert opinion and recommendations derived from the 8th world congress on gastrointestinal cancer&sequencial=155&nomePeriodico=Annals of Oncology" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>156. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Saltz, L. B.</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2007</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1200/JCO.2007.12.0949" target="_blank"></a>Saltz, L. B. ; Lenz, H.-J. ; Kindler, H. L. ; Hochster, H. S. ; Wadler, S. ; <b>Hoff PM</b> ; Kemeny, N. E. ; Hollywood, E. M. ; Gonen, M. ; Quinones, M. ; Morse, M. ; Chen, H. X. ; <b>Hoff PM</b> ; <b>HOFF, P. M.</b> . Randomized Phase II Trial of Cetuximab, Bevacizumab, and Irinotecan Compared With Cetuximab and Bevacizumab Alone in Irinotecan-Refractory Colorectal Cancer: The BOND-2 Study. Journal of Clinical Oncology<sup><img id='0732183X_156' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='0732183X' /></sup>, v. 25, p. 4557-4561, 2007. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1200/JCO.2007.12.0949&issn=0732183X&volume=25&issue=&paginaInicial=4557&titulo=Randomized Phase II Trial of Cetuximab, Bevacizumab, and Irinotecan Compared With Cetuximab and Bevacizumab Alone in Irinotecan-Refractory Colorectal Cancer: The BOND-2 Study&sequencial=156&nomePeriodico=Journal of Clinical Oncology" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>157. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Hoff PM</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2007</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1200/JCO.2007.13.1359" target="_blank"></a><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>; Ellis, L. M. . In Reply. Journal of Clinical Oncology<sup><img id='0732183X_157' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='0732183X' /></sup>, v. 25, p. 4692-4692, 2007. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1200/JCO.2007.13.1359&issn=0732183X&volume=25&issue=&paginaInicial=4692&titulo=In Reply&sequencial=157&nomePeriodico=Journal of Clinical Oncology" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>158. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Hoff PM</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2006</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1002/cncr.21874" target="_blank"></a><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>; Wolff, Robert A. ; Xiong, Henry ; Jones, Dennie ; Lin, Edward ; Eng, Cathy ; Dutta, Ankhi ; Bogaard, Karla R. ; Abbruzzese, James L. . Phase II trial of combined irinotecan and oxaliplatin given every 3 weeks to patients with metastatic colorectal cancer. Cancer<sup><img id='0008543X_158' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='0008543X' /></sup>, v. 106, n.10, p. 2241-2246, 2006. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1002/cncr.21874&issn=0008543X&volume=106&issue=&paginaInicial=2241&titulo=Phase II trial of combined irinotecan and oxaliplatin given every 3 weeks to patients with metastatic colorectal cancer&sequencial=158&nomePeriodico=Cancer" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>159. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Morrow PK</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2006</span>Morrow PK ; <b>Hoff PM</b> . Does the addition of oxaliplatin increase the risk of capecitabine-induced cardiotoxicity ?. Nature Clinical Practice Oncology, Estados Unidos, v. 3, n.2, p. 76-77, 2006. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=&issn=&volume=3&issue=&paginaInicial=76&titulo=Does the addition of oxaliplatin increase the risk of capecitabine-induced cardiotoxicity ?&sequencial=159&nomePeriodico=Nature Clinical Practice Oncology" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>160. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Vauthey, J.-N.</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2006</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1200/JCO.2005.05.3074" target="_blank"></a>Vauthey, J.-N. ; Pawlik TM ; Ribero D ; Wu TT ; Zorzi D ; <b>Hoff PM</b> ; <b>HOFF, P. M.</b> ; Xiong HQ ; Eng C ; Lauwers GY ; MINO-KENUDSON, M. ; Risio M ; Muratore A ; Capussotti L ; Curley SA ; ABDALLA, E. K. . Chemotherapy Regimen Predicts Steatohepatitis and an Increase in 90-Day Mortality After Surgery for Hepatic Colorectal Metastases. Journal of Clinical Oncology<sup><img id='0732183X_160' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='0732183X' /></sup>, Estados Unidos, v. 24, n.13, p. 2065-2072, 2006. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1200/JCO.2005.05.3074&issn=0732183X&volume=24&issue=&paginaInicial=2065&titulo=Chemotherapy Regimen Predicts Steatohepatitis and an Increase in 90-Day Mortality After Surgery for Hepatic Colorectal Metastases&sequencial=160&nomePeriodico=Journal of Clinical Oncology" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>161. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Yang, A. D.</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2006</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1158/1078-0432.CCR-06-0038" target="_blank"></a>Yang, A. D. ; Fan F ; Camp ER ; Van Buren G ; Liu W ; Somcio R ; Gray MJ. ; Cheng H ; <b>Hoff PM</b> ; <b>HOFF, P. M.</b> ; Ellis LM . Chronic Oxaliplatin Resistance Induces Epithelial-to-Mesenchymal Transition in Colorectal Cancer Cell Lines. Clinical Cancer Research<sup><img id='10780432_161' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='10780432' /></sup>, v. 12, p. 4147-4153, 2006. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1158/1078-0432.CCR-06-0038&issn=10780432&volume=12&issue=&paginaInicial=4147&titulo=Chronic Oxaliplatin Resistance Induces Epithelial-to-Mesenchymal Transition in Colorectal Cancer Cell Lines&sequencial=161&nomePeriodico=Clinical Cancer Research" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>162. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Hong, David S.</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2006</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1002/cncr.22125" target="_blank"></a>Hong, David S. ; Abbruzzese, James L. ; Bogaard, Karla ; Lassere, Yvonne ; Fukushima, Masakazu ; Mita, Akira ; Kuwata, Keizo ; <b>Hoff PM</b> ; <b>Hoff, Paulo M.</b> . Phase I study to determine the safety and pharmacokinetics of oral administration of TAS-102 in patients with solid tumors. Cancer<sup><img id='0008543X_162' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='0008543X' /></sup>, v. 107, p. 1383-1390, 2006. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1002/cncr.22125&issn=0008543X&volume=107&issue=&paginaInicial=1383&titulo=Phase I study to determine the safety and pharmacokinetics of oral administration of TAS-102 in patients with solid tumors&sequencial=162&nomePeriodico=Cancer" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>163. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Das P</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2006</span>Das P ; Delclos ME ; Chang GJ ; <b>Hoff PM</b> ; Eng C ; Brown TD ; Crane CH ; Feig BW ; Morris J ; Vadhan-Raj S ; Hamilton SR ; Lin EH . Phase II study of capecitabine (Xeloda(r)) and concomitant boost radiotherapy in patients with locally advanced rectal cancer. International Journal of Radiation Oncology, Biology, Physics<sup><img id='03603016_163' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='03603016' /></sup>, v. 66, p. 762-771, 2006. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=&issn=03603016&volume=66&issue=&paginaInicial=762&titulo=Phase II study of capecitabine (Xeloda(r)) and concomitant boost radiotherapy in patients with locally advanced rectal cancer&sequencial=163&nomePeriodico=International Journal of Radiation Oncology, Biology, Physics" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>164. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>FUCHS, C</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2006</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1016/j.ctrv.2006.07.001" target="_blank"></a>FUCHS, C ; MITCHELL, E ; <b>Hoff PM</b> ; <b>HOFF, P. M.</b> . Irinotecan in the treatment of colorectal cancer. Cancer Treatment Reviews<sup><img id='03057372_164' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='03057372' /></sup>, v. 32, p. 491-503, 2006. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1016/j.ctrv.2006.07.001&issn=03057372&volume=32&issue=&paginaInicial=491&titulo=Irinotecan in the treatment of colorectal cancer&sequencial=164&nomePeriodico=Cancer Treatment Reviews" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>165. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Chapman, William C.</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2006</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1245/s10434-006-9024-x" target="_blank"></a>Chapman, William C. ; <b>Hoff PM</b> ; <b>Hoff, Paulo M.</b> ; Strasberg, Steven M. . Selection of Patients for Resection of Hepatic Colorectal Metastases: Expert Consensus Statement by Charnsangavej et al.. Annals of Surgical Oncology<sup><img id='10689265_165' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='10689265' /></sup>, v. 13, p. 1269-1270, 2006. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1245/s10434-006-9024-x&issn=10689265&volume=13&issue=&paginaInicial=1269&titulo=Selection of Patients for Resection of Hepatic Colorectal Metastases: Expert Consensus Statement by Charnsangavej et al.&sequencial=165&nomePeriodico=Annals of Surgical Oncology" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>166. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Hoff PM</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2006</span><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>; Wolff RA ; Bogaard K ; Waldrum S ; Abbruzzese JL . A phase I study of escalating doses of the tyrosine kinase inhibitor semaxanib (SU5416) in combination with irinotecan in patients with advanced colorectal carcinoma. Japanese Journal of Clinical Oncology<sup><img id='03682811_166' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='03682811' /></sup>, v. 36, p. 100-103, 2006. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=&issn=03682811&volume=36&issue=&paginaInicial=100&titulo=A phase I study of escalating doses of the tyrosine kinase inhibitor semaxanib (SU5416) in combination with irinotecan in patients with advanced colorectal carcinoma&sequencial=166&nomePeriodico=Japanese Journal of Clinical Oncology" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>167. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Hoff PM</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2006</span><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>. Bevacizumab in older patients and patients with poorer performance status. Seminars in Oncology<sup><img id='00937754_167' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='00937754' /></sup>, v. 33, p. 19-25, 2006. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=&issn=00937754&volume=33&issue=&paginaInicial=19&titulo=Bevacizumab in older patients and patients with poorer performance status&sequencial=167&nomePeriodico=Seminars in Oncology" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>168. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Das P</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2006</span>Das P ; Lin EH ; Bhatia S ; Skibber JM ; Rodriguez-Bigas MA ; Feig BW ; Chang GJ ; <b>Hoff PM</b> ; Eng C ; Wolff RA ; Delclos ME ; Krishnan S ; Janjan NA ; Crane CH . Preoperative chemoradiotherapy with capecitabine versus protracted infusion 5-fluorouracil for rectal cancer: a matched-pair analysis. International Journal of Radiation Oncology, Biology, Physics<sup><img id='03603016_168' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='03603016' /></sup>, v. 66, p. 1378-1383, 2006. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=&issn=03603016&volume=66&issue=&paginaInicial=1378&titulo=Preoperative chemoradiotherapy with capecitabine versus protracted infusion 5-fluorouracil for rectal cancer: a matched-pair analysis&sequencial=168&nomePeriodico=International Journal of Radiation Oncology, Biology, Physics" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>169. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Das, Prajnan</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2006</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1097/01.coc.0000214930.78200.4a" target="_blank"></a>Das, Prajnan ; Skibber, John M. ; Rodriguez-Bigas, Miguel A. ; Feig, Barry W. ; Chang, George J. ; <b>Hoff PM</b> ; <b>Hoff, Paulo M.</b> ; Eng, Cathy ; Wolff, Robert A. ; JanJan, Nora A. ; Delclos, Marc E. ; Krishnan, Sunil ; Levy, Lawrence B. ; Ellis, Lee M. ; Crane, Christopher H. . Clinical and Pathologic Predictors of Locoregional Recurrence, Distant Metastasis, and Overall Survival in Patients Treated With Chemoradiation and Mesorectal Excision for Rectal Cancer. American Journal of Clinical Oncology<sup><img id='02773732_169' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='02773732' /></sup>, v. 29, p. 219-224, 2006. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1097/01.coc.0000214930.78200.4a&issn=02773732&volume=29&issue=&paginaInicial=219&titulo=Clinical and Pathologic Predictors of Locoregional Recurrence, Distant Metastasis, and Overall Survival in Patients Treated With Chemoradiation and Mesorectal Excision for Rectal Cancer&sequencial=169&nomePeriodico=American Journal of Clinical Oncology" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>170. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Kopetz S</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2006</span>Kopetz S ; <b>Hoff PM</b> . Cytotoxic chemotherapy for advanced colorectal cancer. Recent advances in management. Oncology (Basel)<sup><img id='00302414_170' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='00302414' /></sup>, v. 19, p. 11-17, 2006. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=&issn=00302414&volume=19&issue=&paginaInicial=11&titulo=Cytotoxic chemotherapy for advanced colorectal cancer. Recent advances in management&sequencial=170&nomePeriodico=Oncology (Basel)" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>171. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Varadhachary CR</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2005</span>Varadhachary CR ; <b>Hoff PM</b> . Front-line therapy for advanced colorectal cancer: emphasis on chemotherapy. Seminars in Oncology<sup><img id='00937754_171' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='00937754' /></sup>, v. 32, n.6, p. 40-42, 2005. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=&issn=00937754&volume=32&issue=&paginaInicial=40&titulo=Front-line therapy for advanced colorectal cancer: emphasis on chemotherapy&sequencial=171&nomePeriodico=Seminars in Oncology" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>172. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Kopetz S</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2005</span>Kopetz S ; <b>Hoff PM</b> . Cytotoxic chemotherapy for advanced colorectal cancer.. Oncology (Basel)<sup><img id='00302414_172' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='00302414' /></sup>, v. 19, n.13, p. 11-17, 2005. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=&issn=00302414&volume=19&issue=&paginaInicial=11&titulo=Cytotoxic chemotherapy for advanced colorectal cancer.&sequencial=172&nomePeriodico=Oncology (Basel)" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>173. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Hoff PM</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2005</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1200/JCO.2005.07.021" target="_blank"></a><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>; Is There a Role for Routine p53 Testing in Colorectal Cancer?. Journal of Clinical Oncology<sup><img id='0732183X_173' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='0732183X' /></sup>, v. 23, n.30, p. 7395-7396, 2005. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1200/JCO.2005.07.021&issn=0732183X&volume=23&issue=&paginaInicial=7395&titulo=Is There a Role for Routine p53 Testing in Colorectal Cancer?&sequencial=173&nomePeriodico=Journal of Clinical Oncology" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>174. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Saad ED</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2005</span>Saad ED ; <b>Hoff PM</b> . Chemotherapy of Metastatic Colorectal Cancer. Current Treatment Options in Gastroenterology<sup><img id='10928472_174' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='10928472' /></sup>, v. 8, n.3, p. 239-247, 2005. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=&issn=10928472&volume=8&issue=&paginaInicial=239&titulo=Chemotherapy of Metastatic Colorectal Cancer&sequencial=174&nomePeriodico=Current Treatment Options in Gastroenterology" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>175. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Domont, J.</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2005</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1200/JCO.2005.06.944" target="_blank"></a>Domont, J. ; Pawlik TM ; Boige V ; Rose M ; Weber JC ; <b>Hoff PM</b> ; <b>HOFF, P. M.</b> ; Brown TD ; Zorzi D ; Morat L ; Pignon JP ; Rashid A ; Jaeck D ; Sabatier L ; Elias D ; Tursz T ; Soria JC ; Vauthey J . Catalytic Subunit of Human Telomerase Reverse Transcriptase Is an Independent Predictor of Survival in Patients Undergoing Curative Resection of Hepatic Colorectal Metastases: A Multicenter Analysis. Journal of Clinical Oncology<sup><img id='0732183X_175' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='0732183X' /></sup>, v. 23, p. 3086-3093, 2005. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1200/JCO.2005.06.944&issn=0732183X&volume=23&issue=&paginaInicial=3086&titulo=Catalytic Subunit of Human Telomerase Reverse Transcriptase Is an Independent Predictor of Survival in Patients Undergoing Curative Resection of Hepatic Colorectal Metastases: A Multicenter Analysis&sequencial=175&nomePeriodico=Journal of Clinical Oncology" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>176. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Kouvaraki MA</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2004</span>Kouvaraki MA ; Ajani JA ; <b>Hoff PM</b> ; Wolff R ; Evans DB ; Lozano R ; Yao JC . Fluorouracil, doxorubicin and streptozocin in the treatment of patients with locally advanced and metastatic pancreatic endocrine carcinomas. Journal of Clinical Oncology<sup><img id='0732183X_176' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='0732183X' /></sup>, v. 22, n.23, p. 4710-4719, 2004. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=&issn=0732183X&volume=22&issue=&paginaInicial=4710&titulo=Fluorouracil, doxorubicin and streptozocin in the treatment of patients with locally advanced and metastatic pancreatic endocrine carcinomas&sequencial=176&nomePeriodico=Journal of Clinical Oncology" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>177. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Hoff PM</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2004</span><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>. Oxaliplatin-related neurotoxicity: is chelation the solution?. Nature Clinical Practice Oncology<sup><img id='17434254_177' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='17434254' /></sup>, v. 1, n.2, p. 78-79, 2004. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=&issn=17434254&volume=1&issue=&paginaInicial=78&titulo=Oxaliplatin-related neurotoxicity: is chelation the solution?&sequencial=177&nomePeriodico=Nature Clinical Practice Oncology" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>178. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Hoff PM</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2004</span><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>. Future directions in the use of antiangiogenic agents in patients with colorectal cancer. Seminars in Oncology<sup><img id='00937754_178' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='00937754' /></sup>, v. 31, n.6, p. 17-21, 2004. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=&issn=00937754&volume=31&issue=&paginaInicial=17&titulo=Future directions in the use of antiangiogenic agents in patients with colorectal cancer&sequencial=178&nomePeriodico=Seminars in Oncology" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>179. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Bonnen M</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2004</span>Bonnen M ; Crane C ; Vauthey J-N ; Skibber J ; Delclos ME ; Rodriguez-Bigas M ; <b>Hoff PM</b> ; Lin E ; Eng C ; Wong A ; Janjan NA ; Feig BW . Long-term results using local excision after preoperative chemoradiation among selected T3 rectal cancer patients. International Journal of Radiation Oncology, Biology, Physics<sup><img id='03603016_179' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='03603016' /></sup>, v. 60, n.4, p. 1098-1105, 2004. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=&issn=03603016&volume=60&issue=&paginaInicial=1098&titulo=Long-term results using local excision after preoperative chemoradiation among selected T3 rectal cancer patients&sequencial=179&nomePeriodico=International Journal of Radiation Oncology, Biology, Physics" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>180. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Shirao, K.</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2004</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1200/JCO.2004.05.017" target="_blank"></a>Shirao, K. ; <b>Hoff PM</b> ; <b>HOFF, P. M.</b> ; Ohtsu A ; Loehrer PJ ; Hyodo I ; Wadler S ; Wadleigh RG ; Muro K ; Yamada Y ; Boku N ; Nagashima F ; Abbruzzese JL . Comparison of the Efficacy, Toxicity, and Pharmacokinetics of a Uracil/Tegafur (UFT) Plus Oral Leucovorin (LV) Regimen Between Japanese and American Patients With Advanced Colorectal Cancer: Joint United States and Japan Study of UFT/LV. Journal of Clinical Oncology<sup><img id='0732183X_180' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='0732183X' /></sup>, v. 22, n.17, p. 3466-3474, 2004. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1200/JCO.2004.05.017&issn=0732183X&volume=22&issue=&paginaInicial=3466&titulo=Comparison of the Efficacy, Toxicity, and Pharmacokinetics of a Uracil/Tegafur (UFT) Plus Oral Leucovorin (LV) Regimen Between Japanese and American Patients With Advanced Colorectal Cancer: Joint United States and Japan Study of UFT/LV&sequencial=180&nomePeriodico=Journal of Clinical Oncology" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>181. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Hoff PM</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2004</span><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>; Saad ED ; Lassere Y ; Bogaard K ; Pazdur R ; Abbruzzese JC . Phase I trial of combined irinotecan and oxaliplatin given every three weeks to patients with metastatic colorectal cancer. Investigational New Drugs<sup><img id='01676997_181' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='01676997' /></sup>, v. 22, n.3, p. 307-313, 2004. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=&issn=01676997&volume=22&issue=&paginaInicial=307&titulo=Phase I trial of combined irinotecan and oxaliplatin given every three weeks to patients with metastatic colorectal cancer&sequencial=181&nomePeriodico=Investigational New Drugs" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>182. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Hoff PM</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2004</span><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>; Pazdur R ; Lassere Y ; Carter S ; Dvorit S ; Polito D ; Abbruzzese JC . Phase II study of capecitabine in patients with 5- fluorouracil resistant metastatic colorectal carcinoma. Journal of Clinical Oncology<sup><img id='0732183X_182' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='0732183X' /></sup>, v. 22, n.11, p. 2078-2083, 2004. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=&issn=0732183X&volume=22&issue=&paginaInicial=2078&titulo=Phase II study of capecitabine in patients with 5- fluorouracil resistant metastatic colorectal carcinoma&sequencial=182&nomePeriodico=Journal of Clinical Oncology" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>183. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Johansen, Mary</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2004</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1007/s00280-003-0743-4" target="_blank"></a>Johansen, Mary ; Zukowski, Thomas ; <b>Hoff PM</b> ; <b>Hoff, Paulo M.</b> ; Newman, Robert A. ; Ni, Dan ; Hutto, Toni ; Abbruzzese, James ; Berghorn, Elmer ; Hausheer, Frederick ; Madden, Timothy . Final results of a phase I and pharmacokinetic study of ?-methylene-10-deazaaminopterin (MDAM) administered intravenously daily for five consecutive days in patients with solid tumors. Cancer Chemotherapy and Pharmacology<sup><img id='03445704_183' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='03445704' /></sup>, v. 53, n.5, p. 370-376, 2004. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1007/s00280-003-0743-4&issn=03445704&volume=53&issue=&paginaInicial=370&titulo=Final results of a phase I and pharmacokinetic study of ?-methylene-10-deazaaminopterin (MDAM) administered intravenously daily for five consecutive days in patients with solid tumors&sequencial=183&nomePeriodico=Cancer Chemotherapy and Pharmacology" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>184. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Hoff PM</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2004</span><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>; Ellis LM ; Abbruzzese JL . Monoclonal antibodies: the foundation of therapy for colorectal cancer in the 21st century?. Oncology (Basel)<sup><img id='00302414_184' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='00302414' /></sup>, v. 18, n.6, p. 736-41, 2004. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=&issn=00302414&volume=18&issue=&paginaInicial=736&titulo=Monoclonal antibodies: the foundation of therapy for colorectal cancer in the 21st century?&sequencial=184&nomePeriodico=Oncology (Basel)" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>185. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Hoff PM</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2004</span><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>; Pazdur R . Progress in the development of novel treatments for colorectal cancer. Oncology (Basel)<sup><img id='00302414_185' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='00302414' /></sup>, v. 18, n.6, p. 705-8, 2004. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=&issn=00302414&volume=18&issue=&paginaInicial=705&titulo=Progress in the development of novel treatments for colorectal cancer&sequencial=185&nomePeriodico=Oncology (Basel)" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>186. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Ellis LM</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2004</span>Ellis LM ; <b>Hoff PM</b> . Targeting the epidermal growth factor receptor: an important incremental step in the battle against colorectal cancer. Journal of Clinical Oncology<sup><img id='0732183X_186' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='0732183X' /></sup>, v. 22, n.7, p. 1177-1179, 2004. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=&issn=0732183X&volume=22&issue=&paginaInicial=1177&titulo=Targeting the epidermal growth factor receptor: an important incremental step in the battle against colorectal cancer&sequencial=186&nomePeriodico=Journal of Clinical Oncology" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>187. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Van Cutsem, E</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2004</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1038/sj.bjc.6601676" target="_blank"></a>Van Cutsem, E ; <b>Hoff PM</b> ; <b>HOFF, P. M.</b> ; Harper, P ; Bukowski, R M ; Cunningham, D ; Dufour, P ; Graeven, U ; Lokich, J ; Madajewicz, S ; Maroun, J A ; Marshall, J L ; Mitchell, E P ; Perez-Manga, G ; Rougier, P ; Schmiegel, W ; Schoelmerich, J ; Sobrero, A ; Schilsky, R L . Oral capecitabine vs intravenous 5-fluorouracil and leucovorin: integrated efficacy data and novel analyses from two large, randomised, phase III trials. British Journal of Cancer<sup><img id='00070920_187' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='00070920' /></sup>, v. 90, n.6, p. 1190-1197, 2004. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1038/sj.bjc.6601676&issn=00070920&volume=90&issue=&paginaInicial=1190&titulo=Oral capecitabine vs intravenous 5-fluorouracil and leucovorin: integrated efficacy data and novel analyses from two large, randomised, phase III trials&sequencial=187&nomePeriodico=British Journal of Cancer" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>188. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Saad ED</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2004</span>Saad ED ; <b>Hoff PM</b> . Molecular-targeted agents in pancreatic cancer. Cancer Control: Journal of the Moffitt Cancer<sup><img id='10732748_188' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='10732748' /></sup>, v. 11, n.1, p. 32-38, 2004. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=&issn=10732748&volume=11&issue=&paginaInicial=32&titulo=Molecular-targeted agents in pancreatic cancer&sequencial=188&nomePeriodico=Cancer Control: Journal of the Moffitt Cancer" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>189. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Lassere Y</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2004</span>Lassere Y ; <b>Hoff PM</b> . Management of hand-foot syndrome in patients treated with capecitabine (Xeloda). European Journal of Oncology Nursing<sup><img id='14623889_189' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='14623889' /></sup>, v. 8, n.1, p. 31-40, 2004. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=&issn=14623889&volume=8&issue=&paginaInicial=31&titulo=Management of hand-foot syndrome in patients treated with capecitabine (Xeloda)&sequencial=189&nomePeriodico=European Journal of Oncology Nursing" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>190. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Royce ME</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2004</span>Royce ME ; Rowinsky EK ; <b>Hoff PM</b> ; Coyle J ; De Jager R ; Pazdur R ; Saltz LB . A phase II study of intravenous exatecan mesylate (DX-8951f) administred daily for five days every three weeks to patients with metastatic adenocarcinoma of the colon or rectum. Investigational New Drugs<sup><img id='01676997_190' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='01676997' /></sup>, v. 22, p. 53-61, 2004. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=&issn=01676997&volume=22&issue=&paginaInicial=53&titulo=A phase II study of intravenous exatecan mesylate (DX-8951f) administred daily for five days every three weeks to patients with metastatic adenocarcinoma of the colon or rectum&sequencial=190&nomePeriodico=Investigational New Drugs" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>191. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Hoff PM</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2004</span><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>. Adjuvant therapy in colorectal cancer. American Journal of Oncology Review<sup><img id='15429520_191' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='15429520' /></sup>, v. 3, p. 4710-4719, 2004. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=&issn=15429520&volume=3&issue=&paginaInicial=4710&titulo=Adjuvant therapy in colorectal cancer&sequencial=191&nomePeriodico=American Journal of Oncology Review" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>192. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Comets E</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2003</span>Comets E ; Ikeda K ; <b>Hoff PM</b> ; Fumoleau P ; Wanders J ; Tanigawara Y . Comparison of the pharmacokinetics of S-1, an oral anticancer agent, in Western and Japanese patients. Journal of Pharmacokinetics and Pharmacodynamics<sup><img id='1567567X_192' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='1567567X' /></sup>, v. 30, n.4, p. 257-283, 2003. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=&issn=1567567X&volume=30&issue=&paginaInicial=257&titulo=Comparison of the pharmacokinetics of S-1, an oral anticancer agent, in Western and Japanese patients&sequencial=192&nomePeriodico=Journal of Pharmacokinetics and Pharmacodynamics" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>193. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Hoff PM</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2003</span><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>. Oxaliplatin: high activity at all stages of colon carcinomas]. Onkologie (Basel)<sup><img id='0378584X_193' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='0378584X' /></sup>, v. 26, p. 2-10, 2003. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=&issn=0378584X&volume=26&issue=&paginaInicial=2&titulo=Oxaliplatin: high activity at all stages of colon carcinomas]&sequencial=193&nomePeriodico=Onkologie (Basel)" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>194. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Hoff PM</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2003</span><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>; Fuchs CS . The experience with oxaliplatin in the treatment of upper gastrointestinal carcinomas. Seminars in Oncology<sup><img id='00937754_194' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='00937754' /></sup>, v. 30, n.4, p. 54-61, 2003. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=&issn=00937754&volume=30&issue=&paginaInicial=54&titulo=The experience with oxaliplatin in the treatment of upper gastrointestinal carcinomas&sequencial=194&nomePeriodico=Seminars in Oncology" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>195. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Hoff PM</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2003</span><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>. Practical considerations in the use of oral fluoropyrimidines. Seminars in Oncology<sup><img id='00937754_195' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='00937754' /></sup>, v. 3, n.3, p. 88-92, 2003. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=&issn=00937754&volume=3&issue=&paginaInicial=88&titulo=Practical considerations in the use of oral fluoropyrimidines&sequencial=195&nomePeriodico=Seminars in Oncology" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>196. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Nasta SD</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2003</span>Nasta SD ; <b>Hoff PM</b> ; George CS ; Neubauer M ; Cohen SC ; Abbruzzese J ; Winn R ; Pazdur RM . Phase II study of MGI-114 administered intravenously for 5 days every 28 days to patients with metastatic colorectal cancer. American Journal of Clinical Oncology<sup><img id='02773732_196' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='02773732' /></sup>, v. 26, n.2, p. 132-134, 2003. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=&issn=02773732&volume=26&issue=&paginaInicial=132&titulo=Phase II study of MGI-114 administered intravenously for 5 days every 28 days to patients with metastatic colorectal cancer&sequencial=196&nomePeriodico=American Journal of Clinical Oncology" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>197. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Hoff PM</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2003</span><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>. New drugs for colorectal cancer. Cancer Chemotherapy Biological Response Modifiers<sup><img id='09214410_197' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='09214410' /></sup>, v. 21, p. 817-829, 2003. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=&issn=09214410&volume=21&issue=&paginaInicial=817&titulo=New drugs for colorectal cancer&sequencial=197&nomePeriodico=Cancer Chemotherapy Biological Response Modifiers" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>198. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Saad, Everardo</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2003</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1081/CNV-120022382" target="_blank"></a>Saad, Everardo ; <b>Hoff PM</b> ; <b>Hoff, Paulo</b> . UFT and Oral Leucovorin as Radiation Sensitizers in Rectal and Other Gastrointestinal Malignancies. Cancer Investigation<sup><img id='07357907_198' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='07357907' /></sup>, v. 21, n.4, p. 624-629, 2003. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1081/CNV-120022382&issn=07357907&volume=21&issue=&paginaInicial=624&titulo=UFT and Oral Leucovorin as Radiation Sensitizers in Rectal and Other Gastrointestinal Malignancies&sequencial=198&nomePeriodico=Cancer Investigation" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>199. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Hoff PM</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2003</span><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>; Saad ED ; Ajani JA ; Lassere Y ; Wenske C ; Medgyesy D ; Dwivedy S ; Russo M ; Pazdur R . Phase I study with pharmacokinetics of S-1 on an oral daily schedule for 28 days in patients with solid tumors. Clinical Cancer Research<sup><img id='10780432_199' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='10780432' /></sup>, v. 9, n.1, p. 134-142, 2003. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=&issn=10780432&volume=9&issue=&paginaInicial=134&titulo=Phase I study with pharmacokinetics of S-1 on an oral daily schedule for 28 days in patients with solid tumors&sequencial=199&nomePeriodico=Clinical Cancer Research" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>200. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Riechelmann RP</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2003</span>Riechelmann RP ; <b>Hoff PM</b> ; Moran RA ; Lopes LH ; Buzaid AC . Acinar cell carcinoma of the pancreas. International journal of gastrointestinal cancer (Cessou em 2006. Cont. ISSN 1941-6628 Journal of gastrointestinal cancer)<sup><img id='15373649_200' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='15373649' /></sup>, v. 34, n.2-3, p. 67-72, 2003. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=&issn=15373649&volume=34&issue=&paginaInicial=67&titulo=Acinar cell carcinoma of the pancreas&sequencial=200&nomePeriodico=International journal of gastrointestinal cancer (Cessou em 2006. Cont. ISSN 1941-6628 Journal of gastrointestinal cancer)" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>201. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Hoff PM</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2003</span><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>; Saltz L ; Von Blanke CD ; Van Cutsem E . Colorectal cancer malignancies. Onkologie (Basel)<sup><img id='0378584X_201' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='0378584X' /></sup>, v. 26, p. 2-10, 2003. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=&issn=0378584X&volume=26&issue=&paginaInicial=2&titulo=Colorectal cancer malignancies&sequencial=201&nomePeriodico=Onkologie (Basel)" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>202. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Saad ED</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2002</span>Saad ED ; Kraut EH ; <b>Hoff PM</b> ; Moore DF ; Jones D ; Pazdur R ; Abbruzzese JA . Phase II study of dolastatin-10 as fisrt-line treatment for advanced colorectal cancer. American Journal of Clinical Oncology<sup><img id='02773732_202' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='02773732' /></sup>, v. 25, n.5, p. 451-453, 2002. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=&issn=02773732&volume=25&issue=&paginaInicial=451&titulo=Phase II study of dolastatin-10 as fisrt-line treatment for advanced colorectal cancer&sequencial=202&nomePeriodico=American Journal of Clinical Oncology" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>203. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Douillard JY</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2002</span>Douillard JY ; <b>Hoff PM</b> ; Skillings JR ; Eisenberg P . Multicenter phase III study of uracil/tegafur and oral leucovorin versus fluorouracil and leucovorin in patients with previously untreated metastatic colorectal cancer. Journal of Clinical Oncology<sup><img id='0732183X_203' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='0732183X' /></sup>, v. 20, n.17, p. 3605-3616, 2002. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=&issn=0732183X&volume=20&issue=&paginaInicial=3605&titulo=Multicenter phase III study of uracil/tegafur and oral leucovorin versus fluorouracil and leucovorin in patients with previously untreated metastatic colorectal cancer&sequencial=203&nomePeriodico=Journal of Clinical Oncology" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>204. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Hoff PM</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2002</span><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>. First-line oral capecitabine therapy in metastatic colorectal cancer: a favorable safety profile compared with intravenous 5-fluorouracil/leucovorin. Annals of Oncology<sup><img id='09237534_204' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='09237534' /></sup>, v. 13, n.4, p. 566-75, 2002. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=&issn=09237534&volume=13&issue=&paginaInicial=566&titulo=First-line oral capecitabine therapy in metastatic colorectal cancer: a favorable safety profile compared with intravenous 5-fluorouracil/leucovorin&sequencial=204&nomePeriodico=Annals of Oncology" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>205. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Van Cutsem E</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2002</span>Van Cutsem E ; <b>Hoff PM</b> ; Blum J ; ABT M ; Osterwalder B . Incidence of cardiotoxicity with the oral fluoropyrimidine capecitabine is typical of that reported with 5-fluorouracil. Annals of Oncology<sup><img id='09237534_205' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='09237534' /></sup>, v. 13, n.3, p. 484-485, 2002. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=&issn=09237534&volume=13&issue=&paginaInicial=484&titulo=Incidence of cardiotoxicity with the oral fluoropyrimidine capecitabine is typical of that reported with 5-fluorouracil&sequencial=205&nomePeriodico=Annals of Oncology" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>206. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Abushullaih S</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2002</span>Abushullaih S ; Saad ED ; Munsell M ; <b>Hoff PM</b> . Incidence and severity of hand-foot syndrome in colorectal cancer patients treated with capecitabine; a single-institution experience. Cancer Investigation<sup><img id='07357907_206' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='07357907' /></sup>, v. 20, n.1, p. 3-10, 2002. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=&issn=07357907&volume=20&issue=&paginaInicial=3&titulo=Incidence and severity of hand-foot syndrome in colorectal cancer patients treated with capecitabine; a single-institution experience&sequencial=206&nomePeriodico=Cancer Investigation" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>207. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Saad ED</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2002</span>Saad ED ; Machado MC ; Wajsbrot D ; Abramoff R ; <b>Hoff PM</b> ; Tabacof J ; Katz A ; <a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/9880218212420078" target="_blank">Simon S</a> ; Simon SD ; Gansl RC . Pretreatment CA 19-9 level as a prognostic factor in patients with advanced pancreatic cancer treated with gemcitabine. International journal of gastrointestinal cancer (Cessou em 2006. Cont. ISSN 1941-6628 Journal of gastrointestinal cancer)<sup><img id='15373649_207' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='15373649' /></sup>, v. 32, n.1, p. 35-41, 2002. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=&issn=15373649&volume=32&issue=&paginaInicial=35&titulo=Pretreatment CA 19-9 level as a prognostic factor in patients with advanced pancreatic cancer treated with gemcitabine&sequencial=207&nomePeriodico=International journal of gastrointestinal cancer (Cessou em 2006. Cont. ISSN 1941-6628 Journal of gastrointestinal cancer)" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>208. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Saad ED</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2002</span>Saad ED ; <b>Hoff PM</b> ; Carnelós RP ; Katz A ; Novis YA ; Pietrocola M ; Hamerschlak N ; Tabacof J ; Gansl R ; <a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/9880218212420078" target="_blank">Simon S</a> . Critérios comuns de toxicidade do Instituto Nacional de Câncer dos Estados Unidos. Revista Brasileira de Cancerologia<sup><img id='00347116_208' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='00347116' /></sup>, v. 48, p. 63-96, 2002. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=&issn=00347116&volume=48&issue=&paginaInicial=63&titulo=Critérios comuns de toxicidade do Instituto Nacional de Câncer dos Estados Unidos&sequencial=208&nomePeriodico=Revista Brasileira de Cancerologia" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>209. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Taylor N</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2001</span>Taylor N ; Crane C ; Skibber J ; Feig B ; Ellis L ; Vauthey J ; Hamilton S ; Cleary K ; Dubrow R ; Brown T ; Wolff R ; <b>Hoff PM</b> ; Sanfilippo N ; Janjan N . Elective groin irradiation is not indicated for patients with adenocarcinoma of the rectum extending to the anal canal. International Journal of Radiation Oncology, Biology, Physics<sup><img id='03603016_209' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='03603016' /></sup>, v. 51, n.3, p. 741-747, 2001. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=&issn=03603016&volume=51&issue=&paginaInicial=741&titulo=Elective groin irradiation is not indicated for patients with adenocarcinoma of the rectum extending to the anal canal&sequencial=209&nomePeriodico=International Journal of Radiation Oncology, Biology, Physics" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>210. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Sanfilippo NJ</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2001</span>Sanfilippo NJ ; Crane CH ; Skibber J ; Feib B ; <b>Hoff PM</b> ; Woff RA . T4 rectal cancer treated with preoperative chemoradiation to the posterior pelvis followed by multivisceral resection: patterns of failure and limitations of treatment. International Journal of Radiation Oncology, Biology, Physics<sup><img id='03603016_210' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='03603016' /></sup>, v. 51, n.1, p. 176-183, 2001. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=&issn=03603016&volume=51&issue=&paginaInicial=176&titulo=T4 rectal cancer treated with preoperative chemoradiation to the posterior pelvis followed by multivisceral resection: patterns of failure and limitations of treatment&sequencial=210&nomePeriodico=International Journal of Radiation Oncology, Biology, Physics" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>211. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Hoff PM</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2001</span><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>; Saad ED ; Ravandi-Kashani R ; Czerny E ; Pazdur R . Phase I trial of i.v. administered tirapazamine plus cyclophosphamide. Anti-Cancer Drugs<sup><img id='09594973_211' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='09594973' /></sup>, v. 12, n.6, p. 499-503, 2001. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=&issn=09594973&volume=12&issue=&paginaInicial=499&titulo=Phase I trial of i.v. administered tirapazamine plus cyclophosphamide&sequencial=211&nomePeriodico=Anti-Cancer Drugs" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>212. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Janjan NS</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2001</span>Janjan NS ; Crane C ; Feig BW ; Cleary K ; Dubrow R ; Curley S ; Vauthey J-N ; Lynch P ; Ellis L ; Wolff R ; Lenzi R ; Abbruzzese JL ; Pazdur R ; <b>Hoff PM</b> ; Allen P . Improved overall survival among responders to preoperative chemoradiation advanced rectal cancer. Journal of Clinical Oncology<sup><img id='0732183X_212' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='0732183X' /></sup>, v. 24, n.2, p. 107-2, 2001. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=&issn=0732183X&volume=24&issue=&paginaInicial=107&titulo=Improved overall survival among responders to preoperative chemoradiation advanced rectal cancer&sequencial=212&nomePeriodico=Journal of Clinical Oncology" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>213. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Elasmar S</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2001</span>Elasmar S ; Saad ED ; <b>Hoff PM</b> . Case report: hand-foot syndrome induced by the oral fluoropyrimidine S-1. Japanese Journal of Clinical Oncology<sup><img id='03682811_213' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='03682811' /></sup>, v. 31, n.4, p. 172-174, 2001. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=&issn=03682811&volume=31&issue=&paginaInicial=172&titulo=Case report: hand-foot syndrome induced by the oral fluoropyrimidine S-1&sequencial=213&nomePeriodico=Japanese Journal of Clinical Oncology" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>214. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Royce ME</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2001</span>Royce ME ; <b>Hoff PM</b> ; Dumas P ; Lassere Y ; Lee JJ ; Coyle J ; Ducharme MP ; De Jager R ; Pazdur R . Phase I and pharmacokinetic study of exatecan mesylate (DX-8951f): a novel camptothecin analog. Journal of Clinical Oncology<sup><img id='0732183X_214' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='0732183X' /></sup>, v. 19, n.4, p. 1493-1500, 2001. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=&issn=0732183X&volume=19&issue=&paginaInicial=1493&titulo=Phase I and pharmacokinetic study of exatecan mesylate (DX-8951f): a novel camptothecin analog&sequencial=214&nomePeriodico=Journal of Clinical Oncology" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>215. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Kozuch P</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2001</span>Kozuch P ; <b>Hoff PM</b> ; Hess K ; Adams J ; Newman RA ; Lee F ; Pazdur R . Phase I bioequivalency study of MitoExtra and mitomycin C in patients with solid tumors. Cancer<sup><img id='0008543X_215' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='0008543X' /></sup>, v. 91, n.4, p. 815-821, 2001. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=&issn=0008543X&volume=91&issue=&paginaInicial=815&titulo=Phase I bioequivalency study of MitoExtra and mitomycin C in patients with solid tumors&sequencial=215&nomePeriodico=Cancer" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>216. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Crane CH</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2001</span>Crane CH ; Janjan NA ; Abbruzzese JL ; Curley S ; Vauthey J-N ; Sawaf HB ; Dubrow R ; Allen P ; Ellis LM ; <b>Hoff PM</b> ; Wolff RA ; Lenzi R ; Brown TD ; Lynch P ; Cleary K . Effective pelvic symptom control using initial chemoradiation without colostomy in metastatic rectal cancer. International Journal of Radiation Oncology, Biology, Physics<sup><img id='03603016_216' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='03603016' /></sup>, v. 49, n.1, p. 107-116, 2001. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=&issn=03603016&volume=49&issue=&paginaInicial=107&titulo=Effective pelvic symptom control using initial chemoradiation without colostomy in metastatic rectal cancer&sequencial=216&nomePeriodico=International Journal of Radiation Oncology, Biology, Physics" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>217. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Hoff PM</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2001</span><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>; Cassidy J ; Schmoll HJ . The evolution of fluoropyrimidine therapy: from intravenous to oral. The Oncologist (Dayton)<sup><img id='10837159_217' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='10837159' /></sup>, v. 6, n.4, p. 3-11, 2001. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=&issn=10837159&volume=6&issue=&paginaInicial=3&titulo=The evolution of fluoropyrimidine therapy: from intravenous to oral&sequencial=217&nomePeriodico=The Oncologist (Dayton)" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>218. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Van Cutsem E</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2001</span>Van Cutsem E ; Cunningham D ; <b>Hoff PM</b> ; Maroun J . Thymidine phosphorylase (TP) activation: convenience through innovation. The Oncologist (Dayton)<sup><img id='10837159_218' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='10837159' /></sup>, v. 6, n.4, p. 1-2, 2001. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=&issn=10837159&volume=6&issue=&paginaInicial=1&titulo=Thymidine phosphorylase (TP) activation: convenience through innovation&sequencial=218&nomePeriodico=The Oncologist (Dayton)" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>219. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Saad ED</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2001</span>Saad ED ; <b>Hoff PM</b> . Other fluorinated pyrimidines in the treatment of solid tumors. Oncology (Basel)<sup><img id='00302414_219' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='00302414' /></sup>, v. 15, n.2, p. 65-68, 2001. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=&issn=00302414&volume=15&issue=&paginaInicial=65&titulo=Other fluorinated pyrimidines in the treatment of solid tumors&sequencial=219&nomePeriodico=Oncology (Basel)" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>220. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Hoff PM</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2001</span><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>; Ansari R ; Batista G ; Cox J ; Kocha W ; Kuperminc M ; Maroun J . Comparison of oral capecitabine versus intravenous fluorouracil plus lecovorin as first-line treatment in 605 patients with metastatic colorectal cancer: results of a randomized phase III study. Journal of Clinical Oncology<sup><img id='0732183X_220' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='0732183X' /></sup>, v. 19, n.8, p. 2282-2292, 2001. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=&issn=0732183X&volume=19&issue=&paginaInicial=2282&titulo=Comparison of oral capecitabine versus intravenous fluorouracil plus lecovorin as first-line treatment in 605 patients with metastatic colorectal cancer: results of a randomized phase III study&sequencial=220&nomePeriodico=Journal of Clinical Oncology" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>221. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Hoff PM</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2000</span><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>; Ellerton JA ; Dakhil SR ; Winn RJ ; Abbruzzese JL ; Pazdur R . Phase II study of intravenous CI-958 in metastatic colorectal adenocarcinoma. American Journal of Clinical Oncology<sup><img id='02773732_221' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='02773732' /></sup>, v. 23, n.6, p. 602-604, 2000. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=&issn=02773732&volume=23&issue=&paginaInicial=602&titulo=Phase II study of intravenous CI-958 in metastatic colorectal adenocarcinoma&sequencial=221&nomePeriodico=American Journal of Clinical Oncology" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>222. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Royce ME</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2000</span>Royce ME ; Medgyesy D ; Zukowski TH ; Dwivedy S ; <b>Hoff PM</b> ; Pazdur R . Colorectal Cancer: chemotherapy treatment overview. Oncology (Basel)<sup><img id='00302414_222' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='00302414' /></sup>, v. 14, n.12, p. 40-46, 2000. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=&issn=00302414&volume=14&issue=&paginaInicial=40&titulo=Colorectal Cancer: chemotherapy treatment overview&sequencial=222&nomePeriodico=Oncology (Basel)" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>223. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Hoff PM</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2000</span><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>. The tegafur-based dihydropyrimidine dehydrogenase inhibitory fluoropyrimidines, UFT/leucovorin (ORZEL) and S-1: a review of their clinical development and therapeutic potential. Investigational New Drugs<sup><img id='01676997_223' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='01676997' /></sup>, v. 18, n.4, p. 331-342, 2000. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=&issn=01676997&volume=18&issue=&paginaInicial=331&titulo=The tegafur-based dihydropyrimidine dehydrogenase inhibitory fluoropyrimidines, UFT/leucovorin (ORZEL) and S-1: a review of their clinical development and therapeutic potential&sequencial=223&nomePeriodico=Investigational New Drugs" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>224. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Hoff PM</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2000</span><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>. Novel therapeutic approaches for metastatic colorectal cancer. Oncology (Basel)<sup><img id='00302414_224' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='00302414' /></sup>, v. 14, n.11A, p. 217-220, 2000. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=&issn=00302414&volume=14&issue=&paginaInicial=217&titulo=Novel therapeutic approaches for metastatic colorectal cancer&sequencial=224&nomePeriodico=Oncology (Basel)" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>225. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Hoff PM</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2000</span><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>; Janjan N ; Saad ED ; Skibber J ; Crane C ; Lassere Y ; Cleary KR ; Benner S ; Randolph J ; Abbruzzese JL ; Pazdur R . Phase I study of preoperative oral uracil and tegafur plus leucovorin and radiation therapy in rectal cancer. Journal of Clinical Oncology<sup><img id='0732183X_225' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='0732183X' /></sup>, v. 18, n.20, p. 3529-3534, 2000. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=&issn=0732183X&volume=18&issue=&paginaInicial=3529&titulo=Phase I study of preoperative oral uracil and tegafur plus leucovorin and radiation therapy in rectal cancer&sequencial=225&nomePeriodico=Journal of Clinical Oncology" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>226. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Nemunaitis J</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2000</span>Nemunaitis J ; Eager R ; Twaddell T ; Corey A ; Sekar K ; Tkaczuk K ; Thompson J ; <b>Hoff PM</b> ; Pazdur R . Phase I assessment of the pharmacokinetics, metabolism and safety of Emitefur(BOF-A2) in patients with refractory solid tumors. Journal of Clinical Oncology<sup><img id='0732183X_226' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='0732183X' /></sup>, v. 18, n.19, p. 3423-3434, 2000. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=&issn=0732183X&volume=18&issue=&paginaInicial=3423&titulo=Phase I assessment of the pharmacokinetics, metabolism and safety of Emitefur(BOF-A2) in patients with refractory solid tumors&sequencial=226&nomePeriodico=Journal of Clinical Oncology" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>227. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Hoff PM</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2000</span><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>. A phase I study. Preoperative UFT/leucovorin and radiation therapy in rectal cancer. Oncology (Basel)<sup><img id='00302414_227' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='00302414' /></sup>, v. 14, n.10, p. 56-8, 2000. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=&issn=00302414&volume=14&issue=&paginaInicial=56&titulo=A phase I study. Preoperative UFT/leucovorin and radiation therapy in rectal cancer&sequencial=227&nomePeriodico=Oncology (Basel)" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>228. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Royce ME</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2000</span>Royce ME ; <b>Hoff PM</b> ; Pazdur R . Progress in colorectal cancer chemotherapy: how far have we come, how far to go?. Drugs & Aging<sup><img id='1170229X_228' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='1170229X' /></sup>, v. 17, n.3, p. 201-216, 2000. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=&issn=1170229X&volume=17&issue=&paginaInicial=201&titulo=Progress in colorectal cancer chemotherapy: how far have we come, how far to go?&sequencial=228&nomePeriodico=Drugs & Aging" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>229. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Janjan NA</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2000</span>Janjan NA ; Crane CN ; Feig BW ; Cleary K ; Dubrow R ; Curley SA ; Ellis LM ; Vauthey J-N ; Lenzi R ; Lynch P ; Wolff R ; Brown T ; Pazdur R ; Abbruzzese JL ; <b>Hoff PM</b> . Prospective trial of preoperative concomitant boost radiotherapy with continuous infusion 5-fluorouracil for locally advanced rectal cancer. International Journal of Radiation Oncology, Biology, Physics<sup><img id='03603016_229' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='03603016' /></sup>, v. 47, n.3, p. 713-718, 2000. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=&issn=03603016&volume=47&issue=&paginaInicial=713&titulo=Prospective trial of preoperative concomitant boost radiotherapy with continuous infusion 5-fluorouracil for locally advanced rectal cancer&sequencial=229&nomePeriodico=International Journal of Radiation Oncology, Biology, Physics" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>230. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Hoff PM</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2000</span><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>; Valero V ; Buzdar AU ; Singletary SE ; Theriault RL ; Booser D ; Asmar L ; Frye D ; McNeese MD ; Hortobagyi GN . Combined modality treatment of locally advanced breast carcinoma in elderly patients or patients with severe comorbid conditions using tamoxifen as the primary therapy. Cancer<sup><img id='0008543X_230' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='0008543X' /></sup>, v. 88, n.9, p. 2054-2060, 2000. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=&issn=0008543X&volume=88&issue=&paginaInicial=2054&titulo=Combined modality treatment of locally advanced breast carcinoma in elderly patients or patients with severe comorbid conditions using tamoxifen as the primary therapy&sequencial=230&nomePeriodico=Cancer" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>231. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Royce ME</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2000</span>Royce ME ; <b>Hoff PM</b> ; Pazdur R . Novel oral chemotherapy agents. CURR ONCOL REP<sup><img id='15233790_231' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='15233790' /></sup>, v. 2, n.1, p. 31-37, 2000. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=&issn=15233790&volume=2&issue=&paginaInicial=31&titulo=Novel oral chemotherapy agents&sequencial=231&nomePeriodico=CURR ONCOL REP" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>232. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Hoff PM</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2000</span><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>; Saad ED ; Janjan N ; Skibber J ; Pazdur R . Preoperative UFT/leucovorin and radiation therapy in rectal cancer: a phase I study. Oncology (Basel)<sup><img id='00302414_232' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='00302414' /></sup>, v. 14, p. 56-58, 2000. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=&issn=00302414&volume=14&issue=&paginaInicial=56&titulo=Preoperative UFT/leucovorin and radiation therapy in rectal cancer: a phase I study&sequencial=232&nomePeriodico=Oncology (Basel)" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>233. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Hoff PM</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>1999</span><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>; Pazdur R . Dihydropyrimidine dehydrogenase inhibitory fluoropyrimidines: a novel class of oral antineoplastic agents. Seminars in Oncology<sup><img id='00937754_233' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='00937754' /></sup>, v. 26, n.6, p. 52-56, 1999. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=&issn=00937754&volume=26&issue=&paginaInicial=52&titulo=Dihydropyrimidine dehydrogenase inhibitory fluoropyrimidines: a novel class of oral antineoplastic agents&sequencial=233&nomePeriodico=Seminars in Oncology" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>234. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Hoff PM</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>1999</span><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>; Royce M ; Medgyesy D ; Brito R ; Pazdur R . Oral fluoropoyrimidines. Seminars in Oncology<sup><img id='00937754_234' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='00937754' /></sup>, v. 26, n.6, p. 640-646, 1999. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=&issn=00937754&volume=26&issue=&paginaInicial=640&titulo=Oral fluoropoyrimidines&sequencial=234&nomePeriodico=Seminars in Oncology" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>235. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Royce ME</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>1999</span>Royce ME ; Mc Garry W ; Bready B ; Dakhil SR ; Belt RJ ; Goodwin JW ; Gray R ; <b>Hoff PM</b> . Sequential biochemical modulation of fluorouracil with folinic acid, N-phosphonacety-l-aspartic acid and interferon alfa-2a in advanced colorectal cancer. Journal of Clinical Oncology<sup><img id='0732183X_235' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='0732183X' /></sup>, v. 17, n.10, p. 3276-3282, 1999. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=&issn=0732183X&volume=17&issue=&paginaInicial=3276&titulo=Sequential biochemical modulation of fluorouracil with folinic acid, N-phosphonacety-l-aspartic acid and interferon alfa-2a in advanced colorectal cancer&sequencial=235&nomePeriodico=Journal of Clinical Oncology" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>236. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Brito RA</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>1999</span>Brito RA ; Medgyesy D ; Zukowski TH ; Royce ME ; Ravandi-Kashani R ; <b>Hoff PM</b> ; Pazdur R . Fluoropyrimidines: a critical review. Oncology (Basel)<sup><img id='00302414_236' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='00302414' /></sup>, v. 57, n.1, p. 2-8, 1999. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=&issn=00302414&volume=57&issue=&paginaInicial=2&titulo=Fluoropyrimidines: a critical review&sequencial=236&nomePeriodico=Oncology (Basel)" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>237. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Hoff PM</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>1999</span><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>; Lassere Y ; Pazdur R ; Janjan N ; Crane C ; Skibber J . Preoperative UFT and calcium folinate and radiotherapy in rectal cancer. Oncology (Basel)<sup><img id='00302414_237' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='00302414' /></sup>, v. 13, n.7, p. 129-131, 1999. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=&issn=00302414&volume=13&issue=&paginaInicial=129&titulo=Preoperative UFT and calcium folinate and radiotherapy in rectal cancer&sequencial=237&nomePeriodico=Oncology (Basel)" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>238. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Pazdur R</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>1999</span>Pazdur R ; Royce M ; Rodriguez GI ; Rinaldi DA ; Patt YZ ; <b>Hoff PM</b> ; Burris HA . Phase II trial of docetaxel for cholangiocarcinoma. American Journal of Clinical Oncology<sup><img id='02773732_238' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='02773732' /></sup>, v. 22, n.1, p. 78-81, 1999. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=&issn=02773732&volume=22&issue=&paginaInicial=78&titulo=Phase II trial of docetaxel for cholangiocarcinoma&sequencial=238&nomePeriodico=American Journal of Clinical Oncology" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>239. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Royce ME</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>1999</span>Royce ME ; <b>Hoff PM</b> ; Pazdur R . Novel chemotherapy agents for colorectal cancer: oral fluoropyrimidines, oxaliplatin and raltitrexed. CURR ONCOL REP<sup><img id='15233790_239' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='15233790' /></sup>, v. 1, n.2, p. 161-167, 1999. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=&issn=15233790&volume=1&issue=&paginaInicial=161&titulo=Novel chemotherapy agents for colorectal cancer: oral fluoropyrimidines, oxaliplatin and raltitrexed&sequencial=239&nomePeriodico=CURR ONCOL REP" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>240. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Hoff PM</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>1999</span><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>; Lassere Y ; Pazdur R . Tegafur/uracil + calcium folinate in colorectal cancer: double modulation of fluorouracil. Drugs (Basel)<sup><img id='00126667_240' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='00126667' /></sup>, v. 58, n.3, p. 77-83, 1999. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=&issn=00126667&volume=58&issue=&paginaInicial=77&titulo=Tegafur/uracil + calcium folinate in colorectal cancer: double modulation of fluorouracil&sequencial=240&nomePeriodico=Drugs (Basel)" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>241. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Pazdur R</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>1999</span>Pazdur R ; Medgyesy DC ; Winn RJ ; Dakhil SR ; Moore DF ; Scalzo A ; <b>Hoff PM</b> ; Arbuck SG ; Abbruzzese JL . Phase II trial of 9-aminocamptothecin (NSC 603071) administered as a 120-hr continuous infusion weekly for three weeks in metastatic colorectal carcinoma. Investigational New Drugs<sup><img id='01676997_241' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='01676997' /></sup>, v. 16, n.4, p. 341-346, 1999. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=&issn=01676997&volume=16&issue=&paginaInicial=341&titulo=Phase II trial of 9-aminocamptothecin (NSC 603071) administered as a 120-hr continuous infusion weekly for three weeks in metastatic colorectal carcinoma&sequencial=241&nomePeriodico=Investigational New Drugs" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>242. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Hoff PM</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>1998</span><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>; Pazdur R ; Benner SE ; Canetta R . UFT and leucovorin: a review of its clinical development and therapeutic potential in the oral treatment of cancer. Anti-Cancer Drugs<sup><img id='09594973_242' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='09594973' /></sup>, v. 9, n.6, p. 479-490, 1998. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=&issn=09594973&volume=9&issue=&paginaInicial=479&titulo=UFT and leucovorin: a review of its clinical development and therapeutic potential in the oral treatment of cancer&sequencial=242&nomePeriodico=Anti-Cancer Drugs" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>243. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Hoff PM</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>1998</span><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>; Valero V ; Ibrahim N ; Wiley J ; Hortobagyi GN . Hand-foot syndrome following prolonged- infusion of high doses of vinorelbine. Cancer<sup><img id='0008543X_243' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='0008543X' /></sup>, v. 83, n.5, p. 1054-1055, 1998. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=&issn=0008543X&volume=83&issue=&paginaInicial=1054&titulo=Hand-foot syndrome following prolonged- infusion of high doses of vinorelbine&sequencial=243&nomePeriodico=Cancer" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>244. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Hoff PM</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>1998</span><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>; Pazdur R . UFT Plus Oral Leucovorin: A New Oral Treatment for Colorectal Cancer. The Oncologist (Dayton)<sup><img id='10837159_244' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='10837159' /></sup>, v. 3, n.3, p. 155-164, 1998. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=&issn=10837159&volume=3&issue=&paginaInicial=155&titulo=UFT Plus Oral Leucovorin: A New Oral Treatment for Colorectal Cancer&sequencial=244&nomePeriodico=The Oncologist (Dayton)" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>245. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Pazdur R</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>1998</span>Pazdur R ; <b>Hoff PM</b> ; Medgyesy D ; Royce M ; Brito RA . The oral fluorouracil prodrugs. Oncology (Basel)<sup><img id='00302414_245' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='00302414' /></sup>, v. 12, p. 48-51, 1998. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=&issn=00302414&volume=12&issue=&paginaInicial=48&titulo=The oral fluorouracil prodrugs&sequencial=245&nomePeriodico=Oncology (Basel)" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>246. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Hoff PM</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>1997</span><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>; Pierce S ; Estey E . Comparison of acute myeloid leukemia patients at MD Anderson: 1982-1986 vs 1992-1996. Leukemia<sup><img id='08876924_246' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='08876924' /></sup>, v. 11, n.12, p. 1997-1998, 1997. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=&issn=08876924&volume=11&issue=&paginaInicial=1997&titulo=Comparison of acute myeloid leukemia patients at MD Anderson: 1982-1986 vs 1992-1996&sequencial=246&nomePeriodico=Leukemia" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>247. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Hoff PM</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>1997</span><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>; Valero V ; Holmes FA ; Whealin H ; Hudis C ; Hortobagyl GN . Paclitaxel-induced pancreatitis: a case report. Journal of the National Cancer Institute<sup><img id='00278874_247' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='00278874' /></sup>, v. 89, n.1, p. 91-93, 1997. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=&issn=00278874&volume=89&issue=&paginaInicial=91&titulo=Paclitaxel-induced pancreatitis: a case report&sequencial=247&nomePeriodico=Journal of the National Cancer Institute" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
</div>
<div class="cita-artigos">
<b><a name="LivrosCapitulos"></a>Livros publicados/organizados ou edições</b>
</div>
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>1. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P M</a></b>; DIZ, M. E. ; TESTA, L. . Manual de Condutas em Oncologia, 3ª Edição.. 3. ed. São Paulo: Atheneu, 2018. v. 01. 240p . </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P M</a></b>; CHAMMAS, R. . Icesp 10 anos!. 1ª. ed. São Paulo: Atheneu, 2018. v. 01. 79p . </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>3. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P M</a></b>; Katz, Artur ; COSTA, F. ; BARIANNI, G. ; FERNANDES, G. S. ; FERRARI, C. L. S. . Oncologia Clinica, Terapia Baseada em Evidências - Tumores Sólidos. 3a.. ed. São Paulo: Hospital Sírio e Libanês, 2017. v. 01. 539p . </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>4. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/4792805111122908" target="_blank">HAJJAR, L. A.</a> ; KALIL, R. ; <b>HOFF, P.M.</b> . Manual de Condutas em Cardio-Oncologia. 1a.. ed. Rio de Janeiro: Atheneu, 2017. v. 01. 291p . </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>5. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P M</a></b>; Katz, Artur (Org.) ; MARQUES, R. (Org.) ; ROCHA, V. (Org.) ; COSTA, F. (Org.) ; DIAS, G. (Org.) ; FERRARI, C. L. S. (Org.) . Oncologia Clínica: Terapia Baseada em Evidências. 2a.. ed. São Paulo, SP: Hospital Sírio Libanês, 2014. v. 01. 625p . </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>6. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P.M.</a></b>; DIZ, M. E. (Org.) ; PEREIRA, JULIANA (Org.) ; TESTA, L. (Org.) ; Mak, Milena Perez (Org.) . Manual de Condutas em Oncologia. 2a.. ed. São Paulo, RJ,: Editora Atheneu, 2013. v. 01. 361p . </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>7. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P M</a></b>; Katz, Artur ; CHAMMAS, R. ; Vicente Odone Filho ; NOVIS, Y. S. . Tratado de Oncologia. 1a.. ed. São Paulo, SP: Atheneu, 2013. v. 02. 2829p . </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>8. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Kalil Filho R (Org.) ; Hajjar LA (Org.) ; Bacal F (Org.) ; <b>Hoff PM</b> (Org.) ; <b>HOFF, P. M.</b> (Org.) ; Diz M del P (Org.) ; Galas FRBG (Org.) . I Diretriz Brasileira de Cardio-Oncologia da Sociedade Brasileira de Cardiologia. 2. ed. São Paulo: Arq Bras Cardiol 2011, 2011. v. 1. 52p . </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>9. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Yao, J. C. (Org.) ; <b>Hoff PM</b> (Org.) ; <a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/4792805111122908" target="_blank">Hoff AO</a> (Org.) . Neuroendocrine tumors. 1. ed. New York: Springer Science + Business Media, 2011. v. 1. 267p . </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>10. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>. Saúde: Como Superar o Câncer. 1. ed. São Paulo: Editora Abril, 2011. v. 1. 185p . </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>11. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>; Cerri GG (Org.) ; Chamone DAF (Org.) . Manual de condutas em Oncologia - Instituto do Câncer do Estado de São Paulo - Octavio Frias de Oliveira. 01. ed. , 2010. v. 01. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>12. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P M</a></b>; VAUTHEY, J. N. ; Audisio RA ; Poston GJ . Liver Metastases. 1a.. ed. London: Springer Science + Business Me, 2010. v. 1. 188p . </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>13. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Vauthey, J.-N. (Org.) ; <b>Hoff PM</b> (Org.) ; Audisio RA (Org.) ; Poston GJ (Org.) . Liver Metastases. 1. ed. London: Springer Science + Business Media, 2009. v. 1. 188p . </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>14. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Buzaid AC (Org.) ; <b>Hoff PM</b> (Org.) ; <b>HOFF, P. M.</b> (Org.) ; Maluf FC (Org.) . Manual Prático de Oncologia Clínica do Hospital Sírio-Libanês. São Paulo: Dendrix Edição e Design Ltda., 2009. 688p . </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>15. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Saad, Everardo D. (Org.) ; Maluf FC (Org.) ; <b>Hoff PM</b> (Org.) ; <b>HOFF, P. M.</b> (Org.) . Oncologia em evidência. 1. ed. São Paulo: Dendrix Edição e Design Ltda., 2009. v. 1. 224p . </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>16. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Buzaid AC (Org.) ; <b>Hoff PM</b> (Org.) ; <b>HOFF, P. M.</b> (Org.) ; Maluf FC (Org.) . Mini-moc - Pocket book do Manual Prático de Oncologia Clínica do Hospital Sírio Libanês. 2. ed. São Paulo: Dendrix Edição e Design Ltda., 2009. v. 1. 286p . </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>17. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Buzaid AC (Org.) ; <b>Hoff PM</b> (Org.) ; <b>HOFF, P. M.</b> (Org.) . Manual Prático de Oncologia Clínica do Hospital Sírio Libanês. 6. ed. São Paulo: Dendrix Edição e Design Ltda, 2008. v. 1. 638p . </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>18. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Buzaid AC (Org.) ; <b>Hoff PM</b> (Org.) ; <b>HOFF, P. M.</b> (Org.) . Mini-MOC - Pocket book do manual prático de Oncologia Clínica do Hospital Sírio Libanês. 1. ed. São Paulo: Dendrix Edição e Design Ltda., 2008. 254p . </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>19. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Buzaid AC (Org.) ; <b>Hoff PM</b> (Org.) . Manual Prático de Oncologia Clínica do Hospital Sírio Libanês. 5. ed. São Paulo: Dendrix Edição e Design Ltda., 2007. 608p . </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>20. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Yao JC (Org.) ; <b>Hoff PM</b> (Org.) . Hematology/Oncology Clinicis. Pennsylvania: W.B. Sauders Company, 2007. v. 21. 588p . </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>21. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P.M.</a></b>; AJANI, J. A. (Org.) ; BARAKAT, R. R. (Org.) ; ESTEY, E. H. (Org.) ; GILBERT, M. R. (Org.) ; LEVINE, D. A. (Org.) ; MARGHOOB, A. A. (Org.) ; MURPHY, B. A. (Org.) ; PATEL, S. (Org.) . Atlas of Cancer. 2a.. ed. Springer Science + Business Me: Philadelphia, 2007. v. 1. 662p . </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>22. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Levin B (Org.) ; Ades T (Org.) ; Brooks D (Org.) ; Crane C (Org.) ; <b>Hoff PM</b> (Org.) ; Limburg P (Org.) ; Rothenberger D (Org.) . Complete Guide to Colorectal Cancer. Atlanta: American Cancer Society, 2006. 418p . </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>23. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Buzaid AC (Org.) ; <b>Hoff PM</b> (Org.) . Manual Prático de Oncologia Clínica. São Paulo: Dendrix Edição e Design Ltda., 2006. 557p . </div>
</div>
<br class="clear">
<div class="cita-artigos">
<b><a name="CapitulosLivrosPublicados"></a>Capítulos de livros publicados</b>
</div>
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>1. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, PM</a></b>; Katz, Artur ; COSTA, F. P. ; FERNANDES, G. S. ; FERRARI, C. . Câncer colorretal. In: Artur Katz; Frederico Perego Costa; Givoanni Bariani; Gustavo S. Fernandes; Claudio S. Ferrari; Paulo M. Hoff. (Org.). Oncologia Clínica - Terapia Baseada em Evidências - Tumores Sólidos. 3a.ed.São Paulo: Hospital Sirio Libanês, 2017, v. 1, p. 147-169. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P.M.</a></b>; MONIZ, C. M. V. ; COUDRY, R. . Pathology of Anal Cancer. In: Cathy Eng; Nicolas J Petrelli. (Org.). Anal Canal Cancers - Surgical Oncology Clinics of North America. 1ed.Philadelphia: Elsevier, 2017, v. 26, p. 57-71. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>3. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P M</a></b>; KANAJI, A. L. ; KARNAKIS, T. . O câncer no Envelhecimento. In: Wilson Jacob Filho; Alexander Augusto de Lima Jorge; Clóvis Eduardo Santos Galvão; Fabiano Pinheiro da Silva; Iolanda de Fátima Lopes Calvo Tibério; Lúcia da Conceição Andrade; Luciano Ferreira Drager; Marcel Machado; Rodrigo Dias Olmos; Rosa Pereira;. (Org.). Envelhecimento. Uma visão Interdisciplinar. 1ed.Rio de Janeiro: Atheneu, 2015, v. 1, p. 45-51. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>4. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P M</a></b>; Katz, Artur ; MARQUES, R. ; NOVIS, Y. S. ; ROCHA, V. ; COSTA, F. P. ; DIAS, G. ; FERRARI, C. . Câncer de Esôfago. In: Paulo M. Hoff; Jorge Sabbaga; Frederico P. Costa; Gustavo dos Santos Fernandes; Fernanda Capareli; Daniel Saragiotto; Guilherme Stelko Pereira; Tulio Pfiffer e Joao Evangelista.. (Org.). Oncologia Clinica, Terapia Baseada em Evidências.. 2a.ed.São Paulo, SP: Hospital Sírio Libanês, 2014, v. 1, p. 93-105. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>5. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P M</a></b>; Katz, Artur ; MARQUES, R. ; NOVIS, Y. S. ; ROCHA, V. . Câncer de Estômago. In: Paulo M. Hoff; Jorge Sabbaga; Frederico P. Costa; Gustavo dos Santos Fernandes; Fernanda Capareli; Daniel Saragiotto; Guilherme Stelko Pereira; Tulio Pfiffer e Joao Evangelista.. (Org.). Oncologia Clínica: Terapia Baseada em Evidências. 2a.ed.São Paulo, SP: Hospital Sírio Libanês, 2014, v. 01, p. 107-120. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>6. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P M</a></b>; Katz, Artur ; MARQUES, R. ; NOVIS, Y. S. ; ROCHA, V. ; COSTA, F. ; FERNANDES, G. S. ; FERRARI, C. L. S. . Câncer de Pâncreas e Vias Biliares. In: Paulo M. Hoff; Jorge Sabbaga; Frederico P. Costa; Gustavo dos Santos Fernandes; Fernanda Capareli; Daniel Saragiotto; Guilherme Stelko Pereira; Tulio Pfiffer e Joao Evangelista.. (Org.). Oncologia Clínica: Terapia Baseada em Evidências. 2a.ed.São Paulo, SP: Hospital Sírio Libanês, 2014, v. 1, p. 121-140. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>7. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P M</a></b>; SABBAGA, J. ; COSTA, F. ; FERNANDES, G. S. ; Capareli-Azevedo FC ; SARAGIOTTO, D. F. ; PEREIRA, G. S. ; Pfiffer TE ; BEZERRA NETO, JOÃO EVANGELISTA . Cancer colorretal. In: Paulo M. Hoff; Jorge Sabbaga; Frederico P. Costa; Gustavo dos Santos Fernandes; Fernanda Capareli; Daniel Saragiotto; Guilherme Stelko Pereira; Tulio Pfiffer e Joao Evangelista.. (Org.). Oncologia Clínica: Terapia Baseada em Evidências. 2a.ed.São Paulo, SP: Hospital Sírio Libanês, 2014, v. 1, p. 159-177. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>8. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P M</a></b>; Katz, Artur ; MARQUES, R. ; NOVIS, Y. S. ; ROCHA, V. ; COSTA, F. ; FERNANDES, G. S. ; FERRARI, C. L. S. . Câncer do Intestino Delgado. In: Paulo M. Hoff; Jorge Sabbaga; Frederico P. Costa; Gustavo dos Santos Fernandes; Fernanda Capareli; Daniel Saragiotto; Guilherme Stelko Pereira; Tulio Pfiffer e Joao Evangelista.. (Org.). Oncologia Clínica: Terapia Baseada em Evidências. 2a.ed.São Paulo, SP: Hospital Sírio Libanês, 2014, v. 1, p. 151-158. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>9. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P M</a></b>; Katz, Artur ; MARQUES, R. ; NOVIS, Y. S. ; ROCHA, V. ; COSTA, F. ; FERNANDES, G. S. ; FERRARI, C. L. S. . Câncer de Canal Anal. In: Paulo M. Hoff; Jorge Sabbaga; Frederico P. Costa; Gustavo dos Santos Fernandes; Fernanda Capareli; Daniel Saragiotto; Guilherme Stelko Pereira; Tulio Pfiffer e Joao Evangelista.. (Org.). Oncologia Clínica: Terapia Baseada em Evidências. 2a.ed.São Paulo, SP: Hospital Sírio Libanês, 2014, v. 1, p. 179-185. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>10. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, PAULO M</a></b>; NOVIS, Y. S. ; Katz, Artur ; MARQUES, R. ; ROCHA, V. ; COSTA, F. P. ; FERNANDES, G. S. ; FERRARI, C. L. S. . Tumores Neuroendócrinos. In: Paulo M. Hoff; Frederico P. Costa; Ana Amélia F. O. Hoff; Gustavo dos Santos Fernandes e Tulio Pfiffer. (Org.). Oncologia Clínica: Terapia Baseada em Evidências. 2a.ed.São Paulo, SP: Hospital Sírio Libanês, 2014, v. 1, p. 187-205. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>11. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P M</a></b>; Katz, Artur ; MARQUES, R. ; NOVIS, Y. S. ; ROCHA, V. ; COSTA, F. P. ; FERNANDES, G. S. ; FERRARI, C. . Tumor Estromal do Trato Gastrintestinal (GIST). In: Paulo M. Hoff; Jorge Sabbaga; Frederico P. Costa; Gustavo dos Santos Fernandes; Fernanda Capareli; Daniel Saragiotto; Guilherme Stelko Pereira; Tulio Pfiffer e Joao Evangelista.. (Org.). Oncologia Clínica: Terapia Baseada em Evidências. 2a.ed.São Paulo, SP: Hospital Sírio Libanês, 2014, v. 1, p. 397-408. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>12. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P.M.</a></b>; SABBAGA, J. . Revisor do Capítulo: adaptação. Epidemiologia do câncer. In: Lee Goldman, Md; Andrew I. Schafer. (Org.). Cecil Medicina, Adaptado à Realidade Brasileira. 24aed.Rio de Janeiro: Elsevier, 2014, v. 02, p. 1351-1356. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>13. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P M</a></b>; SABBAGA, J. . Revisor do Capítulo: adaptação. Abordagem do paciente com câncer - Seção XV - Oncologia. In: Milton de Arruda Martins. (Org.). Cecil Medicina, Adaptado à Realidade Brasileira. 24ªed.Rio de Janeiro: Elsevier, 2014, v. 02, p. 1336-1350. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>14. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P M</a></b>; SABBAGA, J. . Revisor do Capítulo: adaptação. Genética do câncer. In: Milton de Arruda Martins. (Org.). Cecil Medicina, Adaptado à Realidade Brasileira. 24ªed.Rio de Janeiro: Elsevier, 2014, v. 2, p. 1357-1358. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>15. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P M</a></b>; SABBAGA, J. . Revisor do Capítulo: adaptação. Biologia do câncer - Seção XV - Oncologia. In: Milton de Arruda Martins. (Org.). Cecil Medicina, Adaptado à Realidade Brasileira. 24aed.Rio de Janeiro: Elsevier, 2014, v. 2, p. 1359-1362. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>16. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P M</a></b>; Sabbaga, Jorge . Revisor do Capítulo: adaptação. Manifestações endócrinas dos tumores: produção hormonal "Ectópica".. In: Milton de Arruda Martins. (Org.). Cecil Medicina, Adaptado à Realidade Brasileira. 24aed.Rio de Janeiro: Elsevier, 2014, v. 2, p. 1363-1367. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>17. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Kalil K ; Braghiroli, Maria Ignez ; REGO, JULIANA FLORINDA DE MENDONCA ; <b>HOFF, P M</b> . Agentes Antimicrotúbulos. In: Paulo M. Hoff; Artur Katz;Roger Chammas; Vicente Odone Filho; Yana Sarkis Novis. (Org.). Tratado de Oncologia. 1a.ed.São Paulo, SP: Editora Atheneu, 2013, v. 1, p. 767-777. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>18. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P M</a></b>; Takahashi, Tiago K. ; MAK, M. P. ; FERRARI, ANEZKA RUBIM DE CELIS . Inibidores de Tiriosina-Quinase. In: Tiago Kenji Takahashi; Milena Perez Mak; Anezka Carvalho Rubin de Celis Ferrari; Paulo M. Hoff. (Org.). Tratado de Oncologia. 1a.ed.São Paulo, SP: Editora Atheneu, 2013, v. 1, p. 805-820. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>19. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P M</a></b>; MONIZ, C. M. V. ; REGO, J. F. M. . Retinoides, Inibidores da Cicloxigenase e Outros Agentes para Quimioprevenção. In: Paulo M. Hoff; Camila Motta V Moniz; Juliana Florinda de Mendonça Rego. (Org.). Tratado de Oncologia. 1a.ed.São Paulo, SP: Editora Atheneu, 2013, v. 1, p. 925-934. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>20. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">SARAGIOTTO, D. F. ; RIECHELMANN, R. P. ; RIBEIRO, U. ; <b>Hoff, Paulo M.</b> . Tumores de Cólon. In: Daniel Fenrnandes Saragiotto; Rachel Riechelman; Ulysses Ribeiro Junior; Paulo M. Hoff. (Org.). Tratado de Oncologia. 1a.ed.São Paulo, SP: Editora Atheneu, 2013, v. 1, p. 1732-1766. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>21. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P.M.</a></b>; SAHADE, M. . Interações entre Radioterapia e Quimioterapia. In: João Vitor Savajoli; Luis Souhami; Sergio Luiz Faria. (Org.). Interação entre Radioterapia e Tratamentos Sistêmicos. 1a.ed.Rio de Janeiro: Editora Atheneu, 2013, v. 1, p. 291-300. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>22. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1026563052473840" target="_blank">Freitas D</a> ; de Castro Cotti GC ; <b>Hoff PM</b> ; <b>HOFF, P. M.</b> . Câncer de cólon no idoso. In: del Giglio A; Kaliks R; Karnakis T; Jacob-Filho W. (Org.). Oncogeriatria ? uma abordagem multidisciplinar. : , 2012, v. , p. 265-282. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>23. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">SARAGIOTTO, D. F. ; <b>Hoff PM</b> . Câncer de esôfago. In: Artur Katz, Ricardo Marques, Yana Novis, Vandertson Rocha, Frederico Perego Costa, Gustavo dos S. Fernandes, Claudio Luiz S. Ferrari, Paulo M. G. Hoff. (Org.). Oncologia Clínica:Terapia Baseada em Evidências. 1ed.São Paulo: Hospital Sírio Libanês, 2012, v. 1, p. 117-133. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>24. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">CAPARELLI, F. ; <b>Hoff PM</b> ; SARAGIOTTO, D. F. ; COSTA, F. . Câncer de pâncreas e vias biliares. In: Artur Katz, Ricardo Marques, Yana Novis, Vandertson Rocha, Frederico Perego Costa, Gustavo dos S. Fernandes, Claudio Luiz S. Ferrari, Paulo M. G. Hoff. (Org.). Oncologia Clínica: Terapia Baseada em Evidências. 1ed.São Paulo: Hospital Sírio Libanês, 2012, v. 1, p. 156-181. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>25. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">SARAGIOTTO, D. F. ; AZEVEDO, F. C. ; COSTA, F. ; <b>Hoff PM</b> . Câncer de pâncreas e vias biliares. In: Artur Katz, Ricardo Marques, Yana Novis, Vandertson Rocha, Frederico Perego Costa, Gustavo dos S. Fernandes, Claudio Luiz S. Ferrari, Paulo M. G. Hoff. (Org.). Oncologia Clínica: Terapia Baseada em Evidências. 1ed.São Paulo: Hospital Sírio Libanês, 2012, v. 1, p. 155-180. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>26. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">FERRAROTTO, R. ; PAVAN, T. ; COSTA, F. ; <b>Hoff PM</b> . Câncer colorretal. In: Artur Katz, Ricardo Marques, Yana Novis, Vandertson Rocha, Frederico Perego Costa, Gustavo dos S. Fernandes, Claudio Luiz S. Ferrari, Paulo M. G. Hoff. (Org.). Oncologia Clínica: Terapia Baseada em Evidências. 1ed.São Paulo: Hospital Sírio Libanês, 2012, v. 1, p. 207-231. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>27. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P M</a></b>. Tratamento Quimioterápico de Conversão. In: Carlos Walter sobrado, Sidney Roberto Nadal, Afonso Henrique da Silva e Sousa Jr.. (Org.). Manual de Câncer de Cólon, Reto e Ânus. 1ªed.São Paulo: Office Editora e Publicidade Ltda,, 2012, v. 1, p. 233-. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>28. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>; Munhoz RR . Indicações e Resultados do Tratamento Adjuvante para o Câncer no Cólon. Tratado de coloproctologia. 1ed.Rio de Janeiro: Editora Atheneu, 2012, v. 1, p. 361-372. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>29. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">BEZERRA, J. E. ; RIECHELMANN, R. P. ; <b>Hoff PM</b> . Poorly differentiated neuroendocrine tumors. In: James C. Yao; Paulo M. G. Hoff; Ana O. Hoff, editors. (Org.). Neuroendocrine tumors. 1ed.New York: Springer Science + Business Media, 2011, v. 1, p. 157-176. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>30. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>. Prefácio. In: Paulo M. G. Hoff. (Org.). Saúde: Como Superar o Câncer. 1ed.São Paulo: Editora Abril, 2011, v. 1, p. 8-9. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>31. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P M</a></b>; Oliveira, Suilane . Rastreamento de neoplasias. Rastreamento de neoplasias - Prevenção e Diagnóstico Precoce.. 1ed.São Paulo: Editora Manole Ltda., 2011, v. 1, p. 396-396. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>32. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P M</a></b>; Kopetz, Scott . Systemic Therapy for Non-operable Colorectal Cancer Metastases. In: Jean-Nicolas Vauthey; Paulo M. Hoff; Riccardo A. Audisio; Graeme J. Poston. (Org.). Liver Metastases. 1a.ed.London: Springer Science + Business Me, 2010, v. 1, p. 51-58. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>33. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>; Kopetz, S . Systemic therapy for non-operable colorectal cancer metastases. In: Vauthey JN, Hoff PM, Audisio RA, Poston GJ. (Org.). Liver Metastases. 1ed.London: Springer Science + Business Media, 2009, v. 1, p. 51-58. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>34. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Schutz FA ; Costa FP ; <b>Hoff PM</b> ; <b>HOFF, P. M.</b> . Câncer gastrintestinal. Esôfago. In: Buzaid AC, Hoff PM, Maluf FC. (Org.). Manual Prático de Oncologia Clínica do Hospital Sírio Libanês. São Paulo: Dendrix Edição e Design Ltda., 2009, v. , p. 94-105. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>35. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Costa FP ; <b>Hoff PM</b> ; <b>HOFF, P. M.</b> . Câncer gastrintestinal. Estômago. In: Buzaid AC, Hoff PM, Maluf FC. (Org.). Manual Prático de Oncologia Clínica do Hospital Sírio-Libanês. 2ed.São Paulo: Dendrix Edição e Design Ltda., 2009, v. 1, p. 106-115. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>36. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Costa FP ; <b>Hoff PM</b> ; <b>HOFF, P. M.</b> ; Buzaid AC . Câncer Gastrintestinal. Intestino Delgado. In: Buzaid AC, Hoff PM, Maluf FC. (Org.). Manual Prático de Oncologia Clínica do Hospital Sírio Libanês. São Paulo: Dendrix Edição e Design Ltda., 2009, v. , p. 116-119. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>37. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Costa FP ; <b>Hoff PM</b> ; <b>HOFF, P. M.</b> . Câncer gastrintestinal. Reto. In: Buzaid AC, Hoff PM, Maluf FC. (Org.). Manual Prático de Oncologia Clínica do Hospital Sírio-Libanês. São Paulo: Dendrix Edição e Design Ltda., 2009, v. , p. 120-127. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>38. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>; Costa FP ; Buzaid AC . Câncer gastrintestinal. Cólon. In: Buzaid AC, Hoff PM, Maluf FC. (Org.). Manual Prático de Oncologia Clínica do Hospital Sírio Libanês. São Paulo: Dendrix Edição e Design Ltda., 2009, v. , p. 128-145. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>39. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Costa FP ; <b>Hoff PM</b> ; <b>HOFF, P. M.</b> . Câncer gastrintestinal. Pâncreas exócrino. In: Buzaid AC, Hoff PM, Maluf FC. (Org.). Manual Prático de Oncologia Clínica do Hospital Sírio Libanês. São Paulo: Dendrix Edição e Design Ltda., 2009, v. , p. 146-153. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>40. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Costa FP ; <b>Hoff PM</b> ; <b>HOFF, P. M.</b> . Câncer gastrintestinal. Hepatocarcinoma. In: Buzaid AC, Hoff PM, Maluf FC. (Org.). Manual Prático de Oncologia Clínica do Hospital Sírio Libanês. 1ed.São Paulo: Dendrix Edição e Design Ltda., 2009, v. , p. 160-170. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>41. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Costa FP ; <b>Hoff PM</b> ; <b>HOFF, P. M.</b> . Câncer gastrintestinal. Vias Biliares. In: Buzaid AC, Hoff PM, Maluf FC. (Org.). Manual Prático de Oncologia Clínica do Hospital Sírio Libanês. São Paulo: Dendrix Edição e Design, 2009, v. , p. 171-179. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>42. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1026563052473840" target="_blank">Freitas D</a> ; Buzaid AC ; Costa FP ; <b>Hoff PM</b> ; <b>HOFF, P. M.</b> . Tumores neuroendócrinos. In: Buzaid AC, Hoff PM, Maluf FC. (Org.). Manual Prático de Oncologia Clínica do Hospital Sírio Libanês. São Paulo: Dencrix Edição e Design Ltda., 2009, v. , p. 572-585. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>43. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Schutz FA ; Costa FP ; <b>Hoff PM</b> ; <b>HOFF, P. M.</b> . Câncer gastrintestinal: Esôfago. In: Buzaid AC, Hoff PM, Maluf FC. (Org.). Mini-moc. 2ed.São Paulo: Dendrix Edição e Design Ltda., 2009, v. 1, p. 33-37. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>44. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Costa FP ; <b>Hoff PM</b> ; <b>HOFF, P. M.</b> . Câncer gastrintestinal: estômago. In: Buzaid AC, Hoff PM, Maluf FC. (Org.). Mini-Moc. 2ed.São Paulo: Dendrix Edição e Design Ltda., 2009, v. 1, p. 38-41. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>45. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Costa FP ; <b>Hoff PM</b> ; <b>HOFF, P. M.</b> ; Buzaid AC . Câncer gastrintestinal: intestino delgado. In: Buzaid AC, Hoff PM, Maluf FC. (Org.). Mini-moc. 2ed.São Paulo: Dendrix Edição e Design Ltda., 2009, v. 1, p. 42-43. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>46. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Costa FP ; <b>Hoff PM</b> ; <b>HOFF, P. M.</b> . Câncer gastrintestinal: reto. In: Buzaid AC, Hoff PM, Maluf FC. (Org.). Mini-moc. 2ed.São Paulo: Dendrix Edição e Design Ltda., 2009, v. 1, p. 44-46. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>47. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>; Costa FP ; Buzaid AC . Cãncer gastrintestinal: cólon. In: Buzaid AC, Hoff PM, Maluf FC. (Org.). Mini-moc. 2ed.São Paulo: Dendrix Edição e Design Ltda., 2009, v. 1, p. 47-53. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>48. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Costa FP ; <b>Hoff PM</b> ; <b>HOFF, P. M.</b> . Câncer gastrintestinal: pâncreas exócrino. In: Buzaid AC, Hoff PM, Maluf FC. (Org.). Mini-moc. 2ed.São Paulo: Dendrix Edição e Design Ltda., 2009, v. 1, p. 54-56. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>49. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Teixeira CH ; Buzaid AC ; Costa FP ; <b>Hoff PM</b> ; <b>HOFF, P. M.</b> . Câncer gastrintestinal: ânus. In: Buzaid AC, Hoff PM, Maluf FC. (Org.). Mini-moc. 2ed.São Paulo: Dendrix Edição e Design Ltda., 2009, v. 1, p. 57-59. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>50. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Costa FP ; <b>Hoff PM</b> ; <b>HOFF, P. M.</b> . Hepatocarcinoma. In: Buzaid AC, Hoff PM, Maluf FC. (Org.). Mini-moc. 2ed.São Paulo: Dendrix Edição e Design Ltda., 2009, v. 1, p. 60-63. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>51. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Costa FP ; <b>Hoff PM</b> ; <b>HOFF, P. M.</b> . Câncer gastrintestinal: vias biliares. In: Buzaid AC, Hoff PM, Maluf FC. (Org.). Mini-moc. 2ed.São Paulo: Dendrix Edição e Design Ltda., 2009, v. 1, p. 64-67. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>52. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1026563052473840" target="_blank">Freitas D</a> ; Buzaid AC ; Costa FP ; <b>Hoff PM</b> ; <b>HOFF, P. M.</b> . Câncer gastrintestinal: tumores neuroendócrinos. In: Buzaid AC, Hoff PM, Maluf FC. (Org.). Mini-moc. 2ed.São Paulo: Dendrix Edição e Design Ltda., 2009, v. 1, p. 224-229. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>53. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Costa FP ; <b>Hoff PM</b> ; <b>HOFF, P. M.</b> . Câncer gastrintestinal. Esôfago. In: Buzaid Ac, Hoff PM. (Org.). Manual Prático de Oncologia Clínica do Hospital Sírio Libanês. 6ed.São Paulo: Dendrix Edição e Design Ltda, 2008, v. 01, p. 88-97. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>54. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Costa FP ; <b>Hoff PM</b> ; <b>HOFF, P. M.</b> . Câncer gastrintestinal. Estômago. In: Buzaid AC, Hoff PM. (Org.). Manual Prático de Oncologia do Hospital Sírio Libanês. 06ed.São Paulo: Dendrix Edição e Design Ltda., 2008, v. 01, p. 98-103. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>55. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Costa FP ; <b>Hoff PM</b> ; <b>HOFF, P. M.</b> ; Buzaid AC . Câncer gastrintestinal. Intestino Delgado. In: Buzaid AC, Hoff PM. (Org.). Manual Prático de Oncologia Clínica do Hospital Sírio Libanês. 06ed.São Paulo: Dendrix Edição e Design Ltda., 2008, v. 01, p. 107-110. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>56. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Costa FP ; <b>Hoff PM</b> ; <b>HOFF, P. M.</b> . Câncer gastrintestinal.Reto. In: Buzaid AC, Hoff PM. (Org.). Manual Prático de Oncologia Clínica do Hospital Sírio Libanês. 06ed.São Paulo: Dendrix Edição e Design Ltda., 2008, v. 01, p. 111-118. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>57. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Costa FP ; Buzaid AC ; <b>Hoff PM</b> ; <b>HOFF, P. M.</b> . Câncer gastrintestinal. Cólon. In: Buzaid AC, Hoff PM. (Org.). Manual Prático de Oncologia Clínica do Hospital Sírio Libanês. 06ed.São Paulo: Dendrix Edição e Design Ltda., 2008, v. 01, p. 119-136. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>58. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Costa FP ; <b>Hoff PM</b> ; <b>HOFF, P. M.</b> . Câncer gastrintestinal. Pâncreas exócrino. In: Buzaid AC, Hoff PM. (Org.). Manual Prático de Oncologia Clínica do Hospital Sírio Libanês. 06ed.São Paulo: Dendrix Edição e Design Ltda., 2008, v. 01, p. 137-144. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>59. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Buzaid AC ; <b>Hoff PM</b> ; <b>HOFF, P. M.</b> . Câncer gastrintestinal. Ânus. In: Buzaid AC, Hoff PM. (Org.). Manual Prático de Oncologia Clínica do Hospital Sírio Libanês. 06ed.São Paulo: Dendrix Edição e Design Ltda., 2008, v. 01, p. 145-150. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>60. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Costa FP ; <b>Hoff PM</b> ; <b>HOFF, P. M.</b> . Câncer gastrintestinal. Hepatocarcinoma. In: Buzaid AC, Hoff PM. (Org.). Manual Prático de Oncologia Clínica do Hospital Sírio Libanês. 06ed.são Paulo: Dendrix e Design Ltda., 2008, v. 01, p. 151-161. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>61. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Costa FP ; <b>Hoff PM</b> ; <b>HOFF, P. M.</b> . Vias biliares. In: Buzaid AC, Hoff PM. (Org.). Manual Prático de Oncologia Clínica do Hospital Sírio Libanês. 06ed.São Paulo: Dendrix Edição e Design Ltda., 2008, v. 01, p. 162-169. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>62. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Buzaid AC ; Costa FP ; <b>Hoff PM</b> ; <b>HOFF, P. M.</b> . Tumores neuroendõcrinos. In: Buzaid AC, Hoff PM. (Org.). Manual Prático de Oncologia Clínica do Hospital Sírio Libanês. 06ed.São Paulo: Dendrix Edição e Design Ltda., 2008, v. 01, p. 540-552. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>63. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Costa FP ; <b>Hoff PM</b> ; <b>HOFF, P. M.</b> . Câncer gastrintestinal. Esôfago. In: Buzaid AC, Hoff PM. (Org.). Mini-MOC - Pocket book do manual prático de oncologia clínica do Hospital Sírio Libanês. 1ed.São Paulo: Dendrix Edição e Design Ltda., 2008, v. , p. 25-27. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>64. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Costa FP ; Buzaid AC ; <b>Hoff PM</b> ; <b>HOFF, P. M.</b> . Tumor estromal do trato gastrintestinal(GIST). In: Buzaid AC, Hoff PM. (Org.). Manual Prático de Oncologia Clínica do Hospital Sírio Libanês. 6ed.São Paulo: Dendrix Edição e Design Ltda., 2008, v. , p. 486-492. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>65. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Costa FP ; <b>Hoff PM</b> ; <b>HOFF, P. M.</b> . Câncer gastrintestinal. Estômago. In: Buzaid AC, Hoff PM. (Org.). Mini-MOC - Pocket Book do Manual Prático de Oncologia Clínica do Hospital Sírio Libanês. 1ed.São Paulo: Dendrix Edição e Design Ltda., 2008, v. , p. 28-31. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>66. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Costa FP ; <b>Hoff PM</b> ; <b>HOFF, P. M.</b> ; Buzaid AC . Câncer gastrintestinal. Intestino Delgado. In: Buzaid AC, Hoff PM. (Org.). Mini-MOC - Pocket Book do Manual Prático de Oncologia Clínica do Hospital Sírio Libanês. 1ed.São Paulo: Dendrix Edição e Design Ltda., 2008, v. , p. 32-33. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>67. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Costa FP ; <b>Hoff PM</b> ; <b>HOFF, P. M.</b> . Câncer gastrintestinal. Reto. In: Buzaid AC, Hoff PM. (Org.). Mini-MOC - Pocket Book do Manual Prático de Oncologia Clínica do Hospital Sírio Libanês. 1ed.São Paulo: Dendrix Edição e Design Ltda., 2008, v. , p. 34-35. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>68. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Costa FP ; Buzaid AC ; <b>Hoff PM</b> ; <b>HOFF, P. M.</b> . Câncer gastrintestinal. Cólon. In: Buzaid AC, Hoff PM. (Org.). Mini-MOC - Pocket Book do Manual Prático de Oncologia do Hospital Sírio Libanês. 1ed.São Paulo: Dendrix Edição e Design Ltda., 2008, v. , p. 36-42. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>69. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Costa FP ; <b>Hoff PM</b> ; <b>HOFF, P. M.</b> . Câncer gastrintestinal. Pãncreas exócrino. In: Buzaid AC, Hoff PM. (Org.). Mini-MOC do Pocket Book do Manual Prático de Oncologia Clínica do Hospital Sírio Libanês. 1ed.São Paulo: Dendrix Edição e Design Ltda., 2008, v. , p. 43-45. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>70. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Buzaid AC ; <b>Hoff PM</b> ; <b>HOFF, P. M.</b> ; Costa FP . Câncer gastrintestinal. Ânus. In: Buzaid AC, Hoff PM. (Org.). Mini-MOC - Pocket Book do Manual Prático de Oncologia Clínica do Hospital Sírio Libanês. 1ed.São Paulo: Dendrix Edição e Design Ltda., 2008, v. , p. 46-48. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>71. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Costa FP ; <b>Hoff PM</b> ; <b>HOFF, P. M.</b> . Câncer gastrintestinal. Hepatocarcinoma. In: Buzaid AC, Hoff PM. (Org.). Mini-MOC - Pocket Book do Manual Prático de Oncologia Clínica do Hospital Sírio Libanês. 1ed.São Paulo: Dendrix Edição e Design Ltda., 2008, v. , p. 49-52. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>72. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Costa FP ; <b>Hoff PM</b> ; <b>HOFF, P. M.</b> . Câncer gastrintestinal.Vias biliares. In: Buzaid AC, Hoff PM. (Org.). Mini-MOC do Pocket Book do Manual Prático de Oncologia Clínica do Hospital Sírio Libanês. São Paulo: Dendrix Edição e Design Ltda., 2008, v. , p. 53-55. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>73. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Costa FP ; Buzaid AC ; <b>Hoff PM</b> ; <b>HOFF, P. M.</b> . Tumor de trato gastrintestinal. In: Buzaid AC, Hoff PM. (Org.). Mini-MOC do Pocket Book do Manual Prático de Oncologia Clínica do Hospital Sírio Libanês. : , 2008, v. , p. 181-182. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>74. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Buzaid AC ; Costa FP ; <b>Hoff PM</b> ; <b>HOFF, P. M.</b> . Tumores neuroendócrinos. In: Buzaid AC, Hoff PM. (Org.). Mini-MOC do Pocket Book do Manual Prático de Oncologia Clínica do Hospital Sírio Libanês. São Paulo: Dendrix Edição e Design Ltda., 2008, v. , p. 199-204. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>75. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1026563052473840" target="_blank">Freitas D</a> ; <b>Hoff PM</b> ; <b>HOFF, P. M.</b> . Fatores prognósticos no cãncer de pulmão de células pequenas. In: Younes R, Buzaid AC, Katz A. (Org.). Câncer de pulmão - tratamento multidisciplinar. São Paulo: Dendrix Edição e Design Ltda., 2008, v. , p. 231-234. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>76. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1026563052473840" target="_blank">Freitas D</a> ; <b>Hoff PM</b> ; <b>HOFF, P. M.</b> . Tratamento do câncer de pulmão de células pequenas - doença extensa. In: Younes R, Buzaid AC, Katz A. (Org.). Câncer de pulmão - tratamento multidisciplinar. São Paulo: Dendrix Edição e Design Ltda., 2008, v. , p. 247-256. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>77. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Bresalier RS ; <b>Hoff PM</b> ; <b>HOFF, P. M.</b> . Epidemiology, genetics, and prevention of colorectal cancer. In: Markman Maurie and others. (Org.). Atlas of Cancer. 2ed.Philadelphia: Springer Science + Business Media, LLC, 2008, v. , p. 238-247. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>78. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Grothey A ; McWilliams RR ; <b>Hoff PM</b> ; <b>HOFF, P. M.</b> . Treatment of metastatic colorectal cancer. In: Markman M and others. (Org.). Atlas of Cancer. 2ed.Philadelphia: Springer Science + Business Media, LLC, 2008, v. , p. 248-257. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>79. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Vibert E ; Adam R ; <b>Hoff PM</b> ; <b>HOFF, P. M.</b> . Strategic management of colorectal liver metastases. In: Markman M. and others. (Org.). Atlas off Cancer. 2ed.Philadelphia: Springer Science + Business Media, LLC, 2008, v. , p. 258-263. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>80. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Bonsing BA ; Van der Hoop AG ; Van de Velde CJ ; <b>Hoff PM</b> ; <b>HOFF, P. M.</b> . Surgical treatment of localizad rectal cancer. In: Markman M and others. (Org.). Atlas of Cancer. 2ed.Philadelphia: Springer Science + Business Media, LLC, 2008, v. , p. 264-274. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>81. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">El-Khoueiry A ; Lenz HJ ; <b>Hoff PM</b> ; <b>HOFF, P. M.</b> . Pharmacogenomics and molecular biology in gastrointestinal cancer. In: Markman M and others. (Org.). Atlas of cancer. 2ed.Philadelphia: Springer Science + Business Media, LLC, 2008, v. , p. 275-283. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>82. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Costa FP ; Saad ED ; <b>Hoff PM</b> . Câncer Gastrintestinal. Esôfago. In: Dr. Antonio Carlos Buzaid; Dr. Paulo Marcelo Gehm Hoff. (Org.). Manual Prático de Oncologia Clínica do Hospital Sírio Libanês. 5ed.São Paulo: Dendrix Edição e Design Ltda., 2007, v. , p. 76-86. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>83. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Costa FP ; <b>Hoff PM</b> ; Saad ED . Câncer Gastrintestinal. Estômago. In: Dr. Antonio Carlos Buzaid; Dr. Paulo Marcelo Gehm Hoff. (Org.). Manual Prático de Oncologia Clínica do Hospital Sírio Libanês. 5ed.São Paulo: Dendrix Edição e Design Ltda., 2007, v. , p. 87-95. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>84. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Costa FP ; Saad ED ; <b>Hoff PM</b> . Câncer Gastrintestinal. Reto. In: Dr. Antonio Carlos Buzaid; Dr. Paulo Marcelo Gehm Hoff. (Org.). Manual Prático de Oncologia Clínica do Hospital Sírio Libanês. 5ed.São Paulo: Dendrix Edição e Design Ltda., 2007, v. , p. 99-107. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>85. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Costa FP ; <b>Hoff PM</b> ; Buzaid AC . Câncer gastrintestinal. Intestino Delgado. In: Dr. Antonio Carlos Buzaid; Dr. Paulo Marcelo Gehm Hoff. (Org.). Manual Prático de Oncologia Clínica do Hospital Sírio Libanês. 5ed.São Paulo: Dendrix Edição e Design Ltda., 2007, v. , p. 96-98. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>86. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Costa FP ; Buzaid AC ; <b>Hoff PM</b> . Cãncer Gastrintestinal. Cólon. In: Antonio Carlos Buzaid e Paulo Marcelo Gehm Hoff. (Org.). Manual Prático de Oncologia Clínica do Hospital Sírio Libanês. 5ed.São Paulo: Dendrix Publicações, 2007, v. , p. 108-124. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>87. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>; Saad ED ; Costa FP . Câncer Gastrintestinal. Pâncreas exócrino. In: Antonio Carlos Buzaid, Paulo Marcelo Gehm Hoff. (Org.). Manual Prático de Oncologia Clínica do Hospital Sírio Libanês. 5ed.São Paulo: Dendrix Publicações, 2007, v. , p. 125-131. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>88. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Buzaid AC ; Costa FP ; <b>Hoff PM</b> . Câncer gastrintestinal. Ânus. In: Antonio Carlos Buzaid, Paulo Marcelo Gehm Hoff. (Org.). Manual Prático de Oncologia Clínica do Hospital Sírio Libanês. 5ed.São Paulo: Dendrix Publicações, 2007, v. , p. 132-137. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>89. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Costa FP ; <b>Hoff PM</b> . Cãncer Gastrintestinal. Hepatocarcinoma. In: Antonio Carlos Buzaid, Paulo Marcelo Gehm Hoff. (Org.). Manual Prático de Oncologia Clínica do Hospital Sírio Libanês. 5ed.São Paulo: Dendrix Publicações, 2007, v. , p. 138-148. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>90. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Costa FP ; <b>Hoff PM</b> . Câncer gastrintestinal. Vias Biliares. In: Antonio Carlos Buzaid, Paulo Marcelo Gehm Hoff. (Org.). Manual Prático de Oncologia Clínica do Hospital Sírio Libanês. 5ed.São Paulo: Dendrix Publicações, 2007, v. , p. 149-156. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>91. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Buzaid AC ; Costa FP ; <b>Hoff PM</b> . Câncer gastrintestinal. Tumores neuro-endócrinos. In: Antonio Carlos Buzaid, Paulo Marcelo Gehm Hoff. (Org.). Manual Prático de Oncologia Clínica do Hospital Sírio Libanês. 5ed.São Paulo: Dendrix Editora, 2007, v. , p. 514-526. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>92. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/4792805111122908" target="_blank">Hoff AO</a> ; <b>Hoff PM</b> . Medullary thyroid carcinoma. In: Jmes C. Yao, Paulo M Hoff. (Org.). Hematology/Oncology Clinics of North America. Pennsylvania: WB Saunders Company, 2007, v. 21, p. 475-488. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>93. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Yao JC ; <b>Hoff PM</b> . Molecular targeted therapy for neuroendocrine tumors. In: James C Yao, Paulo M. Hoff. (Org.). Hematology/Oncology Clinics of North America. Pennsylvania: WB Saunders Company, 2007, v. 21, p. 575-581. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>94. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Shalan Nabeel ; <b>Hoff PM</b> ; <b>HOFF, P. M.</b> . The role of EGFR inhibition in colorectal cancer. In: Leonard B. Saltz. (Org.). Colorectal cancer evidence-based chemotherapy strategies. Totowa: Current Clinical Oncology, 2007, v. 1, p. 99-118. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>95. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P.M.</a></b>; BRESALIER, R. S. . Epidemiology, Genetics, and Prevention of Colorectal Cancer. In: Jaffer A Ajani; Ashfaq A Marghoob; Richard R. Barakat; Barbara A. Murphy; elihu H. Estey; Shreyaskumar Patel; Mark R. gilbert; Edith A. Perez; Roy S. Herbst; Daniel P. Petrylak; Paulo M. Hoff; Anas Younes; Douglas A. levine. (Org.). Atlas of Cancer. 2a.ed.Philadelphia, PA: Springer Science + Business Me, 2007, v. 1, p. 239-247. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>96. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P.M.</a></b>; Anthony, L ; LENZ, H. . Pharmacogenomics and Molecular Biology in Gastrointestinal Cancers. In: Jaffer A. Ajani; Richard R. Barakat; Elihu H. Estey; Mark R. gilbert; Roy S. Herbst; Paulo M. Hoff; Douglas A. Levine; Asfaq A. Marghoob; Barbara A. Murphy; Shreyaskumar Patel; Edith A. Perez; Daniel P. Petrylak; Anas Younes. (Org.). Atlas of Cancer. 1a.ed.Philadelphia, PA: Springer Science + Business Media LLC, 2007, v. 1, p. 275-283. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>97. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P.M.</a></b>; BONSING, B. A. ; HOOP, A. G. V. D. ; VELDE, C. J. V. . Surgical Treatment of Localized Rectal Cancer. In: Jaffer A. Ajani; Richard R. Barakat; Elihu H. Estey; Mark R. gilbert; Roy S. Herbst; Paulo M. Hoff; Douglas A. Levine; Ashfaq A. Marghoob; Barbara A. Murphy; Shreyaskumar Patel; Edith A. Perez; Daniel P. Petrylak; Ana Younes.. (Org.). Atlas of Cancer. 2a.ed.Springer Science + Business Me: Philadelphia, 2007, v. 1, p. 264-274. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>98. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P.M.</a></b>; GROTHEY, A. ; MACWILLIANS, R. R. . Treatment of Metastic Colorectal Cancer. In: Jaffer A. Ajani; Richard R. Barakat; Elihu H. Estey; Mark R. gilbert; Roy S. Herbst; Paulo M. Hoff; Douglas A. Levine; Ashfaq A marghoob; Barbara A. Murphy; Shreyaskumar Patel; Edith A. Perez; Daniel P. Petrylak; Yana Younes.. (Org.). Atlas of Cancer. 2a.ed.Springer Science + Business Me: Philadelphia, 2007, v. 1, p. 248-257. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>99. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P.M.</a></b>; VIBERT, E. ; ADAM, R. . Strategic Management of Colorectal Liver Metastases. In: Jaffer A. Ajani; Richard R. Barakat; Elihu H. Estey; Mark R. Gilbert; Roy S. Herbst; Paulo M. Hoff; Douglas A. Levine. (Org.). Atlas of Cancer. 2a.ed.Philadelphia, PA: Springer Science + Business Media LLC, 2007, v. 1, p. 258-263. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>100. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Costa FP ; Saad ED ; <b>Hoff PM</b> . Cancer Gastrointestinal. Esofago. In: Buzaid AC, Hoff PM, Cutait C. (Org.). Manual Prático de Oncologia Clínica. Sao Paulo: Editora Dendrix, 2006, v. , p. 68-78. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>101. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Costa FP ; <b>Hoff PM</b> ; Buzaid AC . Cancer Gastrintestinal. Intestino Delgado. In: Buzaid AC, Hoff PM, Cutait R. (Org.). Manual Prático de Oncologia Clínica do Hospital Sírio Libanês. Sao Paulo: Editora Dendrix, 2006, v. , p. 88-90. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>102. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Costa FP ; Saad ED ; <b>Hoff PM</b> . Cancer Gastrintestinal. Reto. In: Buzaid AC, Hoff PM, Cutait R. (Org.). Manula Prático de Oncologia Clínica do Hospital Sírio Libanes. Sao Paulo: Editora Dendrix, 2006, v. , p. 91-98. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>103. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Costa FP ; Buzaid AC ; <b>Hoff PM</b> . Cancer Gastrintestinal. Cólon. In: Buzaid AC, Hoff PM, Cutait C. (Org.). Manual Prático de Oncologia Clínica do Hospital Sírio Libanês. Sao Paulo: Editora Dendrix, 2006, v. , p. 99-117. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>104. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Saad ED ; Costa FP ; <b>Hoff PM</b> . Cancer Gastrintestinal. Pâncreas Exócrino. In: Buzaid AC, Hoff PM, Cutait R. (Org.). Manual Prático de Oncologia Clínica do Hospital Sírio Libanês. Sao Paulo: Editora Dendrix, 2006, v. , p. 118-124. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>105. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Buzaid AC ; Mayer IA ; <b>Hoff PM</b> . Cancer Gastrintestinal. Ânus. In: Buzaid AC, Hoff PM, Cutait R. (Org.). Manual Prático de Oncologia Clínica do Hospital Sírio Libanês. Sao Paulo: Editora Dendrix, 2006, v. , p. 125-130. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>106. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Costa FP ; Mayer IA ; <b>Hoff PM</b> . Cancer Gastrintestinal. Hepatocarcinoma. In: Buzaid AC, Hoff PM, Cutait R. (Org.). Manual Prático de Oncologia Clínica do Hospital Sírio Libanês. Sâo Paulo: Editora Dendrix, 2006, v. , p. 131-140. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>107. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Costa FP ; <b>Hoff PM</b> . Cancer Gastrintestinal. Vias Biliares. In: Buzaid AC, Hoff PM, Cutait R. (Org.). Manual Prático de Oncologia Clínica do Hospital Sírio Libanês. São Paulo: Editora Dendrix, 2006, v. , p. 141-148. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>108. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>. Tumores Neuroendócrinos. In: Buzaid AC, Costa FP, Saad ED, Hoff PM. (Org.). Manual Prático de Oncologia Clínica do Hospital Sírio Libanês. São Paulo: Editora Dendrix, 2006, v. , p. 483-494. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>109. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Buzaid AC ; Costa FP ; Saad ED ; <b>Hoff PM</b> . Tumores Neuroendócrinos. In: Buzaid AC, Hoff PM, Cutati C. (Org.). Manual Prático de Oncologia Clínica. São Paulo: Editora Dendrix, 2006, v. , p. 483-494. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>110. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Costa FP ; <b>Hoff PM</b> ; Saad ED . Cancer Gastrintestinal. Estomago. In: Buzaid AC, Hoff PM, Cutait C. (Org.). Manual Prático de Oncologia Clínica do Hospital Sírio Libanes. Sao Paulo: Editora Dendrix, 2006, v. , p. 79-87. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>111. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Vauthey J-N ; Medgyesy D ; Goffin JR ; Royce M ; Ayoub JP ; <b>Hoff PM</b> . Management Options: Metastatic Colorectal Carcinoma. In: Abbruzzese JL, Evan D, Willett C, Hamilton S. (Org.). The Principles and Practice of Gastrointestinal Oncology. Oxford Press: , 2004, v. , p. -. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>112. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>; Katz A ; Zogbi Y . Drogas com Alvo Molecular Específico. In: Ferreira C, Rocha J. (Org.). Oncologia Molecular. Sao Paulo: Editora Atheneu, 2004, v. , p. -. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>113. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>; Abbruzzese JL ; Pluda JM . Therapeutic Principles of Gastrointestinal Neoplasia: Emerging Therapies: Antiangiogenesis. In: Abbruzzese JL, Evan D, Willett C, Hamilton S. (Org.). The Principles and Practice of Gastrointestinal Oncology. : Oxford Press, 2004, v. , p. -. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>114. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>. New Drugs for Colorectal Cancer. In: Giaccone, Schilsky, Sondel. (Org.). Cancer Chemotherapy & Biological Response Modifiers Annual 21. : Chapter 39, 2003, v. , p. 817-829. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>115. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>; Saad ED . Clinicals Trials of UFT/Leucovorin. In: Yussef Rustum. (Org.). Fluoro-Pyrimidines in Cancer Therapy. : Humana Press, 2003, v. , p. 209-218. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>116. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Thomas MB ; <b>Hoff PM</b> . Oral Fluoropyrimidines in Colorectal Neoplasia. In: Bleiberg H, Kemeny N, Rougier P, Wilke H. (Org.). A Clinical Guide of Therapy. London: Martin Dunitz Publishiers, 2002, v. , p. 483-489. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>117. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>; Saad ED ; Alves AT . O que podemos esperar da quimioterapia no câncer colorretal metastático?. In: Castro LP, Savassi-Rocha PR, Rodrigues MA. (Org.). Tópicos em Gastroenterologia: Cancer do Aparelho Digestivo. Minas Gerais: Medsi, 2002, v. , p. 279-290. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>118. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>; Saad ED ; Abramoff R . Tratamento Adjuvante do Cancer Colorretal e do Cancer de Canal Anal. In: Rodrigues MA. (Org.). Tópicos em Gastroenterologia: Cancer do Aparelho Digestivo. Minas Gerais: Medsi, 2002, v. , p. 305-314. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>119. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>; Ellenhorn JD ; Coia LR ; Alberts SR . .. In: Hoff PM, Ellenhorn JD, Coia LR, Alberts SR. (Org.). Cancer Management: A Multidisciplinary Approach. 6ed.New York: PRR, Inc. Publishing, 2002, v. , p. 295-324. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>120. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Wagman LD ; Robertson JM ; Venook A ; O Neil B ; <b>Hoff PM</b> . Liver, gallbladder and biliary tract cancers. In: Pazdur R, Coia L, Hoskins WY, Wagman L. (Org.). Cancer Management:: A Multidisciplinary Approach. 5ed.New York: PRR, Inc. Publishing, 2001, v. , p. 255-271. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>121. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Skibber JM ; <b>Hoff PM</b> ; Minsky B . Rectal Cancer. In: De Vita, Jr VT, Hellman S, Rosenberg SA. (Org.). Cancer: Principles and Pratice of Oncology. 6ed.Philadelphia: Lippincott Williams & Wilkins, 2001, v. , p. 1271-1319. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>122. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Paz IB ; Suntharalingam M ; Leichman L ; Coia LR ; Bonin SR ; <b>Hoff PM</b> . Esophageal Cancer. In: Pazdur R, Coia L, Hoskins WY, Wagman L. (Org.). Cancer Management: A Multidisciplinary Approach. 5ed.New York: PRR, Inc. Publishing, 2001, v. , p. 201-213. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>123. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Bonin SR ; Schwartz RE ; Blanke CD ; Coia LR ; <b>Hoff PM</b> . Gastric Cancer. In: Pazdur R, Coia L, Hoskins WY, Wagman L. (Org.). Cancer Management: A Multidisciplinary Approach. 5ed.New York: PRR Inc. Publishing, 2001, v. , p. 215-225. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>124. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Brower ST ; Benson III Al B ; Myerson RJ ; <b>Hoff PM</b> . Pancreatic neuroendocrine GI and adrenal cancers. In: Pazdur R, Coia L, Hoskins WY, Wagman L. (Org.). Cancer Management: A Multidisciplinary Approach. 5ed.New York: PRR, Inc. Publishing, 2001, v. , p. 227-253. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>125. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Ellerhorn JDI ; Coia LR ; <b>Hoff PM</b> ; Ayoub JP . Colorectal and Anal Cancers. In: Pazdur R, Coia L, Hoskins WY, Wagman L. (Org.). Cancer Management: A Multidisciplinary Approach. 5ed.New York: PRR, Inc. Publishing, 2001, v. , p. 273-300. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>126. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Bonin SR ; Coia LR ; <b>Hoff PM</b> ; Paz IB . Esophageal Cancer. In: pazdur R, Coia LR, Hoskins WJ, Wagman LD. (Org.). Cancer Management: A Multidisciplinary Approach. 4ed.New York: PRR, Inc. Publishing, 2000, v. , p. 201-213. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>127. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Bonin SR ; Coia LR ; <b>Hoff PM</b> ; Schwartz RE . Gastric Cancer. In: Pazdur R, Coia LR, Hoskins WJ, Wagman LD. (Org.). Cancer Management: A Multidisciplinary Approach. 4ed.New York: PRR, Inc. Publishing, 2000, v. , p. 215-225. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>128. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Brower ST ; Benson AB ; Myerson RJ ; <b>Hoff PM</b> . Pancreatic, neuroendocrine GI and adrenal cancers. In: Pazdur R, Coia LR, Hoskins WJ, Wagman LD. (Org.). Cancer Management: A Multidisciplinary Approach. 4ed.New York: PRR, Inc. Publishing, 2000, v. , p. 227-253. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>129. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Wagman LD ; <b>Hoff PM</b> ; Robertson JM ; Dwivedy S . Liver, gallbladder and biliary tract cancers. In: Pazdur R, Coia LR, Hoskins WJ, Wagman LD. (Org.). Cancer Management: A Multidisciplinary Approach. 4ed.New York: PRR, Inc. Publishing, 2000, v. , p. 255-271. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>130. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Bonin SR ; Coia LR ; <b>Hoff PM</b> ; Pazdur R ; Diaz-Canton EA ; Ellerhorn JDI . Esophageal Cancer. In: pazdur R, Coia L, Hoskins WY, Wagman L. (Org.). Cancer Management: A Multidisciplinary Approach. 3ed.New York: PRR, Inc. Publishing, 1999, v. , p. 88-101. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>131. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Bonin SR ; Coia LR ; <b>Hoff PM</b> ; Pazdur R ; Diaz-Canton EA ; Shwartz RE . Gastric Cancer. In: Pazdur R, Coia L, Hoskins WY, Wagman L. (Org.). Cancer Management: A Multidisciplinary Approach. 3ed.New York: PRR, Inc. Publishing, 1999, v. , p. 103-112. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>132. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Brower ST ; <b>Hoff PM</b> ; Jones DV ; Cunningham JD ; Myerson RJ . Pancreatic Cancer, hepatobiliary cancer and neuroendocrine cancers of the GI tract.. In: Pazdur R, Coia L, Hoskins WY, Wagman L. (Org.). Cancer Management: A Multidisciplinary Approach. 3ed.New York: PRR, Inc. Publishing, 1999, v. , p. 113-148. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>133. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>; Pazdur R . Small cell carcinomas of the gastrointestinal tract. In: Raghavan D, Brecher ML, Johnson DH, Meropol NJ, Thigpen JT. (Org.). Textbook of Uncommon Cancer. 2ed.England: John Wiley and Sons, Baffins Lane, Chichester, Sussex, 1999, v. 40, p. -. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>134. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>; Lima M ; Valero V . Primary Chemotherapy for Breast Cancer. Abordagem Multidisciplinar do Cancer de Mama. 1ed.Rio de Janeiro: Editora Revinter, 1998, v. , p. 235-239. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>135. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Lima M ; <b>Hoff PM</b> ; Valero V . High-dose Chemotherapy for Breast Cancer. Abordagem Multidisciplinar do Cancer de Mama. 1ed.Rio de Janeiro: Editora Revinter, 1998, v. , p. 227-234. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>136. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Bonin SR ; Coia LR ; <b>Hoff PM</b> ; Pazdur R . Esophageal Cancer. In: Pazdur R, Coia L, Hoskins WY, Wagman L. (Org.). Cancer Management: A Multidiciplinary Approach. 2ed.New York: PRR, Inc. Publishing, 1997, v. , p. 94-103. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>137. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Bonin SR ; Coia LR ; <b>Hoff PM</b> ; Pazdur R ; Schwartz RE . Gastric Cancer. In: Pazdur R, Coia L, Hoskins WY, Wagman L. (Org.). Cancer Management: A Multidisciplinary Approach. 2ed.New York: PRR, Inc. Publishing, 1997, v. , p. 104-113. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>138. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Brower ST ; <b>Hoff PM</b> ; Jones DV ; Cunningham JD ; Myerson RJ . Pancreatic cancer, hepatobiliary cancer and neuroendocrine cancers of the GI tract. In: Pazdur R, Coia L, Hoskins WY, Wagman L. (Org.). Cancer Management: A Multidisciplinary Approach. 2ed.New York: PRR, Inc. Publishing, 1997, v. , p. 113-148. </div>
</div>
<br class="clear">
<div class="cita-artigos">
<b><a name="TextosJornaisRevistas"></a>Textos em jornais de notícias/revistas</b>
</div>
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>1. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P.M.</a></b>. Icesp, dez anos de um gigante de medicina. Folha de São Paulo, São Paulo, p. A5 - A5, 07 maio  2018. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P.M.</a></b>. Rx do ICESP. Folha de São Paulo, SP, p. B10 - B11, 06 maio  2018. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>3. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Munhoz RR ; ANJOS, C. A. ; FERREIRA, C. G. M. ; BALDOTO, C. ; MATHIAS, C. M. C. ; <b>HOFF, P.M.</b> . Diretrizes brasileiras de manejo de toxicidades imunomediadas associadas ao uso d ebloqueadores de correceptores imunes. Oncology, SP, p. 1 - 15, 14 mar.  2017. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>4. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, PM</a></b>. Câncer: como os novos medicamentos estão mudando a história da doença (ou das doenças). Veja on line, SP, 21 set.  2016. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>5. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, PM</a></b>. Câncer: como os novos medicamentos estão mudando a história da doença (ou das doenças). Veja on line, SP, 21 set.  2016. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>6. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P.M.</a></b>. O desafio ao SUS no século XXI. O Estado de São Paulo, SP, 15 ago.  2016. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>7. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P M</a></b>. Fosfoetanolamina sintética. Revista Saúde, São Paulo, 28 out.  2015. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>8. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P M</a></b>. Fosfoetanolamina sintética. Estadão, São Paulo, p. 1, 17 out.  2015. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>9. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P M</a></b>; GARICOCHEA, B. . Nova arma contra o câncer. Folha de São Paulo, São Paulo, 21 jul.  2015. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>10. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P M</a></b>. Devagar, quase parando.. Revista Época, São Paulo, p. 67 - 67, 22 jun.  2015. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>11. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, PM</a></b>. Apertando o circo ao tabagismo. Folha de São Paulo, SP, 09 nov.  2014. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>12. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P.M.</a></b>. Crescimento e orgulho pleno.. SP Câncer, São Paulo, p. editorial, 01 ago.  2014. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>13. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P.M.</a></b>. Época Especial. Paulo Hoff - O Médico que assume com o coração o sofrimento de seus pacientes., São Paulo, p. 65/116 - 126, 07 abr.  2014. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>14. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>. Estado regionalizará combate ao câncer. Folha de São Paulo, p. 01 - 01, 19 mar.  2014. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>15. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>. Plano poderá credenciar hospital público. Folha de São Paulo, São Paulo, p. 01, 13 mar.  2014. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>16. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P M</a></b>; UIP, D. . SP em rede contra o câncer. Voz do Vale, Vale do Paraíba, p. 02 - 02, 13 mar.  2014. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>17. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>. Atualmente, os pesquisadores do Inca discutem o que deve ser feito em termos populacionais... Revista Isto É, Medicina e Bem Estar., São Paulo, p. 74 - 75, 06 mar.  2014. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>18. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P.M.</a></b>. A esperança vai no prognóstico. Valor Econômico, São Paulo, p. capa, pag. 18 - 22, 13 dez.  2013. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>19. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P.M.</a></b>; Braghiroli, Maria Ignez . Quo Vadis?. Revista Onco, p. 36, 13 ago.  2013. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>20. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P.M.</a></b>. O Tratado de Oncologia. Revista Isto É., São Paulo, p. 27, 27 mar.  2013. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>21. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P.M.</a></b>. Primeirão 'Primeiro Brasileiro eleito para o Conselho da ASCO'. Folha de São Paulo, São Paulo, 08 fev.  2013. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>22. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P M</a></b>. O Médico das celebridades tem raízes gaúchas.. Jornal AMRIGS, Rio Grande do Sul, p. 04 - 05, 01 fev.  2013. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>23. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P.M.</a></b>. Ainda é cedo para usar aspirina contra o câncer, dizem especialistas. Uol Notícias, São Paulo, 30 mar.  2012. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>24. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>. Diretor do ICESP, visita obras em hospital em Presidente Prdudente. O Imparcial, Presidente Prudente, p. capa - 02, 18 dez.  2011. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>25. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>. Prêmio 'Faz Diferença'. O Globo, São Paulo, p. 1 - 3, 14 dez.  2011. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>26. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P.M.</a></b>. São Paulo lança programa para prevenção do câncer a 1,5 milhão de alunos. Uol, São Paulo, 24 nov.  2011. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>27. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P.M.</a></b>. SP lança projeto para conscientizar jovens sobre prevenção do câncer. G1 Noticias, São Paulo, p. 1 - 5, 24 nov.  2011. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>28. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>. Lançamento do livro 'Como Superar o Câncer'. Folha de São Paulo, São Paulo, p. 02 - 02, 07 out.  2011. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>29. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>; <a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/4792805111122908" target="_blank">MALTEZ FILHO, A.</a> ; PADILHA, A. ; MORAES, M. . Dilma recebe LBCC/ABIFCO. Boletim Informativo do Hospital Aristides Maltez, audiência com Presidenta Dilma Rousseff, Salvador, Bahia, p. capa, 20 ago.  2011. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>30. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>. Pesquisas sobre novo tratamento contra o câncer ganha prêmio.. Folha de São Paulo, São Paulo, p. 08 - 09, 05 ago.  2011. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>31. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>. Health care in Brazil: An injection of reality. The Economist, p. 1 - 2, 03 ago.  2011. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>32. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>. Nova droga antimelanoma. Correio Braziliense, Brasilia, DF, p. 10, 07 jun.  2011. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>33. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>. Um dia contra do câncer. Jornal da Tarde, São Paulo, 19 maio  2011. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>34. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>. Campanha estimula prevenção do câncer. Folha de São Paulo, São Paulo, 17 maio  2011. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>35. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>. Guerra Biológica. Folha de São Paulo, São Paulo, p. 17 - 17, 01 maio  2011. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>36. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>. O câncer, a epidemia e a saúde pública. O Imparcial, Presidente Prudente, p. 23 - 23, 19 abr.  2011. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>37. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>. SP ganha maior laboratório para pesquisa de câncer da América Latina. Jornal de Itupeva, Itupeva, p. 11 - 12, 18 abr.  2011. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>38. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>. ICESP lança ultrassom para destruir células com câncer. G1 - TV Globo, São Paulo, p. 1 - 4, 15 abr.  2011. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>39. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>. O câncer, a epidemia e a saúde pública. Imprensa Livre, Litoral, p. 16 - 16, 12 abr.  2011. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>40. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>. O câncer, a epidemia e a saúde pública. Assis Notícias, Assis, p. 59, 10 abr.  2011. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>41. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>. O câncer, a epidemia e a saúde pública. Folha de São Paulo, São Paulo, p. 02 - 02, 04 abr.  2011. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>42. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>. Entrevista sobre Câncer. Rádio Jovem Pan, São Paulo, 15 mar.  2011. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>43. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>. Dedicação e sorte impulsionaram ascensão meteórica. O Estado de São Paulo, São Paulo, p. 05 - 05, 27 fev.  2011. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>44. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>. O novo dilema de combate ao câncer. Revista Época, São Paulo, p. 90 - 99, 14 fev.  2011. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>45. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>. O Brasil precisa se antecipar à epidemia do câncer. Veja, São Paulo, 04 fev.  2011. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>46. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>. Consumo de alimentos saudáveis pode ajudar na prevenção do câncer. Jornal Hoje, São Paulo, 03 fev.  2011. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>47. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>. Consumo de alimentos saudáveis pode ajudar na prevenção do câncer. 360 graus, 03 fev.  2011. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>48. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P.M.</a></b>. Em Novas Mãos. Folha de São Paulo, São Paulo, p. ilustrada, 19 jan.  2011. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>49. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>. Exame de Sangue detecta avanço do câncer mais cedo. Diário de Marilia, Marilia,SP, p. 15, 09 jan.  2011. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>50. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>. Avanço contra o Câncer. Amazônia Jornal, São Paulo, p. 14, 04 jan.  2011. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>51. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>. Exame de Sangue detecta avanço do câncer mais cedo. Folha de São Paulo, São Paulo, 04 jan.  2011. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>52. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>. Novo teste acha câncer mais cedo. Jornal da Tarde, São Paulo, 04 jan.  2011. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>53. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>. Exame de Sangue que detecta câncer mais cedo será testado. Todo Dia - Americana, Americana,SP, 04 jan.  2011. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>54. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>. Exame de Sangue que detecta câncer mais cedo será testado. Todo Dia - Americana, Americana,SP, 04 jan.  2011. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>55. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>. Câncer e qualidade de vida. Folha de São Paulo, São Paulo, 31 dez.  2010. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>56. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P.M.</a></b>. Dose diária de aspirina previne câncer. Folha on line, São Paulo, 16 dez.  2010. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>57. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P.M.</a></b>. Estudo aponta melhora no diagnósitco de câncer de colo de útero. Rede TV on line., São Paulo, 30 nov.  2010. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>58. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P.M.</a></b>. Médicos detectam câncer de colo de útero mais cedo no Brasil. R7-Agência Estado, São Paulo, 30 nov.  2010. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>59. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P.M.</a></b>. Câncer de pulmão aumenta entre as mulheres, revela estudo em 16 capitais.. O Estado de São Paulo, São Paulo, p. cliping, 27 nov.  2010. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>60. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P.M.</a></b>. Pulmão feminino corre perigo. Jornal da Tarde, São Paulo, p. clipping, 27 nov.  2010. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>61. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P.M.</a></b>. 'Faltam mais estudos que provem riscos do celular'. Folha.com, São Paulo, , v. C14/15, p. 8 - 8, 21 nov.  2010. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>62. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P.M.</a></b>. Mulheres com câncer são alvo de estudo. Diário da Região, São José do Rio Preto, p. clipping, 20 out.  2010. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>63. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P.M.</a></b>. Prevenção, aliada contra o câncer. Assis Notícias, Assis, 15 out.  2010. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>64. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P M</a></b>. Prevenção, aliada contra o câncer. Linortsp, 15 out.  2010. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>65. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P.M.</a></b>. Prevenção, aliada contra o câncer. Jornal da Tarde, São José do Rio Preto, 07 out.  2010. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>66. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P M</a></b>; Takahashi, Tiago K. ; Barbosa CCL ; BUGANO, D. ; YAE, T. . Carcinoma pulmonar de células não-pequenas em pacientes com idade IGUAL ou superior a 65 anos tratados com quimioterapia: análise de segurança e eficácia.. Revista Brasileira de Oncologia Clínica, Edição Especial Câncer de Pulmão, p. 108 - 113, 01 out.  2010. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>67. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P M</a></b>. Instituto do Câncer cria prêmio de incentivo à luta contra a doença. Folha de São Paulo, São Paulo, 04 ago.  2010. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>68. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P.M.</a></b>. Os brasileiros mais influentes de 2009. Época, São Paulo, 07 dez.  2009. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>69. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P.M.</a></b>. Pesquisa contra o câncer. Jornal da Tarde, São Paulo, 27 nov.  2009. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>70. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P.M.</a></b>. Robin Hood às avessas?. Folha de São Paulo, SP, 02 set.  2009. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>71. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P.M.</a></b>. Mais Perto da Cura. ABCFARMA, SP, p. 6 - 12, 03 ago.  2009. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>72. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P M</a></b>. Muheres são mal representadas em pesquisas em câncer. Folha de São Paulo, 08 jun.  2009. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>73. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P.M.</a></b>. O mais jovem dos melhores. Folha de São Paulo, SP, p. 8 - 8, 15 fev.  2009. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>74. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P.M.</a></b>. Mulheres não sabem que câncer atinge mais obesas. Jornal Saúde, SP, p. C7, 27 out.  2008. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>75. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P.M.</a></b>. Terapias menos invasivas. Jornal de Brasília, Brasilia, DF, p. 20 - 21, 22 mar.  2008. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>76. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P M</a></b>. O insubistituível homem de branco. O insubistituível homem de branco, Revista Veja, 14 nov.  2007. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>77. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Takahashi TK ; Barbosa CC ; Bugano D ; Takagaki TY ; Feher O ; <b>Hoff PM</b> ; <b>HOFF, P. M.</b> ; Junior GC . Carcinoma pulmonar de células não-pequenas em pacientes com idade igual ou superior a 65 anos tratados com quimioterapia: análise de segurança e eficácia. Revista Brasileira de Oncologia Clínica, p. 108 - 113. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>78. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>. Câncer não é palavrão. Doctor Word. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>79. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P.M.</a></b>. Cancer: prevenção em sala de aula. Estadão/Folha de SP, São Paulo. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>80. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P.M.</a></b>. Icesp lança programa de prevenção para alunos do ensino médio. Portal Terra, São Paulo. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>81. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P M</a></b>. Situação atual do câncer no Brasil e no mundo.. Revista Época, São Paulo. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>82. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P M</a></b>. Câncer na Adolescência. Revista Isto É., São Paulo. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>83. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">FERNANDES, J. L. ; SERRANO, C. V. ; <b>HOFF, P.M.</b> . Radiação Ionizante em imagem cardiovascular e risco de neoplasias. Revista da Sociedade de Cardiologia do Estado de São Paulo, São Paulo, p. 591 - 596. </div>
</div>
<br class="clear">
<div class="cita-artigos">
<b><a name="TrabalhosPublicadosAnaisCongresso"></a>Trabalhos completos publicados em anais de congressos</b>
</div>
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>1. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Azevedo FC ; <b>Hoff PM</b> ; <b>HOFF, P. M.</b> . Resultados do tratamento não operatório das metátases hepáticas. In: Cirurgião Ano 3 - Atualização em cirurgia geral, emergência e trauma, 2009, São Paulo. Cirurgião Ano 3 - Atualização em cirurgia geral, emergência e trauma. São Paulo: Editora Manole, 2009. p. 163-169. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1200/JCO.2008.21.0807" target="_blank"></a>Claret, L. ; Girard, P. ; <b>Hoff PM</b> ; <b>HOFF, P. M.</b> ; Van Cutsem, E. ; Zuideveld, K. P. ; Jorga, K. ; Fagerberg, J. ; Bruno, R. . Model-Based Prediction of Phase III Overall Survival in Colorectal Cancer on the Basis of Phase II Tumor Dynamics. In: 45th ASCO Annual Meeting, 2009, Orlando, FL, USA. May 29-Jun 2. J Clin Oncol (Suppl. S). v. 27(15). p. 4103-4108. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>3. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1007/s10637-008-9142-3" target="_blank"></a>Overman, Michael J. ; Varadhachary, Gauri ; Kopetz, Scott ; Thomas, Melanie B. ; Fukushima, Masakazu ; Kuwata, Keizo ; Mita, Akira ; Wolff, Robert A. ; <b>Hoff PM</b> ; Xiong, Henry ; Abbruzzese, James L. . Phase 1 study of TAS-102 administered once daily on a 5-day-per-week schedule in patients with solid tumors. In: 93rd Annual Meeting of the American Association for Cancer Research (AACR), 2008, San Francisco-CA, USA Apr 6-10. Invest New Drugs. v. 26(5). p. 445-454. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>4. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1200/JCO.2007.15.2090" target="_blank"></a>Haller, D. G. ; Cassidy, J. ; Clarke, S. J. ; Cunningham, D. ; Van Cutsem, E. ; <b>Hoff PM</b> ; <b>HOFF, P. M.</b> ; Rothenberg, M. L. ; Saltz, L. B. ; Schmoll, H.-J. ; Allegra, C. ; Bertino, J. R. ; Douillard, J.-Y. ; Gustavsson, B. G. ; Milano, G. ; O'Connell, M. ; Rustum, Y. ; Tabernero, J. ; Gilberg, F. ; Sirzen, F. ; Twelves, C. . Potential Regional Differences for the Tolerability Profiles of Fluoropyrimidines. In: 8th World Congress on Gastrointestinal Cancer, 2008, Barcelona, Spain, Jun 28-Jul 1. J Clin Oncol 28 June ? 1 July, 2006. v. 26(13). p. 2118-2123. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>5. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1200/JCO.2007.13.6374" target="_blank"></a>Yao, J. C. ; Phan, A. ; <b>Hoff PM</b> ; <b>HOFF, P. M.</b> ; Chen, H. X. ; Charnsangavej, C. ; Yeung, S.-C. J. ; Hess, K. ; Ng, C. ; Abbruzzese, J. L. ; Ajani, J. A. . Targeting Vascular Endothelial Growth Factor in Advanced Carcinoid Tumor: A Random Assignment Phase II Study of Depot Octreotide With Bevacizumab and Pegylated Interferon Alfa-2b. In: 9th International Symposium on Anti-Angiogenic Agents, 2008, San Diego, CA, USA, Feb 1-3. J Clin Oncol, 2007. v. 26(8). p. 1316-1323. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>6. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1093/annonc/mdm210" target="_blank"></a>Verslype, C Van Cutsem, E Dicato, M Cascinu, S Cunningham, D Diaz-Rubio, E Glimelius, B Haller, D Haustermans, K Heinemann, V <b>Hoff PM</b> Johnston, P. Kerr, D Labianca, R Louvet, C Minsky, B Moore, M Nordlinger, B Pedrazzoli, S Roth, A Rothenberg, M Rougier, P Schmoll, H-J Tabernero, J Tempero, M ,  <a title="Clique para visualizar todos os autores" class="tooltip autores-et-al-plus" href="javascript:void(0)">et al.<span></span></a><span class='autores-et-al'>van de Velde, C Van Laethem, J-L Zalcberg, J <a href="javascript:void(0)" title="Clique para ocultar os autores" class="tooltip autores-et-al-minus"></a></span> ; The management of pancreatic cancer. Current expert opinion and recommendations derived from the 8th World Congress on Gastrointestinal Cancer, Barcelona, 2006. In: 8th World Congress on Gastrointestinal Cancer, 2007, Barcelona, Spain, Jun 28-Jul 1. Annal Oncol (Suppl. 7). v. 18. p. vii1-vii10. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>7. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>. Evollving options for first line treatment for metastatic colorectal cancer. In: Chemotherapy Foundation Symposium XXV Innovative Cancer Therapy for Tomorrow, 2007, New York , NY, Nov 4-8. Abstracts of the Chemotherapy Foundation Symposium XXV Innovative Cancer Therapy for Tomorrow, 2007. v. 01. p. 12-13. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>8. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Moore MR ; Jones C ; Harker G ; Lee F ; Ardalan B ; Saif MW ; <b>Hoff PM</b> ; Coomes J ; Rollins C ; Felt K . Phase II trial of DJ-927, an oral tubulin depolymerization inhibitor, in the treatment of metastatic colorectal cancer. In: ASCO Annual Meeting, 2006, Atlanta, GA, USA, Jun 2-6. J Clin Oncol (Suppl. S). v. 24(18). p. 3591-3591. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>9. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Akaishi E ; Teixeira F ; Katayama M ; Mizumoto N ; Costa FP ; <b>Hoff PM</b> ; Buzaid AC . Peritonectomy procedures long term outcomes of a brazilian institution. In: 5th International Workshop on Peritoneal Surface Malignancy, 2006. Scientific Documents and Abstracts. p. 63-63. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>10. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1016/j.ijrobp.2006.07.1374" target="_blank"></a>DAS, P ; LIN, E ; BHATIA, S ; SKIBBER, J ; RODRIGUEZBIGAS, M ; FEIG, B ; CHANG, G ; <b>Hoff PM</b> ; <b>HOFF, P. M.</b> ; ENG, C ; WOLFF, R . Preoperative chemoradiotherapy with capecitabine versus protracted infusion 5-fluorouracil for rectal cancer: A matched-pair analysis. In: 47th Annual Meeting of the American-Society-for-Therapeutic-Radiology-and-Oncology, 2006, Denver, CO, USA, Oct 16-20. Int J Radiat Oncol Biol Phys. v. 66(5). p. 1378-1383. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>11. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1016/j.ijrobp.2006.05.063" target="_blank"></a>KRISHNAN, S ; JANJAN, N ; SKIBBER, J ; RODRIGUEZBIGAS, M ; WOLFF, R ; DAS, P ; DELCLOS, M ; CHANG, G ; <b>Hoff PM</b> ; <b>HOFF, P. M.</b> ; ENG, C . Phase II study of capecitabine (XelodaÂ®) and concomitant boost radiotherapy in patients with locally advanced rectal cancer. In: 41st Annual Meeting of the American Society of Clinical Oncology, 2006, Orlando, FL, USA, Mat 13-17. Int J Radiat Oncol Biol Phys, 2005. v. 66(3). p. 762-771. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>12. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1245/s10434-006-9024-x" target="_blank"></a>Chapman, William C. ; <b>Hoff PM</b> ; <b>Hoff, Paulo M.</b> ; Strasberg, Steven M. . Selection of Patients for Resection of Hepatic Colorectal Metastases: Expert Consensus Statement by Charnsangavej et al.. In: Consensus Conference on Hepatic Colorectal Metastases, 2006, San Francisco, CA, Jan 25. Ann Surg Oncol, 2006. v. 13(10). p. 1269-1270. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>13. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1002/cncr.22125" target="_blank"></a>Hong, David S. ; Abbruzzese, James L. ; Bogaard, Karla ; Lassere, Yvonne ; Fukushima, Masakazu ; Mita, Akira ; Kuwata, Keizo ; <b>Hoff PM</b> . Phase I study to determine the safety and pharmacokinetics of oral administration of TAS-102 in patients with solid tumors. In: 21st NCI-EORTC Symposium on New Drugs in Cancer Therapy, 2006, Amsterdam, Netherlands. Cancer. v. 107(6). p. 1383-1390. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>14. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1097/01.coc.0000214930.78200.4a" target="_blank"></a>Das, Prajnan ; Skibber, John M. ; Rodriguez-Bigas, Miguel A. ; Feig, Barry W. ; Chang, George J. ; <b>Hoff PM</b> ; <b>Hoff, Paulo M.</b> ; Eng, Cathy ; Wolff, Robert A. ; JanJan, Nora A. ; Delclos, Marc E. ; Krishnan, Sunil ; Levy, Lawrence B. ; Ellis, Lee M. ; Crane, Christopher H. . Clinical and Pathologic Predictors of Locoregional Recurrence, Distant Metastasis, and Overall Survival in Patients Treated With Chemoradiation and Mesorectal Excision for Rectal Cancer. In: 41st Annual Meeting of the American Society of Clinical Oncology, 2006, Orlando, FL, USA, May 13-17. Am J Clin Oncol. v. 29(3). p. 219-224. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>15. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1053/j.seminoncol.2005.04.022" target="_blank"></a>VARADHACHARY, G ; <b>Hoff PM</b> ; <b>HOFF, P. M.</b> . Front-Line Therapy for Advanced Colorectal Cancer: Emphasis on Chemotherapy. In: 1sth Annual Gastrointestinal Oncology Conference of the International Society of Gastrointestingl Oncology, 2005, Arlington, VA, USA, Jul 8-10. Semin Oncol (Suppl. 9), 2004. v. 32(6). p. S40-S42. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>16. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1016/j.ijrobp.2004.04.062" target="_blank"></a>BONNEN, M ; CRANE, C ; VAUTHEY, J ; SKIBBER, J ; DELCLOS, M ; RODRIGUEZBIGAS, M ; <b>Hoff PM</b> ; <b>HOFF, P. M.</b> ; LIN, E ; ENG, C ; WONG, A . Long-term results using local excision after preoperative chemoradiation among selected T3 rectal cancer patients. In: 43rd Annual Meeting of the American Society for Therapeutic Radiology and Oncology, 2004, San Francisco, CA, USA Nov 4-8. Int J Radiat Oncol Biol Phys, 2001. v. 60(4). p. 1098-1105. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>17. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1200/JCO.2004.05.072" target="_blank"></a><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>; Pazdur R ; Lassere Y ; Carter S ; Samid D ; Polito D ; Abbruzzese JL . Phase II Study of Capecitabine in Patients With Fluorouracil-Resistant Metastatic Colorectal Carcinoma. In: 36th Annual Meeting of the American Society of Clinical Oncology, 2004, New Orleans, LA USA, May 20-24. J Clin Oncol. v. 22(11). p. 2078-2083. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>18. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1385/IJGC:32:1:35" target="_blank"></a>Saad, Everardo D. ; Machado, Marcel C. ; Wajsbrot, Dalia ; Abramoff, Roberto ; <b>Hoff PM</b> ; <b>Hoff, Paulo M.</b> ; Tabacof, Jacques ; Katz, Artur ; Simon, Sergio D. ; Gansl, René C. . Pretreatment CA 19-9 Level as a Prognostic Factor in Patients with Advanced Pancreatic Cancer Treated with Gemcitabine. In: 37th Annual Meeting of the American Society of Clinical Oncology, 2002, San Francisco CA USA May 12-15. Int J Gastrointest Cancer, 2001. v. 32(1). p. 35-41. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>19. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1002/1097-0142(20010215)91:4<815::AID-CNCR1069>3.0.CO;2-J" target="_blank"></a>Kozuch, Peter ; <b>Hoff PM</b> ; Hess, Kenneth ; Adams, Jennifer ; Newman, Robert A. ; Lee, Francis ; Pazdur, Richard . Phase I bioequivalency study of MitoExtra and mitomycin C in patients with solid tumors. In: 36th Annual Meeting of the American Society of Clinical Oncology, 2001, New Orleans, LA USA, May 20-23. Cancer. v. 91(4). p. 815-821. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>20. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1634/theoncologist.6-suppl_4-1" target="_blank"></a>Van Cutsem, E. ; Cunningham D ; <b>Hoff PM</b> ; <b>HOFF, P. M.</b> ; Maroun J . Thymidine Phosphorylase (TP) Activation: Convenience Through Innovation. In: Meeting of the Symposium on TP Activation: Convenience Through Innovation, 2001, Frankfurt, Germany, Mar 16-17. Oncologist (Suppl. 4), 2001. v. 6. p. 1-2. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>21. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1634/theoncologist.6-2004-3" target="_blank"></a><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>; Cassidy J ; Schmoll HJ . The Evolution of Fluoropyrimidine Therapy: From Intravenous to Oral. In: Meeting of the Symposium on TP Activation: Convenience Through Innovation, 2001, Frankfurt, Germany, Mar 16-17. Oncologist (Suppl. 4), 2001. v. 6. p. 3-11. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>22. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>; Ansari R ; Batista G ; Cox J ; Kocha W ; Kuperminc M ; Maroun J ; Walde D ; Weaver C ; Harrison E ; Burger HU ; Osterwalder B ; Wong A ; Wong R . Comparison of oral capecitabine versus intravenous fluorouracil plus leucovorin as first-line treatment in 605 patients with metastatic colorectal cancer: Results of a randomized phase III study. In: 35th Annual Meeting of the American Society of Clinical Oncology, 2001, Atlanta, GA, USA, May 13-18. J Clin Oncol (Suppl. S). v. 19(8). p. 2282-2292. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>23. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1002/(SICI)1097-0142(20000501)88:9<2054::AID-CNCR11>3.0.CO;2-J" target="_blank"></a><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>; Valero, Vicente ; Buzdar, Aman U. ; Singletary, S. Eva ; Theriault, Richard L. ; Booser, Daniel ; Asmar, Lina ; Frye, Debra ; McNeese, Marsha D. ; Hortobagyi, Gabriel N. . Combined modality treatment of locally advanced breast carcinoma in elderly patients or patients with severe comorbid conditions using tamoxifen as the primary therapy. In: 34th Annual Meeting of the American Society of Clinical Oncology, 2000, Los Angeles CA, USA, May 14-19. Cancer. v. 88(9). p. 2054-2060. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>24. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Royce ME ; Medgyesy D ; Zukowski TH ; Dwivedy S ; <b>Hoff PM</b> ; <b>HOFF, P. M.</b> ; Pazdur R . Colorectal cancer: Chemotherapy treatment overview. In: University of Texas M.D. Anderson Cancer Center Consensus Conference, 2000, Sonoma, CA, USA, Jul 15-18. Oncology-New York (Suppl. 14), 1999. v. 14(12). p. 40-46. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>25. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>; Saad ED ; Janjan N ; Skibber J ; Pazdur R . A phase I study - Preoperative UFT/leucovorin and radiation therapy in rectal cancer. In: Orzel/UFT Investigators Meeting and Consensus Conference, 2000, Vancouver, Canadá, Oct 7-10. Oncology-New York (Suppl. 9), 1999. v. 14(10). p. 56-58. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>26. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><a class="icone-producao icone-doi" href="http://dx.doi.org/10.2165/00003495-199958003-00011" target="_blank"></a><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>; Lassere, Yvonne ; Pazdur, Richard . Tegafur/Uracil + Calcium Folinate in Colorectal Cancer. In: Conference on Oral Chemotherapy - Past, Present and Future Directions, 1999, Cancun, México, Feb 26-28. Drugs, 1998. v. 58. p. 77-83. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>27. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1159/000055262" target="_blank"></a>Brito, Rogelio A. ; Medgyesy, Diana ; Zukowski, Thomas H. ; Royce, Melanie E ; Ravandi-Kashani, Farhad ; <b>Hoff PM</b> ; <b>Hoff, Paulo M.</b> ; Pazdur, Richard . Fluoropyrimidines: A Critical Evaluation. In: Satellite Symposium on Oral Tumoractivated Chemotherapy - A New Effective and Convenient Treatment in Oncology, at the 23rd ESMO Congress, 1999, Athens, Greece, Nov 6. Oncologist (Suppl. 1), 1998. v. 57. p. 2-8. </div>
</div>
<br class="clear">
<div class="cita-artigos">
<b><a name="TrabalhosPublicadosAnaisCongresso"></a>Resumos publicados em anais de congressos</b>
</div>
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>1. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P M</a></b>; Kalil K ; Ferrarotto R ; CONTE, B. ; Overman, Michael . Colorectal high-grade neuroendocrine carcinoma: A single institution experience.. In: ASCO, 2014. Colorectal high-grade neuroendocrine carcinoma: A single institution experience., 2014. v. 32. p. 540. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P M</a></b>; Abdala, Edson ; IBRAHIM, K. Y. ; FREIRE, M. P. ; PIERROTTI, L. C. ; ZERATTI, A. E. . Eficacia da Terapia de Selo Antimicrobiano no tratamento de infecções relacionadas a cateteres de longa permanência em pacientes com câncer.. In: XVIII Congresso Brasileiro de Infectologia, 2013, Fortaleza, CE. Tema Livre, 2013. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>3. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Crosara MAT ; Mak, Milena P. ; Marques DF ; Capareli-Azevedo FC ; <b>Hoff PM</b> ; <b>HOFF, P. M.</b> . Percutaneous transhepatic biliary drainage (PTBD) in patients (pts) with advanced solid malignancies: Clinical outcomes and prognostic factors. In: ASCO Annual Meeting, 2012, Chicago, IL, USA, Jun 1-5. J Clin Oncol (Suppl. S). v. 30. p. 315-315. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>4. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>; Saragiotto DF ; Barrios CH ; <a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/0925776607072404" target="_blank">del Giglio, A.</a> ; Coutinho, Anelisa K. ; Andrade AC ; Dutra C ; Forones N ; Correa M ; Portella MS ; Passos VQ ; Chinen RN ; Van Eyll, B. . A randomized phase III trial exploring the use of long-acting release octreotide in the prevention of chemotherapy-induced diarrhea in patients with colorectal cancer: The LARCID trial. In: ASCO Annual Meeting, 2012, Chicago, IL, USA, Jun 1-5. J Clin Oncol (Suppl. S). v. 30. p. 549-549. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>5. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Overmann MJ ; George B ; Kalil K ; Ferrarotto R ; Garrett CR ; Loyer E ; <b>Hoff PM</b> ; <b>HOFF, P. M.</b> ; Charnsangavej C ; Kopetz S . Use of bevacizumab to reduce the rate of oxaliplatin-induced thrombocytopenia and splenomegaly. In: ASCO Annual Meeting, 2012, Chicago, IL, USA, Jun 1-5. J Clin Oncol (Suppl. S). v. 30. p. 564-564. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>6. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Riechelmann RP ; Alex AK ; <b>Hoff PM</b> ; <b>HOFF, P. M.</b> ; Almeida da Cruz, Livia . Non-Inferiority Cancer Clinical Trials (NIFCT) often rely on large upper boundaries. In: European Multidisciplinary Cancer Congress on Integrating Basic and Translational Science, Surgery, Radiotherapy, Medical Oncology, Advocacy and Care, 2011, Stockholm, Sweden, Sep 23-27. Eur J Cancer. v. 47(1). p. S163-S163. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>7. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Anjos CH ; <a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/4792805111122908" target="_blank">Leal AIC</a> ; Bariani GM ; Souza FH ; <b>Hoff PM</b> ; <b>HOFF, P. M.</b> . Adequacy of prognostic markers reporting based on NCI-EORTC REMARK guideline - a comparison between pre- and post-REMARK eras. In: European Multidisciplinary Cancer Congress on Integrating Basic and Translational Science, Surgery, Radiotherapy, Medical Oncology, Advocacy and Care, 2011, Stockholm, Sweden, Sep 23-27. Eur J Cancer. v. 47(1). p. S166-S166. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>8. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Bariani GM ; Martins RE ; Cecotti HC ; Pierrotti, Lígia C. ; Abdala, Edson ; Rodrigues L ; <a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/9380674942905578" target="_blank">Castro G</a> ; <b>Hoff PM</b> ; <b>HOFF, P. M.</b> . Febrile neutropenic patients admitted for intravenous antibiotics - analysis of 213 episodes in 201 patients with solid tumours. In: European Multidisciplinary Cancer Congress on Integrating Basic and Translational Science, Surgery, Radiotherapy, Medical Oncology, Advocacy and Care, 2011, Stockholm, Sweden, Sep 23-27. Eur J Cancer. v. 47(1). p. S235-S235. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>9. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Martins RE ; Cecotti HC ; Bariani GM ; Pierrotti, Lígia C. ; Abdala, Edson ; Rodrigues L ; <a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/9380674942905578" target="_blank">Castro G</a> ; <b>Hoff PM</b> ; <b>HOFF, P. M.</b> . MASCC score as a predictor of serious complications in febrile neutropenic patients admitted for intravenous antibiotics. In: European Multidisciplinary Cancer Congress on Integrating Basic and Translational Science, Surgery, Radiotherapy, Medical Oncology, Advocacy and Care, 2011, Stockholm, Sweden, Sep 23-27. Eur J Cancer. v. 47(1). p. S236-S236. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>10. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Mak, Milena P. ; Souza FH ; Nebuloni DR ; Saragiotto DF ; <a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/9380674942905578" target="_blank">Castro G</a> ; Sabbaga J ; <b>Hoff PM</b> ; <b>HOFF, P. M.</b> . Cost utility analysis of modified flox as first line chemotherapy for metastatic colorectal cancer. In: European Multidisciplinary Cancer Congress on Integrating Basic and Translational Science, Surgery, Radiotherapy, Medical Oncology, Advocacy and Care, 2011, Stockholm, Sweden, Sep 23-27. Eur J Cancer. v. 47(1). p. S262-S262. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>11. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Takahashi TK ; <a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/4792805111122908" target="_blank">Braghiroli MI</a> ; Souza CE ; <a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/9380674942905578" target="_blank">Castro G</a> ; Saragiotto DF ; Ribeiro SC ; Nadalin W ; Nahas SC ; Nahas C ; <b>Hoff PM</b> ; <b>HOFF, P. M.</b> . Concurrent chemoradiation as definitive treatment in anal squamous cell carcinoma - efficacy and safety in HIV plus patients under HAART. In: European Multidisciplinary Cancer Congress on Integrating Basic and Translational Science, Surgery, Radiotherapy, Medical Oncology, Advocacy and Care, 2011, Stockholm, Sweden, Sep 23-27. Eur J Cancer. v. 47(1). p. S448-S448. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>12. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Ferrarotto R ; Testa L ; Riechelmann RP ; Saad M ; Siqueira LT ; Costa FP ; <b>Hoff PM</b> ; <b>HOFF, P. M.</b> . Combination of Capecitabine and Oxaliplatin (CAPOX) is an effective option for the Treatment of Neuroendocrine Tumours (NET). In: European Multidisciplinary Cancer Congress on Integrating Basic and Translational Science, Surgery, Radiotherapy, Medical Oncology, Advocacy and Care, 2011, Stockholm, Sweden, Sep 23-27. Eur J Cancer. v. 47(1). p. S471-S471. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>13. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Moniz CMV ; Lima ACM ; <a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/4792805111122908" target="_blank">Leal AIC</a> ; Fukushima, Julia T. ; Dzik C ; <b>Hoff PM</b> ; <b>HOFF, P. M.</b> . Sunitinib for RCC in a public brasilian institution: predictive factors of major toxicity. In: European Multidisciplinary Cancer Congress on Integrating Basic and Translational Science, Surgery, Radiotherapy, Medical Oncology, Advocacy and Care, 2011, Stockholm, Sweden, Sep 23-27. Eur J Cancer. v. 47(1). p. S516-S516. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>14. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/9380674942905578" target="_blank">Castro G</a> ; Anjos CH ; Martins RE ; Okita AL ; Gadia R ; Borges A ; Gil E ; <a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/0925776607072404" target="_blank">del Giglio, A.</a> ; <b>Hoff PM</b> ; <b>HOFF, P. M.</b> . Influence of performance status, hemoglobin level, body mass index and presence of feeding tube on treatment outcomes and toxicities in locally advanced head and neck cancer patients treated with induction chemotherapy and chemoradiation. In: European Multidisciplinary Cancer Congress on Integrating Basic and Translational Science, Surgery, Radiotherapy, Medical Oncology, Advocacy and Care, 2011, Stockholm, Sweden, Sep 23-27. Eur J Cancer. v. 47(1). p. S558-S558. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>15. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Ferrari ARD ; <a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/4792805111122908" target="_blank">Braghiroli MI</a> ; Bariani GM ; Munhoz RR ; Pfiffer TE ; <b>Hoff PM</b> ; <b>HOFF, P. M.</b> ; Riechelmann RP . Extrapulmonary poorly differentiated neuroendocrine carcinomas (PDNEC) treated with cisplatin plus irinotecan. In: ESMO 13th World Congress on Gastrointestinal Cancer, 2011, Barcelona, Spain, Jun 22-25. Ann Oncol (Suppl. 5). v. 22. p. v80-v80. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>16. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Barbosa LTCC ; Chaves AC ; <b>Hoff PM</b> ; <b>HOFF, P. M.</b> ; Riechelmann RP . Health-related quality-of-life (HRQoL) reporting by randomized cancer trials (RCT): Pitfalls for interpretation. In: 47th ASCO Annual Meeting, 2011, Chicago, IL, USA, Jun 3-7. J Clin Oncol (Suppl. S). v. 29(15). p. 6102-6102. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>17. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">George B ; Estrella J ; Machado KK ; Ferrarotto R ; <b>Hoff PM</b> ; <b>HOFF, P. M.</b> ; Rashid A ; Kopetz S . High-grade neuroendocrine carcinomas (HGNECs) of the colon and rectum: A single-institution retrospective analysis. In: 47th ASCO Annual Meeting, 2011, Chicago, IL, USA, Jun 3-7. J Clin Oncol (Suppl. S). v. 29(15). p. e14040-e14040. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>18. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Fielding A ; <b>Hoff PM</b> ; <b>HOFF, P. M.</b> ; Pike L ; Wilson D ; Robertson JD . Exploration of the effect of treatment to progression with the VEGF signaling inhibitor cediranib (CED) plus chemotherapy (CT) on the results of the HORIZON (HZ) II trial in first-line metastatic colorectal cancer. In: 47th ASCO Annual Meeting, 2011, Chicago, IL, USA, Jun 3-7. J Clin Oncol (Suppl. S). v. 29(15). p. e14052-e14052. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>19. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Jurgensmeier JM ; <b>Hoff PM</b> ; <b>HOFF, P. M.</b> ; Pike L ; Robertson JD ; Morgan S ; McWalter G ; Wilson D ; Smith JC . Use of KRAS mutation status to predict clinical outcomes in patients with metastatic colorectal cancer (mCRC) treated with the VEGF signaling inhibitor cediranib. In: 47th ASCO Annual Meeting, 2011, Chicago, IL, USA, Jun 3-7. J Clin Oncol (Suppl. S). v. 29(15). p. 3613-3613. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>20. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Wilson D ; <b>Hoff PM</b> ; <b>HOFF, P. M.</b> ; Schmoll HJ ; Robertson JD ; Stone A . Application of adaptive study designs: Phase II and III results from the cediranib (CED) HORIZON (HZ) II and III studies. In: 47th ASCO Annual Meeting, 2011, Chicago, IL, USA, Jun 3-7. J Clin Oncol (Suppl. S). v. 29(15). p. 3633-3633. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>21. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Saad ED ; Marta GN ; Del Nero LG ; Mangabeira A ; Critchi G ; Silva JLF ; <b>Hoff PM</b> ; <b>HOFF, P. M.</b> . Cancer patient (CP), health care professional (HCP), and layperson priorities between survival time (ST) and quality of life (QOL). In: 47th ASCO Annual Meeting, 2011, Chicago, IL, USA, Jun 3-7. J Clin Oncol (Suppl. S). v. 29(15). p. e19524-e19524. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>22. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Ferrarotto R ; Machado KK ; Mak, Milena P. ; Vieira VA ; Takahashi TK ; Saragiotto DF ; Kopetz S ; Overmann MJ ; <b>Hoff PM</b> ; <b>HOFF, P. M.</b> . A multicenter, multinational retrospective analysis of mitomycin C (MMC) in refractory metastatic colorectal cancer (mCRC). In: 47th ASCO Annual Meeting, 2011, Chicago, IL, USA, Jun 3-7. J Clin Oncol (Suppl. S). v. 29(15). p. 3577-3577. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>23. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Schmoll HJ ; <b>Hoff PM</b> ; <b>HOFF, P. M.</b> ; Robertson JD ; Pike L ; Morgan S ; Wilson D ; Jurgensmeier JM . Association of baseline CEA, VEGF, and soluble VEGF receptor-2 with treatment outcomes in two randomized phase III trials of cediranib in metastatic colorectal cancer (mCRC). In: 47th ASCO Annual Meeting, 2011, Chicago, IL, USA, Jun 3-7. J Clin Oncol (Suppl. S). v. 29(15). p. 3590-3590. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>24. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">De Gramont A ; Van Cutsem E ; Tabernero, J. ; Moore MJ ; Cunningham D ; Rivera F ; Im S ; Makrutzki M ; Shang A ; <b>Hoff PM</b> ; <b>HOFF, P. M.</b> . AVANT: Results from a randomized, three-arm multinational phase III study to investigate bevacizumab with either XELOX or FOLFOX4 versus FOLFOX4 alone as adjuvant treatment for colon cancer. In: 47th ASCO Annual Meeting, 2011, Chicago, IL, USA, Jun 3-7. J Clin Oncol (Suppl. S). v. 29(15). p. 362-362. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>25. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Andre T ; Van Cutsem E ; Schmoll HJ ; Tabernero, J. ; Clarke S ; Moore MJ ; Cunningham D ; Cartwright TH ; Hecht JR ; Rivera F ; Im S ; Bodoky G ; Salazar R ; Maindrault-Goebel F ; Shmueli E ; Bajetta E ; Makrutzki M ; Shang A ; De Gramont A ; <b>Hoff PM</b> ; <b>HOFF, P. M.</b> . A multinational, randomized phase III study of bevacizumab (Bev) with FOLFOX4 or XELOX versus FOLFOX4 alone as adjuvant treatment for colon cancer (CC): Subgroup analyses from the AVANT trial. In: 47th ASCO Annual Meeting, 2011, Chicago, IL, USA, Jun 3-7. J Clin Oncol (Suppl. S). v. 29(15). p. 3509-3509. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>26. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">De Gramont A ; Van Cutsem E ; Tabernero, J. ; Moore MJ ; Cunningham D ; Rivera F ; Im S ; Makrutzki M ; Shang A ; <b>Hoff PM</b> ; <b>HOFF, P. M.</b> . Results from a randomized, three-arm multinational phase III study to investigate bevacizumab with either XELOX or FOLFOX4 versus FOLFOX4 alone as adjuvant treatment for colon cancer. In: 47th ASCO Annual Meeting, 2011, Chicago, IL, USA, Jun 3-7. J Clin Oncol (Suppl. S). v. 29(15). p. 362-362. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>27. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Souza FH ; <a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/9380674942905578" target="_blank">Castro G</a> ; Takahashi TK ; Rosa TBC ; <b>Hoff PM</b> ; <b>HOFF, P. M.</b> . Pemetrexed in comparison to gemcitabine as maintenance chemotherapy (MCT) in advanced non-small cell lung cancer (NSCLC): a systematic review and meta-analysis. In: 35th European Society for Medical Oncology (ESMO) Congress, 2010, Milan, Italy, Oct 8-12. Ann Oncol (Suppl.8). v. 21. p. 159-159. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>28. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Takahashi TK ; Souza FH ; Rosa TBC ; <a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/9380674942905578" target="_blank">Castro G</a> ; <b>Hoff PM</b> ; <b>HOFF, P. M.</b> . Maintenance chemotherapy in advanced non-small cell lung cancer: cost utility of pemetrexed and gemcitabine. In: 35th European Society for Medical Oncology (ESMO) Congress, 2010, Milan, Italy, Oct 8-12. Ann Oncol (Suppl.8). v. 21. p. 337-337. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>29. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>; Hochhaus a ; Pestalozzi BC ; Tebbutt NC ; Li J ; Kim TW ; Pike L ; Fielding A ; Robertson JM ; Saunders MP . Cediranib plus folfox/xelox versus placebo plus folfox/xelox in patients (PTS) with previously untreated metastatic colorectal cancer (mcrc): a randomized, double-blind, phase III study (horizon II). In: 35th European Society for Medical Oncology (ESMO) Congress, 2010, Milan, Italy, Oct 8-12. Ann Oncol (Suppl.8). v. 21. p. 9-9. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>30. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Machado KK ; Stelko Pereira GL ; Oliveira CR ; Freitas HC ; <b>Hoff PM</b> ; <b>HOFF, P. M.</b> . Retrospective single institution experience of cisplatin and irinotecan (CPT-11) as first-line therapy in advanced gastric or gastroesophageal adenocarcinoma. In: 12th World Congress on Gastrointestinal Cancer, 2010, Barcelona, Spain, Jun 30-Jul 3. Ann Oncol (Suppl.6). v. 21. p. 119-119. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>31. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Nebuloni DR ; Mak, Milena P. ; Saragiotto DF ; Julio T ; Viana PCC ; <a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/9380674942905578" target="_blank">Castro G</a> ; Sabbaga J ; <b>Hoff PM</b> ; <b>HOFF, P. M.</b> . Modified Flox (MFLOX) with low-dose leucovorin as first-line chemotherapy for Metastatic Colorectal Cancer (MCRC) patients treated within the public health system in Brazil. In: 12th World Congress on Gastrointestinal Cancer, 2010, Barcelona, Spain, Jun 30-Jul 3. Ann Oncol (Suppl.6). v. 21. p. 119-119. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>32. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Machado KK ; Nebuloni DR ; <a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/4792805111122908" target="_blank">Estevez-Diz MD</a> ; Castro Jr. G ; <b>Hoff PM</b> ; <b>HOFF, P. M.</b> . Nonepithelial ovarian cancer: Outcomes after aggressive treatment with surgery and platinum-based chemotherapy. In: 46th ASCO Annual Meeting, 2010, Chicago, IL, USA, Jun 4-8. J Clin Oncol (Suppl. S). v. 28(15). p. e15548-e15548. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>33. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Saad ED ; Katz A ; Pusztai L ; <b>Hoff PM</b> ; <b>HOFF, P. M.</b> ; Buyse M . Do experts agree on how to assess disease progression (DP) and progression-free survival (PFS) in phase III trials? A survey with experts in breast cancer research. In: 46th ASCO Annual Meeting, 2010, Chicago, IL, USA, Jun 4-8. J Clin Oncol (Suppl. S). v. 28(15). p. 1084-1084. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>34. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/4792805111122908" target="_blank">Leal AI</a> ; Barra WF ; Saragiotto DF ; Saad ED ; <b>Hoff PM</b> ; <b>HOFF, P. M.</b> . Publication bias in randomized controlled trials (RCTs) of colorectal cancer presented at ASCO Annual Meetings. In: ASCO Annual Meeting, 2010, Chicago, IL, USA, Jun 4-8. J Clin Oncol (Suppl. S). v. 28(15). p. 6116-6116. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>35. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/4792805111122908" target="_blank">Estevez-Diz MD</a> ; Maistro S ; Escobar KA ; Pasini FS ; Snitcovsky IM ; Brentani M ; <b>Hoff PM</b> ; <b>HOFF, P. M.</b> ; Federico MH . Prevalence of germline BRCA1 and BRCA2 deleterious and of unknown clinical significance (UCS) mutations in positive hormone receptor female breast cancer patients. In: 46th ASCO Annual Meeting, 2010, Chicago, IL, USA, Jun 4-8. J Clin Oncol (Suppl. S). v. 28(15). p. e12006-e12006. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>36. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Feher O ; Formiga N ; Leal A ; Guindalini RSC ; Souza VC ; Gil E ; Rinck JA ; <b>Hoff PM</b> ; <b>HOFF, P. M.</b> . Standard cisplatin and etoposide (PE)-based chemotherapy in young adult patients with pineal germinomas. In: 46th ASCO Annual Meeting, 2010, Chicago, IL, USA, Jun 4-8. J Clin Oncol (Suppl. S). v. 28(15). p. e12547-e12547. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>37. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Calabrich A ; Azevedo FC ; Maluf FC ; Buzaid AC ; Marques RJ ; Schmerling R ; Costa, F. ; <b>Hoff PM</b> ; <b>HOFF, P. M.</b> ; Katz A . The feasibility and real-life effectiveness of the combination of chemotherapy (CT) and bevacizumab (Bev) in the treatment of high-grade gliomas (HGG) in a private community oncology center. In: 46th ASCO Annual Meeting, 2010, Chicago, IL, USA, Jun 4-8. J Clin Oncol (Suppl. S). v. 28(15). p. e12552-e12552. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>38. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Schmerling R ; Maluf FC ; <b>Hoff PM</b> ; <b>HOFF, P. M.</b> ; Costa, F. ; Buzaid AC . Trabectedin in advanced, pretreated soft tissue sarcoma: The Hospital Sirio-Libanes experience in a compassionate use program. In: 46th ASCO Annual Meeting, 2010, Chicago, IL, USA, Jun 4-8. J Clin Oncol (Suppl. S). v. 28(15). p. e20511-e20511. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>39. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Politano S ; Pathak P ; <b>Hoff PM</b> ; Charnsangavej C ; Overmann MJ ; Loyer E ; Vauthey J ; Wallace MJ ; Wolff RA ; Kopetz S . The use of 5-fluorouracil and oxaliplatin (FOLFOX) for colorectal cancer is associated with the development. In: 44th ASCO Annual Meeting, 2008, Chicago, IL, USA, May 30-Jun 3. J Clin Oncol (Suppl. S). v. 26(15). p. 4102-4102. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>40. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Souza CE ; Castro Jr G ; Saragiotto DF ; Nadalin W ; Kiss DR ; Nahas C ; Siqueira SA ; <b>Hoff PM</b> . Comparison of tolerability and efficacy of concurrent chemoradiation (CRT) for anal squamous cell carcinoma (SCC) in HIV-positive (HIV+) and negative (HIV-) patients (pts.). In: 44th ASCO Annual Meeting, 2008, Chicago, IL, USA May 30-June 3. J Clin Oncol (Suppl. S). v. 26(15). p. 4606-4606. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>41. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Pinheiro CA ; Masson AS ; Borghesi G ; Prisco F ; Rotea W ; <b>Hoff PM</b> ; Saad ED . Characterizing cancer research in Brazil through bibliometric analysis of abstracts from the ASCO meeting 2001-2005. In: 44th ASCO Annual Meeting, 2008, Chicago, LI, USA, May 30-Jun 3. J Clin Oncol (Suppl. S). v. 26(15). p. 17561-17561. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>42. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Diz MD ; Carelli G ; <b>Hoff PM</b> . Identifying best support care patients in an outpatient medical oncology unity: difficulties presented by training medical oncologists. In: 44th ASCO Annual Meeting, 2008, Chicago, IL, USA May 30-June 3. J Clin Oncol (Suppl. S). v. 26(15). p. 20613-20613. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>43. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Kopetz S ; Glover KY ; Eng C ; Wolff RA ; Chang DZ ; Adinin RB ; Morris J ; Abbruzzese JL ; <b>Hoff PM</b> . Phase II study of infucional 5-fluorouracil, leucovorin, and irinotecan (folfiri) plus bevacizumab as first-line treatment for metastatic colorectal cancer. In: 43th Annual Meeting - American Society of Clinical Oncology, 2007, Chicago, IL, USA, Jun 20. J Clin Oncol (Suppl. S). v. 25(18). p. 4089-4089. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>44. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Palhares AC ; Costa FP ; Belfer AJ ; Belfer AJ ; Jokh SH ; <b>Hoff PM</b> ; <b>HOFF, P. M.</b> ; Buzaid AC ; Maluf FC ; Marques RJ ; Dzik C ; Lopes LF . Lack of concordance between i-111 pentreotide(PEN) status and immuno-histochemistry (IHC) status for somatostatin receptors type 1,2 and 3 in neuroendocrine tumors (NET). In: 43th Annual Meeting - American Society of Clinical Oncology, 2007, Chicago, IL, USA, Jun. J Clin Oncol (Suppl. S). v. 25(18). p. 15060-15060. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>45. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Wolff RA ; <b>Hoff PM</b> ; Mita A ; Fukushima M ; Blais JC ; Abbruzzese JL ; Xiong HQ . A phase I trial of TAS-102 administered on a three times a day schedule in patients with solid tumors. In: 42nd ASCO Annual Meeting, 2006, Atlanta, GA, USA, Jun 2-6. J Clin Oncol (Suppl. S - Parte 1), 2006. v. 24(18). p. 92S-92S. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>46. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Haller DG ; Cassidy J ; Clarke S ; Cunningham D ; Van Cutsem E ; <b>Hoff PM</b> ; Rothenberg M ; Saltz L ; Schmoll HJ ; Twelves C . Tolerability of fluoropyrimidines appears to differ by region. In: ASCO Annual Meeting, 2006, Atlanta, GA, USA, Jun 2-6. J Clin Oncol (Suppl. S). v. 24(18). p. 3514-3514. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>47. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Kopetz S ; Abbruzzese JL ; Eng C ; Adinin RB ; Morris J ; Wolff RA ; Lin E ; Chang DZ ; <b>Hoff PM</b> ; Bogaard K . Preliminary results from a phase II study of infusional 5-FU, leucovorin, and irinotecan (FOLFIRI) plus bevacizumab as first-line treatment for metastatic colorectal cancer(mCRC). In: ASCO Annual Meeting, 2006, Atlanta, GA, USA, Jun 2-6. J Clin Oncol (Suppl. S). v. 24(18). p. 3579-3579. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>48. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Claret L ; Girard P ; O shaughnessy J ; <b>Hoff PM</b> ; Van Cutsem E ; Blum J ; Zuideveld K ; Jorga K ; Fagerberg J ; Bruno R . Model-based predicitions of expected anti-tumor response and survival in phase III studies based on phase II data of an investigational agent. In: 2006 ASCO Annual Meeting, 2006, Atlanta, GA, USA, June 2-6. J Clin Oncol (Suppl. S). v. 24(18). p. 6025-6025. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>49. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>; <a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/4792805111122908" target="_blank">Hoff AO</a> ; Phan AT ; Sherman SI ; Yao J ; White N ; Phan L ; Abbruzzese JL ; Gagel RF . Phase I/II trial of capecitabine(C), dacarbazine(D) and imatinib(I) (CDI) for patients(pts) metastatic medullary thyroid carcinomas(MTC). In: 42nd ASCO Annual Meeting, 2006, Atlanta, GA, USA, Jun 2-6. J Clin Oncol (Suppl. S). v. 24(18). p. 13048-13048. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>50. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Mizumoto N ; Akaishi E ; Teixeira F ; Katayama M ; Costa FP ; <b>Hoff PM</b> ; Buzaid AC . General anaesthesia combined with continuous peridural anaesthesia for peritonectomy procedures provide early extubation. In: 5th International Workshop on Peritoneal Surface Malignancy, 2006, Milan, Italy, Dec 4-6. Abstracts of the 5th International Workshop on Peritoneal Surface Malignancy. p. 75-75. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>51. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Whitehead RP ; Mccoy S ; Wollner IS ; Wong L ; Harker G ; <b>Hoff PM</b> ; <b>HOFF, P. M.</b> ; Gold PJ ; Billingsley KG ; Blanke CD . Phase II trial of depsipeptide (NSC-630176) in colorectal cancer patients who have received either one or two prior chemotherapy regimens for metastatic or locally advanced, unresectable disease: a southwest oncology group study. In: 42nd ASCO Annual Meeting, 2006, Atlanta, GA, USA, Jun 2-6. J Clin Oncol (Suppl. S). v. 24(18). p. 170S-170S. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>52. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Saltz LB ; Lenz H ; Hochster H ; Wadler S ; <b>Hoff PM</b> ; Kemeny N ; Hollywood E ; Gonen M ; Wetherbee S ; Chen H . Rancomized phase II trial of Cetuximab/Bevacizumab/Irinotecan(CBI) versus Cetuximab/Bevacizumab (CB) in Irinotecan-Refractory Colorectal. In: 41nd ASCO Annual Meeting, 2005, Orlando, FL, USA, May 13-17. J Clin Oncol (Suppl. S). v. 23(16). p. 3508-3508. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>53. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Das P ; Skibber JM ; Rodriguez-Bigas MA ; Feig B ; <b>Hoff PM</b> ; Eng C ; Janjan NA ; Krishnan S ; Ellis LM ; Crane CH . Clinical and pathhologic predictors of locoregional recurrence, distant metastasis and overall survival in patients treated with chemoradiation and mesorectal excision for locally advanced rectal cancer. In: 41nd ASCO Annual Meeting, 2005, Orlando, FL, USA, May 13-17. J Clin Oncol (Suppl. S - Parte 1). v. 23(16). p. 270S-270S. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>54. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Lin EH ; Skibber J ; Delcos M ; Eng C ; Christopher T ; Brown T ; Vadhan S ; <b>Hoff PM</b> ; Rodriguez-Bigas M ; Janjan NA . A phase II study of capecitabine and concomitant boost radiotherapy(XRT) in patients(pts) with locally advanced rectal cancer(LARC). In: 41nd ASCO Annual Meeting, 2005, Orlando, FL, USA, May 13-17. J Clin Oncol (Suppl. S). v. 23(16). p. 3593-3593. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>55. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Rhee J ; Lee F ; Saif MW ; Ardalan B ; Wolff R ; Eng C ; Bogaard K ; Cheverton P ; Kimura M ; Danna M ; <b>Hoff PM</b> . Phase II trial of DJ-927 as a second-line treatment for colorectal cancer demonstrates objective responses. In: 41nd ASCO Annual Meeting, 2005, Orlando, FL, USA, May 13-17. J Clin Oncol (Suppl. S - Parte 1). v. 23(16). p. 284S-284S. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>56. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Yao JC ; Eng C ; <b>Hoff PM</b> ; Phan TA ; Hess K ; Chen H ; Wang X ; Abbruzzese JL ; Ajani JA . Improved progression free survival(PFS) and rapid, sustained decrease in tumor perfusion among patients with advanced carcinoid treated with bevacizumab. In: 41nd ASCO Annual Meeting, 2005, Orlando, FL, USA, May 13-17. J Clin Oncol (Suppl. S - Parte 1). v. 23(16). p. 309S-309S. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>57. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Thomas MB ; Worah S ; Mathew SV ; Charnsangavej C ; Chen H ; Ajani JA ; <b>Hoff PM</b> ; Phan AT ; Yao JC . A phase II open-label study of OSI-774(NSC 718781) in unresectable hepatocellular carcinoma. In: 41nd ASCO Annual Meeting, 2005, Orlando, FL, USA, May 13-17. J Clin Oncol (Suppl. S - Parte 1). v. 23(16). p. 317S-317S. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>58. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Mares JE ; Worah S ; Mathew SV ; Charnsangavej C ; Chen H ; Ajani JA ; <b>Hoff PM</b> ; Phan AT . Increased rates of hypertension(HTN) among patients with advanced carcinoid treated with bevacizumab. In: 41nd ASCO Annual Meeting, 2005, Orlando, FL, USA, May 13-17. J Clin Oncol (Suppl. S - Parte 1). v. 23(16). p. 329S-329S. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>59. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Glover KY ; Thomas MB ; Brown TD ; <b>Hoff PM</b> ; Iwasaki M ; Abbruzzese JL . A phase study of oxaliplatin and capecitabine(XELOX) in patients with unresectable cholangiocarcinoma, including carcinoma of the galibladder and biliary tract. In: 41nd ASCO Annual Meeting, 2005, Orlando, FL, USA, May 13-17. J Clin Oncol (Suppl. S - Parte 1). v. 23(16). p. 338S-338S. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>60. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Varadhachary CR ; Blais JC ; Raber MN ; Lenzi R ; <b>Hoff PM</b> ; Abbruzzese JL . Phase II study of evaluate the efficacy and toxicity of oxaliplatin in combination with gemcitabine(GEMOX) in cancer of unknown primary(CUP). In: 41nd ASCO Annual Meeting, 2005, Orlando, FL, USA, May 13-17. J Clin Oncol (Suppl. S - Parte 1). v. 23(16). p. 342S-342S. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>61. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Eng C ; Crane CH ; Rosner GL ; Rodriguez-Bigas MA ; Skibber JM ; Bogaard K ; Delclos ME ; Lassere Y ; <b>Hoff PM</b> ; Abbruzzese JL . A phase II study of capecitabine plus oxaliplatin and radiation therapy, Xelox-Xrt in squamous cell carcinoma(Scca) of the anal canal. In: 41nd ASCO Annual Meeting, 2005, Orlando, FL, USA, May 13-17. J Clin Oncol (Suppl. S - Parte 1). v. 23(16). p. 375S-375S. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>62. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1016/j.ijrobp.2005.07.283" target="_blank"></a>DAS, P ; LIN, E ; BHATIA, S ; SKIBBER, J ; RODRIGUEZBIGAS, M ; FEIG, B ; <b>Hoff PM</b> ; ENG, C ; WOLFF, R ; KRISHNAN, S . Neoadjuvant Chemoradiation with Capecitabine Versus Infusional 5-fluorouracil (5-FU) for Locally Advanced Rectal Cancer: A Matched Pair Analysis. In: 47th Annual Meeting of the American Society for Therapeutic Radiology and Oncology, 2005, Denver, CO, USA, Oct 16-20. Int J Radiat Oncol Biol Phys. v. 63(2). p. S164-S164. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>63. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Yao JC ; Charnsangavej C ; Faria SC ; Szklaruk J ; Chen H ; <b>Hoff PM</b> ; Phan A ; Yeung S ; Abbruzzese JL ; Ajani JA . Rapid decrease in blood flow(BF), blood volume(BV), and vascular permeability(PS) in carcinoid patients treated with bevacizumab. In: ASCO Annual Meeting, 2004, New Orleans,LA,USA, Jun 5-8. J Clin Oncol (Suppl. S). v. 22(14). p. 3013-3013. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>64. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Smaletz O ; Katz A ; Simon SD ; Gansl RC ; <b>Hoff PM</b> ; Tabacof J ; Pietrocola M ; Cardoso H . ZD 1839 for patients with advanced no-small cell lung cancer(NSCLC) treated on expanded access(EA) and compassionate use(CU) protocols at a single institution in Brazil. In: ASCO Annual Meeting, 2003, Chicago, IL, USA, May 31-Jun 3. Proceedings American Society of Clinical Oncology. p. 2751-2751. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>65. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Hou Z ; Elasmar SA ; Lozano R ; <b>Hoff PM</b> ; Wolff RA ; Abbruzzese JL ; Ajani JA ; Carr K ; Rashid A ; Yao JC . A pilot study of irinotecan plus cisplatin in patients with metastatic hig-grade neuroendocrine carcinoma. In: ASCO Annual Meeting, 2003, Chicago, IL, USA, May 31-Jun 3. Proceedings of the American Society of Clinical Oncology. p. 1508-1508. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>66. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Katz A ; <b>Hoff PM</b> ; Simon SD ; Gansl RC ; Tabacof J ; Abramoff R ; Pietrocola M ; Smaletz O ; Novis YA . Irinotecan(CPT-11) qne cisplatin(CDDP) in heavily pre-treated metastatic breast cancer(MBC) patients(pts). In: ASCO Annual Meeting, 2003, Chicago, IL, USA, May 31-Jun 3. Proceedings of the American Society of Clinical Oncology. p. 335-335. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>67. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Katz A ; Smaletz O ; Simon SD ; Gansl, Rene C. ; <b>Hoff PM</b> ; <b>HOFF, P. M.</b> ; Tabacof J . Gefitinib ('Iressa', ZD1839) for patients with advanced non-small-cell lung cancer treated in the 'Iressa' Expanded Access Programme at a single institution in Brazil. In: Iressa Clinical Experience (ICE) Meeting, 2003, Madrid, Spain, Jun. Br J Cancer (Suppl. 2). v. 89. p. S29-S29. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>68. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Boku N ; Ohtsu A ; <b>Hoff PM</b> ; Abbruzzese JL . Comparison of pharmacokinetics, pharmacodynamics between American and Japanese patients of metastatic colorectal cancer treated with UFT/Leucovorin: joint USA/Japan study of LFT/LV. In: ASCO Annual Meeting, 2002, Orlando, FL, USA, May 18-21. J Clin Oncol (Suppl. S). v. 21. p. 330-330. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>69. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Thomas MB ; Wolff RA ; <b>Hoff PM</b> ; Lassere Y ; Bogaard K ; Jones DV ; Abbruzzese JL . Phase II trial of oxaliplatin(eloxatin) and CPT-11 administered once every three weeks to patients with metastatic colorectal cancer. In: ASCO Annual Meeting, 2002, Orlando, FL, USA, May 18-21. J Clin Oncol (Suppl. S). v. 21. p. 631-631. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>70. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>; Aguayo A ; Bogaard K ; Lassere Y ; Abbruzzese JL . Phase I trial of oxaliplatin and CPT-11 administered once every three weeks to patients with metastatic colorectal cancer (MCC). In: ASCO Annual Meeting, 2001, San Francisco, USA, May 12?15. J Clin Oncol (Suppl. S). v. 20. p. 543-543. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>71. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Thomas MB ; Langleben A ; Rinald D ; Lowell A ; Irwin D ; Lassere Y ; <b>Hoff PM</b> . A phase II study of UFT + leucovorin given as a twice-daily (BID) regimen in the treatment of patients (pts) with metastatic colorectal cancer (MCC). In: ASCO Annual Meeting, 2001, San Francisco, CA, May 18-25. J Clin Oncol (Suppl. S). v. 20. p. 564-564. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>72. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Wolff RA ; Wilding G ; Carter J ; Abbruzzese JL ; Thomas J ; Bailey H ; Mekki Q ; <b>Hoff PM</b> . Phase I study of FK317 in patients with refractory solid tumors. In: ASCO Annual Meeting, 2001, San Francisco, USA, May 12?15. J Clin Oncol (Suppl. S). v. 20. p. 377-377. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>73. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Dwivedy S ; <b>Hoff PM</b> ; Dumas P ; Lassere Y ; Aguayo A ; Hayakawa T ; Abbruzzese JL . Safety and pharmacokinetics (PK) of an antitumor/antiangiogenic agent. In: ASCO Annual Meeting, 2001, San Francisco, USA, May 12?15. J Clin Oncol (Suppl. S). v. 20. p. 386-386. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>74. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Crane CH ; Thames H ; Phan T ; Skibber J ; Venier J ; Wong A ; Brown T ; <b>Hoff PM</b> ; Abbruzzese JL ; Curley S ; Feig B ; Ellis L ; Wolff R ; Janjan N . 5-FU based adjuvant chemotherapy given after neoadjuvant chemoradiation and surgery for rectal cancer improves survival only among responders (downstaged patients). In: ASCO American Society of Clinical Oncology, 2001, San Francisco, USA, May 12?15. J Clin Oncol (Suppl. S). v. 20. p. 588-588. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>75. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Phan T ; Crane C ; Mendoza T ; Vadhan S ; Brown T ; <b>Hoff PM</b> ; Wolff RA ; Abbruzzese J ; Curley S ; Feib B ; Ellis L ; Skibber J ; Wong A ; Cleeland C ; Janjan N . Low hemoglobin levels after preoperative chemoradiation for locally advanced rectal cancer are associated with a worse survival. In: ASCO Annual Meeting, 2001, San Francisco, USA, May 12?15. J Clin Oncol (Suppl. S). v. 20. p. 596-596. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>76. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">O'Reilly EM ; <b>Hoff PM</b> ; Mani S ; Schwartz GK ; Aird S ; Sharma S ; Hazelwood B ; Kelvin J ; De Jager R ; Kelson D . A phase I study of DX-8951f(exatecan mesylate, DX) and gemcitabine (Gem) in advanced solid tumors. In: ASCO Annual Meeting, 2001, San Francisco, USA, May 12?15. J Clin Oncol (Suppl. S). v. 20. p. 412-412. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>77. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Saad ED ; Machado MC ; Wajsbrot D ; Abramoff R ; <b>Hoff PM</b> ; Tabacof J ; Katz A ; Simon SD ; Gansl RC . CA 19.9 como fator prognóstico em pacientes com câncer de pâncreas tratados com gemcitabina. In: 12º Congresso Brasileiro de Oncologia Clínica, 2001, Albufeira, Portugal, 11-15 Nov. Abstracts of the12º Congresso Brasileiro de Oncologia Clínica. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>78. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>; Loeher P ; Abbruzzese JL ; Ohtsu A ; Hyodo I ; Shirao K . Joint United States of America(USA)/Japan study of UFT(uracil and tegafur) plus leucovorin(LV) in patients(pts) with metastatic colorectal cancer(CRC). In: European Cancer Conference (ECCO 11), 2001, Lisbon, Portugal, Oct 21-25. Eur J Cancer (Suppl.). v. 37. p. 1136-1136. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>79. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Crane C ; Janjan N ; Abbruzzese J ; Curley S ; Dubrow R ; Sawaf H ; Brown T ; Rich T ; <b>Hoff PM</b> ; Cleary K ; Ellis L ; Skibber J . Effective pelvic symptom control using initial chemoradiation in patients presenting with rectal cancer and synchronous metastases. In: ASCO Annual Meeting, 2000, New Orleans, LA, USA May 20-23. J Clin Oncol (Suppl. S). v. 19. p. 250a-250a. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>80. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Zukowski T ; Madden TL ; <b>Hoff PM</b> ; Newman RA ; Ravandi F ; Medgyesy D ; Carter S ; Brito R ; Berghorn E ; Hausheer F ; Pazdur R . Phase I and pharmacokinetic trial of the antifolate methylene-10-deazaaminopterin in patients with advanced solid tumors. In: ASCO Annual Meeting, 2000, New Orleans, LA, USA May 20-23. J Clin Oncol (Suppl. S). v. 19. p. 195a-195a. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>81. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Kozuch P ; <b>Hoff PM</b> ; Hess K ; Newman RA ; Lee FH ; Adams J ; Lassere Y ; Pazdur R . Phase I bioequivalancy study of mitoextra and mitomycin C in cancer patients with solid tumors. In: ASCO Annual Meeting, 2000, New Orleans, LA, USA May 20-23. J Clin Oncol (Suppl. S). v. 19. p. 203a-203a. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>82. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>; Abbruzzese JL ; Medgyesy D ; Thomas M ; Carter S . A phase II study of Xeloda(capecitabine) in patients with metastatic colorectal cancer demonstrating progression on 5-FU therapy. In: ASCO Annual Meeting, 2000, New Orleans, LA USA, May 20-23. J Clin Oncol (Suppl. S). v. 19. p. 256a-256a. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>83. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Royce M ; Saltz L ; Rowinsky EK ; <b>Hoff PM</b> ; Geyer C ; Dumas P ; Lassere Y ; Coyle J ; De Jager R ; Pazdur R . A phase II study of intravenous exatecan mesylate(DX-8951f,DX) administered daily for five days every three weeks to patients with advanced or metastatic adenocarcinoma of the colon or rectum. In: ASCO Annual Meeting, 2000, New Orleans, LA, USA May 20-23. J Clin Oncol (Suppl. S). v. 19. p. 289a-289a. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>84. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Aguayo A ; Kraut EH ; Moore DF ; <b>Hoff PM</b> ; Wright JJ ; Jones D ; Winn R ; Pazdur R . Phase I study of dolastatin 10 administered intravenously every 21 days to patients with metastatic colorectal cancer. In: ASCO Annual Meeting, 2000, New Orleans, LA, USA May 20-23. J Clin Oncol (Suppl. S). v. 19. p. 288a-288a. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>85. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Abushullaih S ; Saad ED ; <b>Hoff PM</b> . Characterizing hand-foot syndrome caused by capecitabine. In: ASCO Annual Meeting, 2000, Hamburg, Germany, Oct 13-17. J Clin Oncol (Suppl. S). v. 19. p. 610a-610a. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>86. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Callister M ; Janjan N ; Brown T ; <b>Hoff PM</b> ; Wolff R ; Sinicrope F ; Skibber J ; Feir B ; Ellis L ; Hunt K ; Curley S ; Bisanz A ; Evetts P ; Allen P . Effective managements of treatment-related enteritis during preoperative chemoradiation for locally advanced rectal cancer. In: International Jorunal Radio Oncology, 2000, Lugano, Switzerland, Mar 5?8. International Jorunal Radio Oncology. v. 48(3). p. 225-225. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>87. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Crane C ; Sanfilippo N ; Taylor N ; Skibber J ; Feig B ; Vauthey N ; Hunt K ; Ellis L ; Curley S ; Dubrow R ; Cleary K ; Hamilton S ; Allen P ; Wolff R ; <b>Hoff PM</b> . Comparison of patterns of failure between T3 and T4 rectal cancer after preoperative chemoradiation. In: International Journal Radio Oncology, 2000, Lugano, Switzerland, Mar 5?8. International Journal Radio Oncology, 2000. v. 48(3). p. 304-304. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>88. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>. Capecitabine as first-line treatment for colorectal cancer (CRC): integrated results of 1207 patients(pts) from 2 randomized phase III studies. In: ESMO - European Society of Medical Oncology, 2000, Hamburg, Germany, Oct 13-17. Annal Oncol (Suppl. 4). v. 11. p. 263-263. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>89. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>; Bogaard K ; Lassere Y ; Aguayo A ; Hayakawa T ; Abbruzzese JL . Phase I safety and pharmacokinetic study of oral TAS-102 once daily for fourteen days in patients with solid tumors. In: 11th NCI--EORTC Symposium on New Drugs in Cancer Therapy, 2000, Amsterdam Netherland Jun 16-19. Metal-Based Drugs. v. 4(6). p. 433a-433a. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>90. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Zukowski T ; Carter S ; <b>Hoff PM</b> ; Royce M ; Medgyesy D ; Brito R ; Ravandi F ; Janjan N ; Skibber J ; Benner S ; Pazdur R . Phase I and pharmacokinetic (PK) trial of the antifolate methylene-10-deazaaminopterin(MDAM) in patients with advanced solid tumors. In: ASCO Annual Meeting, 1999, Atlanta, GA, USA, May 15-18. J Clin Oncol (Suppl. S). v. 18. p. 897a-897a. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>91. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Brito R ; Lassere Y ; <b>Hoff PM</b> ; Royce M ; Ranvandi F ; Zukowski T ; Janjan N ; Skibber J ; Benner S ; Pazdur R . Schedule effect on maximum tolerated dose of orzel (UFT plus leucovorin). In: ASCO Annual Meeting, 1999, Atlanta, GA, USA, May 15-18. J Clin Oncol (Suppl. S). v. 18. p. 787a-787a. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>92. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Ravandi F ; Wenski C ; Royce M ; <b>Hoff PM</b> ; Brito R ; Zukowski T ; Mekki Q ; Pazdur R . Phase I trial of FK317, a novel acitnomycete product, in patients with advanced solid tumors. In: ASCO Annual Meeting, 1999, Atlanta, GA, USA, May 15-18. J Clin Oncol (Suppl. S). v. 18. p. 867a-867a. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>93. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Royce M ; Lassere Y ; <b>Hoff PM</b> ; Brito R ; Ravandi F ; Medgyesy D ; Zukowski T ; Coyle J ; De Jager R ; Pazdur R . DX-8951F:Phase I and pharmacokinetic study of a novel camptothecin analogue administered by 24-hour continuous infusion to patients with advanced solid tumors. In: ASCO Annual Meeting, 1999, Atlanta, GA, USA, May 15-18. J Clin Oncol (Suppl. S). v. 18. p. 682a-282a. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>94. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>; Wenske CA ; Medgyesy D ; Royce M ; Brito R ; Zukowski T ; Ravandi F ; Kuritani J ; Pazdur R . Phase I and pharmacokinetic (PK) study of the novel oral fluoropyrimidine, S-1. In: ASCO Annual Meeting, 1999, Atlanta, GA, USA, May 15-18. Proceedings American Society of Clinical Oncology. v. 18. p. 682a-682a. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>95. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>; Janjan N ; Crane C ; Skibber J ; Bonner S ; Ellis L ; Curley S ; Feig BW ; Vauthey J-N ; Dubrow R ; Cleary K ; Pazdur R . Results of preoperative radiation and UFT an oral fluorinated pyrimidine, plus leucovorin in locally advanced rectal cancer - a pilot study. In: ASCO Annual Meeting, 1999, Atlanta, GA, USA, May 15-18. J Clin Oncol (Suppl. S). v. 45. p. 175-175. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>96. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Janjan NA ; Crane CH ; Feig BW ; Cleary K ; Dubrow R ; Curley S ; Ellis LM ; Vauthey N ; Lenzi R ; Lynch P ; Wolff R ; Brown T ; Pazdur R ; Abbruzzese J ; <b>Hoff PM</b> . Prospective trial of preoperative concomitant boost radiotherapy with continuos infusion 5-fluorouracil for locally advanced rectal cancer. In: ASCO Annual Meeting, 1999, Atlanta, GA, USA, May 15-18. J Clin Oncol (Suppl. S). v. 45. p. 177-177. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>97. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Brown T ; Janjan NA ; Feig BW ; Cleary K ; Dubrow R ; Curley S ; Vauthey N ; Lynch P ; Ellis LM ; Wolff R ; Lenzi R ; Abbruzzese J ; Pazdur R ; <b>Hoff PM</b> . Improved overall survival among responders to preoperative chemoradiation for locally advanced rectal cancer. In: ASCO Annual Meeting, 1999, Atlanta, GA, USA, May 15-18. J Clin Oncol (Suppl. S). v. 45. p. 339-339. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>98. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Kozuch P ; Ibrahim N ; Khuri F ; <b>Hoff PM</b> ; Estey E ; Gandhi V ; Du M ; Rios MB ; Plunkett W ; Keating MJ ; Kantarjian H . Phase I clinical and phamacological study of clofarabine. In: American Society of Hematology, 1999, New Orleans, LA, USA Dec 3-7. Abstracts of the American Society of Hematology. v. 94. p. 127a-127a. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>99. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>; Brito R ; Slaughter M ; Matei C ; Lassere Y ; Janjan N ; Skibber J ; Randolph J ; Benner S ; Pazdur R . Preoperative UFT, oral leucovorin and radiotherapy for patients with resectable rectal carcinoma: an oral regimen with complete pathological responses. In: ASCO (American Society of Clinical Oncology) Annual Meeting, 1998, Los Angeles, CA USA, May 17-19. J Clin Oncol (Suppl. S). v. 17. p. 223a-223a. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>100. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Valero V ; <b>Hoff PM</b> ; Singletary SE ; Buzdar AU ; Theriault RL ; Strom E ; Booser DJ ; Asmar L ; Frye D ; McNeese MD ; Hortobagyi GN . Combined modality treatment of locally advanced breast cancer in elderly patients using tamoxifen as primary therapy. In: ASCO 1998 - American Society of Clinical Oncology 34th Annual Meeting, 1998, Los Angeles, CA USA, May 17-19. J Clin Oncol (Suppl. S). v. 17. p. 105a-105a. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>101. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Royce M ; <b>Hoff PM</b> ; Brito R ; Matei C ; Slaughter M ; Medgyesy D ; Lassere Y ; Lee JJ ; Coyle J ; De Jager RL ; Pazdur R . Phase I trial of DX-8951f, a novel camptothecin analogue, administered by a 24-hour continuos infusion. In: ASCO Annual Meeting, 1998, Los Angeles, CA USA, May 17-19. J Clin Oncol (Suppl. S). v. 17. p. 197a-197a. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>102. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Slaughter M ; Pazdur R ; <b>Hoff PM</b> ; Matei C ; Brito R ; Dumas P ; Yanowitz C ; Vernillet L ; Wertz D ; Lebecq A ; Besenval M . Phase I study of RPR 1098881A, a novel taxoid derivative, administered by a 24-hour continuos infusion. In: ASCO Annual Meeting, 1998, Los Angeles, CA USA, May 17-19. J Clin Oncol (Suppl. S). v. 17. p. 194a-194a. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>103. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Matei C ; <b>Hoff PM</b> ; Brito R ; Slaughter M ; Griego C ; Pazdur R ; Nemunaitis J ; Hanham A ; Callahan J . Phase I trial of oral BOF-42 plus leucovorin in advanced colorectal cancer: antitumor activity in fluorouracil-resistant patients. In: ASCO Annual Meeting, 1998, Los Angeles, CA USA, May 17-19. J Clin Oncol (Suppl. S). v. 17. p. 194a-194a. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>104. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Medgyesy D ; Pazdur R ; Dakhil S ; Moore D ; <b>Hoff PM</b> ; Brito R ; Matei C ; Winn R ; Abbruzzese J . Phase II trial of 5-day continuous infusion of 9-amino camptothecin (9-AC) in advanced colorectal carcinomas. In: ASCO Annual Meeting, 1998, Los Angeles, CA USA, May 17-19. J Clin Oncol (Suppl. S). v. 17. p. 296a-296a. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>105. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>; Brito R ; Slaughter M ; Matei C ; Lassere Y ; Janjan N ; Skibber J ; Randolph J ; Benner S ; Pazdur R . UFT, oral leucovorin (LV) and radiotherapy (RT) for patients (PTS) with resectable rectal carcinoma: an effective oral preoperative regimen. In: 10th NCI-EORTC Symposium on New Drugs in Cancer Therapy, 1998, Amsterdam Netherland Jun 16-19. Metal-Based Drugs. v. 4(6). p. 595a-595a. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>106. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Pazdur R ; <b>Hoff PM</b> ; Slaughter M ; Matei C ; Brito R ; Royce M ; Medgyesy D ; Lassere Y . Clinical development of UFT plus leucovorin. In: 8th International Congress on Anti-Cancer Treatment, 1998, Paris, France, February. Abstracts of the 8th International Congress on Anti-Cancer Treatment. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>107. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>; Lassere Y ; Royce M ; Matei C ; Slaughter M ; Medgyesy D ; Lee J ; Coyle J ; De Jager RL ; Pazdur R . Phase I study of the new camptothecin analogue DX-8951f administered by 24-hour continuos infusion. In: 10th NCI-EORTC Symposium on New Drugs in Cancer Therapy, 1998, Amsterdam Netherland Jun 16-19. Metal-Based Drugs. v. 65. p. 246a-246a. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>108. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Medgyesy D ; Dakhil S ; Moore D ; Scalzo D ; <b>Hoff PM</b> ; Abbruzzese J ; Winn R ; Pazdur R . A phase I trial fo a 5-day continuos infusion of 9-aminocamptothecin (9-AC) weekly for 3 weeks in patients with advanced colorectal carcinomas. In: 10th NCI-EORTC Symposium on New Drugs in Cancer Therapy, 1998, Amsterdam Netherland Jun 16-19. Metal-Based Drugs. v. 4(6). p. 254a-254a. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>109. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Slaughter M ; Dumas P ; <b>Hoff PM</b> ; Yanowitz C ; Semiond D ; Wertz D ; LeMouhaer S ; Besenval M ; Pazdur R . Clinical and pharmacokinetic study of RPR 109881A(RPR): a phase I trial of a novel taxoid derivative administered as a 24-hour continuos infusion. In: 10th NCI-EORTC Symposium on New Drugs in Cancer Therapy, 1998, Amsterdam Netherland Jun 16-19. Metal-Based Drugs. v. 4(6). p. 381a-381a. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>110. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Matei C ; Nemunaitis J ; Griego C ; <b>Hoff PM</b> ; Hanham A ; Callahan J ; Pazdur R . Phase I trial of BOF-A2 (emitefur) plus leucovorin (LV) in patients with advanced colorectal cancer (CRC). In: 10th NCI-EORTC Symposium on New Drugs in Cancer Therapy, 1998, Amsterdam Netherland Jun 16-19. Metal-Based Drugs. v. 4(6). p. 639a-639a. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>111. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Geyer C ; Nemunaitis J ; <b>Hoff PM</b> ; Griego C ; Hanham A ; Callahan J ; Pazdur R . Phase I trial of BOF-A2 (emitefur): a novel fluorinated pyrimidine. In: 10th NCI-EORTC Symposium on New Drugs in Cancer Therapy, 1998, Amsterdam Netherland Jun 16-19. Metal-Based Drugs. v. 4(6). p. 640a-640a. </div>
</div>
<br class="clear">
<div class="cita-artigos">
<b><a name="ApresentacoesTrabalho"></a>Apresentações de Trabalho</b>
</div>
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>1. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, PM</a></b>; Braghiroli, Maria Ignez . Câncer de Cólon - Tratamento Adjuvante. 2018. (Apresentação de Trabalho/Conferência ou palestra). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P.M.</a></b>. Situação do Câncer no Brasil e no Mundo. 2018. (Apresentação de Trabalho/Outra). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>3. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P.M.</a></b>. Situação do Câncer no Brasil.. 2018. (Apresentação de Trabalho/Conferência ou palestra). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>4. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P.M.</a></b>. Authorship e Conflitos de Interesse.. 2017. (Apresentação de Trabalho/Conferência ou palestra). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>5. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P M</a></b>. Inovações no tratamento Oncológico.. 2016. (Apresentação de Trabalho/Conferência ou palestra). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>6. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P M</a></b>. Aula Intramuros Endocrinologia - Avanços do Tratamento de Tumores Neuroendócrinos. 2015. (Apresentação de Trabalho/Outra). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>7. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P M</a></b>. 'Desenvolvimento de novas drogas oncológicas'. 2015. (Apresentação de Trabalho/Conferência ou palestra). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>8. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, PM</a></b>. Conceitos Básicos e História da Pesquisa Clínica. 2015. (Apresentação de Trabalho/Outra). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>9. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>. Desafios do Tratamento do Câncer no SUS: Experiência de São Paulo?.. 2014. (Apresentação de Trabalho/Conferência ou palestra). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>10. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>; WAGATSUMA, V. M. D. . Terapia alvo aplicada para câncer colorretal. 2014. (Apresentação de Trabalho/Conferência ou palestra). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>11. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>; OSORIO, P. S. . Conferência Desafios do tratamento do câncer no Brasil e no sistema do SUS. 2014. (Apresentação de Trabalho/Conferência ou palestra). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>12. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>. Presidente da ?Sessão geral 7: multidisciplinary case review for stage IV colon and rectal cancer (ARS).. 2014. (Apresentação de Trabalho/Conferência ou palestra). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>13. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P M</a></b>. Oncologia e o SUS. 2014. (Apresentação de Trabalho/Conferência ou palestra). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>14. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P.M.</a></b>; RIECHELMANN, RACHEL P. . Authorship e Conflitos de Interesse. 2014. (Apresentação de Trabalho/Conferência ou palestra). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>15. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P.M.</a></b>; ANDREOLI, J. C. . Tratamento oncológico do CCR?. 2013. (Apresentação de Trabalho/Conferência ou palestra). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>16. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P.M.</a></b>. Determinação legal de iniciar tratamento oncologico específico com 60 dias do diagnóstico de câncer ?Gargalos e soluções institucionais - Módulo de Políticas Públicas. 2013. (Apresentação de Trabalho/Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>17. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P.M.</a></b>. Módulo Gastrointestinal, Coordenador. 2013. (Apresentação de Trabalho/Outra). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>18. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P M</a></b>. Overview of Cancer in Brazil. 2013. (Apresentação de Trabalho/Conferência ou palestra). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>19. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>; Debatedor. 2012. (Apresentação de Trabalho/Outra). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>20. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P. M.</a></b>. Tratamento da metástase hepática do câncer colorretal. 2012. (Apresentação de Trabalho/Conferência ou palestra). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>21. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P. M.</a></b>. Tratamento oncológico hoje e perspectivas futuras. 2012. (Apresentação de Trabalho/Conferência ou palestra). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>22. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PMG</a></b>. Câncer gástrico, debatedor do Caso Clínico. 2012. (Apresentação de Trabalho/Outra). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>23. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PMG</a></b>. Resposta completa após quimioterapia e radioterapia neoadjuvante nos tumores de esôfago: há necessidade de cirurgia?. 2012. (Apresentação de Trabalho/Outra). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>24. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PMG</a></b>. Quimioterapia de conversão para cirurgia. 2012. (Apresentação de Trabalho/Conferência ou palestra). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>25. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PMG</a></b>. Tratamento adjuvante na mesa redonda: Tratamento multimodal - impacto na sobrevivência. 2012. (Apresentação de Trabalho/Conferência ou palestra). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>26. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>. Câncer. 2012. (Apresentação de Trabalho/Outra). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>27. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PMG</a></b>. Câncer gástrico avançado: o que virá após o HER-2? - Palestra na Sessão Gastro Intestinal. 2012. (Apresentação de Trabalho/Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>28. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PMG</a></b>. Discussão de Casos Clínicos - Debatedor na Sessão Gastro Intestinal. 2012. (Apresentação de Trabalho/Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>29. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PMG</a></b>. Palestrante - Câncer. 2012. (Apresentação de Trabalho/Simpósio). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>30. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PMG</a></b>. O Lidar com a Indicação de Medicamentos Excepcionais na Oncologia Clínica em Pacientes do SUS. 2012. (Apresentação de Trabalho/Outra). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>31. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P M</a></b>. Assistência Oncológica: parâmetros e limites.. 2012. (Apresentação de Trabalho/Conferência ou palestra). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>32. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PMG</a></b>. Neoadjuvância no câncer gástrico. 2012. (Apresentação de Trabalho/Conferência ou palestra). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>33. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P M</a></b>. Target Therapies em Tumores de Cabeça e Pescoço. 2011. (Apresentação de Trabalho/Conferência ou palestra). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>34. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P M</a></b>. Audiência Pública, Orador.. 2011. (Apresentação de Trabalho/Outra). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>35. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>; Clarke S ; Cunningham, D ; Van Cutsem, E ; M, M. ; Schmoll HJ ; Tabernero, J. ; Mueller B ; De Gramont A . A three-arm phase III randomized trial of FOLFOX-4 vs. FOLFOX-4 plus bevacizumab vs. XELOX plus bevacizumab in the adjuvant treatment of patients with stage III or high-risk stage II colon cancer: results of the interim safety analysis of the AVANT Trial. 2009. (Apresentação de Trabalho/Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>36. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P.M.</a></b>. Curso de Introdutório à Liga de Oncologia. 2009. (Apresentação de Trabalho/Outra). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>37. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P.M.</a></b>. Aula 'Angiogênese' - Curso Anual de Oncologia Clinica. 2009. (Apresentação de Trabalho/Outra). </div>
</div>
<br class="clear">
<div class="cita-artigos">
<b><a name="OutrasProducoesBibliograficas"></a>Outras produções bibliográficas</b>
</div>
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>1. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P M</a></b>; DIZ, M. E. ; TESTA, L. . Manual de Condutas em Oncologia, 3ª edição..
							Rio de Janeiro, 2018. (Prefácio, Pósfacio/Prefácio)>. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P M</a></b>; <a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/9234342804994191" target="_blank">PEREIRA, J.</a> ; TESTA, L. ; DIZ, M. E. ; MAK, M. P. . Manual de condutas em Oncologia - Instituto do Câncer do Estado de São Paulo - Octavio Frias de Oliveira.
							RJ, 2013. (Prefácio, Pósfacio/Apresentação)>. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>3. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P M</a></b>; CERRI, G. G. ; CHAMONE, D. A. F. . Manual de condutas em Oncologia - Instituto do Câncer do Estado de São Paulo - Octavio Frias de Oliveira.
							RJ, 2010. (Prefácio, Pósfacio/Apresentação)>. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>4. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Katz A ; <b>Hoff PM</b> ; Younes RN ; Delgado GL . Terapia dirigida contra alvo molecular em oncologia. Câncer Hoje,
							 2004 (artigo). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>5. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>; Pazdur R . Progress in the development of novel treatments for colorectal cancer. Oncology,
							 2004 (artigo). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>6. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>. The current and future role of chemotherapy in colorectal cancer. Publishing Health System Journals Inc.,
							 2000 (artigo). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>7. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>. Upper gastrointestinal tumors: chemotherapy coming of age ?. Medscape Hematology & Oncology,
							 2000 (artigo). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>8. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>. New directions in anticancer chemotherapy: an update on current research at M.D. Anderson Cancer Center. Progress Reports on Colorectal Cancer,
							 1999 (artigo). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>9. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>. Perspectivas no tratamento do câncer de pâncreas. Revista da Sociedade Brasileira de Oncologia Clínica,
							 1999 (artigo). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>10. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Chase JL ; <b>Hoff PM</b> ; Pazdur R . Management of colorectal cancer.
							San Diego:
									GenQuest Biomedical Educational Services,  1998 (Artigo). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>11. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>; Pazdur R . Oral chemotherapy. Churchill-Livingston,
							 1998 (Artigo). </div>
</div>
<br class="clear">
<a name="ProducaoTecnica"></a><br class="clear" /><div class="inst_back">
<b>Produção técnica</b>
</div>
<div class="cita-artigos">
<b><a name="AssessoriaConsultoria"></a>Assessoria e consultoria</b>
</div>
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>1. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>. Presidir CCVISA, assessoramento ANVISA.. 2018. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">
		<img src="images/curriculo/ico_relevante.gif" style='icone-relevancia' />
		<b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P M</a></b>. Reuniões de Planejamento Estratégico - Conselho ASCO.. 2017. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>3. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>. Reuniões de Planejamento Estratégico - Conselho ASCO.. 2016. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>4. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">
		<img src="images/curriculo/ico_relevante.gif" style='icone-relevancia' />
		<b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P M</a></b>. Reunião de Planejamento Estratégico - ASCO. 2015. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>5. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">
		<img src="images/curriculo/ico_relevante.gif" style='icone-relevancia' />
		<b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P M</a></b>. MEmbro do Comitê de Auditoria - Conselho ASCO. 2015. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>6. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, PM</a></b>. Presidir CCVISA, assessoramento ANVISA.. 2015. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>7. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P M</a></b>. Audiência Pública, Senado Federal. 2015. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>8. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, PM</a></b>. Comitê Gestor da Rede Nacional de Pesquisa em Câncer. 2014. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>9. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, PM</a></b>. Reunião CCVISA, assessoramento ANVISA.. 2014. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>10. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, PM</a></b>. Audiência Pública, Orador.. 2014. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>11. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">
		<img src="images/curriculo/ico_relevante.gif" style='icone-relevancia' />
		<b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, PM</a></b>; BARBANO, D. ; FERREIRA, C. G. M. ; BUCARETCHI, F. ; WANNMACHER, L. ; ALECRIM, M. G. C. ; TEIXEIRA, M. M. ; ZATZ, M. . Presidente do Comissão Cientifica em Vigilância Sanitária - CCVISA. 2013. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>12. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">
		<img src="images/curriculo/ico_relevante.gif" style='icone-relevancia' />
		<b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P M</a></b>. Reunião Comitê Estratégico ASCO. 2012. </div>
</div>
<br class="clear">
<div class="cita-artigos">
<b><a name="TrabalhosTecnicos"></a>Trabalhos técnicos</b>
</div>
<div class="cita-artigos">
<b><a name="EntrevistasMesasRedondas"></a>Entrevistas, mesas redondas, programas e comentários na mídia</b>
</div>
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>1. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P.M.</a></b>. Entrevista Jornal Nacional. 2019. 
						
							(Programa de rádio ou TV/Entrevista).
						</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P.M.</a></b>. Entrevista - Programa GloboNews. 2018. 
						</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>3. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P.M.</a></b>. Carreira e trajetória na Oncologia - SBT. 2018. 
						</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>4. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P M</a></b>. ICESP 10 anos. 2018. 
						
							(Programa de rádio ou TV/Entrevista).
						</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>5. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, PM</a></b>. Judicialização na saúde.. 2018. 
						
							(Programa de rádio ou TV/Entrevista).
						</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>6. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>. Novidades Quimioterpia e Radioterapia. 2018. 
						
							(Programa de rádio ou TV/Entrevista).
						</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>7. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P.M.</a></b>. Entrevista Domingão do Faustão. 2018. 
						
							(Programa de rádio ou TV/Entrevista).
						</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>8. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P M</a></b>. Avança o tratamento do câncer gástrico no Brasil. 2018. 
						
							(Programa de rádio ou TV/Entrevista).
						</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>9. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P M</a></b>; CHAMMAS, R. . Raio-X da Saúde: como prevenir e tratar o câncer. 2018. 
						</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>10. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, PM</a></b>. Oncologia - Carreira.. 2017. 
						
							(Programa de rádio ou TV/Entrevista).
						</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>11. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P.M.</a></b>. Impacto financeiro dos novos tratamentos do câncer. 2017. 
						
							(Programa de rádio ou TV/Entrevista).
						</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>12. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Hoff, P. M. ; <b>Hoff PM</b> . É preciso discutir quanto custa prolongar a sobrevida.. 2017. 
						
							(Programa de rádio ou TV/Entrevista).
						</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>13. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P M</a></b>. Programa Bem Estar da Rede Globo. 2017. 
						</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>14. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P.M.</a></b>. Revista Veja. 2017. 
						
							(Programa de rádio ou TV/Entrevista).
						</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>15. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>. Estudos oncológicos. 2017. 
						
							(Programa de rádio ou TV/Entrevista).
						</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>16. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>. Dieta Ideal. 2016. 
						
							(Programa de rádio ou TV/Entrevista).
						</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>17. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P M</a></b>. Fosfoetanolamina- Eficâcia no Combate ao Câncer. 2016. 
						
							(Programa de rádio ou TV/Entrevista).
						</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>18. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P M</a></b>. Prevenção do Câncer. 2016. 
						
							(Programa de rádio ou TV/Entrevista).
						</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>19. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P M</a></b>. Câncer. 2016. 
						
							(Programa de rádio ou TV/Entrevista).
						</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>20. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P M</a></b>. Medicina de precisão em câncer: a personalização do tratamento.. 2016. 
						
							(Programa de rádio ou TV/Entrevista).
						</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>21. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>. Reportagem 'Fosfoetalonamina sintética'.. 2016. 
						
							(Programa de rádio ou TV/Entrevista).
						</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>22. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P.M.</a></b>. 'Rastreamento de câncer'. 2016. 
						
							(Programa de rádio ou TV/Entrevista).
						</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>23. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P.M.</a></b>. Pesquisa Clínica e novos medicamentos.. 2016. 
						
							(Programa de rádio ou TV/Entrevista).
						</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>24. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P M</a></b>. Fosfoetanolamina. 2016. 
						
							(Programa de rádio ou TV/Entrevista).
						</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>25. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P M</a></b>. Fosfoetanolamina. 2016. 
						
							(Programa de rádio ou TV/Entrevista).
						</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>26. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P M</a></b>. ICESP RUN. 2016. 
						
							(Programa de rádio ou TV/Entrevista).
						</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>27. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P M</a></b>. Câncer. 2016. 
						
							(Programa de rádio ou TV/Entrevista).
						</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>28. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P M</a></b>. Fosfoetanolamina. 2016. 
						
							(Programa de rádio ou TV/Entrevista).
						</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>29. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P M</a></b>. SÉRIE IDEAL PRA VOCÊ :: FANTÁSTICO. 2016. 
						</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>30. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P M</a></b>. ICESP RUN. 2016. 
						
							(Programa de rádio ou TV/Entrevista).
						</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>31. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>; GARICOCHEA, B. . Nova arma contra o câncer. 2016. 
						
							(Programa de rádio ou TV/Entrevista).
						</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>32. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P.M.</a></b>. Pílula do câncer. 2016. 
						
							(Programa de rádio ou TV/Entrevista).
						</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>33. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P.M.</a></b>. Estudo anti-PD1, novo remédio imunoterápico.. 2015. 
						
							(Programa de rádio ou TV/Entrevista).
						</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>34. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P M</a></b>. Caso Oliver Sacks reforça divisão entre médicos sobre morte por câncer. 2015. 
						
							(Programa de rádio ou TV/Entrevista).
						<img class="icone-video" src="http://estatico.cnpq.br/imagens/ico_pw_video.png" onclick="mostrarPreviaVideo('www1.folha.uol.com.br')"></img></div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>35. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P M</a></b>. ?Radiação e Câncer' Programa Bem Estar, Globo. 2015. 
						</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>36. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P M</a></b>. Câncer no Brasil e, em especial, em São Paulo - SBT Brasil. 2015. 
						</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>37. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P M</a></b>. Evolução no tratamento, diagnóstico, pesquisas e medicações e problemas relativos que o país enfrenta.. 2015. 
						
							(Programa de rádio ou TV/Entrevista).
						</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>38. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, PM</a></b>. Câncer Anal. 2015. 
						
							(Programa de rádio ou TV/Entrevista).
						</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>39. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P M</a></b>. Avanços e desafios para o tratamento oncológico na rede pública.. 2015. 
						
							(Programa de rádio ou TV/Entrevista).
						</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>40. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P M</a></b>. Entrevista s/ câncer.. 2015. 
						</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>41. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P M</a></b>. Programa Marilia Gabriela. Entrevista.Imunoterapia; Cardio-Oncologia; Prevenção do câncer; Atendimento Câncer pelo SUS;. 2015. 
						</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>42. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, PM</a></b>. 'O futuro da droga milagrosa' da USP. 2015. 
						
							(Programa de rádio ou TV/Entrevista).
						</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>43. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P.M.</a></b>; BENTO, J. . Participação da edição especial do Programa Bem Estar - Rede Globo. 2014. 
						</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>44. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P M</a></b>. Roda de Conversa com o Diretor. 2014. 
						
							(Programa de rádio ou TV/Mesa redonda).
						</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>45. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P.M.</a></b>. Hospital da Criança de Brasilia 'Parceria da Unidade do Distrito Federal com Brasilia'.. 2014. 
						
							(Programa de rádio ou TV/Entrevista).
						</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>46. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P.M.</a></b>. Centros de Excelência do serviço público - ICESP/HC.. 2014. 
						
							(Programa de rádio ou TV/Entrevista).
						</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>47. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, PM</a></b>. Revista Super Interessante 'Nutrição e Prevenção do Câncer'.. 2014. 
						
							(Programa de rádio ou TV/Entrevista).
						</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>48. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, PM</a></b>; MALUF, F. . Programa Joven Pan. 2014. 
						
							(Programa de rádio ou TV/Entrevista).
						</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>49. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P.M.</a></b>. Tratamentos Alternativos aos Tradicionais e tratamentos individualizados/personalizados.. 2014. 
						
							(Programa de rádio ou TV/Entrevista).
						</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>50. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P.M.</a></b>. Cardio-Oncologia. 2014. 
						
							(Programa de rádio ou TV/Entrevista).
						</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>51. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P.M.</a></b>. 'A Saúde dos Planos de Saúde'. 2014. 
						
							(Programa de rádio ou TV/Comentário).
						</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>52. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, PM</a></b>. Apertando o cerco ao tabagismo. 2014. 
						
							(Programa de rádio ou TV/Entrevista).
						</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>53. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P.M.</a></b>. Globo. 2013. 
						
							(Programa de rádio ou TV/Entrevista).
						</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>54. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P.M.</a></b>. Na luta contra o câncer. 2013. 
						
							(Programa de rádio ou TV/Entrevista).
						</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>55. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P M</a></b>; BUZAID, A. C. . Programa Mais Você - Ana Maria Braga.. 2013. 
						<img class="icone-video" src="http://estatico.cnpq.br/imagens/ico_pw_video.png" onclick="mostrarPreviaVideo('http/mais.uol.com.br')"></img></div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>56. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P.M.</a></b>. Sentir bem.. 2012. 
						
							(Programa de rádio ou TV/Entrevista).
						<img class="icone-video" src="http://estatico.cnpq.br/imagens/ico_pw_video.png" onclick="mostrarPreviaVideo('http:/sentirbem.uol.com.br/index.php')"></img></div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>57. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, PM</a></b>. Uma nova cultura para a saúde. 2012. 
						
							(Programa de rádio ou TV/Entrevista).
						</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>58. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P M</a></b>. Como Superar o Câncer. 2012. 
						
							(Programa de rádio ou TV/Entrevista).
						</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>59. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P M</a></b>. Programa Joven Pan on line. 2011. 
						</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>60. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, PM</a></b>. Câncer e qualidade de vida. 2010. 
						
							(Programa de rádio ou TV/Entrevista).
						</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>61. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, PM</a></b>. Câncer não é palavrão. 2010. 
						
							(Programa de rádio ou TV/Entrevista).
						</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>62. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, PM</a></b>. Dose diária de aspirina previne câncer. 2010. 
						
							(Programa de rádio ou TV/Entrevista).
						</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>63. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P.M.</a></b>. Representatividade das mulheres em pesquisa clinica.. 2009. 
						
							(Programa de rádio ou TV/Entrevista).
						</div>
</div>
<br class="clear">
<div class="cita-artigos">
<b><a name="RedesSociais"></a>Redes sociais, websites e blogs</b>
</div>
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>1. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P.M.</a></b>. Video Redes Sociais. 2017; Tema:
							Câncer - Mitos, Novidades, Principais dúvidas de prevenção, tratamento e pesquisas sobre Oncologia.. (Rede social). </div>
</div>
<br class="clear">
<a name="DemaisProducaoTecnica"></a><br class="clear" /><div class="inst_back">
<b>Demais tipos de produção técnica</b>
</div>
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>1. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>; MONIZ, C. M. V. . Fundamentos da Pesquisa Clinica.. 2018. . </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P M</a></b>; RIECHELMANN, R. P. . Fundamentos da Pesquisa Clinica.. 2014. . </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>3. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>; Curso de Aperfeiçoamento em Cuidados Paliativos. 2012. . </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>4. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P M</a></b>; CHAMMAS, R. ; RIECHELMANN, R. P. . Fundamentos da Pesquisa Clínica. 2011. . </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>5. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P M</a></b>. Curso Incor in Job para Jornalistas. 2010. . </div>
</div>
<br class="clear">
</div><br class="clear" /></div><br class="clear" /><div class="title-wrapper">
<a name="Bancas">
<h1>Bancas</h1>
</a>
<hr class="separator">
<div class="layout-cell layout-cell-12 data-cell">
<a name="ParticipacaoBancasTrabalho"></a><br class="clear" /><div class="inst_back">
<b>Participação em bancas de trabalhos de conclusão</b>
</div>
<div class="cita-artigos">
<b>Mestrado</b>
</div>
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>1. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>; MANO, M. S.; GEBRIN, L. H..  Participação em banca de Elias Abdo Filho. Utilização de recursos para tratamento do câncer de mama avançado de pacientes pós menopáusicas com receptores hormonais positivos no cenário do SUS. 2013. Dissertação (Mestrado em Programa de Pós-Graduação em Oncologia) - Faculdade de Medicina da USP. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">MELO, C. M.; <b>HOFF, P. M.</b>; <b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>.  Participação em banca de Camila Morais Melo. Validação de marcadores moleculares associados à recidiva loco-regional em tumores de cabeça e pescoço. 2010. Dissertação (Mestrado em Ciências) - Fundação Antônio Prudente. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>3. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">De Campos FGC; Lopes A; <b>HOFF, P. M.</b>; <b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>; Montagnini AL; Herman P; Nahas SC.  Participação em banca de Maria Celia Calijuri Hamra. Câncer colorretal localmente avançado: resultados do tratamento cirúrgico e fatores prognósticos. 2009. Dissertação (Mestrado em Cirurgia do aparelho digestivo) - Faculdade de Medicina da Universidade de São Paulo. </div>
</div>
<br class="clear">
<div class="cita-artigos">
<b>Teses de doutorado</b>
</div>
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>1. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">JACOB FILHO, W.; CURIATI, J. A. E.; HAMERSCHLAK, N.; <b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>; RIECHELMANN, R. P..  Participação em banca de Theodora Karnakis. "O uso longitudinal da avaliação geriátrica ampla em um centro oncológico no Brasil: estudo piloto em portadores de câncer de mama".. 2015. Tese (Doutorado em Pós Graduação, Doutorado)  - Faculdade de Medicina da USP. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>; PERES, O.; PERIA, F. M.; REIS, R. B.; COY, C. S. R..  Participação em banca de Thaís Inácio de Carvalho. Análise da expressão dos genes EGFR e KRAS, microRNA-21 e micro RNA-203 em pacientes com câncer de cólon e reto e a correlação com a evolução clínica e com os fatores prognósticos.. 2013. Tese (Doutorado em Pós-Graduação, área cirúrgica.)  - Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>3. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Riechelmann RP; <b>HOFF, P. M.</b>; <b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>.  Participação em banca de Rachel Simões Pimenta Riechelmann. Risco de interações medicamentosas em pacientes com câncer e recebendo cuidados de suporte exclusivo. 2010 - Universidade Federal de São Paulo. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>4. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Baptista AM; Camargo OP; Lopes A; Oliveira CR; Etchebehere M; <b>HOFF, P. M.</b>; <b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>.  Participação em banca de André Mathias Baptista. Estudo da correlação entre a expressão do VEGF e a sobrevida no osteosarcoma. 2010. Tese (Doutorado em Pós-Graduação Ortopedia e Traumatologia)  - Faculdade de Medicina da Universidade de São Paulo. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>5. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Lopes A; Alves VA; Pinto CE; Belfort FA; <b>HOFF, P. M.</b>; <b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>; Rasslan S; Ferraz AR; De Mello EL; Ferreira FO; Chammas R.  Participação em banca de Claudio de Almeida Quadros. Linfonodectomia retroperitoneal e pélvica lateral guiada por tadiotraçador e azul patente no estadiamento do adenocarcinoma do reto. 2009. Tese (Doutorado em Clínica cirúrgica)  - Faculdade de Medicina da Universidade de São Paulo. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>6. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">PIMENTA, C. A. M.; Cunha, F.C.; Jacobsen, M.; Kimura, M; <b>HOFF, P. M.</b>; <b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>.  Participação em banca de Karine A São Leão Ferreira. Relações entre citocinas pró-inflamatórias, dor e qualidade de vida em pacientes com câncer. 2008. Tese (Doutorado em Enfermagem)  - Universidade de São Paulo. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>7. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Zago, M.M.F.; Kurita, GP; Cruaz, D.A.L.M.; Rossi, B.M.; Gutiérrez, M.G.R.; Meneazes, M.F.B.; Secoli. S.R.; <b>HOFF, P. M.</b>; <b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>.  Participação em banca de Dalete Delalibera Corrêa de Faria Mota. Fadiga no doente com câncer colo-retal: fatores de risco e preditivos. 2008. Tese (Doutorado em Enfermagem)  - Universidade de São Paulo. </div>
</div>
<br class="clear"><br class="clear" /><a name="ParticipacaoBancasComissoes"></a><br class="clear" /><div class="inst_back">
<b>Participação em bancas de comissões julgadoras</b>
</div>
<div class="cita-artigos">
<b>Professor titular</b>
</div>
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>1. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">KALIL FILHO, J. E.; <b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>; GIGLIO, A.; LEDERMAN, H. M.; MARCHIORI, E. S.. Professor Titular do Departamento de Radiologia e Oncologia - Área Medicina Nuclear. 2014. Faculdade de Medicina da USP. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>; <b>HOFF, P. M.</b>. Professor Titular, junto ao Departamento de Clínica Médica - Área de Oncologia Clínica. 2009. Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo. </div>
</div>
<br class="clear">
<div class="cita-artigos">
<b>Concurso público</b>
</div>
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>1. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Cury PM; Strauss BE; Villa LL; <b>HOFF, P. M.</b>; <b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>. Professor Doutor, junto ao Departamento de Radiologia e Oncologia.
							2010. Faculdade de Medicina da Universidade de São Paulo. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>. Professor Doutor, junto ao Departamento de Radiologia e Oncologia.
							2010. </div>
</div>
<br class="clear">
<div class="cita-artigos">
<b>Livre docência</b>
</div>
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>1. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>; BUCHPIGUEL, C. A.; KOWALSKI, L. P.; Rossi, B.M.; ZANATTA, L. A.. Professor Doutor, junto ao Departamento de Radiologia e Oncologia.
						2013. Faculdade de Medicina da USP. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Vicente Odone Filho; <b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>; CARNEIRO-SAMPAIO, M. M. S.; CERRI, G. G.; VIANNA, M. B.; ZAGO, M. A.; ZA, C. A. S.. Professor Doutor, junto ao Departamento de Pediatria.
						2013. Faculdade de Medicina da USP. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>3. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>; ANDREOLLO, N. A.; LOPES FILHO, G. J.; LOPES, A.. Cirurgia citorredutora e quimioterapia intraperitoneal hipertérmica: fatores preditivos de complicações pós-operatórias e análise de sobrevida..
						2012. Faculdade de Medicina da USP. </div>
</div>
<br class="clear">
<div class="cita-artigos">
<b>Outras participações</b>
</div>
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>1. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b>HOFF, P.M.</b>; PETRILLI, A. S.; CARVALHEIRA, J. B. C.. Professor Contratado.
							2018.
							Faculdade de Medicina da Universidade de São Paulo. </div>
</div>
<br class="clear">
</div><br class="clear" /></div><br class="clear" /><div class="title-wrapper">
<a name="Eventos">
<h1>Eventos</h1>
</a>
<hr class="separator">
<div class="layout-cell layout-cell-12 data-cell">
<div class="layout-cell layout-cell-12 data-cell">
<a name="ParticipacaoEventos"></a><br class="clear" /><div class="inst_back">
<b>Participação em eventos, congressos, exposições e feiras</b>
</div>
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>1. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Comitê de Saúde Amcham.?Terapias individualizadas e seu impacto no sistema de saúde?.. 2019. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Fórum Saúde: Um Novo Olhar para a Saúde do Homem.."O tratamento do câncer de próstata no SUS e na saúde suplementar: como diminuir as desigualdades?",. 2019. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>3. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">III International Symposium on Hepato Pancreatic Biliary Surgey.Speaker in the Module Oncology 1..
							2019. (Simpósio). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>4. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">X Simpósio de Oncologia Clínica e Cirúrgica do Aparelho Digestivo - Gastrão 2019. Câncer de Cólon e Reto.. 2019. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>5. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">4º Seminário da Folha sobre câncer..Tecnologia Contra o Câncer?,. 2018. (Seminário). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>6. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">ASCO - Annual Meeting 2018 - Fellow of the American Society of Clinical Oncology -. Homenagem - Reconhecimento serviços prestados c/ dedicação, compromisso com a ASCO, em prol da especialidade de Oncologia, e indiividuos em risco ou com câncer. - FASCO -. 2018. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>7. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Consenso de Câncer Colorretal GTG.Bloco Tratamento Sistêmico na Doença Metastática Irressecável. 2018. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>8. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Doctalks.Revolucionando a Oncologia, a partir do Brasil.. 2018. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>9. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">FEHOSUL - Federação dos Hospitais do Rio Grande do Sul.. "A TERAPÊUTICA DO FUTURO".. 2018. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>10. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">I Congresso Brasileiro Médico Acadêmico | IX Congresso Nordestino Médico Acadêmico | XXV Congresso Médico Acadêmico do Piauí. Palestra de encerramento do Congresso.. 2018. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>11. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">II Diretriz de Carcinoma Hepatocelular - 2º Congresso Paulista de Fígado SBH e IV Fórum de Jovens.. Terapia sistêmica: Existe evidência para quimioterapia convencional ? - Mesa V: Tratamento do CHC BCLC C. 2018. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>12. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">IX Simpósio Internacional de Oncologia Clínica e Cirúrgica dp Aparelho Digestivo - Gastrão. Papel do Oncologista no tratamento curativo do câncer gástrico.. 2018. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>13. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">IX Simpósio Internacional de Oncologia Clínica e Cirúrgica dp Aparelho Digestivo - Gastrão. Imunoterapia nos tumores gastrointestinais.. 2018. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>14. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Simpósio Câncer do Colon e Reto (CCR).Tratamento do CCR avançado.
							2018. (Simpósio). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>15. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Simpósio Câncer do Colon e Reto (CCR).Apresentação e Introdução.
							2018. (Simpósio). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>16. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Simpósio de Cólon e Reto - ANM.Abertura e Aula s/ Tratamento do CCR avançado.
							2018. (Simpósio). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>17. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">V Simposio Internacional de Câncer Gastrointestinal Oncologia D'Or.Chair Módulo 3 - Miscelânia.
							2018. (Simpósio). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>18. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">V Simposio Internacional de Câncer Gastrointestinal Oncologia D'Or.Tratamento do Câncer Metastático de Colon.
							2018. (Simpósio). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>19. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">XVII SBAD - Semana Brasileira do Aparelho Digestivo (SBAD 2018) e Semana Pan-americana de Enfermidades Digestivas (SPED 2018.Diagnóstico e acompanhamento pós-terapêutica.. 2018. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>20. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">XX Curso Introdutório a Liga de Oncologia FMUSP.Situação do Câncer no Brasil e no Mundo.. 2018. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>21. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">2º Simpósio Internacional do Grupo de Tumores Gastrointestinais.CCR metastático.
							2017. (Simpósio). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>22. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">44o. Curso de Atualização em Cirurgia do Aparelho Digestivo e e Coloproctologia - Gastrão 2017. Neoajduvância em câncer gástrico. 2017. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>23. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Abertura do Intersections III.Abertura do Evento..
							2017. (Simpósio). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>24. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">COMU 2017 - Congresso Médico Universitário. Presidente de Honra dos Prêmios Cientificos - COMU 2017. 2017. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>25. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Evento de lançamento do Centro Tecnologico da Libbs Farmacêutica.Lançamento ldo Centro Tecnologico da Libbs Farmacêutica. 2017. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>26. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Fórum Nacional Oncoguia 2017..Participação na Abertura do Evento, IEP, HSL. 2017. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>27. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Internacional Meeting in Oncology Research in Celebration of 80 years of the INCA..The challenges of Oncology in the 21st century..
							2017. (Simpósio). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>28. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">International Medicine Institute - University of Miami Health Sustem. Speaker. 2017. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>29. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Intersections III - Debatedor.Debatedor da Seção Multidisciplinar - Gastrintestinal - Módulo III - Câncer Cólon.
							2017. (Simpósio). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>30. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Intersections III - palestrante.Palestrante no Módulo III Câncer de Cólon - palestra: CCR - quanto o lado conta..
							2017. (Simpósio). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>31. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">IX Jornada de Pós-Graduação e XIV Jornada de Iniciação Cientifica.Closing Conference - Chair TBA - palestra tema: The Challenges of oncology in the 21 st century. 2017. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>32. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Mesa de Abertura das boas vindas aos Residentes-FMUSP.Mesa de Abertura das boas vindas aos Residentes do Complexo- COREME, fala do Prof. Hoff às 8h20; presentes Prof. José Otávio, Profa. Eloisa, Tonzé, Presiente do CREMESP, AMB.
							2017. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>33. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Roche Getting Ready 2017. Os caminhos da carreira médica - vida acadêmica, prática privada e experiência internacional.. 2017. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>34. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Seminário Folha de São Paulo.Jornada de Paciente com Câncer - Abertura. 2017. (Seminário). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>35. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Simpósio: O Uso e a Produção de Biológicos no Brasil: Desafios e Perspectivas.Paul Ehrlich e as Terapias Biológicas para o Câncer..
							2017. (Simpósio). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>36. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Simpósio: O Uso e a Produção de Biológicos no Brasil: Desafios e Perspectivas..A Produção de Biológicos no Brasil: Desafios e Perspectivas.
							2017. (Simpósio). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>37. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Simpósio "O uso e a produção de biológicos no Brasil: desafios e perspectivas..Paul Ehrlich e as terapias biológicas para o câncer..
							2017. (Simpósio). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>38. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Simpósio Academia Nacional de Medicina.Cãncer de pancrêas.
							2017. (Simpósio). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>39. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">V Congresso Internacional Oncologia D'Or. Novo Modelo de Pesquisa Clínica em Oncologia. 2017. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>40. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">V Congresso Internacional Oncologia D'Or. Tratamento do câncer, onde estamos, para onde vamos?. 2017. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>41. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">V Congresso Internacional Oncologia D'Or. Chairman - Módulo Gastroinestinal. 2017. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>42. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">V Congresso Internacional Oncologia D'Or. Perspectivas para a Oncologia. 2017. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>43. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">V INTERONCO.Carreira em Oncologia no Brasil e no mundo..
							2017. (Simpósio). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>44. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">XIX Curso Introdutório à Liga de Oncologia.Câncer no Brasil e no Mundo. 2017. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>45. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">XX Congresso Brasileiro de Oncologia Clínica - SBOC. Diminuindo restrições no acesso ao diagnóstico e tratamento precoce da doença: como diminuir. 2017. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>46. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">XX Congresso Brasileiro de Oncologia Clínica - SBOC. Interação da Quimioterapia com a Radioterapia. 2017. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>47. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">XX Congresso Brasileiro de Oncologia Clínica - SBOC. Como escolher a primeira linha de tratamento em CCR metastático? O "lado" importa?. 2017. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>48. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">2º Programa Roche de Residentes em Oncologia e Hematologia.Chairman - Módulo Futuro da Oncologia e Módulo Ética - Palestrante"Pesquisa Clínica no Brasil"..
							2016. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>49. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">46a. Jornada Paulista de Radiologia - JPR'2016.Speaker - Impacto Clínico do PET.CT: Visões do Cirurgião e do Oncologista.. 2016. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>50. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Abertura do Evento "Tumores Cutâneos"..Abertura do Evento "Tumores Cutâneos".. 2016. (Seminário). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>51. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Abertura do Preceptorship Cancer de Colon.Abertura do Evento e Aula "Estadio II e III: atualização em fatores preditivos e prognósticos.. 2016. (Seminário). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>52. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Abertura do Seminário "O futuro do Combate ao Câncer"."O futuro do Combate ao Câncer". 2016. (Seminário). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>53. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Congresso Medico Universitário - COMU. Epidemiologia e Situação do Câncer no Brasil. 2016. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>54. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Debate A Legislação da Ética na Pesquisa em Seres Humanos: O Projeto de Lei n° 200.Debate A Legislação da Ética na Pesquisa em Seres Humanos: O Projeto de Lei n° 200. 2016. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>55. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Evento MRCT/Harvard Post-trial access to study medication.Mesa Redonda - Pesquisa Clínica. 2016. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>56. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">HIS - Hospital Innovation Show 2016.Palestra - HIS.
							2016. (Simpósio). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>57. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">IHPBA 2016 - 12th World Congress of the International - Hepato - Pancreato.Global Perspectives on Gallbladder Cancer - O Papel da quimioterpia para cancer de Gb: antes? depopis? nunca? Moderador Reid Adms e giles Toogood..
							2016. (Simpósio). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>58. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">III Oncologia Integrada - HSL. Discussão de Casos clínicos:Câncer de cólon com carcinomatose peritoneal e Câncer de cólon metastático pós-progressão a Oxaliplatina e irinotecano.. 2016. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>59. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Jornada Estadual de Prevenção do Câncer.Mesa Redonda: Magnitude do Câncer enquanto sério Problema de Saúde Pública Epidemiologia do Câncer: ?Tecendo um quadro comparativo do Mundo, Brasil e Estado de São Paulo? Palestrante: Prof. Dr Paulo Hoff - Diretor Geral do Instituto do Cânce.
							2016. (Simpósio). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>60. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Jornada Estadual de Prevenção do Câncer "enfocando Práticas Alimentares Saudáveis e a Sustentabilidade Ambiental.Epidemiologia do Câncer: Tecendo um quadro comparativo do Mundo, Brasil e Estado de São Paulo.. 2016. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>61. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">SP ONCO III, Abertura.Abertura do Evento.
							2016. (Simpósio). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>62. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Workshop Metástases Hepáticas - Hospital Moinho dos Ventos.Workshop Metástases Hepáticas. 2016. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>63. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">'Multidisciplinary Cancer Management Course ASCO-ICESP 2015'. Relevance of multidisciplinary care Importância do cuidado multidisciplinar .. 2015. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>64. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">"A importância da Pesquisa Clínica para a Saúde Pública e o Desenvolvimento Tecnológico e Científico do Brasil"..A importância da Pesquisa Clínica para os Pacientes: os prazos regulatórios atuais e a urgência de acesso à inovação farmacêutica.. 2015. (Seminário). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>65. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">19° Congresso Brasileiro de Oncologia Clínica (SBOC). Coordenador do Módulo. 2015. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>66. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">1º Simpósio Internacional do Grupo Brasileiro de Tumores Gastrointestinais.Painel de Debatedores: Ressecar metástases durante progressão de doença: sim ou não?.
							2015. (Simpósio). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>67. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">1º Simpósio Internacional do Grupo Brasileiro de Tumores Gastrointestinais.Sessão Especial: Encontro de Experts (3) "Sim ou não?" CCRm: há diferenças clínicas entre os AcMo da mesma classe? sim ou não?.
							2015. (Simpósio). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>68. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">1º Simpósio Internacional do Grupo Brasileiro de Tumores Gastrointestinais.Terapia sistêmica em ressecção de metástases: por que neodjuvância e conversão são diferentes? ou não são? - visão do oncologista..
							2015. (Simpósio). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>69. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">42º Curso de Atualização em Cirurgia do aparelho Digestivo e Coloproctologia e Transplante do Aparelho Digestivo.. Neoplasia de Esôfago , Moderador e o Tema: Como selecionar o melhor tratamento sistêmico para o câncer colorretal avançado. 2015. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>70. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">42º Curso de Atualização em Cirurgia do aparelho Digestivo e Coloproctologia e Transplante do Aparelho Digestivo.. Neoplasia de Esôfago , Moderador. 2015. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>71. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Abertura do III InterOnco - O Congresso das Ligas de Oncologia Clínica , 3ª Edição.. Abertura do III InterOnco - O Congresso das Ligas de Oncologia Clínica , 3ª Edição.. 2015. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>72. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Congresso Internacional de Tumores Gastrointestinais. Chemotherapy for Hereditart GI Cancer. 2015. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>73. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">ESMO Summit Americas - Accommodations & Signed COI's. Summit Americas 2015, Chair, Sessão GI. 2015. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>74. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Fórum Desafios da Pesquisa Clínica do Brasil.Fórum Desafios da Pesquisa Clínica do Brasil. 2015. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>75. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Fórum Permanente de Cômites de Ética e Profissionais de Pesquisa Clínica.Fórum Permanente de Cômites de Ética e Profissionais de Pesquisa Clínica.. 2015. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>76. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Fórum Regulamento da Pesquisa Clinica no Brasil.Regulamentação da Pesquisa Clinica no Brasil. 2015. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>77. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">III Jornada Norte-Riograndense de Oncologia.conferência V - O Futuro da Oncologia.. 2015. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>78. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">III Jornada Norte-Riograndense de Oncologia.Mesa Redonda de Câncer Colorretal: Metástase Hepática. 2015. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>79. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">II Simpósio Internacional de Coloproctologia - Prof. Daher Cutati.Sessão interativa: Discussão de casos selecionados..
							2015. (Simpósio). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>80. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">II Simpósio Internacional de Coloproctologia - Prof. Daher Cutati.Excisão Total do Mesorreto. Quimioterapia pós-TME.
							2015. (Simpósio). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>81. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">International Society for Gastrointestinal Hereditary Tumours.Chemotherapy for Hereditart GI Cancer.
							2015. (Simpósio). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>82. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">INTERSECTIONS II, International Cooperative Cancer Symposium.Chairm.
							2015. (Simpósio). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>83. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">IV Simpósio Internacional de Oncologia Clínica e Cirúrgica do Apareclho Digestivo - Gastro 2015.Como selecionar o tratamento sistêmico para o câncer colorretal avançado..
							2015. (Simpósio). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>84. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">IV Simpósio Internacional de Oncologia Clínica e Cirúrgica do Apareclho Digestivo - Gastro 2015.Manuseio metástases hepáticas câncer colorretal..
							2015. (Simpósio). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>85. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">IV Simpósio Internacional de Oncologia Clínica e Cirúrgica do Apareclho Digestivo - Gastro 2015.Debate interativo.
							2015. (Simpósio). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>86. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">MCM ? ASCO 2015.Relevance of multidisciplinary care Importância do cuidado multidisciplinar..
							2015. (Simpósio). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>87. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Reunião na Sociedade Russa de Oncologia.Representante do Brasil na discussão do tema: Oncologia. 2015. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>88. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Simpósio Satélite.Cardio Oncologia ? O coração do paciente com câncer - cenário atual da cardiotoxicidade.
							2015. (Simpósio). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>89. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">SP Onco II - II Simpósio Paulista de Oncologia,.Coordenador do Módulo - Pesquisa em Câncer - Regulamentação da Pesquisa Clínica.
							2015. (Simpósio). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>90. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Theaching and Research Institute of HSL.Interventional Day Diagnostics and Therapy in Cardiology and Oncology - Lecture: Welcome & Overview of How Interventional Oncology is Evolving?. 2015. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>91. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Theaching and Research Institute of HSL.Interventional Day Diagnostics and Therapy in Cardiology and Oncology. 2015. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>92. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">X Simpósio de PET/CT e VII Simpósio de SPECT/CT em Oncologia..Abertura.
							2015. (Simpósio). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>93. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">XVII Curso Introdutório à Liga de Oncologia.História da Oncologia. 2015. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>94. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">XVIII Destaques ASCO 2015.Coordenador do Módulo Gastrointestinal: Colón Adjuvante, Colón Metastático, Gástrico.
							2015. (Simpósio). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>95. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">19º Congresso Franco Brasileiro. Doença metastática: posso combinar oxaliplatina e irinotecano com todos os anticorpos? Posso utilizar a evidência para os anticorpos de mesma classe de forma intercambiável?. 2014. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>96. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">31° Congresso Brasileiro de Endocrinologia e Metabologia. Dilemas terapêuticos em tumores neuroendócrinos. 2014. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>97. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">63º Congresso Brasileiro de Coloproctologia. Câncer de cólon - Quimioterapia neoadjuvante. 2014. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>98. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">6º congresso Internacional de Atualização em Câncer Gastrintestinal.Debatedor dos Casos Clínicios no Módulo VII - Cólon.
							2014. (Simpósio). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>99. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">7º Congresso Internacional de Atualização em Câncer de Mama.Debatedor dos Casos Clínicios no Módulo VII - Cólon.
							2014. (Simpósio). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>100. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">9º Congresso Médico de Passo Fundo. QT Neo-adjuvante do CA Gástrico - Papel da Quimioterapia no CA Gátrico Neo-adjuvante.. 2014. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>101. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">9º Congresso Médico de Passo Fundo. Rastreamento do Câncer Digestivo no Programa Cientifico Geral. 2014. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>102. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Advances in the Management of Colorectal Cancer: A Latin-American Perspective.Case studies..
							2014. (Simpósio). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>103. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Advances in the Management of Colorectal Cancer: A Latin-American Perspective.Colorectal cancer molecular subtyping.key to future personalization of treatment.
							2014. (Simpósio). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>104. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Advances in the Management of Colorectal Cancer: A Latin-American Perspective.Rational approach to first-line treatment of colorectal cancer..
							2014. (Simpósio). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>105. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Advances in the Management of Colorectal Cancer: A Latin-American Perspective.New targets and treatments for metastic colorectal cancer.
							2014. (Simpósio). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>106. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Advances in the Management of Colorectal Cancer: A Latin-American Perspective.Adjuvant chemotherapy. Can we select those who will benefit?.
							2014. (Simpósio). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>107. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Cirurgião Ano 8 - Atualização em Cirurgia Geral, Emergência e Trauma..Novas Drogas e os Limites da Quimioterapia: quando parar?.
							2014. (Simpósio). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>108. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Congresso Internacional de Humanidades e Humanização em Saúde,. A experiência do Instituto do Câncer. 2014. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>109. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Escola São Paulo de Ciências Avançadas em Oncogênese e Medicina Translacional para o Tratamento do Câncer. Speaker - Targeted therapy applied to colorectal cancer.. 2014. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>110. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">ESMO - World Congress on Gastrointestinal Cancer. Participated in the education Activity entitled.. 2014. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>111. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Gastrointestinal Cancers Symposium - ASCO.Chair session 7: Multidisciplinary case review for stage IV colon and rectal cancer (ARS).
							2014. (Simpósio). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>112. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Hospital Universitário de Brasilia, aula inaugural.Desafios do Tratamento do Câncer no SUS: Experiências de São Paulo. 2014. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>113. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">II Bienal Internacional de Oncologia.Módulo Cólon e Reto ? Tratamento adjuvante no estádio II .. 2014. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>114. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">I Simpósiio Internacional de Cardio-Oncologia Brasil-Estados Unidosdo.Presidente do Simpósio.
							2014. (Simpósio). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>115. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">I Simposio Internacional de Cardio-Oncologia Brasil.Relacionamento entre Oncologistas e Cardiologistas - Desafios para Cardio-Oncologia.
							2014. (Simpósio). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>116. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">I Simposio Internacional de Cardio-Oncologia Brasil.Participação da abertura.
							2014. (Simpósio). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>117. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Jornada Oncológica Mulltidisciplinar - Hospital Oncológico de Brasilia.Coordenador e Apresentador: Mesa 3 - Tumor TEG: adjuvância e neodjuvância.. 2014. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>118. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Oncology at the limits IV 2014. Meeting to be held at the DKFZ. 2014. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>119. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Pós ASCO/Pós Esmo GI - 2014. Novidades em Tumores Gastrointestinais. 2014. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>120. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Recepção Residentes Ingressantes no HSL.Recepção. 2014. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>121. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Simpósio Internacional de Câncer de Fígado, Pâncreas e Vias Biliares da CB-IHPA.Comissão de Experts: Bloco 2: Manejo das Metástases Ressecáveis..
							2014. (Simpósio). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>122. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">VIII Congresso Paulista de Doenças Digestivas. Sessão Interativa de Oncologia GI (II) ? 2 casos. 2014. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>123. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">V Simpósio Internacional de Oncologia Clínica e Cirúrgica do Aparelho Digestivo.Mesa redonda: Requerimentos mínimos para quimioterapia..
							2014. (Simpósio). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>124. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">V Simpósio Internacional de Oncologia Clínica e Cirúrgica do Aparelho Digestivo.Organização do Evento..
							2014. (Simpósio). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>125. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">WHS Regional Meeting Available - The Challenge of Forming Cancer Networks in Emerging Countries.. The Challenge of Forming Cancer Networks in Emerging Countries. 2014. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>126. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">XIII Semana Brasileira do Aparelho Digestivo - Programa em conjunto c CBCD e GTG.Ainda há espaço para adjuvância no câncer de reto?. 2014. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>127. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">10th Latin American Workshop on Molecular Targeted Therapy of Cancer (MTTC.Speaker for L11: Molecular Treatment of gastric cancer. 2013. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>128. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">10th Latin American Workshop on Molecular Targeted Therapy of Cancer (MTTC).Chairman of Session II - Biological targets in the treatment of cancer. 2013. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>129. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">ABIFICC.PRONON, estágio atual. 2013. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>130. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Encontro Grupo Brasileiro de Tumores Gastrointestinais.Estudos clínicos, visão critica, impacto dos resultados na prática clíica, pontos chave, recomendações..
							2013. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>131. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">ENETS - European Neuroendocrine Tumor Society. 2013. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>132. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">ESMO - Word Congresso Gastrointestinal Cancer. Membro do Comitê. 2013. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>133. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">GASTRÃO - 40º curso de atualização em cirurgia do aparelho digestivstivo e coloproctologia.Visão geral de terapias alvo específicas para tumores do aparelho digestivo. 2013. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>134. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Gastrointestinal Cancer Symposium - American Society of Clinical Oncology. Chair, General session III: cancer of the colon and rectum: multdisciplinary treatment. 2013. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>135. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">GI ARS Onsite Meeting, Gastrointestinal Cancer Symposium - American Society of Clinical OncOnology. Colon and Rectum. 2013. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>136. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">IBCC/IGICC. Angiogenesis 2013-State-of-the Art. 2013. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>137. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">III Congresso Latino-Americano de Enfermagem Oncológica. Políticas Públicas e Pesquisa em Oncologia. 2013. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>138. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">III Fórum Internacional de Transplantes do Aparelho Digestivo.Solenidade de abertura do Congresso. 2013. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>139. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">III International Congress of Gastrointestinal Cancer. Sequência de tratamento no CCRm pós-ASCO 2013 (módulo câncer colorretal). 2013. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>140. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">III International Congress of Gastrointestinal Cancer. Evoluçao da terapia do câncer do Brasil. 2013. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>141. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">IRCI Metastatic Relapsed Anal Cancer.Brasil. 2013. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>142. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Jornada Oncológica Mulltidisciplinar - Hospital Oncológico de Brasilia. Terapia de conversão nas metástases hepáticas: timing e protocolos. 2013. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>143. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Jornada Oncológica Mulltidisciplinar - Hospital Oncológico de Brasilia.Adenocarcinoma de pâncreas. Novos protocolos de tratamento de adenocarcinoma d pâncreas - estamos realmente melhorando?. 2013. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>144. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Jornada Oncológica Multidisciplinar, Hospital Sírio Libanês.Tumor do reto baixo - Módulo: Câncer Gastrintestinal.. 2013. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>145. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Jornada Oncológica Multidisciplinar, Hospital Sírio Libanês.Protocolos de tratamento de adenocarcinoma do pãncreas estamos realmente melhorando ?. 2013. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>146. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Jornada Oncológica Multidisciplinar, Hospital Sírio Libanês.Tumor TEG: adjuvância e neodjuvância - Módulo Gastrointestinal e apresentação de casos.. 2013. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>147. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Palestra no Grupo Folha de São Paulo.Novas Fronteiras no tratamento do câncer. 2013. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>148. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Primary Liver Cancer Joint Meeting Brazil & Korea.Major topic HCC treatment: present and future. 2013. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>149. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Programa de Residência em Cancerologia Clínica, Instituto do Câncer de São Paulo.Câncer de cólon - tratamento adjuvante. 2013. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>150. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Programa de residência em oncologia clínica Hospital Sirio Libanres.Cólon - doença metastática. 2013. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>151. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Rede Hebe Camargo de Combate ao Câncer.Lançamento da Rede Hebe Camargo de Combate ao Câncer. 2013. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>152. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">The Best of ASCO.Módulo gastrointestinal. 2013. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>153. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">The Jacob study - investigator meeting.Treatment of advanced gastroesophageal cancer: focused in targeted therapies. 2013. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>154. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">VIII Conferência de Onco-hematologia.Acesso ao tratamento oncológico no SUS. 2013. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>155. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Workshop sobre medicamentos oncológicos.Perspectiva brasileira em relaçao aos critérios internacionais e discussão do desenho de estudo clínico e seus desfechos em oncologia. 2013. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>156. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">XII Semana Brasileira do Aparelho Digestivo. Tratamento Oncológico do CCR. 2013. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>157. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">XV Curso Introdutório à Liga de Oncologia.História da Oncologia. 2013. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>158. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">XVIII Congresso Brasileiro de Oncologia Clínica. 3a. Reunião Cientifica referente ao SBOC 2013. 2013. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>159. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">XVIII Congresso Brasileiro de Oncologia Clínica. Determinação legal de iniciar tratamento oncologico específico com 60 dias de diagnóstico de câncer-Gargalos e soluções institucionais - Módulos de Políticas Públicas.. 2013. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>160. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">1ª Reunião Cientifica SBOC.Reunião Cientifica Internacional - SBOC 2103.
							2012. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>161. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">2012 Gastrointestinal Cancers Symposium. Chair. 2012. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>162. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Asco 2012 Annual Meeting. Reunião Anual. 2012. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>163. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Conferência Liga Bahiana contra o Câncer.Conferencista no Centro de Estudos do Hospital Aristides Maltez. 2012. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>164. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Congresso Paulista de Coloproctologia. Mesa redonda: câncer colo-retal metástases e recidiva Aula: novos protocolos de qt: melhores resultados ?. 2012. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>165. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">I Congresso Panamericano de Câncer Gástrico. Tratamento multimodal - impacto na sobrevivência, tratamento adjuvante.. 2012. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>166. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">II Congresso Colombiano de Actualización em Hematologia y Oncología Clínica. Actualizacion en Hematologia y Oncología Clínica.. 2012. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>167. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">II International Clinical Trials Workshop - ICTW.Early drug development in LATAM. 2012. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>168. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">I International Clinical Trials Workshop Brazil. Early drug development in Latam. 2012. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>169. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">IV Simpósio Internacional CDPI de PET/CT em Oncologia; São Paulo, SP, 28 de abril.Tumor de pâncreas: Tratamento neoadjuvante nos tumores borderline de pâncreas: como avaliar e qual evidência para o tratamento?.
							2012. (Simpósio). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>170. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">IX Congresso Paulista de Clínica Médica; São Paulo, SP, 20 e 21 de abril. Avanços nos diagnósticos e nos tratamentos das neoplasias. 2012. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>171. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Preceptorships in Oncology - LC&RCC Edition.Speaker. 2012. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>172. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Semana da Segurança do Trabalho no ICESP.Abertura da Semana da Segurança do Trabalho no ICESP. 2012. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>173. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Simpósio Câncer Metastático.O papel da terapia alvo para o câncer colorretal com metástase hepática.
							2012. (Simpósio). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>174. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">VII Congresso Franco-Brasileiro de Oncologia. Câncer Gástrico avançado: O virá após o HER-22? - Sessão Gastrointestinal.. 2012. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>175. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">10º Simpósio Internacional de Economia da Saúde.Infra-estrutura pública e privada na atenção ao câncer e acesso aos serviços assistenciais.
							2011. (Simpósio). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>176. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">1ª Jornada de Nutrição e Câncer e Econtro de Caquexia e Câncer.Abertura. 2011. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>177. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">2º Congresso da Sociedade Brasileira de Cirurgia Oncológica - Capítulo de MInas Gerais. Papel da quimioterapia no câncer gástrico. 2011. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>178. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">38º Simpósio de Oncologia do Aparelho Digestivo.Tratamento neoadjuvante do câncer do trato gastrointestinal. Como avaliar a resposta terapêutica?.
							2011. (Simpósio). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>179. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">3º Forum Internacional de Câncer de reto - FICARE 2011.Sessão 6 - Atualizações no tratamento neoadjuvante - O espaço da quimioterapia. 2011. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>180. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Advances in targeted therapy of GI Cancer.Advances in targeted therapy of GI cancers.
							2011. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>181. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Amgen Latin America Gastrointestinal Oncology Summit.Treatment of gastrointestinal cancers in 2012 and beyond. 2011. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>182. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Amgen Latin America Gastrointestinal Oncology Summit.Skin toxicity related to anti-EGFR treatment. 2011. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>183. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Cirurgião Ano 5. Oncologia clínica: o que é possível fazer na recorrência ?. 2011. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>184. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Gene Expression Profiling in Breast and Colon Cancer: advancing our understanding in Latin America.The challenge of therapy selection in stage II colon cancer.
							2011. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>185. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">I Congresso Acadêmio da AMB, II Congresso Acadêmio da APM, I Congresso Brasileiro das Ligas Acadêmicas de Medicina, I Congresso do Núcleo da Saúde Júnior e I Simpósio da IFMSA-Brasil. História da Oncologia. 2011. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>186. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">I Congresso Brasil-Chile de Radiologia. NOPR Panel discussion. 2011. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>187. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">II Encontro Brasileiro de Portadoras de Câncer, VII Encontro Catarinense da Mulher Mastectomizada.Experiência do ICESP na mesa redonda: processo administrativo para medicamentos oncológicos de alto custo.
							2011. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>188. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">II Fórum de Discussão de Políticas de Saúde em Oncologia.Sistema Único de Saúde e Saúde Complementar. 2011. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>189. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">II Simpósio de Enfermagem em Oncologia.Panorama atual do câncer no Brasil e no mundo.
							2011. (Simpósio). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>190. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Interchange Meeting Lung & GI Cancer.Decision making in colorectal cancer: futures perspectives. 2011. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>191. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Interchang Meeting Lung & GI Cancer.Cell signaling pathways with prognostic/predictive value in gastric cancer. 2011. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>192. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Jornada Rede D'or.Módulo III - Módulo Oncologia - Câncer colorretal II - Tratamento de metástase. 2011. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>193. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Jornada Rede D'or.Terapia alvo molecular no câncer colorretal metastático. 2011. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>194. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Pós-graduação em oncologia da FMUSP.Como escrever um artigo científico, authorship e conflitos de interesse. 2011. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>195. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Preceptorships in Oncology - GI Edition.Second-line and beyond in mCRC. 2011. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>196. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Preceptorships in Oncology - GI Edition.Advanced gastric cancer: state of art and perspectives. 2011. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>197. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Pré-Congresso SBOC. Reunião Cientifica, Pré-Congresso. 2011. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>198. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Programa de Residência Médica em Cancerologia.Introdução à Oncologia. 2011. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>199. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Residência em Oncologia Clínica do Hospital Sírio Libanês.Câncer gástrico - doença metastática. 2011. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>200. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Reunião de especialistas para elaboração de consenso brasileiro em câncer de cólon.Algoritmo de tratamento proposto para estadio IV de câncer de cólon.
							2011. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>201. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Simpósio CEOF.Apresentação e discussão de casos clínicos.
							2011. (Simpósio). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>202. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Simpósio CEOF.ASCO GI 2011 O que tem de novo ? O que muda ?.
							2011. (Simpósio). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>203. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Simpósio de Cardio-oncologia: Hospital Sírio Libanês/Hospital da Bahia - Cardiotoxicidade dos Quimiterápicos.Risco, diagnóstico e história natural da cardiotoxicidade.
							2011. (Simpósio). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>204. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Top 10 2011.Sessão: gastrointestinal.
							2011. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>205. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Top 10 2011.Artigo comentado: Efficacy of venlafaxine for the prevention and relief of oxaliplatin-induced acute neuroxicity: results of EFFOX, a randomized, double-blind, placebo-controllad phase III trial.
							2011. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>206. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">XIII Curso da Liga da Oncologia.História da Oncologia. 2011. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>207. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">XVII Congresso Brasileiro de Oncologia Clínica. Módulo Gastrointestinal Colorretal. 2011. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>208. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">XVII Congresso Brasileiro de Oncologia Clínica. A pesquisa clínica em oncologia no âmbito SUS. 2011. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>209. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">XVII Congresso Brasileiro de Oncologia Clínica. Sessão II do módulo gastrointestinal colorretal. 2011. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>210. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">XXX Congresso Médico Universitário da FMUSP. História da Oncologia. 2011. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>211. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">12th World Congress on Gastrointestinal Cancer. Apresentação oral: Subsed analysis of 5-FU refractory patients from a randomized ph ii study of Perifosine + Capecitabine (P-CAP) vs. placebo + Capecitabine in patients with 2nd or 3rd line metastatic CRC. 2010. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>212. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">1º CEMAI Oncology Meeting.Patient treatment strategies in mCRC.
							2010. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>213. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">1º CEMAI Oncology Meeting.Clinical experience exchange: meet the experts GI (CRC and gastric) workshop.
							2010. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>214. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">23º Curso Continuado de Atualização em Coloproctologia.Tratamento adjuvante: indicações e modalidades. 2010. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>215. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">65º Congresso Brasileiro de Cardiologia. Efeitos da quimioterapia no coração. 2010. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>216. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">8º Latin American Education Initiative.Managing targeted therapy side-effects. 2010. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>217. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">8º Latin American Medical Education. Initiative on molecular targeted therapy of cancer.Introduction to the medical education. Initiative on molecular targeted therapy of cancer. 2010. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>218. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Aula para residentes do ICESP.Câncer de cólon 1 - tratamento adjuvante. 2010. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>219. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Aula para residentes do ICESP.Câncer de reto e canal anal. 2010. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>220. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Aula para residentes em Oncologia Clínica do Hospital Sírio Libanês.Tumores de cólon II. 2010. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>221. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Aula para residentes em Oncologia Clínica do Hospital Sírio Libanês.Tumores de cólon I. 2010. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>222. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Aula para residentes em Oncologia Clínica do Hospital Sírio Libanês.Tumores de reto e canal anal. 2010. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>223. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Caoc (Centro Acadêmio Oswaldo Cruz) convida.Oportunidades no ICESP para alunos em medicina. 2010. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>224. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Cirurgião Ano 4.Tem papel o tratamento sistêmico do tumor neuroendócrino ?. 2010. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>225. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Cirurgião Ano 4.Tem papel o tratamento sistêmico do tumor neuroendócrino ?. 2010. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>226. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Clínica AMO.Tratamento do câncer cólon retal: intersecção entre o oncologista e o cirurgião. 2010. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>227. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Curso INCOR In Job para Jornalista.Câncer: a multiplicação do mal. 2010. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>228. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Encontro Roche de Oncologia.Câncer colorretal.
							2010. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>229. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">ESMO 2010 colorectal carcinoma consensus conference.Post-operative management of stage II and stage III colon cancer.
							2010. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>230. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">First International Cancer Meeting.20 anos de adjuvância: o que mudou na abordagem desta doença ?.
							2010. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>231. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">First International Cancer Meeting.Chair - sessão: cólon e reto.
							2010. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>232. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Fórum de Comunicação em Saúde da Interfarma.Câncer - mitos e verdades. 2010. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>233. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Forum Intersetorial de Controle de Câncer de Mama no Estado de São Paulo.Diagnóstico e tratamento. 2010. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>234. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">I Diretriz Brasileira de Cardio-oncologia.Agentes quimioterápicos e cardiotoxicidade: perspectivas. 2010. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>235. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">I Fórum de Discussão de Políticas Públicas em Oncologia.O acesso a um tratamento integral e seu custo: a experiência do ICESP. 2010. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>236. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">II Congresso Internacional Oncologia Gastrointestinal. Tratamento sistêmico adjuvante em pacientes acima de 70 anos. 2010. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>237. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">II Simpósio Internacional de PET-CT em Oncologia.O que o oncologista clínico espera do PET-CT para melhorar sua prática ? (TGI superior).
							2010. (Simpósio). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>238. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Investigators Meeting on Colorectal Cancer.State of the art treatment of CRC in 2010: how to maximize results.
							2010. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>239. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Lacore.Novel therapeutics approaches in advanced neuroendocrine tumors.
							2010. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>240. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Lacore.Developing a clinicar research site of excellence.
							2010. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>241. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Merck Serono Oncology Symposium.Biomarkers for clinical decision in colorectal cancer.
							2010. (Simpósio). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>242. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Merck Serono Oncology Symposium.Câncer coloretal.
							2010. (Simpósio). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>243. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Metátases Hepáticas do Carcinoma atual.Terapia neoadjuvante: conversão. 2010. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>244. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Preceptorships in Oncology - GI Oncology. Front-line treatment for mCRC. 2010. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>245. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Preceptorships in Oncology - GI Oncology.Changing perceptions in mCRC:neo-adjuvancy and surgery. 2010. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>246. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Preceptorships in Oncology - GI Oncology.State-of-the-art adjuvant chemotherapy and the future. 2010. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>247. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Reunião Multidisciplinar Gastrointestinal.Metástases em câncer de cólon e reto: curáveis ?.
							2010. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>248. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Roche Avastin Satellite Symposium.Managing patients with unresectable mCRC: optimizing first-line therapy.
							2010. (Simpósio). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>249. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Seminários Científicos - Laboratórios de Investigação Médica do Hospital das Clínicas da FMUSP.Avanços na terapia alvo no tratamento do câncer. 2010. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>250. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Simposio Internacional de Câncer Urológico.Quimioterapia no câncer urológico: novas perspectivas.
							2010. (Simpósio). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>251. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Top 10.Tumores gastrointestinais. 2010. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>252. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Top 10.Apresentação do trabalho: Randomized phase III trial comparing biweekly infusional fluorouracil/leucovorin alone or with irinotecan in the adjuvant treatment of stage III colon cancer: PETACC-3. 2010. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>253. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">VII Congresso de Oncologia de Botucatu(COB). Fatores genéticos na estratificação de pacientes com câncer. 2010. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>254. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">VI Simpósio de Pesquisa Clínica do Hospital das Clínicas da FMUSP.Medicina translacional e a experiência da academia.
							2010. (Simpósio). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>255. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">X Curso de Radioterapia de Última Geração.Preditores de moleculares e genéticos de recorrência locoregional em câncer de mama: dilema da decisão entre a ciência e a prática clínica. 2010. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>256. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">XII Curso da Liga da Oncologia.Introdução à Oncologia. 2010. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>257. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">XXIX Congresso Médico Universitário da FMUSP. O papel do SUS na assistência e pesquisa. 2010. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>258. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">XXIX Congresso Médico Universitário da FMUSP. Introdução à Oncologia. 2010. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>259. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">XXIX Congresso Médico Universitário da FMUSP. Câncer colorretal. 2010. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>260. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">12º Destaques ASCO.Gastrointestinal.
							2009. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>261. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">34th ESMO e 15th ECCO Congressos. Colorectal cancer. 2009. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>262. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">34th ESMO e 15th ECCO Congressos. discussão de casos. 2009. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>263. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">36º Curso de atualização em cirurgia do aparelho digestivo e coloproctologia - Gastrão 2009.Neoadjuvância no câncer de pâncreas. 2009. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>264. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">4º Workshop educativo tratamento do câncer como terapia de alvo molecular.Incorporação de novas tecnologias contra o câncer no Brasil - exemplo de São Paulo. 2009. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>265. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">58º Congresso Brasileiro de Coloproctologia. Quimioterapia em câncer colorretal. 2009. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>266. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">7º Molecular Targeted Therapy of Cancer Molecular Targeted Therapy of Cancer.Molecular treatment of colorectal cancer. 2009. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>267. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">7º Molecular treatment of colorectal cancer Molecular Targeted Therapy of Cancer.Molecular treatment of gastric cancer. 2009. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>268. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Advisory Board de Vias Digestivas.Manejo del cancer colorrectal metastasico. Nuevos estandares.
							2009. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>269. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Atualizações Oncohematos, Simpósio Câncer colorretal.Quimioterapia paliativa.
							2009. (Simpósio). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>270. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Aula Onco-Vida.Avanços no tratamento do câncer colorretal: aspectos clínicos.
							2009. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>271. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Board Review Oncologia.Câncer de cólon, reto e canal anal não-metastáticos. 2009. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>272. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Board Review Oncologia.Câncer colo-retal metastático. 2009. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>273. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Cirurgião Ano 3 ? Atualização em cirurgia geral, emergência e trauma. Resultados do tratamento não operatório das metátases hepáticas. 2009. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>274. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Curso Anual de Oncologia Clínica.Angiogênese. 2009. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>275. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Curso de EBUS.Importância do estadiamento mediastinal. 2009. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>276. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Evento Top 10.Artigo comentado: K-ras mutations and benefit from Cetuximab in advanced colorectal cancer.
							2009. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>277. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Fórum de debates em Onco-hematologia do Hospital de Câncer de Barretos.Câncer colorretal.
							2009. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>278. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Fórum de Debates em Onco-hematologia do Hospital de Câncer de Barretos.Aula moderada: Visão da Secretaria de Saúde do Estado de São Paulo.
							2009. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>279. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">I Congresso de Oncologia Brasil-Portugal, I Forum de Oncologia. Chair do módulo colorectal cancer. 2009. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>280. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">I Congresso de Oncologia Brasil-Portugal, I Fórum de Oncologia. State of the art in the treatment of colorectal cancer. 2009. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>281. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">II GI Insights.II GI Insights.
							2009. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>282. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Ii Simpósio Latino Americano de Gastroenterologia Oncológica. Treatment adjuvant of colorectal cancer: update and perspectives. 2009. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>283. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">II Simpósio Latino Americano de Gastroenterologia Oncológica. Ensayos con terapias target Estrategias para aprobación, validación de target, o ayuda a pacientes ?. 2009. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>284. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">II Simpósio Latino Americano de Gastroenterologia Oncológica. Continuidad en la terapia de cáncer colorectal. 2009. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>285. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">I Jornada de Atualização em Câncer Ginecológico do ICESP - Câncer de Ovário..Novos Alvos Terapêuticos. 2009. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>286. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">I Jornada do Departamento de Cirurgia da Santa Casa de São Paulo.Tumor de Pâncreas - O que há de Novo? Neodjuvância e Adjuvância no Câncer Ressecável. 2009. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>287. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">I Jornada do Departamento de Cirurgia da Santa Casa de São Paulo, Oncologia em Cirurgia do Aparelho Digestivo.Neoadjuvância e adjuvância no câncer ressecável. 2009. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>288. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Jornada de Pós-Graduação do ICESP.Como publicar eficientemente. 2009. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>289. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Lacore.New concepts in neuroendocrine tumors treatment. 2009. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>290. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Latin American Roche Experience Excahnge Meeting - GI edition.Front-line treatment for mCRC. 2009. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>291. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Latin American Roche Experience Exchange Meeting - GI edition.Biomarkers in mCRC: K-ras and beyond. 2009. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>292. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Latin American Roche Experience Exchange Meeting - GI edition.State-of-the-art adjuvant chemotherapy and the future. 2009. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>293. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Logic Study Investigators Meeting.CapeOx & Gastric Cancer. 2009. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>294. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Programa de Residência em Oncologia do Hospital Sírio Libanês.Tumores de esôfago e estômago. 2009. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>295. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Programa de Residência em Oncologia do Hospital Sírio Libanês.Tumores de reto e canal anal. 2009. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>296. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Programa de Residência em Oncologia do Hospital Sírio Libanês.Tumores de cólon. 2009. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>297. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Reunião científica da SBOC.Tratamento sistêmico. 2009. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>298. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Reunião científica da SBOC.Tratamento sistêmico. 2009. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>299. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Rotary Club de São Paulo - Reunião Ordinária.Os avanços da Oncologia..
							2009. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>300. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Seminário Internacional sobre Medicamentos.Impacto, financiamento público e uso de novos fármacos oncológicos. 2009. (Seminário). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>301. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">The Chemotherapy Foundation Symposium.Cediranib an active VEGF inhibitor in colorectal cancer.
							2009. (Simpósio). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>302. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">The Chemotherapy Foundation Symposium.Update on the avant study.
							2009. (Simpósio). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>303. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">V Encontro dos Registros Médicos Hospitalares de Câncer do Estado de Sâo Paulo.Instituto do Câncer do Estado de São Paulo: Uma realidade.
							2009. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>304. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">XII Latin America Thyroid Congress. Tyrosine kinase inhibitor and the recist criteria in clinical. 2009. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>305. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">XVI Congresso Brasileiro de Oncologia Clínica. Hipoglicemia sintomática relacionada a IGF-II em Tumor desmoplásico de células pequenas e redondas abdmonais.. 2009. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>306. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">XVI Congresso Brasileiro de Oncologia Clínica. Quimioterapia de indução baseada em derivados de platina e paclitaxel no carcinoma epidermóide de cabeça e pescoço localmente avançado.. 2009. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>307. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">XVI Congresso Brasileiro de Oncologia Clínica. Apresentação Atípica de Tumor Neuroendócrino. 2009. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>308. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">XVI Congresso Brasileiro de Oncologia Clínica. Simpósio sobre atualização no tratamento do câncer colorretal na era K-ras: uma visão crítica. 2009. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>309. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">XVI Congresso Brasileiro de Oncologia Clínica. Sobrevida prolongada após tratamento agressivo locorregional em paciente com metástase única cerebral operada de adenocarcinoma de pulmão.. 2009. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>310. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">XVI Congresso Brasileiro de Oncologia Clínica. Metástase de adenocarcinoma de vesícula biliar simulando celulite extensa.. 2009. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>311. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">XVI Congresso Brasileiro de Oncologia Clínica. Impacto do esquema flox modificado em primeira linha de tratamento para câncer colorretal metastático - experiência do Instituto do Câncer do Estado de São Paulo.. 2009. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>312. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">XVI Congresso Brasileiro de Oncologia Clínica. Tratamento sistêmico para câncer colorretal. 2009. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>313. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">XVI Congresso Brasileiro de Oncologia Clínica. Discrepância entre os achados radiológicos e histopatológicos em um caso de adenocarcinoma mucinoso de reto submetido a quimiorradioterapia neoadjuvante.. 2009. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>314. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">XVI Congresso Brasileiro de Oncologia Clínica. Análise de 18 casos de tumor do cordão sexual do ovário.. 2009. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>315. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">XVI Congresso Brasileiro de Oncologia Clínica. Íleo-Paralítico possivelmente secundário à associação de vinvlastina e ritonavir em paciente portador linfoma de hodgklin (LH) e síndrome da imunodeficiência adquirida (SIDA). 2009. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>316. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">XVI Congresso Brasileiro de Oncologia Clínica. Controle de hipoglicemia refratária secundária a insulina maligmo com o uso de capecitabina e oxaliplatina.. 2009. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>317. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">XVI Congresso Brasileiro de Oncologia Clínica. Coagulação intravascular disseminada como apresentação inicial isolada de câncer gástrico, seguida por resposta ao tratamento quimioterápico.. 2009. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>318. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">XVI Congresso Brasileiro de Oncologia Clínica. Análise de 23 casos de tumores malignos de células germinativas do ovário.. 2009. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>319. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">XVIII Congresso Brasileiro de Cancerologia -CONCAN 2009. Câncer colo-retal como tratar o paciente com doença metastática ao diagnóstico. 2009. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>320. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">XVIII Congresso Brasileiro de Cancerologia -CONCAN 2009. Terapia alvo molecular. 2009. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>321. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">XVIII Congresso Brasileiro de Cancerologia -CONCAN 2009. Tumores Neuroendócrinos metastáticos. 2009. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>322. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">XXVIII Congresso Médico Universitário da Faculdade de Medicina da Universidade de São Paulo. Carreiras e conquistas. 2009. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>323. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">10th World Congress on Gastrointestinal Cancer. Expert discussion: hepatocellular carcinoma. 2008. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>324. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">38² Jornada Paulista de Radiologia.Visão oncológica e tratamento clínico. 2008. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>325. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">44th Annual Meetign - American Society of Clinical Oncology. Chair, Managment of Chronic Toxicites from Colorectal Colorectal Cancer Systemic Therapy. 2008. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>326. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">4º Simpósio internacional de atualização em câncer de mama.Controvérsias no tratamento da doença metastática.
							2008. (Simpósio). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>327. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">4º Simpósio internacional de atualização em câncer de mama.Estratégias contemporâneas para o tratamento do câncer colorretal metastático.
							2008. (Simpósio). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>328. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">4º Simpósio internacional de atualização em câncer de mama.Seleção de pacientes para utilização de agentes alvo.
							2008. (Simpósio). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>329. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">4º Simpósio internacional de atualização em câncer de mama.Novas estratégias no tratamento do hepatocarcinoma.
							2008. (Simpósio). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>330. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">4º Simpósio internacional de atualização em câncer de mama.Situação atual na adjuvância no câncer de estômago.
							2008. (Simpósio). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>331. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">4º Simpósio internacional de atualização em câncer de mama.Quimioterapia neoadjuvante versus adjuvante para metástases hepáticas.
							2008. (Simpósio). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>332. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Actualización en Coloproctologia.Quimioterapia de conversión en enfermedad metastática irresecable.
							2008. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>333. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Actualización en Coloproctologia.Quimioterapia de primera línea: nuevos conceptos y costo efectividad.
							2008. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>334. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Aula no Dan Acadia Hotel.Optimizing treatment outcomes in mCRC.
							2008. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>335. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Aula no Hadassah Medical Center.Optimizing treatment outcomes in mCRC.
							2008. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>336. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Aula no Núcleo de Oncologia da Bahia.Atualização em câncer de cólon 2008.
							2008. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>337. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Aula no Rambam Medical Center.Optimizing treatment outcomes in mCRC.
							2008. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>338. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Aula no Soroka Medical Center.Optimizing treatment outcomes in mCRC.
							2008. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>339. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Aula para os residentes da Oncologia Clínica e Radioterapia do Hospital Sírio Libanês.Tumores de reto e canal anal. 2008. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>340. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Aula para os residentes da Oncologia Clínica e Radioterapia do Hospital Sírio Libanês.Tumores de cólon. 2008. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>341. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Aula para residentes da Oncologia Clínica e Radioterapia do Hospital Sírio Libanês.Tumores de esôfago. 2008. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>342. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Avastin Satelite Symposium at 10th World Congress on Gastrointestinal Cancer. Avastin-based therapy for patients undergoing surgery with curative intent. 2008. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>343. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Avastin-Xelda Launch Meeting.How long to treat ? Optimising treatment outcomes in MCRC.
							2008. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>344. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Avastin-Xeloda Launch Meeting.A Multidisciplinary CRC panel.
							2008. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>345. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Chemotherapy Foundation Symposium XXIV, Mount Sinai School of Medicine.New tyrosine kinase inhibitors for metastatic colorectal cancer.
							2008. (Simpósio). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>346. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">CNC - Conferência nacional de câncer.homenagem.
							2008. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>347. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Congresso Cirurgião do Ano. O que o cirurgião precisa saber sobre terapia alvo: GIST como modelo ?. 2008. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>348. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Congresso Gastrão. Simpósio Novartis desvendando e discutindo sobre GIST (tumor estromal gastrointestinal). 2008. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>349. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Controversies in Oncology Meeting, MD Anderson Cancer Center. Oncology update: integratin targeted therapies into clinical practice - new targeted agents. Is there a role for maintence therapy with targeted agents ?. 2008. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>350. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Curso de Especialização em Coloproctologia.Discussão de casos. 2008. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>351. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Curso de Especialização em Coloproctologia.Quimioterapia: processo decisóriopara adjuvância, neoadjuvância e doença metastática. 2008. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>352. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Curso de pós-graduação MGT - 5723 - aplicação de métodos de investigação clínica e experimental em gastroenterologia.Bases racionais da Qt neo-adjuvante nos tumores do Tgi. 2008. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>353. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Curso Liga da Oncologia.Introdução à oncologia.
							2008. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>354. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Dia Nacional de Combate ao Câncer.Câncer adulto. 2008. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>355. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Fórum Permanente de Educação em Saúde para Profissionais de Comunicação, Instituto do Câncer de São Paulo Octavio Frias de Oliveira.Tratamento do câncer: mitos e verdades. 2008. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>356. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Gi & Lung Expert Forum.Eficácia do bevacizumabe em combinação com diversos regimos quimioterápicos. 2008. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>357. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">GI & Lung Expert Forum.Ressecção hepática e potencial de cura para pacientes com CCRm. 2008. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>358. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">GI & Lung Expert Forum.Integração de agentes biológicos no tratamento do ccrm. 2008. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>359. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">GI & Lung Expert Forum.Câncer colorretal. 2008. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>360. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">GI Summit.The enviroment and its impact on furthering progress in colorectal cancer.
							2008. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>361. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Horizon II brasilian investigator's meeting.Chemotherapy duration.
							2008. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>362. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Horizon II brazilian investigator's meeting.Recruitment.
							2008. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>363. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Horizon III Start-up meeting North America.Chemotherapy duration.
							2008. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>364. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">I Congresso Internacional - Oncologia Gastrointestinal. Tratamento médico de tumores neuroendócrinos metastáticos. 2008. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>365. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">I Congresso Internacional - Oncologia Gastrointestinal. Sessão: apresentação e discussão de casos clínicos. 2008. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>366. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">I Congresso Internacional - Oncologia Gastrointestinal. Cólon: adjuvância. 2008. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>367. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">I Congresso Internacional - Oncologia Gastrointestinal. Mesa: take home message/discussão. 2008. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>368. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">III Simpósio PET/CT em Oncologia: neoplasias torácicas.Estado atual da abordagem oncológica.
							2008. (Simpósio). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>369. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">I Latin American Roche Oncology Summit.Irinotecan-based regimens + Avastin.
							2008. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>370. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">I Latin American Roche Oncology Summit.K-ras mutations and targeted cancer therapies.
							2008. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>371. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Instituto Santista de Cancerologia.Atualização em neoplasias gastrointestinais.
							2008. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>372. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Interchang Meeting.O câncer no aparelho digestivo/Panorama da doença no Brasil/Tratamentos orais - comodidade e eficácia para os pacientes com câncer no aparelho digstivo. 2008. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>373. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">IV Simpósio de Pesquisa Clínica - Hospital das Clínicas.Desafios da moderna pesquisa em oncologia.
							2008. (Simpósio). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>374. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">IV Simpósio de Pesquisa Clínica - Hospital das Clínicas - FMUSP.Desafios da pesquisa translacional em oncologia.
							2008. (Simpósio). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>375. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Merck Serono Oncology Symposium Combination is key: advancing the treatment of cancer.MCRC overview.
							2008. (Simpósio). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>376. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Molecular targeted therapy of cancer - 6º Latin America Workshop. Introduction to the medical education initiative on molecular targeted therapy of cancer. 2008. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>377. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Molecular targeted therapy of cancer - 6º Latin America Workshop.Molecular treatments of colorectal cancer.
							2008. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>378. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">MTTC - Molecular targeted therapy of cancer.Tratamento molecular do câncer colorretal.
							2008. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>379. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">O câncer tem cura quando descoberto em fase inicial.Câncer pediátrico e adulto. 2008. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>380. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Preceptorship TNE.RAD 001 and SOM 230 in TNE.
							2008. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>381. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Simpósio Merck Serono de Oncologia.UFT no tratamento dos tumores gastrointestinais.
							2008. (Simpósio). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>382. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Simpósio Merck Serono de Oncologia.Visão geral do tratamento do CCRm - The state of art.
							2008. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>383. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Simpósio Novartis Desvendando e discutindo sobre GIST(tumor estromal gastrointestinal).Tratamento medicamentoso - terapia alvo.
							2008. (Simpósio). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>384. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Third Latin-American Avastin Preceptorship Meeting.Colorectal cancer cases - interactive session.
							2008. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>385. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Third Latin-American Avastin Preceptorship Meeting.Anti-angiogenesis as a treatment for colorectal cancer.
							2008. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>386. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">V Congresso Franco Brasileiro. ´Tempo ótimo de duração do tratamento. 2008. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>387. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">VI Oncocesp (Encontro de Oncologia do Centro-Oeste Paulista).Cãncer colo-retal: tratamento da doença avançada/metastática.
							2008. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>388. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Workshop Roche.Avanços no tratamento do câncer colorretal:o que muda com o teste do K-ras.
							2008. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>389. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">34º Curso de atualização em cirurgia do aparelho digestivo e coloproctologia.Avanços no tratamento quimioterápico.
							2007. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>390. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">34º Curso de atualização em cirurgia do aparelho digestivo e coloproctologia, simpósio satélite Novarts.Terapia clínica do GIST.
							2007. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>391. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">43rd ASCO Annual Meeting. The continuum of care in colorectal cancer: eliminating the concept of distinct lines of treatment. 2007. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>392. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">5º Latin American Workshop Molecular Targeted Therapy of Cancer.Molecular treatment of colorectal cancer and hepatocellular cancer.
							2007. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>393. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">7th INCRT Annual Meeting.Avaliação de trabalhos sobre câncer adulto.
							2007. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>394. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">7th International Gastric Cancer Congress. Gastric cancer: the challenges for effective tratment options. 2007. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>395. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">7th International Gastric Cancer Congress. Antiangiogenics as a therapeutic target in gastrointestinal malignancy. 2007. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>396. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">7th International Gastric Cancer Congress. Pushing the frontiers of gastric cancer therapy: past, present and future of Taxotere therapy. 2007. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>397. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">7th International Gastric Cancer Congress. The past: recent advances in gastric cancer: the role of Taxotere. 2007. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>398. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">7th International Gastric Cancer Congress. Neoadjuvancy and Adjuvancy II. 2007. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>399. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">AstraZeneca Receting Consulting Group.Colorectal cancer overview.
							2007. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>400. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Atualização e Tratamento de CCR.Tratamento multidisciplinar do câncer colo retal - tratamento paliativo e adjuvância.
							2007. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>401. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Atualização no tratamento do câncer gastrointestinal - UFT e Cetuximabe.UFT no tratamento do câncer gastrointestinal.
							2007. (Simpósio). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>402. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Atualização no tratamento do câncer gastrointestinal - UFT e Cetuximabe.Anticorpos monoclonais no tratamento do cãcner.
							2007. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>403. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Board Review.Câncer colo-retal metastático.
							2007. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>404. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Board Review.Cãncer de cólon, reto e canal anal não metastáticos.
							2007. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>405. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Board Review.TE4: urgências oncológicas.
							2007. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>406. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Chemotherapy Foundation Symposium XXIV Mount Sinai School of Medicine.Continuum care in colorectal cancer.
							2007. (Simpósio). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>407. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Clube dos tumores neuroendócrinos & estromais gastrointestinais.Angiogênese como alvo no tratamento de turmores carcinóides.
							2007. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>408. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Congresso Cearense de Cancerologia. Alvo no câncer colorretal. 2007. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>409. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Congresso Cearense de Cancerologia. Sunitinibe - uma nova alternativa no tratamento do câncer. 2007. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>410. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">First Latin-American Avastin Preceptorship Meeting.First Latin-American Avastin Preceptorship Meeting.
							2007. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>411. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">First Latin-American Avastin Preceptorship Meeting.The role of angiogenesis in cancer.
							2007. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>412. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">First-Latin American Avastin Preceptorship Meeting.Anti-angiogenesis as a treatment for colorectal cancer.
							2007. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>413. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Fórum Internacional de Câncer Gastrointestinal.Controvérsias em câncer colorretal e manejo de eventos adversos. 2007. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>414. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Fórum Internacional de Câncer Gastrointestinal.Debate: Avastin + oxaliplatinas versus Avastin + Irinotecano. 2007. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>415. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Fórum Internacional de Câncer Gastrointestinal.Tratamento do câncer gástrico e pancreático. 2007. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>416. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Hematology and Medical Oncology Board Review MD Anderson Cancer Center.Neuroendocrine cancers.
							2007. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>417. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Hematology and Medical Oncology Board Review MD Anderson Cancer Center.Colorectal and canal anal including HIV-associated.
							2007. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>418. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Horizon II - Reunião de Investigadores.Avanços no tratamento do CCR.
							2007. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>419. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">I Congresso de Oncologia para Imprensa - Hospital Sírio Libanês. Evolução no tratamento da doença. 2007. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>420. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">I Congresso de Oncologia para Imprensa - Hospital Sírio Libanês. As fases dos estudos clínicos I, II e III. 2007. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>421. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">I Congresso Oncologia para Imprensa - Hospital Sírio Libanês. Como são realizados os estudos em Oncologia. 2007. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>422. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">II Simpósio PET/CT em Oncologia: câncer do trato gastro-intestinal.Papel da oncologia clínica no câncer colo-retal.
							2007. (Simpósio). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>423. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">IV Fórum de Farmacoeconomia e Oncologia.Avanços em Medicina - terapia alvo.
							2007. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>424. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Lectures in Saudi Arabia.Angiogenesis and the role of anti-angiogenic agents in treating metastatic colorectal cancer.
							2007. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>425. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Lectures in United Arab Emirates.Angiogenesis ant the role of anti-angiogenic agents in treating metastatic colorectal cancer.
							2007. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>426. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">LNETS 2007 - II Latin America ENETS.Role of Chemotherapy in NET.
							2007. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>427. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">NetGastro - Curso nacional à distância de atualização em gastroenterologia e cirurgia geral.GIST - tratamento medicamentosos com mesilato de imatinibe. 2007. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>428. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Nibs & Mabs.Bevacizumabe. 2007. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>429. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Nibs & Mabs.Cetuximabe. 2007. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>430. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Reunião da III Clínica Cirúrgica do Hospital das Clínicas da Universidade de São Paulo.O cãncer no idoso. Quando tratar ?.
							2007. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>431. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Reunião geral das disciplinas de cirurgia do aparellho digestivo e coloproctologia, Hospital das Clínicas da FMUSP.Tumores neuro-endócrinos.
							2007. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>432. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Reunião mensal SBOC-RJ.Câncer colorretal - discussão do manual de condutas da SBOC.
							2007. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>433. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Reunião Nacional de Residentes em Oncologia.Câncer de reto - tratamento neoadjuvante e adjuvante.
							2007. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>434. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Second Latin-American Avastin Preceptorship Meeting.Colorectal cancer cases - interactive session.
							2007. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>435. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Second Latin-American Avstin Preceptorship Meeting.Anti-angiogenesis as a treatment for colorectal cancer.
							2007. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>436. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Simpósio Internacional de cãncer de pulmão.Custo da terapia.
							2007. (Simpósio). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>437. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Simpósio Internacional de Cãncer de Pulmão.Custo da terapia.
							2007. (Simpósio). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>438. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Simpósio Satélite Merck, O papel do Erbitux e UFT no tratamento do câncer gastrointestinal.O papel do Cetuximabe no tratamento do câncer gastrointestinal.
							2007. (Simpósio). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>439. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Simpósio Satélite Merck - O papel do Erbitux e UFT no tratamento do câncer gastrointestinal. Recente avanços no tratamento do câncer gastrointestinal. 2007. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>440. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Simpósio Satélite Merck - O papel do Erbitux e UFT no tratamento do câncer gastrointestinal.O papel do Erbitux e UFT no tratamento do câncer gastrointestinal.
							2007. (Simpósio). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>441. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Southern Antiangiogenesis Summit.Atualizações em câncer colorretal.
							2007. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>442. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">The 9th International Symposium on Anti-Angiogenic Agents: recent advances and future directions in basic and clinical cancer research.Anti-angiogenic therapy for the treatment of colon cancer.
							2007. (Simpósio). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>443. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Treinamento Staff Roche IEP-Hospital Sírio Libanês.Como seleciono meus pacientes para o tratamento de primeira e segunda linha. 2007. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>444. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">World Congress on Gastrointestinal Cancer, Avastin Satellite Symposium. Avastin is well tolerated in the long-term treatment of patients. 2007. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>445. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">X Destaques ASCO.Gastrointestinal.
							2007. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>446. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">XV Congresso Brasileiro de Oncologia Clínica. Câncer cólon/reto. 2007. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>447. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">XV Congresso Brasileiro de Oncologia Clínica. Avaliação de novas drogas em outros países. 2007. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>448. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">XV Congresso Brasileiro de Oncologia Clínica. Uso de terapia molecular em tumores neuroendócrinos. 2007. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>449. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">2º Workshop Molecular Targeted Therapy of Cancer.Anticorpos monoclonais em câncer colorretal.
							2006. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>450. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">2º Workshop Molecular Targeted Therapy of Cancer.Papel dos inibidores angiogênicos no tratamento de câncer.
							2006. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>451. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">3rd Annual Meeting of the International Society of Gastrointestinal Oncology.Panel discussion: liver surgery for CRC metastases.
							2006. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>452. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">3rd Annual Meeting of the International Society of Gastrointestinal Oncology.Liver surgery for CRC metastases.
							2006. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>453. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">7th Annual Oncology Update: advances and controversies. Is there a role for targeted therapy in stage III disease ?. 2006. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>454. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">7th International Medical Education Workshop on Molecular Targeted Therapy of Cancer.Workshop colorectal cancer.
							2006. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>455. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">7th International Medical Education Workshop on Molecular Targeted Therapy of Cancer.New aspects of signal transduction in cancer therapy.
							2006. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>456. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">7th International Medical Education Workshop on Molecular Targeted Therapy of Cancer.Targeting the her family with monoclonal antibodies.
							2006. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>457. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">7th International Medical Education Workshop on Molecular Targeted Therapy of Cancer.Colorectal Cancer.
							2006. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>458. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">8th World Congress on Gastrointestinal Cancer. Rare tumors: neuroendocrine tumors and GIST tumors. 2006. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>459. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">8th World Congress on Gastrointestinal Cancer. Expert discussion: pancreatic cancer. 2006. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>460. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">American Society of Clinical Oncology Gastrointestinal Cancers Symposium. Oral Abstract Presentation Session Discussant. 2006. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>461. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Argentinean Investigator's Meeting.New approaches to CRC treatments.
							2006. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>462. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Argentinean Investigators Meeting.New approaches to CRC treatments.
							2006. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>463. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Avastin in the Treatment of colorectal Cancer Advisory Board meeting.Avastin in the Treatment of colorectal Cancer Advisory Board meeting.
							2006. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>464. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Board Review.Câncer de pâncreas. 2006. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>465. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Board Review.Câncer de cólon, reto e canal anal: tratamento adjuvante e neoadjuvante. 2006. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>466. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Board Review.Câncer de colo-retal metastático. 2006. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>467. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Colorectal Cancer Rounds.Therapeutic perspectives: Integration of emerging diagnostic tools and targeted therapies in the treatment of colorectal cancer.
							2006. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>468. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Community Oncologist Advisory Board Meeting.Community Oncologist Advisory Board Meeting.
							2006. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>469. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Conference on Avastin and CRC Tratment.Bevacizumab en el cancer avanzado de colon.
							2006. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>470. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Congresso Argentino de Gastroenterologia y Endoscopia Digestiva. Novedades en el tratamiento del câncer colorrectal. Tiro al blanco y desnutrición tumoral. 2006. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>471. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Congresso Argentino de Gastroenterologia y Endoscopia Digestiva. Síndrome mano-pie. 2006. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>472. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Congresso Argentino de Gastroenterologia y Endoscopia Digestiva. Taller de toxicidad de los tratamientos de los tumores digestivos. 2006. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>473. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Congresso Argentino de Gastroenterologia y Endoscopia Digestiva. Perforación, cicatrización cutânea y otras toxicidades de los antiangiogênicos. 2006. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>474. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Congresso Argentino de Gastroenterologia y Endoscopia Digestiva. Tumor carcinoide: no se acalore, hay novedades. 2006. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>475. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Controvérsias no tratamento do câncer colorretal.Discussão de casos gastrointestinais.
							2006. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>476. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">European Investigators Meeting Horizon II.Advances in the treatment of colorectal cancer.
							2006. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>477. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Global Erbitux Colorectal Cancer Leaders and Experts Meeting.Faculty Discussion: Optimal targeted therapy in pre-treated patients ?.
							2006. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>478. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Hematology and Medical Oncology Board Review.Meet the professors.
							2006. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>479. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Hematology and Medical Oncology Board Review - M.D. Anderson Cancer Center.Neuroendocrine Cancer.
							2006. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>480. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Hematology and Medical Oncology Board Review - M.D. Anderson Cancer Center.Colon, rectal, and anal canal, including HIV-associated.
							2006. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>481. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Hospital Português.Avanços em Oncologia. 2006. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>482. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">IEC Council Meeting.IEC Council Meeting.
							2006. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>483. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">III Fórum Científico UNESCO Anvisa.Racional para aprovação de medicamentos oncológicos com estudos fase II. 2006. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>484. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">II Simpósio Nacional de Cancro Digestivo.Doença Avançada.
							2006. (Simpósio). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>485. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Interchange Meeting Colorectal Cancer.Avastin: is it essential in first-line treatment of metastatic colorectal cancer ?.
							2006. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>486. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Interchange Meeting Colorectal Cancer.How to use and combine Avastin in first time ?.
							2006. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>487. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">IV Congresso Franco Brasileiro de Oncologia. Atualizações no tratamento de GIST. 2006. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>488. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">IV Congresso Franco Brasileiro de Oncologia. Advanced colorectal cancer. 2006. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>489. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">IV Workshop - Novos Paradigmas em TNE & GIST.Tratamento sistêmico de TNE metastáticos.
							2006. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>490. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Molecular targeted therapy of cancer.Targeted based therapy important targets and their inhibition.
							2006. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>491. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Molecular Targeted Therapy of Cancer.Medical education initiative on molecular targeted therapy of cancer.
							2006. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>492. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Molecular Targeted Therapy of Cancer.Molecular treatment of colorectal cancer and pancreatic cancer.
							2006. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>493. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Onconection TNE & GIST.Pasireotide e octreotide em tumores neuroendócrinos.
							2006. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>494. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Optimizing combination therapy in MCRC - Challenging Case Estudies.Optimizing combination therapy in MCRC - Challenging Case Estudies.
							2006. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>495. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Optimizing Combination Therapy in MCRC - Challenging Case Estudies.Optimizing Combination Therapy in MCRC - Challenging Case Estudies.
							2006. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>496. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Optimizing Combination Therapy in MCRC - Challenging Case Estudies.Optimizing Combination Therapy in MCRC - Challenging Case Estudies.
							2006. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>497. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Optimizing Combination Therapy in MCRC - Challenging Case Estudies.Optimizing Combination Therapy in MCRC - Challenging Case Estudies.
							2006. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>498. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Optimizing EGFR Targeted Therapies in Colorectal Cancer. Rationale and clinical trials with a combined EGFR and VEGF Blockade in Colorectal Cancer. 2006. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>499. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Pfizer Satellite Symposium - Understanding Issues, Formulating Answers - Optimizing the Cotinum of Care in Colorectal Cancer.Options for therapy in the second-line setting following disease recurrence.
							2006. (Simpósio). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>500. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Reunião Científica do Depto. de Cirurgia da Faculdade de Medicina da Universidade de São Paulo.Avanços no tratamento multimodal do câncer.
							2006. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>501. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Reunião - Faculdade de Medicina da Universidade de São Paulo.Terapia monoclonal em tumor do aparelho digestivo.
							2006. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>502. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Reunião - Hospital das Clínicas do Paraná.Câncer gástrico.
							2006. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>503. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Roche Avastin Satellite Symposium.Treatment duration: a critical variable for success.
							2006. (Simpósio). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>504. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Second Merck Symposium on Oncology.Erbitux in CRC.
							2006. (Simpósio). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>505. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Second Merck Symposium on Oncology.UFT.
							2006. (Simpósio). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>506. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Selection for resection of liver metastasis.American Hepato-Pancreato-Biliary Association.
							2006. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>507. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Simpósio da Academia Brasileira de Ciência.Câncer em Idosos.
							2006. (Simpósio). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>508. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Simpósio da Evolução no Tratamento do Câncer Colorretal.Discussão de casos.
							2006. (Simpósio). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>509. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Simposio en Câncer del Tracto Gastrointestinal.Xeloda: use in pancreatic câncer.
							2006. (Simpósio). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>510. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Simpósio en Câncer del Tracto Gastrointestinal.Xeloda: use in adjuvant treatment in colorectal cancer.
							2006. (Simpósio). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>511. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Simpósio en Câncer del Tracto Gastrointestinal.Xeloda: use in metastatic colorectal cancer.
							2006. (Simpósio). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>512. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Simpósio Internacional de Câncer Colorretal - Hospital Sírio Libanês e Memorial Sloan Kettering Cancer Center.Quimioterapia adjuvante: indicações e principais esquemas.
							2006. (Simpósio). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>513. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Simpósio Internacional de Câncer Colorretal - Hospital Sírio Libanês e Memorial Sloan Kettering Cancer Center.Adjuvância e neoadjuvância para câncer de reto.
							2006. (Simpósio). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>514. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Simpósio Internacional de Câncer Colorretal - Hospital Sírio Libanês e Memorial Sloan Kettering Cancer Center.Quimioterapia e radioterapia.
							2006. (Simpósio). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>515. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Simpósio Internacional de Câncer Colorretal - Hospital Sírio Libanês e Memorial Sloan Kettering Cancer Center.Novas Drogas e Combinações.
							2006. (Simpósio). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>516. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Simpósio Internacional de Câncer de Mama.Você indica quimioterapia neoadjuvante para o carcinoma de mama medindo 4-5cm ?.
							2006. (Simpósio). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>517. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Staff Meeting Sanofi-Aventis.Discussão de casos gastrointestinais.
							2006. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>518. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Terapia Alvo: A Oncologia como Saúde Suplementar.Câncer de cólon como modelo de avanço: passado, presente e futuro.
							2006. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>519. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">XVII Congresso Brasileiro de Cancerologia. Atualizações e controvérsias no tratamento do câncer colorretal - uma abordagem prática. 2006. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>520. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">XVII Congresso Brasileiro de Cancerologia. Targeting the EGFR for cancer therapy. 2006. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>521. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">XVII Congresso Brasileiro de Cancerologia. The role of Erbitux in cancer therapy. 2006. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>522. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">XVII Congresso Brasileiro de Cancerologia. Curso pré-congresso de coloproctologia. 2006. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>523. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">XVII Congresso Brasileiro de Cancerologia. Evolução do tratamento sistêmico do câncer colon retal metastático. 2006. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>524. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">XXIV Chemotherapy Foundation Symposium, Mount Sinai Scholl of Medicine.Metastatic colorectal cancer: is there one standard of care ?.
							2006. (Simpósio). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>525. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">3rd Latin American Workshop Molecular Targeted Therapy of Cancer.3rd Latin American Workshop Molecular Targeted Therapy of Cancer.
							2005. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>526. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">4th International Colorectal Cancer Congress. 4th International Colorectal Cancer Congress. 2005. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>527. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">5th Annual Oncology Update: Advances and Controversies. 5th Annual Oncology Update: Advances and Controversies. 2005. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>528. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Adjuvant therapy in colorectal cancer.NOCR Challenging Cases in Oncology.
							2005. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>529. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Adjuvant therapy in colorectal cancer.NOCR, Challenging Cases in Emerging Data.
							2005. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>530. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Best of ASCO.Best of ASCO.
							2005. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>531. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Best of ASCO.Best of ASCO.
							2005. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>532. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Case Studies by the Experts: Therapeutic Advances in the Treatment of Cancer.Case Studies by the Experts: Therapeutic Advances in the Treatment of Cancer.
							2005. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>533. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Colorectal Grand Rounds On-Line Speaker Workshop.Colorectal Grand Rounds On-Line Speaker Workshop.
							2005. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>534. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">CRC Update Research Leader Meeting.CRC Update Research Leader Meeting.
							2005. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>535. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Cytoxic and molecular targeted therapy for colorectal metastases.Multidisciplinary Treatment of Pancreas, Liver and Biliary Tract Cancer.
							2005. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>536. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Discussion in the Gastrointestinal Cancer Discussion. American Society of Clinical Oncology 41st Meeting. 2005. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>537. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Leaders and Experts Meeting.Leaders and Experts Meeting.
							2005. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>538. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Medical Treatment of Colon Cancer.SAES/ACS/AHPBA Joint Symposium: Modern Management of Colon Cancer.
							2005. (Simpósio). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>539. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Modern Chemotherapy for Colorectal Cancer.Modern Chemotherapy for Colorectal Cancer.
							2005. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>540. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">New targets and new drugs in colon cancer.NOCR Challenging Cases in Emerging Data.
							2005. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>541. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">NOCR Challenging Cases in Emerging Data.NOCR Challenging Cases in Emerging Data.
							2005. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>542. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Novel approaches in GI malignancies.US Oncology Meeting.
							2005. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>543. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Oncology Adjuvant Panel.Oncology Adjuvant Panel.
							2005. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>544. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Options in the management of metastatic colorectal cancer.The Chemotherapy Foundation Symposium XXIII, Innovative Cancer Therapy for Tomorrow. 2005. (Seminário). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>545. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Panel Discussion.Daiichi Opinion Leader Meeting. 2005. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>546. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">PER Targeted Signaling Pathways in Gastrointestinal.PER Targeted Signaling Pathways in Gastrointestinal.
							2005. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>547. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Swedish Medical Center, 3rd Annual West Coast Colorectal Cancer Symposium.Swedish Medical Center, 3rd Annual West Coast Colorectal Cancer Symposium.
							2005. (Simpósio). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>548. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">SWOG United States-Japan Clinical Trials Summit.SWOG United States-Japan Clinical Trials Summit.
							2005. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>549. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">The Angiogenesesi Porto Meeting.The Angiogenesesi Porto Meeting.
							2005. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>550. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">The impact of novel therapies on colorectal liver metastasis. th Annual Oncology Update: Advances and Controversies. 2005. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>551. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">The Society of Interventional Radiology.The Society of Interventional Radiology.
							2005. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>552. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Treatment of Metastatic Disease: VEGFR, EGFR and other targeted agents in metastatic colorectal cancer.Post ASCO Update.
							2005. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>553. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Update on Gastrointestinal Malignancies.Aultman Cancer Center Post-ASCO Symposium.
							2005. (Simpósio). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>554. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">What's new in angiogenesis.Projectsin Knowledge Webcast.
							2005. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>555. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">XIV Congresso Brasileiro da Sociedade Oncologia Clínica. XIV Congresso Brasileiro da Sociedade Oncologia Clínica. 2005. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>556. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">2nd International Medical Education Latin America.2nd International Medical Education Latin America.
							2004. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>557. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">2nd Multidisciplinary Management of GI Malignancies.2nd Multidisciplinary Management of GI Malignancies.
							2004. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>558. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">6th World Congress of the International Hepato-Pancreato-Biliary Association Meeting (IHPBA). 6th World Congress of the International Hepato-Pancreato-Biliary Association Meeting (IHPBA). 2004. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>559. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Advanced Colorectal Cancer: is there one standard of care ?.ASCO-Fellows Education Session.
							2004. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>560. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Advances in oncology: emerging trends.CME - Oncology.
							2004. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>561. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Advances in the mgmt. of colorectal cancer.2 Hour CME national Symposia.
							2004. (Simpósio). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>562. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Antibody-Based Therapy-Relevance for Clinical Applications.4th International Workshop, Molecular Targeted Therapy of Cancer.
							2004. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>563. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Avant Investigator Meeting.Avant Investigator Meeting.
							2004. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>564. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Capecitabine: single-agent and combination data. 3rd International Colorectal Cancer Congress. 2004. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>565. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Chemotherapy Tretment: where do we stand in current practice ?.Eloxatin Asia Meeting Facing Cancer Challenges Today in Asia.
							2004. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>566. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">CME Lecture at hte University of Miami Sylvester Cancer Center.CME Lecture at hte University of Miami Sylvester Cancer Center.
							2004. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>567. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Colorectal Cancer.4th International Workshop, Molecular Targeted Therapy of Cancer.
							2004. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>568. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Colorectal Tumor Session of the Oncology Research Summit.Colorectal Tumor Session of the Oncology Research Summit.
							2004. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>569. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Comprehensive cancer center: contributions of multidisciplinary teams to cancer treatment progress.Moinhos de Vento Hospital Cancer Center. 2004. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>570. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Frontline therapy of advanced colorectal cancer: emphasis on chemotherapy. The 2004 Gastrointestinal Oncology Conference. 2004. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>571. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Gastrointestinal Colorectal Cancer. ASCO Poster Discussion. 2004. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>572. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Molecular target therapies: a new way to cancer treatment.The Medical Society Instituto Nacional de Cancerologia.
							2004. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>573. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">New therapeutic strategies.Eloxatin Asia Meeting Facing Cancer Challenges Today in Asia.
							2004. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>574. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Novartis Regional Scientific Advisors Training Session.Novartis Regional Scientific Advisors Training Session.
							2004. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>575. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Oxaliplatin based therapy in metastatic colorectal cancer.Update on the management of gastrointestinal malignancies.
							2004. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>576. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Practical updates in colorectal cancer.CME Program.
							2004. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>577. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">PTK-787 Steering Committee.PTK-787 Steering Committee.
							2004. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>578. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Rectal cancer: are we moving forward ?.Institutional Grand Rounds.
							2004. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>579. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Roche X-Act Study Investigators Meeting.Roche X-Act Study Investigators Meeting.
							2004. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>580. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Targeted therapies in colorectal cancer.International Oncology Network 6th Annual National Meeting.
							2004. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>581. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Therapeutic advances in the treatment of cancer.Web-based Program: Case Studies by the Experts.
							2004. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>582. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Update on Tyrosine Kinase Inhibitors.4th Annual Oncology Update: advances and controversies.
							2004. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>583. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">What is the optimal duration of treatment in metastatic colorectal cancer ?. World Congress on GI Cancer. 2004. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>584. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Adjuvant Chemoradiotherapy in Residual Gastric Cancer and Irinotecan in Colorectal Cancer.XVI Congresso Brasileiro de Cancerologia. 2003. (Seminário). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>585. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Colon, rectal and anal, including HIV-associated.A Comprehensive Board Review in Hematology and Medical Oncology.
							2003. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>586. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Comprehensive Cancer - Why Refer.6th Annual Meeting of the Association of Physicians Assistants in Oncology.
							2003. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>587. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Effect of Celocoxib on treatment induced hand-foot syndrome.Roche Oncology Nordic Symposium.
							2003. (Simpósio). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>588. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Fluoropirimidines in Colorectal Cancer.1st International Course-Advances and Results in Cancer Treatment. 2003. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>589. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Future Perspective in Colorectal Cancer. XVI Congresso Brasileiro de Cancerologia. 2003. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>590. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Management of Colorectal Cancer: Current Approaches and Futures Perspectives.Speakers' Bureau Development Meeting.
							2003. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>591. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Medical Tretment fo Gastric Cancer.Sanofi-Synthelabo.
							2003. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>592. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">New Drugs in Metastatic Colorectal Cancer.1st International Course-Advances and Results in Cancer Treatment. 2003. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>593. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">New Indications of Eloxatin.KOL Meeting.
							2003. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>594. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Principles of Antibody-Based Therapy.1st Latin American Workshop: Molecular Targeted Therapy of Cancer.
							2003. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>595. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Update of Eloxatin in Colorectal Cancer.KOL Meeting.
							2003. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>596. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Xeloda combinations in CRC: bridging the Atlantic.Xeloda Investigators Meeting: Building Bridges with Xeloda.
							2003. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>597. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Adjuvant and Palliative Chemotherapy for Colorectal Cancer. II South-Brazilian Oncology Congress, XII Journey of the Erasto Gartner Hospital. 2002. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>598. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Advances in Colorectal Cancer.Advances in Colorectal Cancer.
							2002. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>599. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Advances in Gastrointestinal Cancer Treatment. III International Congress of Oncology and Immune-Biomodulation - ICOI. 2002. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>600. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Antibody Based Treatment Concepts in Lymphoma and Chronic Leukemia.Workshop Molecular Targeted Therapy of Cancer.
							2002. (Simpósio). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>601. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Capecitabine: a new model for colorectal cancer treatment ?. II Congresso Franco Brasileiro de Oncologia. 2002. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>602. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Capecitabine Vs 5-FU/LV in Metastatic Colorectal Cancer.Korean Coloproctology Symposium.
							2002. (Simpósio). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>603. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Chemotherapy for GI Cancers. 4th Amil Congress of Medicine. 2002. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>604. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Clinical Aspects.Symposium - Gleevec Molecular Therapy for GIST.
							2002. (Simpósio). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>605. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Colon, Rectal, and Anal Canal, including HIV associated.A Comprehensive Board Review in Hematology and Medical Oncology.
							2002. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>606. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Colon, Rectal, and Anal Canal Including HIV Associated.A Comprehensive Board Review in Hematology and Medical Oncology, MD Anderson Cancer Center.
							2002. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>607. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Colon and Anal Canal Carcinomas.IV Meeting of the Brazilian Radiotherapy Society.
							2002. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>608. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Colon Cancer.I International Symposium of Evidence Based Oncology, Confederação das Unimeds do Estado de São Paulo.
							2002. (Simpósio). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>609. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Colorectal Cancer Chemotherapy. Uruguayan Oncology Congress. 2002. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>610. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Colorectal Cancer Oncology and Hematology,.Refresh Couse in Oncology - Devita Institute. 2002. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>611. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Complementary Treatment for Gastric Adenocarcinoma.4th Meeting of the Brazilian Society fo Gastric Cancer.
							2002. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>612. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Controversies in Adjuvant Therapy for Colorectal Cancer.Multidisciplinary Management of Gastrointestinal Malignancies.
							2002. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>613. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Criteria for an Effective Therapeutic Strategy.Criteria for an Effective Therapeutic Strategy.
							2002. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>614. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Current and Novel Therapies for Metastatic Colorectal Cancer.Multidisciplinary Management fo Gastrointestinal Malignancies.
							2002. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>615. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Early Diagnosis and Prevention of GI Cancer. 4th Amil Congress of Medicine. 2002. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>616. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Economical Impact and Cost-Benefit of Adjuvant Chemotherapy for Colorectal Cancer.IV Simpósio Mineiro de Oncologia.
							2002. (Simpósio). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>617. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Eloxatin Speaker Training Meeting.Eloxatin Speaker Training Meeting.
							2002. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>618. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Gastrointestinal Stromal Tumors.SBOC Regional Chapter.
							2002. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>619. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Gastrointestinal Tumors.Lilly Investigartors Meeting.
							2002. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>620. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Genetic Testing in Oncology: Use in Diagnosis, Prognosis and Treatment.Clinical Applications for Genetic Testing.
							2002. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>621. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">III International Congress of Oncology and Immune-Biomodulation - ICOI.Xeloda Efficacy in Colorectal Cancer.
							2002. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>622. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Integrating New Drugs in Metastatic Colorectal Cancer. II Congresso Franco Brasileiro de Oncologia. 2002. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>623. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Monoclonal Antibodies. IV Brasilian Hospital Pharmacy Society Congress. 2002. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>624. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Oral Chemotherapy and New Drugs for Elderly Patients. II South-Brazilian Oncology Congress, XII Journey of the Erasto Gartner Hospital. 2002. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>625. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Pancreatic Cancer Chemotherapy. Uruguayan Oncology Congress. 2002. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>626. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Phase III Study on Xeloda as 1st Line Treatment in Colorectal Cancer.Oncolatina Xeloda and Herceptin Symposium.
							2002. (Simpósio). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>627. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Practical Consideration in Use of Oral Fluoropyrimidines.Multidisciplinary Management of Gastrointestinal Malignancies.
							2002. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>628. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Prognostic and Risk Factors for Pancreatic Cancer.Surgical Gastrointestinal Doctorate Program at the Federal University of São Paulo - Escola Paulista de Medicina. 2002. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>629. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Results Obtained with Gleevec in Patients with GIST.ASCO 2002 Highlights Novartis Oncologia.
							2002. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>630. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Stomach, Esophagus and Pancreas.ASCO 2002 Highlights.
							2002. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>631. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Systemic Therapy for Colorectal Cancer - State of the Art and Future Perspectives.I Anglo-Brazilian Oncology Meeting.
							2002. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>632. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Tumor Activated Therapy: From Theory to Practice.Colrectal and Breast Cancer Treatment.
							2002. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>633. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Adjuvant and Palliative Chemotherapy for Anal Canal.Interactive Oncology Symposium - Hospital São Rafael.
							2001. (Simpósio). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>634. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Adjuvant Chemotherapy for Colorectal Cancer.Interactive Oncololgy Symposium - Hospital São Rafael.
							2001. (Simpósio). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>635. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Advanced Colorectal Cancer: Strategies for the XXI Century.Advanced Colorectal Cancer: Strategies for the XXI Century.
							2001. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>636. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Advances in Colorectal Cancer Chemotherapy.GI Cancer Review.
							2001. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>637. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Advances in Gastric Cancer Chemotherapy.GI Cancer Review - Hospital Mãe de Deus.
							2001. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>638. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Advances in Medical Treatment for Colorectal Cancer.4th International Oncology Review Meeting.
							2001. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>639. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Aventis International Gastric Advisory Board Meeting.Aventis International Gastric Advisory Board Meeting.
							2001. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>640. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Bridging Study with UFT/Leucovorin.Taiho Investigators Meeting: ASCO.
							2001. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>641. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Capecitabine: ImprovingTreatment for Metastatic Colorectal Cancer.Capecitabine: ImprovingTreatment for Metastatic Colorectal Cancer. 2001. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>642. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Capecitabine: Improving Treatment for Metastatic Colorectal Cancer.Capecitabine: Improving Treatment for Metastatic Colorectal Cancer.
							2001. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>643. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Capecitabine: Improving Treatment for Metastatic Colorectal Cancer.Capecitabine: Improving Treatment for Metastatic Colorectal Cancer.
							2001. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>644. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Capecitabine for Colorectal Cancer.Hoffman-La Roche Meeting: ASCO.
							2001. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>645. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Capecitabine Monotherapy - First Line Treatment for CRC.Roche in Oncology II - Therapeutic Advances in Cancer Managment.
							2001. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>646. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Chemotherapy for Pancreatic, Hepatic and Biliary Cancers.3rd International Symposium About Hepatobiliar Cancer - Hospital do Câncer.
							2001. (Simpósio). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>647. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Clinical Development of Tegafur-Based Dif.Tokyo International Symposium on Fluoropyrimidines.
							2001. (Simpósio). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>648. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Colorectal and Anal Canal Cancers.Interactive Oncology Symposium - Hospital São Rafael.
							2001. (Simpósio). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>649. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Colorectal Cancer.M.D. Anderson Post-ASCO Review for Foreign Oncologists.
							2001. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>650. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Colorectal Cancer Treatment.SBOC Regional Chapter.
							2001. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>651. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Eloxatin - Key Partner in Your Treatment Strategy.First NCI meeting: Towards Better Management of Colorectal Cancer.
							2001. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>652. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Evaluation the Role of Oral TP - Activated Xeloda.Roche Investigators Meeting, ASCO.
							2001. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>653. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Gastric Cancer Clinical Update Meeting.Gastric Cancer Clinical Update Meeting.
							2001. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>654. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Gastric Cancer Overview. 12th Brazilian Congress of Clinical Oncology. 2001. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>655. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Gastrointestinal Cancer. National Cancer Conference. 2001. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>656. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">GI Cancers.Asco Review Conference.
							2001. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>657. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Improving the Quality of Life of Colorectal Cancer Patients.Improving the Quality of Life of Colorectal Cancer Patients.
							2001. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>658. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Metastatic Pancreatic Cancer Treatment.GI Cancer Review - Hospital Mãe de Deus.
							2001. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>659. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Molecular Targeted Therapy in Cancer Treatment.Merck KGaA First Meeting of Biotherapeutic Core Group.
							2001. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>660. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">New Developments in Gastric Cancer Treatment. 12th Brazilian Congress of Clinical Oncology. 2001. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>661. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">New Treatments for Colorectal Cancer. Sixth Annual NCCN Conference (Practice Guidelins & Outcomes Data in Oncology. 2001. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>662. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Oral Xeloda: Improving Patient Care in Colorectal Cancer Therapy.Roche Satellite Symposium ECCO.
							2001. (Simpósio). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>663. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Pancreatic and Colorectal Cancer.ASCO Review.
							2001. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>664. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Phase III Xeloda Trials in CRC: Oral Xeloda an Active, Innovative Therapy.Xeloda Colorectal Cancer Meeting: TP Activation: Convenience through Innovation.
							2001. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>665. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Review of the GI Cancer Abstracts from the ASCO 2001.Piracicaba Medical Association.
							2001. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>666. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Sixth Annual NCCN Conference: Practice Guidelines and Outcomes Data in Oncology. Sixth Annual NCCN Conference: Practice Guidelines and Outcomes Data in Oncology. 2001. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>667. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">SU 5416: Angiogenesis Inhibitor. National Cancer Conference. 2001. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>668. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Tarceva: EFG-R Inhibitor. National Cancer Conference. 2001. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>669. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">The First Pharmacia GI Consortium.The First Pharmacia GI Consortium.
							2001. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>670. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Advances in Colorectal Cancer.Department of Nuclear Medicine Seminar The M.D. Anderson Cancer Center. 2000. (Seminário). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>671. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Anal Cancer: Improving Nigro. Argentinean Gastroenterology and Digestive Endoscopy Congress. 2000. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>672. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Basics on Colorectal Cancer.Division of Gastroenterology, Hepatology and Nutrition, The University of Texas Houston health Science Center Medical School.
							2000. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>673. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Camptosar in Colorectal Cancer.Camptosar Latin America Meeting.
							2000. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>674. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Colon, Rectal, and Anal Canal Cancer.The M.D. Anderson Cancer Center Medical Oncology Review. 2000. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>675. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Colorectal Cancer: New Drugs. Argentinean Gastroenterology and Digestive Endoscopy Congress. 2000. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>676. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">First-Line Treatment for Colorectal Cancer.Covenant Hospital Grand Rounds.
							2000. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>677. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Irinoteca+Oxaliplatin Combinations.Pharmacia Oncology Academic Investigators Meeting.
							2000. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>678. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">New Alternatives in Advanced Disease. Cancer Research Foundation of America and the American Digestive Health Foundation Conference. 2000. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>679. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">New Drugs and Regimens in Colorectal Cancer.Digestive Disease Week Sunrise Breakfast Symposium Update on Recent Advances in Oral Fluropyrimidines in the Treatment of Colorectal Cancer.
							2000. (Simpósio). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>680. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Novel Therapeutic Approaches for Metastatic Colorectal Cancer. National Comprehensive Cancer Network(NCCN) Annual Conference. 2000. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>681. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Oral Agents as Radiation Sensitizers in Rectal Cancer.Institutional Grand Rounds, The University of Texas M.D. Anderson Cancer Center.
							2000. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>682. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Other Fluorinated Pyrimidines in Solid Tumors.Symposium Perspectives on Fluorinated Pyrimidine Use in Breast and Gastrointestinal Oncology.
							2000. (Simpósio). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>683. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Oxaliplatin and Irinotecan in Colorectal Cancer.Chemotherapy Foundation Symposium XVIII Innovative Cancer Therapy for Tomorrow.
							2000. (Simpósio). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>684. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Phase III Experience with UFT/Orzel. 10th International Congress on Anti-Canceer Treatment. 2000. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>685. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Principles of Radiation Therapy and Chemotherapy.Graduate Course Clinical Perspectives of Malignant Disease. 2000. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>686. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Update in Gastrointestinal Oncology. ASCO Review Conference. 2000. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>687. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">When to Treat and When Not to Treat Colon Cancer. Argentinean Gastroenterology and Digestive Endoscopy Congress. 2000. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>688. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Advances in Chemotherapy Agents for Colorectal Cancer.Clinical Oncology Grand Rounds, The University of Texas M.D. Anderson Cancer Center.
							1999. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>689. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Advances in Colorectal Cancer.Medical Grand Rounds, Marshall University.
							1999. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>690. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Advances in Current Therapy.Central Alabama Hematology Oncology Forum. 1999. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>691. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Advance Treatment of Colorectal Cancer Tumor Board, Arlington Cancer Center.Tumor Board, Arlington Cancer Center.
							1999. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>692. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Chemotherapy for Colorectal Cancer. 11th Brazilian Congress of Clinical Oncology. 1999. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>693. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Colorectal Cancer Systemic Therapy. UT M.D. Anderson Approach Cancer Care Conference. 1999. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>694. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Colorectal Screening. 1st Annual Primary Care Oncology Screening & Prevention Conference. 1999. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>695. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Grand Rounds.Grand Rounds, Rush Presbyterian Hospital.
							1999. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>696. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Grand Rounds, Long Island Hospital.Grand Rounds, Long Island Hospital.
							1999. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>697. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Multidisciplinary Approach to Colorectal Cancer. Ellis Fischell Cancer Center Annual Oncology Conference. 1999. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>698. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">New Agents for Colorectal Cancers: Irinotecan, Oxaliplatin, and Oral Fluorinated Pyrimidines. Cleveland Clinic Taussig Cancer Center Research Conference. 1999. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>699. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">New Agents for Colorectal Cancers: Irinotecan, Oxaliplatin, and Oral Fluorinated Pyrimidines.4th National VA Oncology Symposium.
							1999. (Simpósio). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>700. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">New Chemotherapeutic Agents in the Therapy of Colorectal Cancer.Blood Club Reception, Marshall University.
							1999. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>701. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">New Drug Treatment for Colon Cancer.Grand Rounds, University of Miami.
							1999. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>702. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Novel Chemotherapy in Advanced Colorectal Cancer.9th Annual Solid tumor Symposium.
							1999. (Simpósio). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>703. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Novel Chemotherapy in Colorectal Cancer.Cornwall Hospital Tumor Board.
							1999. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>704. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Oncology 2000 Symposium M.D. Anderson Cancer Center.Oncology 2000 Symposium M.D. Anderson Cancer Center.
							1999. (Simpósio). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>705. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Oral Agents in Treatment of colorectal Cancer.Chemotherapy Foundation Symposium XVII Innovative Cancer Therapy for Tomorrow.
							1999. (Simpósio). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>706. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Oral Chemotherapy: The Fluoropyrimidines.Clinical Research Coordinator's Symposium.
							1999. (Simpósio). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>707. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Oral Fluoropyrimidines for Colorectal Cancer.3rd Annual Charles William Rasco III Symposium on Colorectal Cancer.
							1999. (Simpósio). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>708. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Updates on Colorectal Cancer. International Oncology Network National Conference. 1999. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>709. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">A Comprehensive Review M.D. Anderson Cancer Center. Pharmacology and Mock Board Sections Medical Oncology. 1998. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>710. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Advances in the Management of Gastrointestinal Malignancies.Oncology Grand Rounds, University of Alabama.
							1998. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>711. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">New Drug Treatments for Colon Cancer. 10th Annual Western North Carolina Cancer Conference. 1998. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>712. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Phase I Study of Combined Orzel and Radiotherapy in Operable Rectal Cancer.M.D. Anderson International Orzel Meeting Phase I Study of Combined Orzel and Radiotherapy in Operable Rectal Cancer.
							1998. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>713. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Review and Interpretation of the GI Cancer Abstracts at ASCO 98.McLaren Regional Medical Center/ Michigan State University. 1998. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>714. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Update in Colon Cancer. Local Oncology Nursing Society (ONS) Chapter Meeting. 1998. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>715. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Bone Marrow Transplant in Breast Cancer.First symposium in controversies in breast cancer treatment.
							1997. (Simpósio). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>716. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Comparison of Acute Myeloid Leukemia Patients at M.D. Anderson.Hematology-Oncology Fellowship Program in Hematologic Malignancies. 1997. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>717. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">The Mechanism of antineoplastic chemotherapy related emesis: the role fo antiserotoninergic agents.Brazilian Society of Clinical Oncology Symposium.
							1997. (Simpósio). 
					</div>
</div>
<br class="clear">
</div>
<a name="OrganizacaoEventos"></a><br class="clear" /><div class="inst_back">
<b>Organização de eventos, congressos, exposições e feiras</b>
</div>
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>1. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>; CHAMMAS, R. . Prêmio Octávio Frias de Oliveira. 2018. (Outro). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>. Lançamento Endowment dos Alunos de Medicina da USP. 2016. (Outro). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>3. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">BATTISTELLA, LINAMARA RIZZO ; <b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b> . Lançamento da Iniciativa Global de Reabilitação em Câncer. 2016. (Outro). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>4. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>; CHAMMAS, R. ; SARAGIOTTO, D. F. . XXXV Congresso Médico Universitário - COMU. 2016. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>5. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>. IV Simpósio Internacional CDPI de PET/CT em Oncologia; São Paulo, SP, 28 de abril. 2012. (Outro). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>6. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff, Paulo M.</a></b>; Preceptorships in Oncology - LC & RCC Edition. 2011. (Outro). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>7. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P. M.</a></b>; Preceptorships in Oncology - GI Edition. 2011. (Outro). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>8. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P. M.</a></b>; Hospital Sírio Libanês Preceptorships em Oncologia. 2011. (Outro). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>9. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P. M.</a></b>; Amgen Latin America Gastrointestinal Oncology. 2011. (Outro). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>10. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P. M.</a></b>; Hospital Sírio-Libanês Preceptorships in Oncology - LC & RCC. 2010. (Outro). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>11. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P. M.</a></b>; Hospital Sírio-Libanês Preceptorships in Oncology Mama. 2010. (Outro). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>12. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P. M.</a></b>; II Congresso Internacional Oncologia Gastrointestinal. 2010. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>13. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P. M.</a></b>; Hospital Sírio Libanês Preceptorships in Oncology - GI Oncology. 2010. (Outro). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>14. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P. M.</a></b>; Latin American Roche Experience Exchange GI Edition. 2009. (Outro). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>15. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P. M.</a></b>; 1st. Meeting 2009 of the MTTC Education Council Latin America. 2009. (Outro). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>16. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P. M.</a></b>; Latin American Roche Experience Exchange - LC & RCC Edition,. 2009. (Outro). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>17. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">CUTAIT, R. ; <b>HOFF, P. M.</b> ; <b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b> ; SILVA, J. L. F. . II Simpósio Internacional de Câncer Colorretal. 2009. (Outro). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>18. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P. M.</a></b>; Gastrointestinal - colorectal cancer session. 2009. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>19. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P. M.</a></b>; Board Review Oncologia. 2009. (Outro). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>20. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P. M.</a></b>; 4º Workshop educativo tratamento do câncer como terapia de alvo molecular. 2009. (Outro). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>21. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P. M.</a></b>; XVI Congresso Brasileiro de Oncologia Clínica. 2009. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>22. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P. M.</a></b>; XVI Congresso Brasileiro de Oncologia Clínica - Módulo câncer gastrointestinal. 2009. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>23. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P. M.</a></b>; Comissão científica internacional, XVIII Congresso Brasileiro de Cancerologia. 2009. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>24. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P. M.</a></b>; 7º Latin American Medical Education Initiative Molecular Targeted Therapy of Cancer. 2009. (Outro). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>25. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P. M.</a></b>; Third Latin-American Avastin Preceptorship Meeting. 2008. (Outro). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>26. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P. M.</a></b>; III Simpósio PET/CT. 2008. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>27. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P. M.</a></b>; MTTC - Molecular targeted therapy of cancer. 2008. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>28. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P. M.</a></b>; Simpósio Merck Serono de Oncologia. 2008. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>29. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P. M.</a></b>; I Congresso Internacional - Oncologia Gastrointestinal. 2008. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>30. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P. M.</a></b>; V Congresso Franco Brasileiro. 2008. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>31. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff, Paulo</a></b>; Molecultar Targeted Therapy of Cancer - 6º Latin America Workshop. 2008. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>32. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff, Paulo</a></b>; Merck Serono Oncology Symposium Combination Key: advancing the treatment of cancer. 2008. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>33. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>. First Latin-American Avastin Preceptorship Meeting. 2007. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>34. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P. M.</a></b>; Second Latin-American Avastin Preceptorship Meeting. 2007. (Outro). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>35. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P. M.</a></b>; Board Review. 2007. (Outro). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>36. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P. M.</a></b>; I Congresso de Oncologia para Imprensa - Hospital Sírio Libanês. 2007. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>37. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P. M.</a></b>; 5º Latin American Workshop Molecular Targeted Therapy of Cancer. 2007. (Outro). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>38. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Saad ED ; <b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b> . Board Review. 2006. (Outro). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>39. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>. MTTC - Molecular Targeted Therapy of Cancer. 2006. (Outro). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>40. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>. MTTC - Molecular Target Therapy of Cancer. 2006. (Outro). </div>
</div>
<br class="clear">
</div><br class="clear" /></div><br class="clear" /><div class="title-wrapper">
<a name="Orientacoes">
<h1>Orienta&ccedil;&otilde;es</h1>
</a>
<hr class="separator">
<div class="layout-cell layout-cell-12 data-cell">
<a name="Orientacaoemandamento"></a><br class="clear" /><div class="inst_back">
<b>Orientações e supervisões em andamento</b>
</div>
<div class="cita-artigos">
<b>Tese de doutorado</b>
</div>
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>1. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Maria Ignez Freitas Melro Braghrioli. Avaliação do uso de irinotecano em combinação com tratamento anti-EGFR no tratamento do câncer colorretal retratário a irinotecano..
						Início: 2019. Tese (Doutorado em Doutorado)  - Faculdade de Medicina da Universidade de São Paulo. (Orientador). </div>
</div>
<br class="clear">
<a name="Orientacoesconcluidas"></a><br class="clear" /><div class="inst_back">
<b>Orientações e supervisões concluídas</b>
</div>
<div class="cita-artigos">
<b>Dissertação de mestrado</b>
</div>
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>1. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><a class='icone-lattes' target='_blank' href='http://lattes.cnpq.br/4308837437325300'><img src='images/curriculo/logolattes.gif' /></a>ELIAS ABDO FILHO. Utilização dos recursos no tratamento do câncer de mama avançado de pacientes pós menopáusicas com receptores hormonais positivos no cenário do Sistema Único de Saúde, SUS.
							2013.
						
					Dissertação  (Mestrado em Programa de Pós-Graduação em Oncologia)  - Faculdade de Medicina da USP, . Orientador: Paulo Marcelo Gehm Hoff. </div>
</div>
<br class="clear">
<div class="cita-artigos">
<b>Tese de doutorado</b>
</div>
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>1. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><a class='icone-lattes' target='_blank' href='http://lattes.cnpq.br/5254690483587057'><img src='images/curriculo/logolattes.gif' /></a>Camila Mota Venchiarutti Moniz.
						Oncologia.
							2017. Tese
					 (Doutorado em Doutorado Direto Oncologia 5155)  - Faculdade de Medicina da USP, . Orientador: Paulo Marcelo Gehm Hoff. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Suilaine C. R. Oliveira.
						Estudo de fase II de substituição do 5-FU por capecitabina no esquema de quimio-radioterapia em pacientes com carcinoma de céluas escamosas do canal anal..
							2015. Tese
					 (Doutorado em Doutorado Direto Oncologia 5155)  - Faculdade de Medicina da USP, . Orientador: Paulo Marcelo Gehm Hoff. </div>
</div>
<br class="clear">
<div class="cita-artigos">
<b>Supervisão de pós-doutorado</b>
</div>
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>1. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">João Evangelista Bezerra Neto.
							2013. Faculdade de Medicina da USP, . Paulo Marcelo Gehm Hoff. </div>
</div>
<br class="clear">
<div class="cita-artigos">
<b>Iniciação científica</b>
</div>
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>1. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Guilherme Garcia.
							Aderencia as recomendações de colonoscopia em pacientes com cancer colorretal abaixo de 50 anos..
							2011.
							Iniciação Científica. (Graduando em Graduando em Oncologia)  - Instituto do Câncer do Estado de São Paulo,
							Fundação de Amparo à Pesquisa do Estado de São Paulo. Orientador: Paulo Marcelo Gehm Hoff.
						</div>
</div>
<br class="clear">
</div><br class="clear" /></div><br class="clear" /><div class="title-wrapper">
<a name="EducacaoPopularizacaoCTA">
<h1>Educa&ccedil;&atilde;o e Populariza&ccedil;&atilde;o de C &amp; T</h1>
</a>
<hr class="separator">
<div class="layout-cell layout-cell-12 data-cell">
<a name="ArtigosEPCTA"></a><br class="clear" /><div class="inst_back">
<b>Artigos</b>
</div>
<div class="cita-artigos">
<b><a name="ArtigosCompletos"></a>Artigos completos publicados em periódicos</b>
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>1. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>HOFF, P.M.</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2017</span><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">HOFF, P.M.</a></b>; Munhoz RR ; LIMA, A. A. P. ; SASSE, ANDRE DEEKE ; TRAINA, TIFFANY A. ; HUDIS, CLIFFORD ; MARQUES, R. . The role of LHRH agonists in ovarian function preservation in premenopausal womem undergoing chemortherapy for early stage breast cancer: A systematic review and meta-analysis.. JOURNAL OF CLINICAL ONCOLOGY<sup><img id='0732183X_1' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='0732183X' /></sup>, v. 1, p. 1-5, 2017. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=&issn=0732183X&volume=1&issue=&paginaInicial=1&titulo=The role of LHRH agonists in ovarian function preservation in premenopausal womem undergoing chemortherapy for early stage breast cancer: A systematic review and meta-analysis.&sequencial=1&nomePeriodico=JOURNAL OF CLINICAL ONCOLOGY" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<a name="ApresentacoesTrabalhoEPCTA"></a><br class="clear" /><div class="inst_back">
<b>Apresentações de Trabalho</b>
</div>
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>1. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>; Debatedor. 2012. (Apresentação de Trabalho/Outra). </div>
</div>
<br class="clear">
<a name="CursosCurtaEPCTA"></a><br class="clear" /><div class="inst_back">
<b>Cursos de curta duração ministrados</b>
</div>
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>1. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1161396481073464" target="_blank">Hoff PM</a></b>; Curso de Aperfeiçoamento em Cuidados Paliativos. 2012. . </div>
</div>
<br class="clear">
</div><br class="clear" /></div><br class="clear" /><div class="title-wrapper">
<a name="OutrasInformacoesRelevantes">
<h1>Outras informa&ccedil;&otilde;es relevantes</h1>
</a>
<hr class="separator">
<div class="layout-cell layout-cell-12 data-cell">
<pre class="outras-informacoes">Primeiro Brasileiro a ser eleito para um cargo no Conselho Diretor da American Society of Clinical Oncology (ASCO), organização que representa Oncologistas no mundo, vigente até 2017 .

Eleito Presidente da Comissão CCVISA - Comissão Científica em Vigilância Sanitária , que tem como missão assessorar a Agência de Vigilância Sanitária na avaliação e regulação de novas tecnologias de interesse da saúde e em temas e discussões estratégicas de cunho técnico-científico relacionados à vigilância sanitária, em dezembro de 2013.

Eleito com número expressivo de votos pelos Acadêmicos como Membro Titular da Academia Nacional de Medicina.</pre>
</div><br class="clear" /></div><br class="clear" /><br class="clear" /><div class="rodape-cv">P&aacute;gina gerada pelo Sistema Curr&iacute;culo Lattes em 19/09/2019 &agrave;s 12:04:51</div><br class="clear" /><div class="control-bar-wrapper"><a href="download.do?metodo=apresentar&amp;idcnpq=1161396481073464" target="_blank" class="button"><span class="mini-ico mini-ico-down"></span>Baixar Currículo</a><a class="button" href="javascript:window.print()"><span class="mini-ico mini-ico-list"></span>Imprimir Curr&iacute;culo</a>
</div><br class="clear" /></div>
</div>
</div>
</div>
</div>
<div class="to-top-bar" id="toTop">
<a href="javascript:void(0)" class="topo-width center">
<div class="id-orgao">
<span>CNPq</span> | Uma ag&ecirc;ncia do Minist&eacute;rio da Ci&ecirc;ncia, Tecnologia e Inova&ccedil;&atilde;o</div>
</a>
</div>
</BODY>
</HTML>
